1	From	IN	O	from	dep	25	SENT_1	[p1l94t1654r157b1675],
2	the	DT	O	the	det	3	SENT_1	[p1l168t1652r208b1675],
3	Division	NN	O	division	pobj	1	SENT_1	[p1l222t1654r323b1675],
4	of	IN	O	of	_	0	SENT_1	[p1l336t1651r364b1675],
5	Hematology/Oncology	NN	O	hematology/oncology	nn	7	SENT_1	[p1l373t1652r628b1683, p1l92t1697r136b1720],
6	(	CD	NUMBER	(	num	7	SENT_1	[p1l150t1691r213b1720],
7	S.K.	NNP	LOCATION	S.K.	prep_of	3	SENT_1	[p1l150t1691r213b1720],
8	,	,	O	,	_	0	SENT_1	[p1l150t1691r213b1720],
9	T.D.	NNP	LOCATION	T.D.	conj_and	7	SENT_1	[p1l226t1691r282b1717],
10	,	,	O	,	_	0	SENT_1	[p1l226t1691r282b1717],
11	D.G.T.	NNP	O	D.G.T.	conj_and	7	SENT_1	[p1l298t1691r382b1717],
12	,	,	O	,	_	0	SENT_1	[p1l298t1691r382b1717],
13	B.H.	NNP	O	B.H.	nn	14	SENT_1	[p1l397t1691r460b1720],
14	)	NNP	O	)	conj_and	7	SENT_1	[p1l397t1691r460b1720],
15	and	CC	O	and	_	0	SENT_1	[p1l475t1689r520b1713],
16	the	DT	O	the	det	17	SENT_1	[p1l532t1689r572b1713],
17	Department	NNP	O	Department	conj_and	7	SENT_1	[p1l586t1691r628b1713, p1l93t1731r210b1757],
18	of	IN	O	of	_	0	SENT_1	[p1l221t1726r249b1750],
19	Patholoy	NNP	LOCATION	Patholoy	prep_of	17	SENT_1	[p1l258t1727r382b1758],
20	(	CD	NUMBER	(	num	19	SENT_1	[p1l396t1728r478b1758],
21	O.K.	NNP	O	O.K.	dep	17	SENT_1	[p1l396t1728r478b1758],
22	)	CD	NUMBER	)	num	21	SENT_1	[p1l396t1728r478b1758],
23	,	,	O	,	_	0	SENT_1	[p1l396t1728r478b1758],
24	Beth	NNP	ORGANIZATION	Beth	nn	25	SENT_1	[p1l492t1727r546b1750],
25	Israel	NNP	ORGANIZATION	Israel	_	0	SENT_1	[p1l561t1727r627b1750],
26	Deaconess	NNP	ORGANIZATION	Deaconess	nn	28	SENT_1	[p1l94t1766r231b1788],
27	Medical	NNP	ORGANIZATION	Medical	nn	28	SENT_1	[p1l243t1764r341b1788],
28	Center	NNP	ORGANIZATION	Center	dep	25	SENT_1	[p1l352t1766r438b1792],
29	,	,	O	,	_	0	SENT_1	[p1l352t1766r438b1792],
30	Harvard	NNP	ORGANIZATION	Harvard	nn	32	SENT_1	[p1l451t1764r551b1788],
31	Medical	NNP	ORGANIZATION	Medical	nn	32	SENT_1	[p1l564t1764r628b1788, p1l93t1801r133b1825],
32	School	NNP	ORGANIZATION	School	dep	25	SENT_1	[p1l143t1801r235b1829],
33	;	:	O	;	_	0	SENT_1	[p1l143t1801r235b1829],
34	the	DT	O	the	det	39	SENT_1	[p1l243t1801r283b1825],
35	Departments	NNP	O	Departments	nn	39	SENT_1	[p1l293t1803r459b1832],
36	ofCancer	NNP	O	ofCancer	nn	39	SENT_1	[p1l468t1801r588b1825],
37	Biology	NNP	O	Biology	nn	39	SENT_1	[p1l597t1803r627b1825, p1l92t1839r160b1870],
38	(	CD	NUMBER	(	num	39	SENT_1	[p1l179t1841r257b1870],
39	T.j.B.	NNP	O	T.j.B.	dep	32	SENT_1	[p1l179t1841r257b1870],
40	,	,	O	,	_	0	SENT_1	[p1l179t1841r257b1870],
41	M.j.E.	NNP	O	M.j.E.	nn	42	SENT_1	[p1l278t1841r369b1870],
42	)	NNP	O	)	conj_and	39	SENT_1	[p1l278t1841r369b1870],
43	,	,	O	,	_	0	SENT_1	[p1l278t1841r369b1870],
44	Medical	NNP	O	Medical	nn	47	SENT_1	[p1l390t1839r487b1862],
45	Oncology	NNP	O	Oncology	nn	47	SENT_1	[p1l506t1839r628b1870],
46	(	NNP	O	(	nn	47	SENT_1	[p1l95t1878r173b1907],
47	P.A.J.	NNP	PERSON	P.A.J.	conj_and	39	SENT_1	[p1l95t1878r173b1907],
48	,	,	O	,	_	0	SENT_1	[p1l95t1878r173b1907],
49	B.E.J.	NNP	O	B.E.J.	dep	32	SENT_1	[p1l183t1878r251b1907],
50	,	,	O	,	_	0	SENT_1	[p1l183t1878r251b1907],
51	M.M.	NNP	O	M.M.	nn	52	SENT_1	[p1l261t1878r343b1907],
52	)	NNP	O	)	dep	32	SENT_1	[p1l261t1878r343b1907],
53	,	,	O	,	_	0	SENT_1	[p1l261t1878r343b1907],
54	and	CC	O	and	_	0	SENT_1	[p1l352t1876r396b1900],
55	Pathology	NN	O	pathology	nn	58	SENT_1	[p1l406t1876r526b1908],
56	(	CD	NUMBER	(	num	58	SENT_1	[p1l535t1878r627b1907],
57	M.M.	NNP	LOCATION	M.M.	nn	58	SENT_1	[p1l535t1878r627b1907],
58	)	NNP	O	)	dep	32	SENT_1	[p1l535t1878r627b1907],
59	,	,	O	,	_	0	SENT_1	[p1l535t1878r627b1907],
60	Dana	NNP	PERSON	Dana	appos	58	SENT_1	[p1l94t1914r257b1938],
61	.	.	O	.	_	0	SENT_1	[p1l94t1914r257b1938],

1	—	NN	O	—	_	0	SENT_2	[p1l94t1914r257b1938],
2	.	.	O	.	_	0	SENT_2	[p1l94t1914r257b1938],

1	Farber	NNP	ORGANIZATION	Farber	nn	3	SENT_3	[p1l94t1914r257b1938],
2	Cancer	NNP	ORGANIZATION	Cancer	nn	3	SENT_3	[p1l278t1916r366b1938],
3	Institute	NNP	ORGANIZATION	Institute	_	0	SENT_3	[p1l389t1916r501b1942],
4	,	,	O	,	_	0	SENT_3	[p1l389t1916r501b1942],
5	Harvard	NNP	ORGANIZATION	Harvard	nn	7	SENT_3	[p1l526t1914r626b1938],
6	Medical	NNP	ORGANIZATION	Medical	nn	7	SENT_3	[p1l94t1952r191b1976],
7	School	NNP	ORGANIZATION	School	appos	3	SENT_3	[p1l208t1952r301b1980],
8	;	:	O	;	_	0	SENT_3	[p1l208t1952r301b1980],
9	the	DT	O	the	det	10	SENT_3	[p1l316t1952r356b1976],
10	Department	NNP	ORGANIZATION	Department	dep	3	SENT_3	[p1l373t1954r526b1983],
11	of	IN	ORGANIZATION	of	_	0	SENT_3	[p1l540t1951r568b1976],
12	Biological	NNP	ORGANIZATION	Biological	nn	13	SENT_3	[p1l581t1954r628b1976, p1l93t1990r172b2021],
13	Chemistry	NNP	ORGANIZATION	Chemistry	prep_of	10	SENT_3	[p1l185t1990r314b2021],
14	and	CC	O	and	_	0	SENT_3	[p1l325t1990r370b2013],
15	Molecular	JJ	O	molecular	amod	16	SENT_3	[p1l384t1990r511b2013],
16	Pharmacology	NN	O	pharmacology	prep_of	10	SENT_3	[p1l522t1990r628b2013, p1l92t2027r177b2059],
17	,	,	O	,	_	0	SENT_3	[p1l522t1990r628b2013, p1l92t2027r177b2059],
18	Harvard	NNP	ORGANIZATION	Harvard	nn	19	SENT_3	[p1l200t2027r300b2051],
19	Medical	NNP	ORGANIZATION	Medical	conj_and	13	SENT_3	[p1l323t2027r420b2051],
20	School	NNP	ORGANIZATION	School	nn	22	SENT_3	[p1l441t2027r525b2051],
21	(	NNP	O	(	nn	22	SENT_3	[p1l549t2029r626b2058],
22	T.J.B.	NNP	O	T.J.B.	dep	19	SENT_3	[p1l549t2029r626b2058],
23	,	,	O	,	_	0	SENT_3	[p1l549t2029r626b2058],
24	M.j.E.	NNP	O	M.j.E.	conj_and	13	SENT_3	[p1l94t2067r185b2096],
25	)	CD	NUMBER	)	num	24	SENT_3	[p1l94t2067r185b2096],
26	;	:	O	;	_	0	SENT_3	[p1l94t2067r185b2096],
27	and	CC	O	and	_	0	SENT_3	[p1l197t2065r242b2089],
28	the	DT	O	the	det	37	SENT_3	[p1l253t2065r293b2089],
29	Department	NNP	ORGANIZATION	Department	poss	37	SENT_3	[p1l305t2067r458b2096],
30	of	IN	ORGANIZATION	of	_	0	SENT_3	[p1l468t2065r496b2089],
31	Medicine	NNP	ORGANIZATION	Medicine	prep_of	29	SENT_3	[p1l504t2065r627b2093],
32	,	,	O	,	_	0	SENT_3	[p1l504t2065r627b2093],
33	Brigham	NNP	ORGANIZATION	Brigham	prep_of	29	SENT_3	[p1l94t2103r199b2134],
34	and	CC	ORGANIZATION	and	_	0	SENT_3	[p1l211t2103r256b2126],
35	Women	NNP	ORGANIZATION	Women	prep_of	29	SENT_3	[p1l266t2104r386b2126],
36	's	POS	ORGANIZATION	's	_	0	SENT_3	[p1l266t2104r386b2126],
37	Hospital	NNP	ORGANIZATION	Hospital	prep_of	10	SENT_3	[p1l399t2103r513b2133],
38	,	,	O	,	_	0	SENT_3	[p1l399t2103r513b2133],
39	Harvard	NNP	ORGANIZATION	Harvard	appos	37	SENT_3	[p1l526t2103r627b2126],

1	Medical	NNP	ORGANIZATION	Medical	nn	3	SENT_4	[p1l94t2210r192b2233],
2	School	NNP	ORGANIZATION	School	nn	3	SENT_4	[p1l211t2210r295b2233],
3	(	NNP	O	(	_	0	SENT_4	[p1l317t2211r399b2241],
4	P.A.j.	NNP	O	P.A.j.	nn	6	SENT_4	[p1l317t2211r399b2241],
5	,	,	O	,	_	0	SENT_4	[p1l317t2211r399b2241],
6	B.E.J.	NNP	O	B.E.J.	dep	3	SENT_4	[p1l420t2212r493b2241],
7	)	CD	NUMBER	)	number	8	SENT_4	[p1l420t2212r493b2241],
8	—	CD	NUMBER	—	dep	6	SENT_4	[p1l512t2224r543b2226],
9	all	DT	O	all	dep	3	SENT_4	[p1l560t2210r586b2233],
10	in	IN	O	in	_	0	SENT_4	[p1l606t2212r627b2233],
11	Boston	NNP	LOCATION	Boston	prep_in	9	SENT_4	[p1l94t2249r189b2275],
12	;	:	O	;	_	0	SENT_4	[p1l94t2249r189b2275],
13	and	CC	O	and	_	0	SENT_4	[p1l208t2247r253b2271],
14	the	DT	O	the	det	17	SENT_4	[p1l271t2247r311b2271],
15	Ireland	NNP	O	Ireland	nn	17	SENT_4	[p1l331t2247r416b2271],
16	Cancer	NNP	O	Cancer	nn	17	SENT_4	[p1l436t2249r523b2271],
17	Center	NNP	O	Center	prep_in	9	SENT_4	[p1l540t2249r626b2275],
18	,	,	O	,	_	0	SENT_4	[p1l540t2249r626b2275],
19	University	NNP	ORGANIZATION	University	nn	20	SENT_4	[p1l94t2287r221b2316],
20	Hospitals	NNPS	ORGANIZATION	Hospitals	dep	3	SENT_4	[p1l239t2285r360b2316],
21	of	IN	ORGANIZATION	of	_	0	SENT_4	[p1l378t2285r406b2309],
22	Cleveland	NNP	ORGANIZATION	Cleveland	prep_of	20	SENT_4	[p1l419t2285r550b2313],
23	,	,	O	,	_	0	SENT_4	[p1l419t2285r550b2313],
24	Case	NNP	ORGANIZATION	Case	nn	25	SENT_4	[p1l569t2287r628b2309],
25	School	NNP	ORGANIZATION	School	appos	3	SENT_4	[p1l92t2323r177b2346],
26	of	IN	ORGANIZATION	of	_	0	SENT_4	[p1l188t2322r216b2346],
27	Medicine	NNP	ORGANIZATION	Medicine	prep_of	25	SENT_4	[p1l223t2323r345b2350],
28	,	,	O	,	_	0	SENT_4	[p1l223t2323r345b2350],
29	Cleveland	NNP	LOCATION	Cleveland	appos	3	SENT_4	[p1l356t2323r479b2346],
30	(	CD	NUMBER	(	num	29	SENT_4	[p1l492t2325r575b2354],
31	B.H.	NNP	LOCATION	B.H.	dep	29	SENT_4	[p1l492t2325r575b2354],
32	)	CD	NUMBER	)	num	31	SENT_4	[p1l492t2325r575b2354],
33	.	.	O	.	_	0	SENT_4	[p1l492t2325r575b2354],

1	Address	NN	O	address	nsubj	2	SENT_5	[p1l585t2323r627b2346, p1l92t2360r159b2383],
2	reprint	VB	O	reprint	_	0	SENT_5	[p1l172t2362r257b2391],
3	requests	NNS	O	request	dobj	2	SENT_5	[p1l268t2364r375b2391],
4	to	TO	O	to	_	0	SENT_5	[p1l386t2364r411b2383],
5	Dr.	NNP	O	Dr.	nn	6	SENT_5	[p1l424t2362r457b2383],
6	Tenen	NNP	PERSON	Tenen	prep_to	2	SENT_5	[p1l468t2362r543b2383],
7	at	IN	O	at	_	0	SENT_5	[p1l555t2364r578b2383],
8	the	DT	O	the	det	10	SENT_5	[p1l588t2360r628b2383],
9	Harvard	NNP	ORGANIZATION	Harvard	nn	10	SENT_5	[p1l94t2397r194b2421],
10	Institutes	NNPS	ORGANIZATION	Institutes	prep_at	6	SENT_5	[p1l208t2399r326b2421],
11	of	IN	ORGANIZATION	of	_	0	SENT_5	[p1l336t2397r364b2421],
12	Medicine	NNP	ORGANIZATION	Medicine	prep_of	10	SENT_5	[p1l372t2397r494b2425],
13	,	,	O	,	_	0	SENT_5	[p1l372t2397r494b2425],
14	HIM-954	NN	O	him-954	prep_of	10	SENT_5	[p1l508t2399r627b2425],
15	,	,	O	,	_	0	SENT_5	[p1l508t2399r627b2425],
16	77	CD	NUMBER	77	num	19	SENT_5	[p1l93t2437r121b2459],
17	Louis	NNP	ORGANIZATION	Louis	nn	19	SENT_5	[p1l132t2437r198b2459],
18	Pasteur	NNP	ORGANIZATION	Pasteur	nn	19	SENT_5	[p1l210t2437r305b2459],
19	Ave.	NNP	ORGANIZATION	Ave.	conj_or	12	SENT_5	[p1l313t2437r372b2463],
20	,	,	O	,	_	0	SENT_5	[p1l313t2437r372b2463],
21	Boston	NNP	LOCATION	Boston	prep_of	10	SENT_5	[p1l385t2437r480b2463],
22	,	,	O	,	_	0	SENT_5	[p1l385t2437r480b2463],
23	MA	NNP	LOCATION	MA	prep_of	10	SENT_5	[p1l493t2437r535b2458],
24	02215	CD	DATE	02215	num	23	SENT_5	[p1l544t2437r626b2463],
25	,	,	O	,	_	0	SENT_5	[p1l544t2437r626b2463],
26	or	CC	O	or	_	0	SENT_5	[p1l92t2481r118b2496],
27	at	IN	O	at	advmod	12	SENT_5	[p1l127t2477r149b2496],
28	dtenen@bidmc.harvard.edu	NN	O	dtenen@bidmc.harvard.edu	prep_of	10	SENT_5	[p1l158t2472r528b2501],
29	.	.	O	.	_	0	SENT_5	[p1l158t2472r528b2501],

1	N	NN	MISC	n	nn	3	SENT_6	[p1l94t2549r111b2571],
2	Englj	NNP	MISC	Englj	nn	3	SENT_6	[p1l125t2547r193b2579],
3	Med	NNP	O	Med	_	0	SENT_6	[p1l206t2547r260b2571],
4	2005	CD	DATE	2005	num	3	SENT_6	[p1l270t2549r487b2575],
5	;	:	O	;	_	0	SENT_6	[p1l270t2549r487b2575],
6	352:786	CD	NUMBER	352:786	number	7	SENT_6	[p1l270t2549r487b2575],
7	-92	CD	NUMBER	-92	dep	3	SENT_6	[p1l270t2549r487b2575],
8	.	.	O	.	_	0	SENT_6	[p1l270t2549r487b2575],

1	Copyright	NN	O	copyright	_	0	SENT_7	[p1l92t2589r185b2615],
2	©	CD	NUMBER	©	num	6	SENT_7	[p1l193t2591r214b2612],
3	2005	CD	DATE	2005	num	6	SENT_7	[p1l223t2591r272b2609],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_7	[p1l280t2589r420b2609],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_7	[p1l428t2589r505b2609],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_7	[p1l512t2590r583b2614],
7	.	.	O	.	_	0	SENT_7	[p1l512t2590r583b2614],

1	The	DT	O	the	det	3	SENT_8	[p1l1001t81r1038b103],
2	NEW	NNP	O	NEW	nn	3	SENT_8	[p1l1050t83r1130b103],
3	ENGLAND	NNP	O	ENGLAND	_	0	SENT_8	[p1l1144t83r1319b103],
4	JOURNAL	NNP	O	JOURNAL	nn	5	SENT_8	[p1l1333t83r1499b110],
5	afMEDICINE	NNP	O	afMEDICINE	dep	3	SENT_8	[p1l1513t81r1729b109],

1	BRIEF	JJ	O	brief	amod	2	SENT_9	[p1l1195t235r1333b261],
2	REPORT	NN	O	report	_	0	SENT_9	[p1l1353t234r1538b261],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_10	[p1l921t392r1069b442],
2	Mutation	NN	O	mutation	_	0	SENT_10	[p1l1080t388r1354b442],
3	and	CC	O	and	_	0	SENT_10	[p1l1371t387r1480b442],
4	Resistance	NN	O	resistance	conj_and	2	SENT_10	[p1l1496t388r1811b445],
5	of	IN	O	of	_	0	SENT_10	[p1l721t469r791b524],
6	N	NN	O	n	prep_of	2	SENT_10	[p1l794t475r846b525],
7	on	IN	O	on	prep	2	SENT_10	[p1l849t470r1270b524],
8	.	.	O	.	_	0	SENT_10	[p1l849t470r1270b524],

1	—	NN	O	—	_	0	SENT_11	[p1l849t470r1270b524],
2	.	.	O	.	_	0	SENT_11	[p1l849t470r1270b524],

1	Small	JJ	O	small	_	0	SENT_12	[p1l849t470r1270b524],
2	.	.	O	.	_	0	SENT_12	[p1l849t470r1270b524],

1	—	NN	O	—	_	0	SENT_13	[p1l849t470r1270b524],
2	.	.	O	.	_	0	SENT_13	[p1l849t470r1270b524],

1	Cell	NN	O	cell	_	0	SENT_14	[p1l849t470r1270b524],
2	Lung	NN	O	lung	nn	3	SENT_14	[p1l1286t475r1439b540],
3	Cancer	NN	O	cancer	dep	1	SENT_14	[p1l1454t474r1661b524],
4	to	TO	O	to	_	0	SENT_14	[p1l1676t481r1731b524],
5	Gefitinib	NNP	LOCATION	Gefitinib	prep_to	3	SENT_14	[p1l1750t469r2012b524],

1	Susumu	NNP	PERSON	Susumu	nn	2	SENT_15	[p1l699t606r837b635],
2	|	NNP	O	|	_	0	SENT_15	[p1l855t604r1033b645],
3	<	JJR	O	<	amod	4	SENT_15	[p1l855t604r1033b645],
4	obayashi	NNS	O	obayashus	dep	2	SENT_15	[p1l855t604r1033b645],
5	,	,	O	,	_	0	SENT_15	[p1l855t604r1033b645],
6	M.D.	NNP	O	M.D.	appos	4	SENT_15	[p1l1051t607r1141b640],
7	,	,	O	,	_	0	SENT_15	[p1l1051t607r1141b640],
8	Ph.D.	NNP	O	Ph.D.	appos	4	SENT_15	[p1l1158t604r1257b641],
9	,	,	O	,	_	0	SENT_15	[p1l1158t604r1257b641],
10	Titus	NNP	O	Titus	nn	11	SENT_15	[p1l1270t607r1386b644],
11	]	NN	O	]	appos	4	SENT_15	[p1l1270t607r1386b644],
12	.	.	O	.	_	0	SENT_15	[p1l1270t607r1386b644],

1	Boggon	NNP	PERSON	Boggon	nn	6	SENT_16	[p1l1403t607r1540b645],
2	,	,	O	,	_	0	SENT_16	[p1l1403t607r1540b645],
3	Ph.D.	NNP	O	Ph.D.	appos	6	SENT_16	[p1l1558t604r1656b640],
4	,	,	O	,	_	0	SENT_16	[p1l1558t604r1656b640],
5	Tajhal	NNP	PERSON	Tajhal	appos	6	SENT_16	[p1l1670t604r1767b645],
6	Dayaram	NNP	PERSON	Dayaram	_	0	SENT_16	[p1l1784t607r1942b645],
7	,	,	O	,	_	0	SENT_16	[p1l1784t607r1942b645],
8	B.A.	NNP	O	B.A.	dep	6	SENT_16	[p1l1960t606r2033b641],
9	,	,	O	,	_	0	SENT_16	[p1l1960t606r2033b641],

1	Pasi	NNP	PERSON	Pasi	nn	25	SENT_17	[p1l899t656r963b684],
2	A.	NNP	PERSON	A.	nn	25	SENT_17	[p1l977t655r1126b693],
3	Janne	NNP	PERSON	Janne	nn	25	SENT_17	[p1l977t655r1126b693],
4	,	,	O	,	_	0	SENT_17	[p1l977t655r1126b693],
5	M.D.	NNP	O	M.D.	appos	25	SENT_17	[p1l1143t656r1233b690],
6	,	,	O	,	_	0	SENT_17	[p1l1143t656r1233b690],
7	Ph.D.	NNP	O	Ph.D.	appos	25	SENT_17	[p1l1251t653r1350b689],
8	,	,	O	,	_	0	SENT_17	[p1l1251t653r1350b689],
9	Olivier	NNP	PERSON	Olivier	appos	25	SENT_17	[p1l1365t653r1477b684],
10	Kocher	NNP	PERSON	Kocher	nn	25	SENT_17	[p1l1491t653r1611b690],
11	,	,	O	,	_	0	SENT_17	[p1l1491t653r1611b690],
12	M.D.	NNP	O	M.D.	appos	25	SENT_17	[p1l1628t656r1718b690],
13	,	,	O	,	_	0	SENT_17	[p1l1628t656r1718b690],
14	Ph.D.	NNP	O	Ph.D.	appos	25	SENT_17	[p1l1736t653r1835b690],
15	,	,	O	,	_	0	SENT_17	[p1l1736t653r1835b690],
16	Matthew	NNP	PERSON	Matthew	appos	25	SENT_17	[p1l877t702r1024b733],
17	Meyerson	NNP	PERSON	Meyerson	nn	25	SENT_17	[p1l1038t705r1211b743],
18	,	,	O	,	_	0	SENT_17	[p1l1038t705r1211b743],
19	M.D.	NNP	O	M.D.	appos	25	SENT_17	[p1l1229t705r1319b738],
20	,	,	O	,	_	0	SENT_17	[p1l1229t705r1319b738],
21	Ph.D.	NNP	O	Ph.D.	appos	25	SENT_17	[p1l1336t702r1435b739],
22	,	,	O	,	_	0	SENT_17	[p1l1336t702r1435b739],
23	Bruce	NNP	PERSON	Bruce	appos	25	SENT_17	[p1l1452t705r1545b733],
24	E.	NNP	PERSON	E.	nn	25	SENT_17	[p1l1561t702r1750b742],
25	Johnson	NNP	PERSON	Johnson	_	0	SENT_17	[p1l1561t702r1750b742],
26	,	,	O	,	_	0	SENT_17	[p1l1561t702r1750b742],
27	M.D.	NNP	O	M.D.	dep	25	SENT_17	[p1l1767t705r1857b739],
28	,	,	O	,	_	0	SENT_17	[p1l1767t705r1857b739],

1	Michael	NNP	PERSON	Michael	nn	2	SENT_18	[p1l707t751r870b791],
2	]	NNP	O	]	_	0	SENT_18	[p1l707t751r870b791],
3	.	.	O	.	_	0	SENT_18	[p1l707t751r870b791],

1	Eck	NNP	PERSON	Eck	nn	11	SENT_19	[p1l887t751r950b787],
2	,	,	O	,	_	0	SENT_19	[p1l887t751r950b787],
3	M.D.	NNP	O	M.D.	appos	11	SENT_19	[p1l967t754r1057b788],
4	,	,	O	,	_	0	SENT_19	[p1l967t754r1057b788],
5	Ph.D.	NNP	O	Ph.D.	appos	11	SENT_19	[p1l1074t751r1173b788],
6	,	,	O	,	_	0	SENT_19	[p1l1074t751r1173b788],
7	Daniel	NNP	PERSON	Daniel	appos	11	SENT_19	[p1l1191t751r1295b782],
8	G.	NNP	PERSON	G.	nn	11	SENT_19	[p1l1310t753r1345b782],
9	Tenen	NNP	PERSON	Tenen	nn	11	SENT_19	[p1l1358t754r1468b787],
10	,	,	O	,	_	0	SENT_19	[p1l1358t754r1468b787],
11	M.D.	NNP	O	M.D.	_	0	SENT_19	[p1l1485t754r1575b787],
12	,	,	O	,	_	0	SENT_19	[p1l1485t754r1575b787],
13	and	CC	O	and	_	0	SENT_19	[p1l1590t751r1649b782],
14	Balazs	NNP	PERSON	Balazs	nn	15	SENT_19	[p1l1667t751r1772b782],
15	Halmos	NNP	PERSON	Halmos	conj_and	11	SENT_19	[p1l1789t751r1930b788],
16	,	,	O	,	_	0	SENT_19	[p1l1789t751r1930b788],
17	M.D.	NNP	O	M.D.	appos	11	SENT_19	[p1l1947t754r2027b782],

1	SUMMARY	NN	O	summary	_	0	SENT_20	[p1l1259t898r1472b921],

1	Mutations	NNS	O	mutation	nsubjpass	14	SENT_21	[p1l666t995r834b1025],
2	of	IN	O	of	_	0	SENT_21	[p1l845t994r884b1025],
3	the	DT	O	the	det	7	SENT_21	[p1l887t994r937b1025],
4	epidermal	JJ	O	epidermal	amod	7	SENT_21	[p1l947t994r1112b1034],
5	growth	NN	O	growth	nn	7	SENT_21	[p1l1121t994r1239b1034],
6	factor	NN	O	factor	nn	7	SENT_21	[p1l1248t994r1344b1025],
7	receptor	NN	O	receptor	prep_of	1	SENT_21	[p1l1352t1001r1488b1034],
8	(	CD	NUMBER	(	num	11	SENT_21	[p1l1499t997r1601b1030],
9	EGFR	NN	ORGANIZATION	egfr	nn	11	SENT_21	[p1l1499t997r1601b1030],
10	)	NN	O	)	nn	11	SENT_21	[p1l1499t997r1601b1030],
11	gene	NN	O	gene	dep	7	SENT_21	[p1l1612t1004r1689b1034],
12	have	VBP	O	have	aux	14	SENT_21	[p1l1699t994r1772b1025],
13	been	VBN	O	be	auxpass	14	SENT_21	[p1l1782t994r1859b1025],
14	identiﬁed	VBN	O	identiﬁed	_	0	SENT_21	[p1l1869t994r2025b1025],
15	in	IN	O	in	_	0	SENT_21	[p1l2034t995r2066b1025],
16	specimens	NNS	O	specimen	prep_in	14	SENT_21	[p1l668t1045r840b1084],
17	from	IN	O	from	_	0	SENT_21	[p1l849t1044r929b1075],
18	patients	NNS	O	patient	prep_from	16	SENT_21	[p1l937t1045r1067b1084],
19	with	IN	O	with	_	0	SENT_21	[p1l1074t1044r1147b1075],
20	non	JJ	O	non	amod	26	SENT_21	[p1l1155t1044r1400b1075],
21	—	JJ	O	—	amod	26	SENT_21	[p1l1155t1044r1400b1075],
22	small	JJ	O	small	amod	26	SENT_21	[p1l1155t1044r1400b1075],
23	—	NN	O	—	nn	26	SENT_21	[p1l1155t1044r1400b1075],
24	cell	NN	O	cell	nn	26	SENT_21	[p1l1155t1044r1400b1075],
25	lung	NN	O	lung	nn	26	SENT_21	[p1l1408t1044r1483b1084],
26	cancer	NN	O	cancer	prep_with	14	SENT_21	[p1l1490t1054r1597b1075],
27	who	WP	O	who	nsubj	28	SENT_21	[p1l1602t1044r1673b1075],
28	have	VBP	O	have	rcmod	26	SENT_21	[p1l1682t1044r1755b1075],
29	a	DT	O	a	det	30	SENT_21	[p1l1762t1055r1780b1075],
30	response	NN	O	response	dobj	28	SENT_21	[p1l1787t1054r1934b1084],
31	to	TO	O	to	_	0	SENT_21	[p1l1943t1051r1973b1075],
32	anilinoquinazoline	JJ	O	anilinoquinazoline	amod	34	SENT_21	[p1l1981t1044r2066b1075, p1l667t1094r904b1133],
33	EGFR	NN	ORGANIZATION	egfr	nn	34	SENT_21	[p1l918t1096r1019b1127],
34	inhibitors	NNS	O	inhibitor	prep_to	28	SENT_21	[p1l1029t1094r1200b1125],
35	.	.	O	.	_	0	SENT_21	[p1l1029t1094r1200b1125],

1	Despite	IN	O	despite	_	0	SENT_22	[p1l1216t1094r1340b1133],
2	the	DT	O	the	det	4	SENT_22	[p1l1355t1094r1405b1125],
3	dramatic	JJ	O	dramatic	amod	4	SENT_22	[p1l1420t1094r1564b1125],
4	responses	NNS	O	response	prep_despite	12	SENT_22	[p1l1579t1104r1742b1133],
5	to	TO	O	to	_	0	SENT_22	[p1l1757t1100r1788b1125],
6	such	JJ	O	such	amod	7	SENT_22	[p1l1804t1094r1879b1125],
7	inhibitors	NNS	O	inhibitor	prep_to	4	SENT_22	[p1l1894t1094r2064b1131],
8	,	,	O	,	_	0	SENT_22	[p1l1894t1094r2064b1131],
9	most	JJS	O	most	amod	10	SENT_22	[p1l667t1150r751b1174],
10	patients	NNS	O	patient	nsubj	12	SENT_22	[p1l760t1144r890b1183],
11	ultimately	RB	O	ultimately	advmod	12	SENT_22	[p1l903t1143r1067b1183],
12	have	VBP	O	have	_	0	SENT_22	[p1l1077t1143r1150b1174],
13	a	DT	O	a	det	14	SENT_22	[p1l1161t1153r1178b1174],
14	relapse	NN	O	relapse	dobj	12	SENT_22	[p1l1189t1143r1314b1183],
15	.	.	O	.	_	0	SENT_22	[p1l1189t1143r1314b1183],

1	The	DT	O	the	det	2	SENT_23	[p1l1327t1143r1390b1174],
2	mechanism	NN	O	mechanism	nsubj	8	SENT_23	[p1l1401t1143r1593b1174],
3	of	IN	O	of	_	0	SENT_23	[p1l1605t1143r1644b1174],
4	the	DT	O	the	det	6	SENT_23	[p1l1648t1143r1698b1174],
5	drug	NN	O	drug	nn	6	SENT_23	[p1l1710t1143r1788b1183],
6	resistance	NN	O	resistance	prep_of	2	SENT_23	[p1l1798t1144r1962b1174],
7	is	VBZ	O	be	cop	8	SENT_23	[p1l1973t1144r1999b1174],
8	unknown	JJ	O	unknown	_	0	SENT_23	[p1l2011t1153r2066b1174, p1l667t1193r789b1225],
9	.	.	O	.	_	0	SENT_23	[p1l2011t1153r2066b1174, p1l667t1193r789b1225],

1	Here	RB	O	here	advmod	3	SENT_24	[p1l804t1196r882b1224],
2	we	PRP	O	we	nsubj	3	SENT_24	[p1l893t1204r939b1224],
3	report	VBP	O	report	_	0	SENT_24	[p1l952t1200r1054b1233],
4	the	DT	O	the	det	5	SENT_24	[p1l1065t1193r1115b1224],
5	case	NN	O	case	dobj	3	SENT_24	[p1l1127t1203r1196b1224],
6	of	IN	O	of	_	0	SENT_24	[p1l1209t1193r1248b1224],
7	a	DT	O	a	det	8	SENT_24	[p1l1253t1204r1270b1224],
8	patient	NN	O	patient	prep_of	5	SENT_24	[p1l1282t1194r1397b1233],
9	with	IN	O	with	_	0	SENT_24	[p1l1406t1193r1480b1224],
10	EGFR	NN	ORGANIZATION	egfr	nn	12	SENT_24	[p1l1491t1196r1712b1231],
11	—	CD	NUMBER	—	num	12	SENT_24	[p1l1491t1196r1712b1231],
12	mutant	NN	O	mutant	prep_with	3	SENT_24	[p1l1491t1196r1712b1231],
13	,	,	O	,	_	0	SENT_24	[p1l1491t1196r1712b1231],
14	geﬁtinib	NN	O	geﬁtinib	nn	15	SENT_24	[p1l1727t1193r2064b1233],
15	—	NN	O	—	appos	12	SENT_24	[p1l1727t1193r2064b1233],
16	responsive	JJ	O	responsive	amod	18	SENT_24	[p1l1727t1193r2064b1233],
17	,	,	O	,	_	0	SENT_24	[p1l1727t1193r2064b1233],
18	advanced	JJ	O	advanced	amod	20	SENT_24	[p1l667t1243r819b1274],
19	non	JJ	O	non	amod	20	SENT_24	[p1l828t1243r1073b1274],
20	—	NN	O	—	dep	15	SENT_24	[p1l828t1243r1073b1274],
21	small	JJ	O	small	amod	25	SENT_24	[p1l828t1243r1073b1274],
22	—	NN	O	—	nn	25	SENT_24	[p1l828t1243r1073b1274],
23	cell	NN	O	cell	nn	25	SENT_24	[p1l828t1243r1073b1274],
24	lung	NN	O	lung	nn	25	SENT_24	[p1l1081t1243r1157b1283],
25	cancer	NN	O	cancer	dobj	3	SENT_24	[p1l1165t1253r1272b1274],
26	who	WP	O	who	nsubj	27	SENT_24	[p1l1278t1243r1349b1274],
27	had	VBD	O	have	rcmod	25	SENT_24	[p1l1359t1243r1419b1274],
28	a	DT	O	a	det	29	SENT_24	[p1l1428t1253r1445b1274],
29	relapse	NN	O	relapse	dobj	27	SENT_24	[p1l1453t1243r1569b1283],
30	after	IN	O	after	_	0	SENT_24	[p1l1578t1243r1653b1274],
31	two	CD	DURATION	two	num	32	SENT_24	[p1l1661t1250r1720b1274],
32	years	NNS	NUMBER	year	prep_after	29	SENT_24	[p1l1728t1253r1811b1283],
33	of	IN	O	of	_	0	SENT_24	[p1l1821t1243r1860b1274],
34	complete	JJ	O	complete	amod	35	SENT_24	[p1l1863t1243r2013b1283],
35	remission	NN	O	remission	prep_of	32	SENT_24	[p1l2022t1253r2066b1274, p1l667t1294r800b1324],
36	during	IN	O	during	_	0	SENT_24	[p1l812t1293r924b1333],
37	treatment	NN	O	treatment	prep_during	27	SENT_24	[p1l934t1300r1098b1324],
38	with	IN	O	with	_	0	SENT_24	[p1l1106t1293r1181b1324],
39	geﬁtinib	NN	O	geﬁtinib	prep_with	37	SENT_24	[p1l1192t1293r1343b1333],
40	.	.	O	.	_	0	SENT_24	[p1l1192t1293r1343b1333],

1	The	DT	O	the	det	3	SENT_25	[p1l1354t1293r1418b1324],
2	DNA	NN	O	dna	nn	3	SENT_25	[p1l1429t1296r1512b1324],
3	sequence	NN	O	sequence	nsubj	15	SENT_25	[p1l1522t1303r1676b1333],
4	of	IN	O	of	_	0	SENT_25	[p1l1687t1293r1727b1324],
5	the	DT	O	the	det	7	SENT_25	[p1l1731t1293r1782b1324],
6	EGFR	NN	ORGANIZATION	egfr	nn	7	SENT_25	[p1l1792t1296r1875b1325],
7	gene	NN	O	gene	prep_of	3	SENT_25	[p1l1884t1303r1962b1333],
8	in	IN	O	in	_	0	SENT_25	[p1l1973t1294r2005b1324],
9	his	PRP$	O	he	poss	12	SENT_25	[p1l2017t1293r2065b1324],
10	tumor	NN	O	tumor	nn	12	SENT_25	[p1l667t1350r771b1374],
11	biopsy	NN	O	biopsy	nn	12	SENT_25	[p1l779t1343r887b1382],
12	specimen	NN	O	specimen	prep_in	7	SENT_25	[p1l894t1344r1050b1382],
13	at	IN	O	at	_	0	SENT_25	[p1l1057t1350r1088b1374],
14	relapse	NN	O	relapse	prep_at	12	SENT_25	[p1l1094t1343r1210b1382],
15	revealed	VBD	O	reveal	_	0	SENT_25	[p1l1218t1343r1351b1374],
16	the	DT	O	the	det	17	SENT_25	[p1l1360t1343r1410b1374],
17	presence	NN	O	presence	dobj	15	SENT_25	[p1l1417t1353r1562b1382],
18	of	IN	O	of	_	0	SENT_25	[p1l1570t1343r1609b1374],
19	a	DT	DURATION	a	det	22	SENT_25	[p1l1610t1353r1628b1374],
20	second	JJ	DURATION	second	amod	22	SENT_25	[p1l1635t1343r1750b1374],
21	point	NN	O	point	nn	22	SENT_25	[p1l1757t1344r1846b1382],
22	mutation	NN	O	mutation	prep_of	17	SENT_25	[p1l1852t1344r2012b1380],
23	,	,	O	,	_	0	SENT_25	[p1l1852t1344r2012b1380],
24	resulting	VBG	O	result	partmod	15	SENT_25	[p1l2022t1353r2066b1374, p1l668t1392r781b1432],
25	in	IN	O	in	_	0	SENT_25	[p1l789t1393r820b1423],
26	threonine	NN	O	threonine	prep_in	24	SENT_25	[p1l831t1392r1236b1423],
27	—	CD	NUMBER	—	number	29	SENT_25	[p1l831t1392r1236b1423],
28	to	TO	O	to	dep	29	SENT_25	[p1l831t1392r1236b1423],
29	—	CD	NUMBER	—	num	33	SENT_25	[p1l831t1392r1236b1423],
30	methionine	NN	O	methionine	nn	33	SENT_25	[p1l831t1392r1236b1423],
31	amino	NN	O	amino	nn	33	SENT_25	[p1l1246t1393r1349b1423],
32	acid	NN	O	acid	nn	33	SENT_25	[p1l1359t1392r1425b1423],
33	change	NN	O	change	dobj	24	SENT_25	[p1l1435t1392r1551b1432],
34	at	IN	O	at	_	0	SENT_25	[p1l1561t1399r1592b1423],
35	position	NN	O	position	prep_at	33	SENT_25	[p1l1599t1393r1733b1432],
36	790	CD	NUMBER	790	num	35	SENT_25	[p1l1743t1395r1802b1423],
37	of	IN	O	of	_	0	SENT_25	[p1l1813t1392r1851b1423],
38	EGFR	NN	ORGANIZATION	egfr	prep_of	35	SENT_25	[p1l1854t1395r1958b1425],
39	.	.	O	.	_	0	SENT_25	[p1l1854t1395r1958b1425],

1	Structural	JJ	MISC	structural	amod	2	SENT_26	[p1l1971t1395r2066b1423, p1l667t1442r743b1473],
2	modeling	NN	O	modeling	nsubj	6	SENT_26	[p1l752t1442r911b1482],
3	and	CC	O	and	_	0	SENT_26	[p1l920t1442r980b1473],
4	biochemical	JJ	O	biochemical	amod	5	SENT_26	[p1l991t1442r1191b1473],
5	studies	NNS	O	study	nsubj	6	SENT_26	[p1l1201t1442r1315b1473],
6	showed	VBD	O	show	_	0	SENT_26	[p1l1327t1442r1452b1473],
7	that	IN	O	that	complm	11	SENT_26	[p1l1462t1442r1527b1473],
8	this	DT	DATE	this	det	10	SENT_26	[p1l1536t1442r1595b1473],
9	second	JJ	DATE	second	amod	10	SENT_26	[p1l1606t1442r1721b1473],
10	mutation	NN	O	mutation	nsubj	11	SENT_26	[p1l1731t1443r1882b1473],
11	led	VBD	O	lead	ccomp	6	SENT_26	[p1l1892t1442r1941b1473],
12	to	TO	O	to	_	0	SENT_26	[p1l1951t1449r1982b1473],
13	geﬁtjnib	JJ	O	geﬁtjnib	amod	14	SENT_26	[p1l1992t1442r2066b1482, p1l667t1492r742b1522],
14	resistance	NN	O	resistance	prep_to	11	SENT_26	[p1l752t1492r925b1522],
15	.	.	O	.	_	0	SENT_26	[p1l752t1492r925b1522],

1	ON-SMALL-CELL	NN	O	on-small-cell	nn	3	SENT_27	[p1l832t1653r1123b1675],
2	LUNG	NN	O	lung	nn	3	SENT_27	[p1l1142t1653r1245b1675],
3	CANCER	NNP	O	CANCER	nsubj	7	SENT_27	[p1l1263t1653r1409b1675],
4	IS	VBZ	O	be	cop	7	SENT_27	[p1l1427t1653r1457b1675],
5	THE	DT	O	the	det	7	SENT_27	[p1l1476t1653r1548b1675],
6	LEADING	VBG	O	lead	amod	7	SENT_27	[p1l1569t1653r1732b1675],
7	CAUSE	NN	O	cause	_	0	SENT_27	[p1l1751t1653r1861b1675],
8	OF	IN	O	of	_	0	SENT_27	[p1l1880t1653r1926b1675],
9	DEATH	NN	O	death	prep_of	7	SENT_27	[p1l1946t1653r2065b1675],
10	from	IN	O	from	_	0	SENT_27	[p1l832t1694r912b1725],
11	cancer	NN	O	cancer	prep_from	9	SENT_27	[p1l924t1705r1031b1725],
12	in	IN	O	in	_	0	SENT_27	[p1l1040t1695r1072b1725],
13	both	DT	O	both	det	14	SENT_27	[p1l1083t1695r1158b1725],
14	men	NNS	O	man	prep_in	11	SENT_27	[p1l1169t1705r1241b1725],
15	and	CC	O	and	_	0	SENT_27	[p1l1252t1695r1313b1725],
16	women	NNS	O	woman	nsubj	32	SENT_27	[p1l1322t1705r1445b1726],
17	in	IN	O	in	_	0	SENT_27	[p1l1456t1695r1487b1725],
18	the	DT	O	the	det	22	SENT_27	[p1l1499t1695r1549b1725],
19	United	NNP	LOCATION	United	nn	22	SENT_27	[p1l1560t1695r1671b1725],
20	States	NNPS	LOCATION	States	nn	22	SENT_27	[p1l1682t1693r1805b1725],
21	}	NNP	O	}	nn	22	SENT_27	[p1l1682t1693r1805b1725],
22	Chemotherapy	NNP	MISC	Chemotherapy	prep_in	16	SENT_27	[p1l1816t1695r2064b1734],
23	,	,	O	,	_	0	SENT_27	[p1l1816t1695r2064b1734],
24	the	DT	O	the	det	25	SENT_27	[p1l832t1745r882b1775],
25	mainstay	NN	O	mainstay	appos	16	SENT_27	[p1l891t1745r1039b1784],
26	of	IN	O	of	_	0	SENT_27	[p1l1047t1744r1086b1775],
27	treatment	NN	O	treatment	prep_of	25	SENT_27	[p1l1087t1751r1247b1775],
28	in	IN	O	in	_	0	SENT_27	[p1l1253t1745r1284b1775],
29	advanced	JJ	O	advanced	amod	30	SENT_27	[p1l1293t1745r1444b1775],
30	disease	NN	O	disease	prep_in	27	SENT_27	[p1l1453t1745r1578b1782],
31	,	,	O	,	_	0	SENT_27	[p1l1453t1745r1578b1782],
32	is	VBZ	O	be	conj_and	7	SENT_27	[p1l1589t1745r1614b1775],
33	only	RB	O	only	advmod	32	SENT_27	[p1l1624t1745r1693b1784],
34	marginally	RB	O	marginally	advmod	32	SENT_27	[p1l1701t1745r1876b1784],
35	effect1	NN	O	effect1	nsubj	36	SENT_27	[p1l1883t1743r2065b1782],
36	've	VBP	O	have	ccomp	32	SENT_27	[p1l1883t1743r2065b1782],
37	,2	CD	NUMBER	,2	number	38	SENT_27	[p1l1883t1743r2065b1782],
38	’	CD	NUMBER	’	num	39	SENT_27	[p1l1883t1743r2065b1782],
39	3	CD	NUMBER	3	dobj	36	SENT_27	[p1l1883t1743r2065b1782],
40	but	CC	O	but	_	0	SENT_27	[p1l668t1794r722b1825],
41	geﬂtinib	NN	O	geﬂtinib	nsubj	57	SENT_27	[p1l731t1794r868b1834],
42	and	CC	O	and	_	0	SENT_27	[p1l879t1794r940b1825],
43	erlotinib	NN	O	erlotinib	conj_and	41	SENT_27	[p1l951t1794r1099b1832],
44	,	,	O	,	_	0	SENT_27	[p1l951t1794r1099b1832],
45	which	WDT	O	which	nsubj	46	SENT_27	[p1l1110t1794r1212b1825],
46	target	VBP	O	target	rcmod	41	SENT_27	[p1l1222t1801r1319b1834],
47	the	DT	O	the	det	51	SENT_27	[p1l1328t1794r1378b1825],
48	epidermal	JJ	O	epidermal	amod	51	SENT_27	[p1l1389t1794r1554b1834],
49	growth	NN	O	growth	nn	51	SENT_27	[p1l1564t1794r1682b1834],
50	factor	NN	O	factor	nn	51	SENT_27	[p1l1693t1794r1788b1825],
51	receptor	NN	O	receptor	nsubj	55	SENT_27	[p1l1798t1801r1934b1834],
52	(	CD	NUMBER	(	num	55	SENT_27	[p1l1945t1797r2064b1830],
53	EGFR	NN	ORGANIZATION	egfr	nn	55	SENT_27	[p1l1945t1797r2064b1830],
54	)	NN	O	)	nn	55	SENT_27	[p1l1945t1797r2064b1830],
55	pathway	NN	O	pathway	xcomp	46	SENT_27	[p1l667t1844r808b1883],
56	,	,	O	,	_	0	SENT_27	[p1l667t1844r808b1883],
57	show	VBP	O	show	conj_but	7	SENT_27	[p1l819t1844r907b1875],
58	promise	NN	O	promise	iobj	57	SENT_27	[p1l913t1845r1047b1883],
59	in	IN	O	in	_	0	SENT_27	[p1l1056t1845r1088b1874],
60	the	DT	O	the	det	61	SENT_27	[p1l1097t1844r1147b1875],
61	treatment	NN	O	treatment	prep_in	58	SENT_27	[p1l1156t1851r1315b1875],
62	of	IN	O	of	_	0	SENT_27	[p1l1322t1844r1361b1875],
63	metastatic	JJ	O	metastatic	amod	65	SENT_27	[p1l1363t1845r1531b1875],
64	non	JJ	O	non	amod	65	SENT_27	[p1l1540t1844r1782b1875],
65	—	NN	O	—	prep_of	61	SENT_27	[p1l1540t1844r1782b1875],
66	small	JJ	O	small	amod	70	SENT_27	[p1l1540t1844r1782b1875],
67	—	NN	O	—	nn	70	SENT_27	[p1l1540t1844r1782b1875],
68	cell	NN	O	cell	nn	70	SENT_27	[p1l1540t1844r1782b1875],
69	lung	NN	O	lung	nn	70	SENT_27	[p1l1791t1844r1866b1884],
70	cancer	NN	O	cancer	dobj	57	SENT_27	[p1l1873t1842r2003b1875],
71	.	.	O	.	_	0	SENT_27	[p1l1873t1842r2003b1875],

1	“	NN	O	“	nn	3	SENT_28	[p1l1873t1842r2003b1875],
2	Response	NN	O	response	nn	3	SENT_28	[p1l2011t1847r2065b1877, p1l668t1904r781b1934],
3	rates	NNS	O	rate	nsubj	8	SENT_28	[p1l793t1901r869b1925],
4	are	VBP	O	be	cop	8	SENT_28	[p1l881t1905r930b1925],
5	10	CD	NUMBER	10	number	7	SENT_28	[p1l943t1897r981b1925],
6	to	TO	O	to	dep	7	SENT_28	[p1l993t1901r1024b1925],
7	20	CD	PERCENT	20	num	8	SENT_28	[p1l1036t1897r1075b1925],
8	percent	NN	PERCENT	percent	_	0	SENT_28	[p1l1086t1901r1211b1934],
9	when	WRB	O	when	advmod	17	SENT_28	[p1l1219t1895r1309b1925],
10	these	DT	O	these	det	15	SENT_28	[p1l1321t1895r1406b1925],
11	ATP	NN	O	atp	nn	15	SENT_28	[p1l1416t1895r1688b1934],
12	—	NN	O	—	nn	15	SENT_28	[p1l1416t1895r1688b1934],
13	competitive	JJ	O	competitive	amod	15	SENT_28	[p1l1416t1895r1688b1934],
14	anilinoquinazoline	NN	O	anilinoquinazoline	nn	15	SENT_28	[p1l1700t1895r2010b1934],
15	inhibitors	NNS	O	inhibitor	nsubjpass	17	SENT_28	[p1l2021t1895r2066b1925, p1l667t1945r794b1976],
16	are	VBP	O	be	auxpass	17	SENT_28	[p1l805t1955r854b1976],
17	used	VBN	O	use	dep	8	SENT_28	[p1l863t1945r939b1976],
18	as	IN	O	as	_	0	SENT_28	[p1l948t1955r981b1976],
19	second	JJ	ORDINAL	second	amod	20	SENT_28	[p1l992t1945r1119b1976],
20	—	NN	O	—	prep_as	17	SENT_28	[p1l992t1945r1119b1976],
21	or	CC	O	or	_	0	SENT_28	[p1l1130t1955r1164b1976],
22	third-line	JJ	O	third-line	amod	23	SENT_28	[p1l1173t1945r1327b1976],
23	treatment	NN	O	treatment	prep_as	17	SENT_28	[p1l1337t1951r1498b1976],
24	for	IN	O	for	_	0	SENT_28	[p1l1505t1944r1553b1976],
25	advanced	JJ	O	advanced	amod	27	SENT_28	[p1l1561t1945r1713b1976],
26	disease	NN	O	disease	nn	27	SENT_28	[p1l1723t1943r1893b1976],
27	.5	NN	NUMBER	.5	prep_for	20	SENT_28	[p1l1723t1943r1893b1976],
28	'	''	O	'	_	0	SENT_28	[p1l1723t1943r1893b1976],
29	7	CD	NUMBER	7	tmod	17	SENT_28	[p1l1723t1943r1893b1976],

1	Responsiveness	NN	O	responsiveness	nsubj	7	SENT_29	[p1l717t1996r976b2034],
2	to	TO	O	to	_	0	SENT_29	[p1l987t2002r1018b2026],
3	these	DT	O	these	det	4	SENT_29	[p1l1029t1995r1114b2026],
4	drugs	NNS	O	drug	prep_to	1	SENT_29	[p1l1125t1995r1217b2035],
5	is	VBZ	O	be	cop	7	SENT_29	[p1l1229t1996r1254b2026],
6	a	DT	O	a	det	7	SENT_29	[p1l1265t2005r1282b2026],
7	characteristic	NN	O	characteristic	_	0	SENT_29	[p1l1293t1995r1511b2026],
8	of	IN	O	of	_	0	SENT_29	[p1l1522t1995r1561b2026],
9	distinct	JJ	O	distinct	amod	10	SENT_29	[p1l1565t1995r1688b2026],
10	subgroups	NNS	O	subgroup	prep_of	7	SENT_29	[p1l1698t1995r1871b2035],
11	of	IN	O	of	_	0	SENT_29	[p1l1882t1995r1921b2026],
12	patients	NNS	O	patient	prep_of	10	SENT_29	[p1l1924t1996r2065b2034],
13	:	:	O	:	_	0	SENT_29	[p1l1924t1996r2065b2034],
14	women	NNS	O	woman	conj_and	7	SENT_29	[p1l666t2055r798b2083],
15	,	,	O	,	_	0	SENT_29	[p1l666t2055r798b2083],
16	patients	NNS	O	patient	appos	14	SENT_29	[p1l808t2046r938b2085],
17	who	WP	O	who	nsubj	20	SENT_29	[p1l945t2046r1016b2076],
18	have	VBP	O	have	aux	20	SENT_29	[p1l1025t2045r1098b2076],
19	never	RB	O	never	neg	20	SENT_29	[p1l1107t2055r1195b2076],
20	smoked	VBN	O	smoke	rcmod	16	SENT_29	[p1l1203t2045r1341b2083],
21	,	,	O	,	_	0	SENT_29	[p1l1203t2045r1341b2083],
22	patients	NNS	O	patient	conj_and	7	SENT_29	[p1l1351t2046r1481b2084],
23	with	IN	O	with	_	0	SENT_29	[p1l1488t2045r1562b2076],
24	adenocarcinoma	NN	O	adenocarcinoma	prep_with	22	SENT_29	[p1l1570t2045r1852b2083],
25	,	,	O	,	_	0	SENT_29	[p1l1570t2045r1852b2083],
26	and	CC	O	and	_	0	SENT_29	[p1l1862t2045r1923b2076],
27	Asians	NNPS	MISC	Asians	conj_and	7	SENT_29	[p1l1930t2044r2065b2076],
28	?	.	O	?	_	0	SENT_29	[p1l1930t2044r2065b2076],

1	In	IN	O	in	_	0	SENT_30	[p1l667t2098r701b2126],
2	the	DT	O	the	det	3	SENT_30	[p1l711t2096r761b2126],
3	majority	NN	O	majority	prep_in	13	SENT_30	[p1l771t2096r907b2135],
4	of	IN	O	of	_	0	SENT_30	[p1l916t2095r955b2126],
5	patients	NNS	O	patient	prep_of	3	SENT_30	[p1l958t2096r1087b2135],
6	with	IN	O	with	_	0	SENT_30	[p1l1097t2096r1170b2126],
7	highly	RB	O	highly	advmod	8	SENT_30	[p1l1180t2096r1284b2135],
8	responsive	JJ	O	responsive	amod	9	SENT_30	[p1l1292t2096r1466b2135],
9	tumors	NNS	O	tumor	prep_with	5	SENT_30	[p1l1477t2102r1604b2133],
10	,	,	O	,	_	0	SENT_30	[p1l1477t2102r1604b2133],
11	the	DT	O	the	det	12	SENT_30	[p1l1616t2096r1666b2126],
12	tumor	NN	O	tumor	nsubj	13	SENT_30	[p1l1676t2102r1778b2126],
13	contains	VBZ	O	contain	_	0	SENT_30	[p1l1788t2096r1927b2126],
14	somatic	JJ	O	somatic	amod	15	SENT_30	[p1l1938t2096r2067b2126],
15	mutations	NNS	O	mutation	dobj	13	SENT_30	[p1l667t2216r834b2246],
16	of	IN	O	of	_	0	SENT_30	[p1l845t2215r884b2246],
17	the	DT	O	the	det	19	SENT_30	[p1l887t2215r937b2246],
18	EGFR	NN	ORGANIZATION	egfr	nn	19	SENT_30	[p1l946t2218r1028b2246],
19	gene	NN	O	gene	prep_of	15	SENT_30	[p1l1036t2225r1122b2255],
20	.	.	O	.	_	0	SENT_30	[p1l1036t2225r1122b2255],

1	These	DT	O	these	det	2	SENT_31	[p1l1132t2215r1230b2246],
2	mutations	NNS	O	mutation	nsubj	5	SENT_31	[p1l1240t2216r1407b2246],
3	are	VBP	O	be	cop	5	SENT_31	[p1l1417t2225r1466b2246],
4	small	JJ	O	small	amod	5	SENT_31	[p1l1476t2215r1565b2246],
5	deletions	NNS	O	deletion	_	0	SENT_31	[p1l1574t2215r1722b2246],
6	that	WDT	O	that	nsubj	7	SENT_31	[p1l1733t2215r1798b2246],
7	affect	VBP	O	affect	rcmod	5	SENT_31	[p1l1805t2215r1897b2246],
8	amino	NN	O	amino	nn	9	SENT_31	[p1l1904t2216r2009b2246],
9	acids	NNS	O	acid	dobj	7	SENT_31	[p1l2019t2225r2066b2246, p1l667t2265r714b2296],
10	747	CD	NUMBER	747	npadvmod	7	SENT_31	[p1l725t2268r784b2296],
11	through	IN	O	through	_	0	SENT_31	[p1l796t2265r928b2305],
12	750	CD	NUMBER	750	prep_through	7	SENT_31	[p1l939t2268r998b2296],
13	or	CC	O	or	_	0	SENT_31	[p1l1009t2275r1044b2296],
14	point	NN	O	point	nn	15	SENT_31	[p1l1053t2266r1142b2305],
15	mutations	NNS	O	mutation	nsubj	16	SENT_31	[p1l1150t2266r1317b2296],
16	(	VBP	O	(	conj_or	5	SENT_31	[p1l1330t2268r1426b2301],
17	most	RBS	O	most	advmod	18	SENT_31	[p1l1330t2268r1426b2301],
18	commonly	RB	O	commonly	advmod	16	SENT_31	[p1l1435t2265r1611b2304],
19	a	DT	O	a	det	20	SENT_31	[p1l1620t2276r1637b2296],
20	replacement	NN	O	replacement	dep	32	SENT_31	[p1l1647t2266r1852b2304],
21	of	IN	O	of	_	0	SENT_31	[p1l1861t2265r1900b2296],
22	leucine	NN	O	leucine	prep_of	20	SENT_31	[p1l1903t2265r2019b2296],
23	by	IN	O	by	_	0	SENT_31	[p1l2030t2265r2068b2304],
24	arginine	NN	O	arginine	prep_by	22	SENT_31	[p1l667t2316r803b2355],
25	at	IN	O	at	_	0	SENT_31	[p1l813t2322r844b2346],
26	codon	NN	O	codon	nn	29	SENT_31	[p1l852t2316r953b2346],
27	858	CD	NUMBER	858	num	29	SENT_31	[p1l963t2318r1022b2346],
28	[	NN	O	[	nn	29	SENT_31	[p1l1036t2314r1250b2351],
29	L858R	NN	O	l858r	prep_at	24	SENT_31	[p1l1036t2314r1250b2351],
30	]	CD	NUMBER	]	num	31	SENT_31	[p1l1036t2314r1250b2351],
31	)	NN	O	)	dep	32	SENT_31	[p1l1036t2314r1250b2351],
32	.9	CD	NUMBER	.9	dep	37	SENT_31	[p1l1036t2314r1250b2351],
33	‘	CD	NUMBER	‘	num	34	SENT_31	[p1l1036t2314r1250b2351],
34	11	CD	NUMBER	11	dep	32	SENT_31	[p1l1036t2314r1250b2351],
35	These	DT	O	these	det	36	SENT_31	[p1l1259t2316r1356b2346],
36	mutations	NNS	O	mutation	nsubj	37	SENT_31	[p1l1366t2316r1533b2346],
37	mediate	VBP	O	mediate	dep	5	SENT_31	[p1l1544t2316r1674b2346],
38	oncogenic	JJ	O	oncogenic	amod	39	SENT_31	[p1l1684t2316r1854b2355],
39	effects	NNS	O	effect	dobj	37	SENT_31	[p1l1864t2315r1969b2346],
40	by	IN	O	by	_	0	SENT_31	[p1l1980t2316r2017b2355],
41	altering	VBG	O	alter	prepc_by	37	SENT_31	[p1l2025t2316r2066b2346, p1l667t2366r765b2405],
42	downstream	JJ	O	downstream	amod	43	SENT_31	[p1l772t2365r977b2396],
43	signaling	NN	O	signaling	dobj	41	SENT_31	[p1l985t2365r1138b2405],
44	and	CC	O	and	_	0	SENT_31	[p1l1145t2365r1205b2396],
45	antiapoptotic	JJ	O	antiapoptotic	amod	46	SENT_31	[p1l1213t2366r1431b2404],
46	mechanisms	NNS	O	mechanism	conj_and	43	SENT_31	[p1l1439t2363r1690b2396],
47	.	.	O	.	_	0	SENT_31	[p1l1439t2363r1690b2396],

1	”	NN	O	”	nsubj	6	SENT_32	[p1l1439t2363r1690b2396],
2	Both	CC	O	both	dep	1	SENT_32	[p1l1697t2365r1776b2396],
3	types	NNS	O	type	conj	1	SENT_32	[p1l1784t2372r1866b2404],
4	of	IN	O	of	_	0	SENT_32	[p1l1875t2365r1914b2396],
5	mutation	NN	O	mutation	prep_of	1	SENT_32	[p1l1915t2366r2066b2396],
6	increase	VBP	O	increase	dep	50	SENT_32	[p1l667t2416r801b2446],
7	the	DT	O	the	det	8	SENT_32	[p1l815t2416r865b2446],
8	sensitivity	NN	O	sensitivity	dobj	6	SENT_32	[p1l879t2416r1041b2455],
9	of	IN	O	of	_	0	SENT_32	[p1l1053t2415r1092b2446],
10	the	DT	O	the	det	11	SENT_32	[p1l1099t2416r1149b2446],
11	tumor	NN	O	tumor	prep_of	8	SENT_32	[p1l1162t2422r1264b2446],
12	to	TO	O	to	_	0	SENT_32	[p1l1276t2422r1307b2446],
13	anilinoquinazoline	NN	O	anilinoquinazoline	nn	14	SENT_32	[p1l1321t2416r1631b2455],
14	inhibitors	NNS	O	inhibitor	prep_to	11	SENT_32	[p1l1644t2416r1804b2446],
15	of	IN	O	of	_	0	SENT_32	[p1l1819t2415r1858b2446],
16	EGFR	NN	ORGANIZATION	egfr	prep_of	14	SENT_32	[p1l1863t2418r1969b2453],
17	,	,	O	,	_	0	SENT_32	[p1l1863t2418r1969b2453],
18	most	RBS	O	most	advmod	19	SENT_32	[p1l1984t2422r2068b2446],
19	likely	RB	O	likely	advmod	11	SENT_32	[p1l667t2465r755b2505],
20	by	IN	O	by	_	0	SENT_32	[p1l764t2465r802b2505],
21	repositioning	VBG	O	reposition	prepc_by	6	SENT_32	[p1l811t2466r1033b2505],
22	critical	JJ	O	critical	amod	23	SENT_32	[p1l1043t2465r1153b2496],
23	residues	NNS	O	residue	dobj	21	SENT_32	[p1l1163t2465r1298b2496],
24	surrounding	VBG	O	surround	xcomp	21	SENT_32	[p1l1310t2465r1517b2505],
25	the	DT	O	the	det	29	SENT_32	[p1l1526t2465r1576b2496],
26	ATP	NN	O	atp	nn	29	SENT_32	[p1l1586t2465r1797b2505],
27	—	NN	O	—	nn	29	SENT_32	[p1l1586t2465r1797b2505],
28	binding	NN	O	binding	nn	29	SENT_32	[p1l1586t2465r1797b2505],
29	cleft	NN	O	cleft	dobj	24	SENT_32	[p1l1807t2465r1878b2496],
30	of	IN	O	of	_	0	SENT_32	[p1l1887t2465r1926b2496],
31	the	DT	O	the	det	34	SENT_32	[p1l1930t2465r1980b2496],
32	tyrosine	NN	O	tyrosine	nn	34	SENT_32	[p1l1991t2472r2066b2505, p1l668t2516r733b2546],
33	kinase	NN	O	kinase	nn	34	SENT_32	[p1l741t2515r846b2546],
34	domain	NN	O	domain	prep_of	29	SENT_32	[p1l855t2515r981b2546],
35	of	IN	O	of	_	0	SENT_32	[p1l989t2515r1028b2546],
36	the	DT	O	the	det	37	SENT_32	[p1l1029t2515r1079b2546],
37	receptor	NN	O	receptor	prep_of	34	SENT_32	[p1l1088t2522r1230b2554],
38	,	,	O	,	_	0	SENT_32	[p1l1088t2522r1230b2554],
39	thereby	RB	O	thereby	advmod	40	SENT_32	[p1l1241t2515r1363b2554],
40	stabilizing	VBG	O	stabilize	partmod	6	SENT_32	[p1l1370t2515r1544b2555],
41	their	PRP$	O	they	poss	42	SENT_32	[p1l1551t2515r1628b2546],
42	interactions	NNS	O	interaction	dobj	40	SENT_32	[p1l1634t2516r1829b2546],
43	with	IN	O	with	_	0	SENT_32	[p1l1836t2515r1909b2546],
44	both	DT	O	both	det	45	SENT_32	[p1l1918t2515r1993b2546],
45	ATP	NN	ORGANIZATION	atp	prep_with	40	SENT_32	[p1l1999t2518r2067b2545],
46	and	CC	O	and	_	0	SENT_32	[p1l667t2565r727b2596],
47	its	PRP$	O	its	poss	49	SENT_32	[p1l736t2566r774b2596],
48	competitive	JJ	O	competitive	amod	49	SENT_32	[p1l784t2566r974b2605],
49	inhibitors	NNS	O	inhibitor	prep_with	40	SENT_32	[p1l983t2563r1211b2596],
50	.9	VBP	NUMBER	.9	_	0	SENT_32	[p1l983t2563r1211b2596],
51	’	NN	O	’	dobj	50	SENT_32	[p1l983t2563r1211b2596],
52	1	CD	NUMBER	1	number	53	SENT_32	[p1l983t2563r1211b2596],
53	°	CD	NUMBER	°	nsubj	50	SENT_32	[p1l983t2563r1211b2596],
54	Notwithstanding	IN	O	notwithstanding	_	0	SENT_32	[p1l1220t2565r1503b2605],
55	the	DT	O	the	det	56	SENT_32	[p1l1511t2565r1561b2596],
56	success	NN	O	success	prep_notwithstanding	76	SENT_32	[p1l1571t2576r1692b2596],
57	of	IN	O	of	_	0	SENT_32	[p1l1702t2565r1741b2596],
58	these	DT	O	these	det	59	SENT_32	[p1l1744t2565r1828b2596],
59	drugs	NNS	O	drug	prep_of	56	SENT_32	[p1l1838t2565r1930b2605],
60	in	IN	O	in	_	0	SENT_32	[p1l1940t2566r1971b2596],
61	cases	NNS	O	case	prep_in	59	SENT_32	[p1l1981t2576r2065b2596],
62	of	IN	O	of	_	0	SENT_32	[p1l668t2615r707b2646],
63	non	JJ	O	non	amod	69	SENT_32	[p1l709t2616r954b2646],
64	—	JJ	O	—	amod	69	SENT_32	[p1l709t2616r954b2646],
65	small	JJ	O	small	amod	69	SENT_32	[p1l709t2616r954b2646],
66	—	NN	O	—	nn	69	SENT_32	[p1l709t2616r954b2646],
67	cell	NN	O	cell	nn	69	SENT_32	[p1l709t2616r954b2646],
68	lung	NN	O	lung	nn	69	SENT_32	[p1l964t2616r1039b2655],
69	cancer	NN	O	cancer	prep_of	61	SENT_32	[p1l1048t2626r1155b2646],
70	with	IN	O	with	_	0	SENT_32	[p1l1162t2616r1235b2647],
71	activating	VBG	O	activate	amod	73	SENT_32	[p1l1245t2616r1405b2655],
72	EGFR	NN	ORGANIZATION	egfr	nn	73	SENT_32	[p1l1412t2618r1495b2647],
73	mutations	NNS	O	mutation	prep_with	69	SENT_32	[p1l1502t2616r1679b2653],
74	,	,	O	,	_	0	SENT_32	[p1l1502t2616r1679b2653],
75	it	PRP	O	it	nsubj	76	SENT_32	[p1l1691t2616r1714b2646],
76	appears	VBZ	O	appear	rcmod	53	SENT_32	[p1l1722t2626r1849b2655],
77	that	IN	O	that	complm	81	SENT_32	[p1l1860t2616r1925b2646],
78	all	DT	O	all	det	79	SENT_32	[p1l1932t2616r1971b2646],
79	cases	NNS	O	case	nsubj	81	SENT_32	[p1l1981t2626r2065b2646],
80	eventually	RB	O	eventually	advmod	81	SENT_32	[p1l668t2666r831b2705],
81	progress	VBP	O	progress	ccomp	76	SENT_32	[p1l839t2676r981b2705],
82	despite	IN	O	despite	_	0	SENT_32	[p1l992t2666r1108b2705],
83	such	JJ	O	such	amod	84	SENT_32	[p1l1118t2666r1194b2696],
84	treatment	NN	O	treatment	prep_despite	81	SENT_32	[p1l1204t2672r1371b2696],
85	.	.	O	.	_	0	SENT_32	[p1l1204t2672r1371b2696],

1	N	NN	O	n	nn	2	SENT_33	[p1l968t2786r981b2802],
2	ENGLJ	NN	O	englj	_	0	SENT_33	[p1l997t2786r1080b2808],
3	MED	NN	O	med	dep	2	SENT_33	[p1l1096t2786r1148b2801],
4	352	CD	NUMBER	352	num	3	SENT_33	[p1l1160t2780r1227b2808],
5	;	:	O	;	_	0	SENT_33	[p1l1160t2780r1227b2808],
6	8	CD	NUMBER	8	num	8	SENT_33	[p1l1160t2780r1227b2808],
7	WWW.NEJM.oRG	NNP	O	WWW.NEJM.oRG	nn	8	SENT_33	[p1l1261t2786r1473b2808],
8	FEBRUARY	NNP	DATE	FEBRUARY	dep	3	SENT_33	[p1l1512t2786r1639b2802],
9	24,2005	CD	DATE	24,2005	num	8	SENT_33	[p1l1651t2786r1765b2808],

1	The	DT	O	the	det	5	SENT_34	[p1l880t2883r931b2907],
2	New	NNP	O	New	nn	5	SENT_34	[p1l940t2884r1002b2907],
3	England	NNP	O	England	nn	5	SENT_34	[p1l1011t2883r1122b2914],
4	J	NNP	O	J	nn	5	SENT_34	[p1l1130t2884r1143b2907],
5	oumal	NN	O	oumal	_	0	SENT_34	[p1l1144t2883r1228b2907],
6	of	IN	O	of	_	0	SENT_34	[p1l1238t2883r1266b2907],
7	Medicine	NN	O	medicine	prep_of	5	SENT_34	[p1l1273t2883r1398b2907],

1	Downloaded	VBN	O	download	_	0	SENT_35	[p1l322t2924r492b2947],
2	from	IN	O	from	_	0	SENT_35	[p1l501t2924r565b2947],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_35	[p1l574t2924r692b2954],
4	at	IN	O	at	_	0	SENT_35	[p1l702t2928r725b2947],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_35	[p1l734t2924r916b2947],
6	on	IN	O	on	_	0	SENT_35	[p1l926t2931r958b2947],
7	January	NNP	DATE	January	prep_on	1	SENT_35	[p1l967t2924r1070b2954],
8	5	CD	DATE	5	num	7	SENT_35	[p1l1080t2924r1102b2951],
9	,	,	DATE	,	_	0	SENT_35	[p1l1080t2924r1102b2951],
10	2014	CD	DATE	2014	num	7	SENT_35	[p1l1113t2924r1185b2947],
11	.	.	O	.	_	0	SENT_35	[p1l1113t2924r1185b2947],

1	For	IN	O	for	_	0	SENT_36	[p1l1196t2924r1242b2947],
2	personal	JJ	O	personal	amod	3	SENT_36	[p1l1250t2924r1363b2954],
3	use	NN	O	use	pobj	1	SENT_36	[p1l1372t2931r1415b2947],
4	only	RB	O	only	advmod	3	SENT_36	[p1l1425t2924r1490b2954],
5	.	.	O	.	_	0	SENT_36	[p1l1425t2924r1490b2954],

1	No	DT	O	no	det	3	SENT_37	[p1l1500t2924r1540b2947],
2	other	JJ	O	other	amod	3	SENT_37	[p1l1550t2924r1618b2947],
3	uses	NNS	O	use	_	0	SENT_37	[p1l1627t2931r1682b2947],
4	without	IN	O	without	_	0	SENT_37	[p1l1693t2924r1794b2947],
5	permission	NN	O	permission	prep_without	3	SENT_37	[p1l1802t2924r1955b2954],
6	.	.	O	.	_	0	SENT_37	[p1l1802t2924r1955b2954],

1	Copyright	NN	O	copyright	_	0	SENT_38	[p1l672t2965r806b2996],
2	©	CD	NUMBER	©	num	6	SENT_38	[p1l816t2965r839b2989],
3	2005	CD	DATE	2005	num	6	SENT_38	[p1l849t2965r913b2989],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_38	[p1l924t2965r1115b2989],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_38	[p1l1125t2965r1233b2989],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_38	[p1l1243t2965r1348b2996],
7	.	.	O	.	_	0	SENT_38	[p1l1243t2965r1348b2996],

1	All	DT	O	all	det	2	SENT_39	[p1l1359t2965r1400b2989],
2	rights	NNS	O	rights	nsubj	3	SENT_39	[p1l1410t2965r1484b2996],
3	reserved	VBN	O	reserve	_	0	SENT_39	[p1l1494t2965r1613b2989],
4	.	.	O	.	_	0	SENT_39	[p1l1494t2965r1613b2989],

1	BRIEF	JJ	O	brief	amod	2	SENT_40	[p1l958t3071r1056b3090],
2	REPORT	NN	O	report	_	0	SENT_40	[p1l1070t3071r1201b3090],

1	CASE	NN	O	case	nn	2	SENT_41	[p1l690t3349r952b3407],
2	REPORT	NN	O	report	_	0	SENT_41	[p1l1007t3349r1447b3407],

1	A	DT	O	a	det	4	SENT_42	[p1l7t3535r73b3605],
2	71-year-old	JJ	DURATION	71-year-old	amod	4	SENT_42	[p1l92t3527r571b3628],
3	former	JJ	O	former	amod	4	SENT_42	[p1l592t3527r886b3606],
4	smoker	NN	O	smoker	nsubjpass	6	SENT_42	[p1l905t3527r1224b3606],
5	was	VBD	O	be	auxpass	6	SENT_42	[p1l1237t3554r1398b3606],
6	found	VBN	O	find	_	0	SENT_42	[p1l1421t3527r1672b3606],
7	to	TO	O	to	aux	9	SENT_42	[p1l1693t3544r1772b3606],
8	have	VB	O	have	aux	9	SENT_42	[p1l1794t3527r1982b3606],
9	advanced	VBN	O	advance	xcomp	6	SENT_42	[p1l2003t3527r2134b3606, p1l6t3655r322b3751],
10	,	,	O	,	_	0	SENT_42	[p1l2003t3527r2134b3606, p1l6t3655r322b3751],
11	moderately	RB	O	moderately	advmod	12	SENT_42	[p1l349t3655r824b3756],
12	differentiated	VBN	O	differentiate	dep	9	SENT_42	[p1l841t3655r1410b3734],
13	adenocarcinoma	NN	O	adenocarcinoma	dobj	12	SENT_42	[p1l1430t3655r2137b3734],
14	of	IN	O	of	_	0	SENT_42	[p2l11t20r112b99],
15	the	DT	O	the	det	16	SENT_42	[p2l136t20r267b99],
16	lung	NN	O	lung	prep_of	13	SENT_42	[p2l312t20r509b121],
17	in	IN	O	in	_	0	SENT_42	[p2l550t21r633b98],
18	May	NNP	DATE	May	prep_in	16	SENT_42	[p2l675t28r856b121],
19	2001	CD	DATE	2001	num	18	SENT_42	[p2l897t26r1132b99],
20	.	.	O	.	_	0	SENT_42	[p2l897t26r1132b99],

1	The	DT	O	the	det	7	SENT_43	[p2l1180t20r1343b99],
2	diagnostic	JJ	O	diagnostic	amod	7	SENT_43	[p2l1389t20r1838b121],
3	transbronchial	JJ	O	transbronchial	amod	7	SENT_43	[p2l1883t37r2133b99, p2l11t148r424b227],
4	tumor	NN	O	tumor	nn	7	SENT_43	[p2l451t148r1042b249],
5	—	NN	O	—	nn	7	SENT_43	[p2l451t148r1042b249],
6	biopsy	NN	O	biopsy	nn	7	SENT_43	[p2l451t148r1042b249],
7	specimen	NN	O	specimen	nsubj	8	SENT_43	[p2l1065t149r1476b249],
8	had	VBD	O	have	_	0	SENT_43	[p2l1502t148r1660b227],
9	a	DT	O	a	det	10	SENT_43	[p2l1686t175r1730b227],
10	deletion	NN	O	deletion	dobj	8	SENT_43	[p2l1756t148r2129b244],
11	,	,	O	,	_	0	SENT_43	[p2l1756t148r2129b244],
12	delL747	NN	O	dell747	appos	10	SENT_43	[p2l11t271r712b372],
13	.	.	O	.	_	0	SENT_43	[p2l11t271r712b372],

1	—	NN	O	—	_	0	SENT_44	[p2l11t271r712b372],
2	.	.	O	.	_	0	SENT_44	[p2l11t271r712b372],

1	S752	NN	O	s752	_	0	SENT_45	[p2l11t271r712b372],
2	,13	CD	NUMBER	,13	num	1	SENT_45	[p2l11t271r712b372],
3	identical	JJ	O	identical	amod	1	SENT_45	[p2l736t276r1094b355],
4	to	TO	O	to	_	0	SENT_45	[p2l1118t293r1196b355],
5	a	DT	O	a	det	9	SENT_45	[p2l1220t303r1264b355],
6	previously	RB	DATE	previously	advmod	7	SENT_45	[p2l1285t276r1715b377],
7	described	VBN	O	describe	amod	9	SENT_45	[p2l1735t276r2136b355],
8	EGFR	NN	ORGANIZATION	egfr	nn	9	SENT_45	[p2l9t411r222b484],
9	mutation	NN	O	mutation	prep_to	3	SENT_45	[p2l248t405r637b483],
10	that	WDT	O	that	nsubjpass	12	SENT_45	[p2l670t404r837b483],
11	is	VBZ	O	be	auxpass	12	SENT_45	[p2l864t405r929b483],
12	associated	VBN	O	associate	rcmod	9	SENT_45	[p2l963t404r1401b483],
13	with	IN	O	with	_	0	SENT_45	[p2l1429t404r1618b483],
14	responsiveness	NN	O	responsiveness	prep_with	12	SENT_45	[p2l1651t405r2134b505, p2l11t558r194b611],
15	to	TO	O	to	_	0	SENT_45	[p2l237t549r316b611],
16	geﬁtinib	NN	O	geﬁtinib	prep_to	12	SENT_45	[p2l357t532r737b633],
17	.	.	O	.	_	0	SENT_45	[p2l357t532r737b633],

1	The	DT	O	the	det	2	SENT_46	[p2l779t532r940b611],
2	disease	NN	O	disease	nsubj	3	SENT_46	[p2l982t532r1285b611],
3	progressed	VBD	O	progress	_	0	SENT_46	[p2l1324t532r1794b633],
4	despite	IN	O	despite	_	0	SENT_46	[p2l1835t532r2135b633],
5	treatment	NN	O	treatment	prep_despite	3	SENT_46	[p2l11t677r422b739],
6	with	IN	O	with	_	0	SENT_46	[p2l446t660r633b739],
7	carboplatin	NN	O	carboplatin	prep_with	3	SENT_46	[p2l668t660r1166b761],
8	,	,	O	,	_	0	SENT_46	[p2l668t660r1166b761],
9	taxanes	NNS	O	taxane	prep_with	3	SENT_46	[p2l1206t677r1542b756],
10	,	,	O	,	_	0	SENT_46	[p2l1206t677r1542b756],
11	and	CC	O	and	_	0	SENT_46	[p2l1581t660r1735b739],
12	gemcita	NN	O	gemcita	nn	14	SENT_46	[p2l1768t661r2135b761],
13	—	CD	NUMBER	—	num	14	SENT_46	[p2l1768t661r2135b761],
14	bine	NN	O	bine	conj_and	7	SENT_46	[p2l11t788r215b867],
15	.	.	O	.	_	0	SENT_46	[p2l11t788r215b867],

1	However	RB	O	however	advmod	5	SENT_47	[p2l243t796r635b884],
2	,	,	O	,	_	0	SENT_47	[p2l243t796r635b884],
3	the	DT	O	the	det	4	SENT_47	[p2l664t788r793b867],
4	patient	NN	O	patient	nsubj	5	SENT_47	[p2l816t789r1115b889],
5	had	VBD	O	have	_	0	SENT_47	[p2l1134t788r1289b867],
6	a	DT	O	a	det	10	SENT_47	[p2l1313t815r1357b867],
7	clinical	JJ	O	clinical	amod	10	SENT_47	[p2l1380t788r1681b867],
8	and	CC	O	and	_	0	SENT_47	[p2l1704t788r1860b867],
9	radiographic	JJ	O	radiographic	amod	10	SENT_47	[p2l1884t788r2134b867, p2l10t916r331b1017],
10	response	NN	O	response	dobj	5	SENT_47	[p2l359t942r739b1017],
11	to	TO	O	to	_	0	SENT_47	[p2l768t933r847b995],
12	geﬁtinib	NN	O	geﬁtinib	nn	13	SENT_47	[p2l877t916r1232b1017],
13	monotherapy	NN	O	monotherapy	prep_to	10	SENT_47	[p2l1262t916r1845b1017],
14	,	,	O	,	_	0	SENT_47	[p2l1262t916r1845b1017],
15	which	WDT	O	which	nsubjpass	17	SENT_47	[p2l1875t916r2135b995],
16	was	VBD	O	be	auxpass	17	SENT_47	[p2l6t1071r167b1123],
17	started	VBN	O	start	rcmod	13	SENT_47	[p2l196t1044r484b1123],
18	in	IN	O	in	_	0	SENT_47	[p2l508t1045r589b1122],
19	August	NNP	DATE	August	prep_in	17	SENT_47	[p2l611t1052r917b1145],
20	2002	CD	DATE	2002	num	19	SENT_47	[p2l937t1050r1168b1123],
21	.	.	O	.	_	0	SENT_47	[p2l937t1050r1168b1123],

1	After	IN	O	after	_	0	SENT_48	[p2l136t1172r349b1251],
2	24	CD	DURATION	24	num	3	SENT_48	[p2l373t1178r474b1251],
3	months	NNS	NUMBER	month	prep_after	19	SENT_48	[p2l500t1172r824b1251],
4	of	IN	O	of	_	0	SENT_48	[p2l854t1172r955b1251],
5	complete	JJ	O	complete	amod	6	SENT_48	[p2l963t1172r1351b1273],
6	remission	NN	O	remission	prep_of	3	SENT_48	[p2l1377t1173r1821b1268],
7	,	,	O	,	_	0	SENT_48	[p2l1377t1173r1821b1268],
8	during	IN	O	during	_	0	SENT_48	[p2l1854t1172r2139b1273],
9	which	WDT	O	which	rel	11	SENT_48	[p2l6t1300r267b1379],
10	he	PRP	O	he	nsubj	11	SENT_48	[p2l291t1300r389b1379],
11	continued	VBD	O	continue	rcmod	6	SENT_48	[p2l415t1300r838b1379],
12	to	TO	O	to	aux	13	SENT_48	[p2l863t1317r942b1379],
13	take	VB	O	take	xcomp	11	SENT_48	[p2l968t1300r1143b1380],
14	geﬁtinib	JJ	O	geﬁtinib	amod	15	SENT_48	[p2l1167t1300r1522b1401],
15	monotherapy	NN	O	monotherapy	dobj	13	SENT_48	[p2l1547t1300r2130b1401],
16	,	,	O	,	_	0	SENT_48	[p2l1547t1300r2130b1401],
17	his	PRP$	O	he	poss	18	SENT_48	[p2l11t1428r133b1507],
18	symptoms	NNS	O	symptom	nsubj	19	SENT_48	[p2l171t1445r609b1529],
19	worsened	VBD	O	worsen	_	0	SENT_48	[p2l641t1428r1054b1507],
20	and	CC	O	and	_	0	SENT_48	[p2l1088t1428r1245b1507],
21	computed	VBD	O	compute	conj_and	19	SENT_48	[p2l1281t1428r1704b1529],
22	tomography	NN	O	tomography	nsubj	23	SENT_48	[p2l1740t1445r2134b1529, p2l10t1556r165b1657],
23	revealed	VBD	O	reveal	ccomp	21	SENT_48	[p2l181t1556r519b1635],
24	progressive	JJ	O	progressive	amod	26	SENT_48	[p2l539t1557r1015b1657],
25	lung	NN	O	lung	nn	26	SENT_48	[p2l1035t1556r1227b1657],
26	abnormalities	NNS	O	abnormality	nsubj	27	SENT_48	[p2l1243t1556r1817b1635],
27	consistent	JJ	O	consistent	xcomp	23	SENT_48	[p2l1841t1557r2135b1635, p2l11t1701r175b1763],
28	With	IN	O	with	dep	27	SENT_48	[p2l192t1684r379b1764],
29	the	DT	O	the	det	30	SENT_48	[p2l406t1684r535b1763],
30	occurrence	NN	O	occurrence	pobj	28	SENT_48	[p2l563t1710r1025b1763],
31	of	IN	O	of	_	0	SENT_48	[p2l1053t1684r1153b1763],
32	a	DT	O	a	det	33	SENT_48	[p2l1161t1711r1206b1763],
33	relapse	NN	O	relapse	prep_of	30	SENT_48	[p2l1230t1684r1553b1785],
34	.	.	O	.	_	0	SENT_48	[p2l1230t1684r1553b1785],

1	At	IN	O	at	_	0	SENT_49	[p2l1581t1692r1681b1763],
2	this	DT	O	this	det	3	SENT_49	[p2l1703t1684r1855b1763],
3	point	NN	O	point	prep_at	11	SENT_49	[p2l1883t1685r2130b1785],
4	,	,	O	,	_	0	SENT_49	[p2l1883t1685r2130b1785],
5	geﬁtinib	NN	O	geﬁtinib	nsubjpass	7	SENT_49	[p2l10t1812r365b1913],
6	was	VBD	O	be	auxpass	7	SENT_49	[p2l388t1839r548b1892],
7	stopped	VBN	O	stop	dep	11	SENT_49	[p2l578t1812r937b1913],
8	,	,	O	,	_	0	SENT_49	[p2l578t1812r937b1913],
9	the	DT	O	the	det	10	SENT_49	[p2l968t1812r1098b1891],
10	patient	NN	O	patient	nsubj	11	SENT_49	[p2l1122t1813r1420b1913],
11	provided	VBD	O	provide	_	0	SENT_49	[p2l1439t1812r1811b1913],
12	written	VBN	O	write	amod	14	SENT_49	[p2l1832t1813r2135b1892],
13	informed	VBN	O	inform	amod	14	SENT_49	[p2l10t1940r405b2019],
14	consent	NN	O	consent	dobj	11	SENT_49	[p2l450t1957r802b2036],
15	,	,	O	,	_	0	SENT_49	[p2l450t1957r802b2036],
16	and	CC	O	and	_	0	SENT_49	[p2l852t1940r1007b2019],
17	a	DT	O	a	det	19	SENT_49	[p2l1051t1967r1095b2019],
18	transbronchial	JJ	O	transbronchial	amod	19	SENT_49	[p2l1139t1940r1761b2019],
19	aspirate	NN	O	aspirate	nsubjpass	25	SENT_49	[p2l1803t1941r2135b2041],
20	and	CC	O	and	_	0	SENT_49	[p2l10t2068r164b2147],
21	transbronchial	JJ	O	transbronchial	amod	23	SENT_49	[p2l185t2068r796b2147],
22	biopsy	NN	O	biopsy	nn	23	SENT_49	[p2l816t2068r1091b2169],
23	specimen	NN	O	specimen	conj_and	19	SENT_49	[p2l1109t2069r1505b2169],
24	were	VBD	O	be	auxpass	25	SENT_49	[p2l1522t2095r1721b2147],
25	obtained	VBN	O	obtain	conj_and	11	SENT_49	[p2l1742t2068r2130b2147],
26	.	.	O	.	_	0	SENT_49	[p2l1742t2068r2130b2147],

1	Both	DT	O	both	det	5	SENT_50	[p2l9t2196r209b2275],
2	cytologic	JJ	O	cytologic	amod	5	SENT_50	[p2l233t2196r606b2297],
3	and	CC	O	and	_	0	SENT_50	[p2l628t2196r783b2275],
4	pathological	JJ	O	pathological	amod	5	SENT_50	[p2l805t2196r1326b2297],
5	analysis	NN	O	analysis	nsubj	6	SENT_50	[p2l1349t2196r1676b2297],
6	conﬁrmed	VBD	O	conﬁrmed	_	0	SENT_50	[p2l1702t2196r2136b2275],
7	the	DT	O	the	det	8	SENT_50	[p2l11t2324r139b2403],
8	presence	NN	O	presence	dobj	6	SENT_50	[p2l159t2350r529b2425],
9	of	IN	O	of	_	0	SENT_50	[p2l551t2324r651b2403],
10	recurrent	JJ	O	recurrent	prep_of	8	SENT_50	[p2l653t2341r1060b2420],
11	,	,	O	,	_	0	SENT_50	[p2l653t2341r1060b2420],
12	moderately	RB	O	moderately	advmod	13	SENT_50	[p2l1086t2324r1556b2425],
13	differentiated	VBN	O	differentiate	partmod	10	SENT_50	[p2l1574t2324r2136b2403],
14	adenocarcinoma	NN	O	adenocarcinoma	nn	16	SENT_50	[p2l10t2452r716b2531],
15	(	CD	NUMBER	(	num	16	SENT_50	[p2l743t2453r926b2553],
16	Fig	NN	O	fig	dobj	13	SENT_50	[p2l743t2453r926b2553],
17	.	.	O	.	_	0	SENT_50	[p2l743t2453r926b2553],

1	1A	NN	O	1a	nn	2	SENT_51	[p2l959t2458r1097b2543],
2	)	NN	O	)	nsubj	17	SENT_51	[p2l959t2458r1097b2543],
3	against	IN	O	against	_	0	SENT_51	[p2l1126t2453r1435b2553],
4	a	DT	O	a	det	5	SENT_51	[p2l1452t2479r1497b2531],
5	background	NN	O	background	prep_against	2	SENT_51	[p2l1520t2452r2029b2553],
6	of	IN	O	of	_	0	SENT_51	[p2l2053t2452r2153b2531],
7	normal	JJ	O	normal	amod	8	SENT_51	[p2l11t2580r315b2659],
8	tissue	NN	O	tissue	prep_of	5	SENT_51	[p2l336t2581r598b2676],
9	,	,	O	,	_	0	SENT_51	[p2l336t2581r598b2676],
10	with	IN	O	with	_	0	SENT_51	[p2l621t2580r809b2659],
11	approximately	RB	O	approximately	quantmod	12	SENT_51	[p2l830t2580r1432b2681],
12	30	CD	PERCENT	30	num	13	SENT_51	[p2l1450t2586r1548b2659],
13	percent	NN	PERCENT	percent	prep_with	5	SENT_51	[p2l1570t2597r1887b2681],
14	of	IN	O	of	_	0	SENT_51	[p2l1904t2580r2004b2659],
15	the	DT	O	the	det	16	SENT_51	[p2l2007t2580r2135b2659],
16	specimen	NN	O	specimen	prep_of	13	SENT_51	[p2l12t2709r411b2809],
17	made	VBD	O	make	_	0	SENT_51	[p2l433t2708r662b2787],
18	up	RP	O	up	prt	17	SENT_51	[p2l684t2734r788b2809],
19	of	IN	O	of	_	0	SENT_51	[p2l812t2708r912b2787],
20	tumor	NN	O	tumor	nn	21	SENT_51	[p2l917t2725r1176b2787],
21	cells	NNS	O	cell	prep_of	17	SENT_51	[p2l1197t2708r1402b2787],
22	.	.	O	.	_	0	SENT_51	[p2l1197t2708r1402b2787],

1	We	PRP	O	we	nsubj	2	SENT_52	[p2l1426t2716r1558b2787],
2	hypothesized	VBD	O	hypothesize	_	0	SENT_52	[p2l1581t2708r2136b2809],
3	that	IN	O	that	complm	11	SENT_52	[p2l11t2836r178b2915],
4	the	DT	O	the	det	5	SENT_52	[p2l204t2836r333b2915],
5	patient	NN	O	patient	poss	7	SENT_52	[p2l363t2837r725b2937],
6	’s	POS	O	’s	_	0	SENT_52	[p2l363t2837r725b2937],
7	relapse	NN	O	relapse	nsubj	11	SENT_52	[p2l758t2836r1057b2937],
8	may	MD	O	may	aux	11	SENT_52	[p2l1088t2862r1265b2937],
9	have	VB	O	have	aux	11	SENT_52	[p2l1291t2836r1480b2915],
10	been	VBN	O	be	cop	11	SENT_52	[p2l1512t2836r1711b2915],
11	due	JJ	O	due	ccomp	2	SENT_52	[p2l1742t2836r1893b2915],
12	to	TO	O	to	_	0	SENT_52	[p2l1924t2853r2003b2915],
13	an	DT	O	a	det	17	SENT_52	[p2l2035t2862r2135b2915],
14	acquired	VBN	O	acquire	amod	17	SENT_52	[p2l10t2964r398b3065],
15	,	,	O	,	_	0	SENT_52	[p2l10t2964r398b3065],
16	second	JJ	ORDINAL	second	amod	17	SENT_52	[p2l443t2964r739b3043],
17	mutation	NN	O	mutation	prep_to	11	SENT_52	[p2l777t2965r1166b3043],
18	in	IN	O	in	_	0	SENT_52	[p2l1205t2965r1286b3042],
19	the	DT	O	the	det	21	SENT_52	[p2l1325t2964r1454b3043],
20	EGFR	NN	ORGANIZATION	egfr	nn	21	SENT_52	[p2l1491t2971r1703b3044],
21	gene	NN	O	gene	prep_in	17	SENT_52	[p2l1735t2990r1934b3065],
22	that	WDT	O	that	nsubj	23	SENT_52	[p2l1973t2964r2140b3043],
23	conferred	VBD	O	confer	rcmod	21	SENT_52	[p2l11t3092r418b3171],
24	resistance	NN	O	resistance	dobj	23	SENT_52	[p2l442t3093r864b3171],
25	to	TO	O	to	_	0	SENT_52	[p2l890t3109r969b3171],
26	geﬁtinib	NN	O	geﬁtinib	prep_to	23	SENT_52	[p2l994t3092r1374b3193],
27	,	,	O	,	_	0	SENT_52	[p2l994t3092r1374b3193],
28	and	CC	O	and	_	0	SENT_52	[p2l1403t3092r1559b3171],
29	therefore	RB	O	therefore	advmod	32	SENT_52	[p2l1584t3092r1991b3188],
30	,	,	O	,	_	0	SENT_52	[p2l1584t3092r1991b3188],
31	we	PRP	O	we	nsubj	32	SENT_52	[p2l2016t3119r2135b3171],
32	resequenced	VBD	O	resequence	conj_and	2	SENT_52	[p2l11t3220r534b3321],
33	the	DT	O	the	det	37	SENT_52	[p2l554t3220r682b3299],
34	EGFR	NN	ORGANIZATION	egfr	nn	37	SENT_52	[p2l700t3227r911b3300],
35	tyrosine	NN	O	tyrosine	nn	37	SENT_52	[p2l926t3221r1256b3321],
36	kinase	NN	O	kinase	nn	37	SENT_52	[p2l1277t3220r1544b3300],
37	domain	NN	O	domain	dobj	32	SENT_52	[p2l1566t3220r1886b3299],
38	in	IN	O	in	_	0	SENT_52	[p2l1906t3221r1987b3298],
39	the	DT	O	the	det	42	SENT_52	[p2l2007t3220r2135b3299],
40	second	JJ	ORDINAL	second	amod	42	SENT_52	[p2l12t3348r308b3427],
41	biopsy	NN	O	biopsy	nn	42	SENT_52	[p2l333t3348r612b3449],
42	specimen	NN	O	specimen	prep_in	32	SENT_52	[p2l634t3349r1060b3449],
43	.	.	O	.	_	0	SENT_52	[p2l634t3349r1060b3449],

1	Since	IN	O	since	_	0	SENT_53	[p2l1093t3349r1314b3427],
2	the	DT	O	the	det	3	SENT_53	[p2l1340t3348r1469b3427],
3	relapse	NN	O	relapse	prep_since	9	SENT_53	[p2l1495t3348r1817b3449],
4	,	,	O	,	_	0	SENT_53	[p2l1495t3348r1817b3449],
5	the	DT	O	the	det	6	SENT_53	[p2l1848t3348r1977b3427],
6	patient	NN	O	patient	nsubj	9	SENT_53	[p2l2002t3374r2134b3449, p2l11t3477r205b3555],
7	has	VBZ	O	have	aux	9	SENT_53	[p2l236t3476r377b3555],
8	been	VBN	O	be	aux	9	SENT_53	[p2l416t3476r615b3555],
9	receiving	VBG	O	receive	_	0	SENT_53	[p2l652t3477r1035b3577],
10	various	JJ	O	various	amod	12	SENT_53	[p2l1064t3477r1369b3555],
11	salvage	NN	O	salvage	nn	12	SENT_53	[p2l1410t3476r1711b3577],
12	therapies	NNS	O	therapy	dobj	9	SENT_53	[p2l1748t3476r2133b3577],
13	for	IN	O	for	_	0	SENT_53	[p2l11t3604r134b3683],
14	advanced	JJ	O	advanced	amod	16	SENT_53	[p2l155t3604r547b3683],
15	lung	NN	O	lung	nn	16	SENT_53	[p2l571t3604r765b3705],
16	cancer	NN	O	cancer	prep_for	9	SENT_53	[p2l787t3630r1078b3683],
17	.	.	O	.	_	0	SENT_53	[p2l787t3630r1078b3683],

1	METHODS	NNS	O	method	_	0	SENT_54	[p3l790t157r1341b216],

1	SEQUENCING	NN	O	sequencing	nsubjpass	9	SENT_55	[p3l11t379r573b444],
2	or	CC	O	or	_	0	SENT_55	[p3l616t379r721b429],
3	THE	DT	O	the	det	7	SENT_55	[p3l757t379r917b428],
4	EGFR	NN	ORGANIZATION	egfr	nn	7	SENT_55	[p3l958t379r1165b429],
5	GENE	NN	O	gene	nn	7	SENT_55	[p3l1207t379r1428b429],
6	Genomic	JJ	O	genomic	amod	7	SENT_55	[p3l11t479r396b557],
7	DNA	NN	O	dna	nsubjpass	9	SENT_55	[p3l412t485r623b557],
8	was	VBD	O	be	auxpass	9	SENT_55	[p3l635t505r794b557],
9	extracted	VBN	O	extract	_	0	SENT_55	[p3l816t478r1190b557],
10	from	IN	O	from	_	0	SENT_55	[p3l1210t478r1414b557],
11	both	DT	O	both	det	13	SENT_55	[p3l1434t478r1624b557],
12	tumor	NN	O	tumor	nn	13	SENT_55	[p3l1644t495r1904b557],
13	specimens	NNS	O	specimen	prep_from	9	SENT_55	[p3l1922t504r2135b579, p3l10t607r263b685],
14	from	IN	O	from	_	0	SENT_55	[p3l299t606r504b685],
15	the	DT	O	the	det	16	SENT_55	[p3l539t606r668b685],
16	patient	NN	O	patient	prep_from	9	SENT_55	[p3l700t607r1018b707],
17	,	,	O	,	_	0	SENT_55	[p3l700t607r1018b707],
18	and	CC	O	and	_	0	SENT_55	[p3l1056t606r1212b685],
19	exons	NNS	O	exon	nsubjpass	50	SENT_55	[p3l1246t632r1487b685],
20	18	CD	NUMBER	18	num	19	SENT_55	[p3l1526t612r1622b685],
21	through	IN	O	through	_	0	SENT_55	[p3l1659t606r2001b707],
22	21	CD	NUMBER	21	number	23	SENT_55	[p3l2034t612r2135b684],
23	(	CD	NUMBER	(	num	25	SENT_55	[p3l15t734r173b826],
24	the	DT	O	the	det	25	SENT_55	[p3l15t734r173b826],
25	area	NN	O	area	prep_through	19	SENT_55	[p3l193t760r366b813],
26	of	IN	O	of	_	0	SENT_55	[p3l386t734r486b813],
27	the	DT	O	the	det	29	SENT_55	[p3l488t734r616b813],
28	EGFR	NN	ORGANIZATION	egfr	nn	29	SENT_55	[p3l635t741r846b814],
29	gene	NN	O	gene	prep_of	25	SENT_55	[p3l860t760r1057b835],
30	coding	VBG	O	code	partmod	29	SENT_55	[p3l1079t734r1368b835],
31	for	IN	O	for	_	0	SENT_55	[p3l1385t734r1507b813],
32	the	DT	O	the	det	34	SENT_55	[p3l1525t734r1653b813],
33	tyrosine	NN	O	tyrosine	nn	34	SENT_55	[p3l1674t735r2005b835],
34	kinase	NN	O	kinase	prep_for	30	SENT_55	[p3l2025t734r2134b814, p3l11t888r198b941],
35	domain	NN	O	domain	nsubjpass	38	SENT_55	[p3l219t862r569b953],
36	)	CD	NUMBER	)	num	35	SENT_55	[p3l219t862r569b953],
37	were	VBD	O	be	auxpass	38	SENT_55	[p3l589t889r789b941],
38	ampliﬁed	VBN	O	ampliﬁed	rcmod	34	SENT_55	[p3l810t862r1210b963],
39	and	CC	O	and	_	0	SENT_55	[p3l1229t862r1383b941],
40	sequenced	VBN	O	sequence	rcmod	34	SENT_55	[p3l1405t862r1844b963],
41	as	IN	O	as	_	0	SENT_55	[p3l1863t889r1947b941],
42	previously	RB	DATE	previously	advmod	43	SENT_55	[p3l1967t888r2134b963, p3l6t991r301b1092],
43	described	VBN	O	describe	amod	48	SENT_55	[p3l325t987r800b1070],
44	.9	CD	NUMBER	.9	num	45	SENT_55	[p3l325t987r800b1070],
45	Sense	NN	O	sense	nn	48	SENT_55	[p3l830t997r1068b1070],
46	and	CC	O	and	_	0	SENT_55	[p3l1096t991r1251b1070],
47	antisense	JJ	O	antisense	nn	48	SENT_55	[p3l1278t992r1674b1070],
48	sequences	NNS	O	sequence	prep_as	38	SENT_55	[p3l1704t1017r2133b1092],
49	were	VBD	O	be	auxpass	50	SENT_55	[p3l6t1145r208b1198],
50	obtained	VBN	O	obtain	conj_and	9	SENT_55	[p3l241t1119r612b1198],
51	from	IN	O	from	_	0	SENT_55	[p3l643t1119r850b1198],
52	the	DT	O	the	det	53	SENT_55	[p3l882t1119r1011b1198],
53	products	NNS	O	product	prep_from	50	SENT_55	[p3l1041t1119r1413b1220],
54	of	IN	O	of	_	0	SENT_55	[p3l1447t1119r1548b1198],
55	the	DT	O	the	det	58	SENT_55	[p3l1561t1119r1690b1198],
56	same	JJ	O	same	amod	58	SENT_55	[p3l1723t1145r1940b1198],
57	ampliﬁcation	NN	O	ampliﬁcation	nn	58	SENT_55	[p3l1971t1145r2134b1198, p3l10t1247r433b1348],
58	reactions	NNS	O	reaction	prep_of	53	SENT_55	[p3l456t1248r857b1326],
59	.	.	O	.	_	0	SENT_55	[p3l456t1248r857b1326],

1	All	DT	O	all	det	4	SENT_56	[p3l883t1247r1000b1325],
2	polymerase-chain	JJ	O	polymerase-chain	amod	4	SENT_56	[p3l1022t1247r2136b1348],
3	—	NN	O	—	nn	4	SENT_56	[p3l1022t1247r2136b1348],
4	reaction	NN	O	reaction	nsubjpass	10	SENT_56	[p3l1022t1247r2136b1348],
5	(	CD	NUMBER	(	num	8	SENT_56	[p3l15t1381r254b1467],
6	PCR	NN	O	pcr	nn	8	SENT_56	[p3l15t1381r254b1467],
7	)	NN	O	)	nn	8	SENT_56	[p3l15t1381r254b1467],
8	assays	NNS	O	assay	dep	4	SENT_56	[p3l286t1402r547b1476],
9	were	VBD	O	be	auxpass	10	SENT_56	[p3l573t1402r774b1454],
10	repeated	VBN	O	repeat	_	0	SENT_56	[p3l803t1375r1163b1476],
11	twice	RB	O	twice	advmod	10	SENT_56	[p3l1191t1376r1432b1454],
12	.	.	O	.	_	0	SENT_56	[p3l1191t1376r1432b1454],

1	The	DT	O	the	det	2	SENT_57	[p3l1463t1375r1624b1454],
2	presence	NN	O	presence	nsubjpass	8	SENT_57	[p3l1651t1401r2024b1476],
3	of	IN	O	of	_	0	SENT_57	[p3l2053t1375r2153b1454],
4	the	DT	O	the	det	6	SENT_57	[p3l11t1503r140b1582],
5	second	JJ	ORDINAL	second	amod	6	SENT_57	[p3l184t1503r480b1582],
6	mutation	NN	O	mutation	prep_of	2	SENT_57	[p3l521t1504r911b1582],
7	was	VBD	O	be	auxpass	8	SENT_57	[p3l948t1530r1109b1583],
8	conﬁrmed	VBN	O	conﬁrmed	_	0	SENT_57	[p3l1154t1503r1592b1582],
9	by	IN	O	by	_	0	SENT_57	[p3l1634t1503r1731b1604],
10	isolating	VBG	O	isolate	agent	8	SENT_57	[p3l1768t1503r2139b1604],
11	RNA	NN	O	rna	dobj	10	SENT_57	[p3l9t1638r215b1715],
12	from	IN	O	from	_	0	SENT_57	[p3l233t1631r441b1710],
13	the	DT	O	the	det	15	SENT_57	[p3l464t1631r592b1710],
14	tumor	NN	O	tumor	nn	15	SENT_57	[p3l615t1648r878b1710],
15	specimen	NN	O	specimen	prep_from	10	SENT_57	[p3l899t1632r1302b1732],
16	and	CC	O	and	_	0	SENT_57	[p3l1323t1631r1478b1710],
17	sequencing	NN	O	sequencing	prep_from	10	SENT_57	[p3l1502t1632r1987b1732],
18	the	DT	O	the	det	25	SENT_57	[p3l2006t1631r2135b1710],
19	resultant	JJ	O	resultant	amod	25	SENT_57	[p3l11t1759r390b1838],
20	complementary	JJ	O	complementary	amod	25	SENT_57	[p3l409t1759r1076b1860],
21	DNA	NN	O	dna	nn	25	SENT_57	[p3l1093t1766r1305b1838],
22	(	NN	O	(	nn	25	SENT_57	[p3l1331t1766r1550b1851],
23	cDN	NN	O	cdn	nn	25	SENT_57	[p3l1331t1766r1550b1851],
24	A	NN	O	a	nn	25	SENT_57	[p3l1550t1766r1671b1851],
25	)	NN	O	)	dep	17	SENT_57	[p3l1550t1766r1671b1851],
26	.	.	O	.	_	0	SENT_57	[p3l1550t1766r1671b1851],

1	Total	JJ	O	total	amod	2	SENT_58	[p3l1696t1759r1912b1838],
2	RNA	NN	O	rna	nsubjpass	4	SENT_58	[p3l1933t1766r2139b1843],
3	Was	VBD	O	be	auxpass	4	SENT_58	[p3l6t1914r166b1966],
4	extracted	VBN	O	extract	_	0	SENT_58	[p3l192t1887r569b1966],
5	from	IN	O	from	_	0	SENT_58	[p3l591t1887r797b1966],
6	parafﬁn	NN	O	parafﬁn	prep_from	4	SENT_58	[p3l819t1887r1626b1988],
7	—	CD	NUMBER	—	num	10	SENT_58	[p3l819t1887r1626b1988],
8	embedded	JJ	O	embedded	amod	10	SENT_58	[p3l819t1887r1626b1988],
9	tumor	NN	O	tumor	nn	10	SENT_58	[p3l1650t1904r1910b1966],
10	samples	NNS	O	sample	dep	24	SENT_58	[p3l1932t1913r2134b1966, p3l10t2015r177b2116],
11	with	IN	O	with	_	0	SENT_58	[p3l197t2015r385b2094],
12	the	DT	O	the	det	13	SENT_58	[p3l407t2015r536b2094],
13	use	NN	O	use	prep_with	10	SENT_58	[p3l558t2042r698b2094],
14	of	IN	O	of	_	0	SENT_58	[p3l721t2015r821b2094],
15	an	DT	O	a	det	17	SENT_58	[p3l824t2041r924b2094],
16	RNA	NN	MISC	rna	nn	17	SENT_58	[p3l945t2022r1149b2099],
17	isolation	NN	O	isolation	prep_of	13	SENT_58	[p3l1168t2015r1536b2094],
18	kit	NN	O	kit	dep	24	SENT_58	[p3l1558t2015r1671b2095],
19	(	CD	NUMBER	(	num	18	SENT_58	[p3l1692t2016r2135b2116],
20	Optimum	NNP	O	Optimum	nn	24	SENT_58	[p3l1692t2016r2135b2116],
21	FFPE	NNP	O	FFPE	nn	24	SENT_58	[p3l9t2150r246b2239],
22	,	,	O	,	_	0	SENT_58	[p3l9t2150r246b2239],
23	Ambion	NNP	ORGANIZATION	Ambion	appos	24	SENT_58	[p3l277t2143r623b2222],
24	Diagnostics	NNPS	ORGANIZATION	Diagnostics	dep	6	SENT_58	[p3l650t2144r1209b2244],
25	)	NN	O	)	dep	24	SENT_58	[p3l650t2144r1209b2244],
26	.	.	O	.	_	0	SENT_58	[p3l650t2144r1209b2244],

1	Then	RB	O	then	advmod	9	SENT_59	[p3l1239t2143r1482b2239],
2	,	,	O	,	_	0	SENT_59	[p3l1239t2143r1482b2239],
3	800	CD	NUMBER	800	num	4	SENT_59	[p3l1517t2149r1669b2222],
4	ng	NN	O	ng	nsubjpass	9	SENT_59	[p3l1699t2169r1809b2244],
5	of	IN	O	of	_	0	SENT_59	[p3l1835t2143r1935b2222],
6	total	JJ	O	total	amod	7	SENT_59	[p3l1946t2143r2136b2222],
7	RNA	NN	MISC	rna	prep_of	4	SENT_59	[p3l9t2278r215b2355],
8	was	VBD	O	be	auxpass	9	SENT_59	[p3l252t2298r414b2350],
9	subjected	VBN	O	subject	_	0	SENT_59	[p3l463t2271r857b2372],
10	to	TO	O	to	aux	11	SENT_59	[p3l903t2288r982b2350],
11	reVerse	VB	O	reverse	xcomp	9	SENT_59	[p3l1029t2272r1911b2372],
12	—	CD	NUMBER	—	num	14	SENT_59	[p3l1029t2272r1911b2372],
13	transcription	NN	O	transcription	nn	14	SENT_59	[p3l1029t2272r1911b2372],
14	PCR	NN	O	pcr	dobj	11	SENT_59	[p3l1954t2277r2145b2355],

1	Sense	NN	O	sense	nn	2	SENT_60	[p4l167t1383r313b1425],
2	Strand	NN	O	strand	_	0	SENT_60	[p4l330t1379r490b1425],
3	Antisense	JJ	O	antisense	amod	4	SENT_60	[p4l942t1381r1186b1425],
4	Strand	NN	O	strand	dep	2	SENT_60	[p4l1203t1379r1363b1425],

1	TCATCACGCAGCT	NNP	MISC	TCATCACGCAGCT	nn	2	SENT_61	[p4l138t1537r515b1561],
2	AGCTGCGTGATGA	NNP	MISC	AGCTGCGTGATGA	_	0	SENT_61	[p4l933t1536r1317b1560],

1	First	NNP	ORDINAL	First	_	0	SENT_62	[p4l1734t1761r1832b1799],
2	biopsy	NN	O	biopsy	nn	3	SENT_62	[p4l1851t1757r1998b1813],
3	specimen	NN	O	specimen	dep	1	SENT_62	[p4l1782t1825r2000b1876],

1	Biopsy	NN	O	biopsy	nn	2	SENT_63	[p4l1674t2187r1824b2238],
2	specimen	NN	O	specimen	nsubj	3	SENT_63	[p4l1842t2187r2059b2238],
3	obtained	VBN	O	obtain	_	0	SENT_63	[p4l1734t2247r1933b2289],
4	after	IN	O	after	_	0	SENT_63	[p4l1954t2247r2056b2289],
5	relapse	NN	O	relapse	prep_after	3	SENT_63	[p4l1815t2311r1976b2366],

1	AGCTGCGTGATGA	NNP	O	AGCTGCGTGATGA	nn	2	SENT_64	[p4l715t2470r1095b2495],
2	AGCTGCATGATGA	NNP	O	AGCTGCATGATGA	_	0	SENT_64	[p4l1204t2470r1587b2495],

1	Subcloning	NN	O	subcloning	nn	2	SENT_65	[p4l1738t2670r1996b2726],
2	illlllll	NN	O	illlllll	_	0	SENT_65	[p4l713t2639r1098b2867],
3	_	NN	O	_	nn	5	SENT_65	[p4l1203t2623r1504b2867],
4	ҭ	NN	O	ҭ	nn	5	SENT_65	[p4l1820t2735r1969b2777],
5	n	NN	O	n	dep	2	SENT_65	[p4l1820t2735r1969b2777],
6	+	CC	O	+	rcmod	5	SENT_65	[p4l1820t2735r1969b2777],

1	Wild	NNP	O	Wild	_	0	SENT_66	[p4l795t2909r896b2951],
2	type	NN	O	type	dep	1	SENT_66	[p4l915t2917r1010b2964],

1	Figure	NNP	O	Figure	_	0	SENT_67	[p4l66t3159r228b3221],
2	1	CD	NUMBER	1	dep	1	SENT_67	[p4l248t3162r289b3206],
3	.	.	O	.	_	0	SENT_67	[p4l248t3162r289b3206],

1	Identiﬁcation	NN	O	identiﬁcation	_	0	SENT_68	[p4l312t3157r654b3206],
2	of	IN	O	of	_	0	SENT_68	[p4l674t3157r734b3206],
3	a	DT	DURATION	a	det	6	SENT_68	[p4l741t3174r768b3206],
4	Second	JJ	DURATION	second	amod	6	SENT_68	[p4l786t3158r976b3206],
5	EGFR	NN	O	egfr	nn	6	SENT_68	[p4l999t3161r1148b3206],
6	Mutation	NN	O	mutation	prep_of	1	SENT_68	[p4l1167t3159r1421b3206],
7	.	.	O	.	_	0	SENT_68	[p4l1167t3159r1421b3206],

1	Panel	NN	O	panel	nn	2	SENT_69	[p4l67t3254r202b3302],
2	A	NN	O	a	nsubj	3	SENT_69	[p4l222t3257r259b3302],
3	shows	VBZ	O	show	_	0	SENT_69	[p4l278t3254r440b3302],
4	the	DT	O	the	det	5	SENT_69	[p4l459t3254r541b3302],
5	patient	NN	O	patient	poss	9	SENT_69	[p4l563t3258r785b3317],
6	’s	POS	O	’s	_	0	SENT_69	[p4l563t3258r785b3317],
7	transbronchial	JJ	O	transbronchial	amod	9	SENT_69	[p4l804t3254r1184b3302],
8	biopsy	NN	O	biopsy	nn	9	SENT_69	[p4l1209t3254r1377b3317],
9	specimen	NN	O	specimen	dobj	3	SENT_69	[p4l1396t3258r1645b3317],
10	obtained	VBN	O	obtain	partmod	9	SENT_69	[p4l1667t3254r1894b3302],
11	at	IN	O	at	_	0	SENT_69	[p4l1917t3263r1963b3302],
12	the	DT	O	the	det	13	SENT_69	[p4l1979t3254r2062b3302],
13	time	NN	O	time	prep_at	10	SENT_69	[p4l61t3338r178b3383],
14	of	IN	O	of	_	0	SENT_69	[p4l197t3333r255b3383],
15	relapse	NN	O	relapse	prep_of	13	SENT_69	[p4l267t3334r466b3397],
16	.	.	O	.	_	0	SENT_69	[p4l267t3334r466b3397],

1	Nests	NNS	O	nest	nsubj	4	SENT_70	[p4l491t3338r637b3383],
2	of	IN	O	of	prep	1	SENT_70	[p4l658t3333r715b3383],
3	moderately	RB	O	moderately	pcomp	2	SENT_70	[p4l728t3334r1019b3398],
4	differentiated	VBN	O	differentiate	_	0	SENT_70	[p4l1037t3333r1384b3383],
5	adenocarcinoma	NN	O	adenocarcinoma	nn	6	SENT_70	[p4l1407t3334r1845b3383],
6	cells	NNS	O	cell	dobj	4	SENT_70	[p4l1865t3334r1977b3383],
7	(	JJ	O	(	amod	9	SENT_70	[p4l68t3418r250b3478],
8	arrow	NN	O	arrow	nn	9	SENT_70	[p4l68t3418r250b3478],
9	)	NN	O	)	nsubjpass	11	SENT_70	[p4l68t3418r250b3478],
10	are	VBP	O	be	auxpass	11	SENT_70	[p4l275t3431r352b3463],
11	intermixed	VBN	O	intermix	rcmod	6	SENT_70	[p4l373t3414r647b3463],
12	with	IN	O	with	_	0	SENT_70	[p4l666t3414r774b3463],
13	normal	JJ	O	normal	amod	17	SENT_70	[p4l798t3414r980b3463],
14	stromal	JJ	O	stromal	amod	17	SENT_70	[p4l1002t3414r1199b3463],
15	and	CC	O	and	_	0	SENT_70	[p4l1221t3414r1313b3463],
16	epithelial	JJ	O	epithelial	conj_and	14	SENT_70	[p4l1335t3414r1570b3477],
17	elements	NNS	O	element	prep_with	11	SENT_70	[p4l1591t3414r1844b3463],
18	.	.	O	.	_	0	SENT_70	[p4l1591t3414r1844b3463],

1	In	IN	O	in	_	0	SENT_71	[p4l1869t3419r1912b3462],
2	Panel	NN	O	panel	nn	3	SENT_71	[p4l1938t3414r2073b3463],
3	B	NN	O	b	prep_in	8	SENT_71	[p4l67t3499r109b3551],
4	,	,	O	,	_	0	SENT_71	[p4l67t3499r109b3551],
5	sequencing	NN	O	sequencing	nn	6	SENT_71	[p4l133t3499r432b3558],
6	ofexon	NN	O	ofexon	nsubj	8	SENT_71	[p4l450t3494r635b3543],
7	20	CD	NUMBER	20	dep	6	SENT_71	[p4l658t3498r718b3543],
8	demonstrates	VBZ	O	demonstrate	_	0	SENT_71	[p4l737t3495r1099b3543],
9	a	DT	O	a	det	17	SENT_71	[p4l1120t3512r1145b3543],
10	novel	JJ	O	novel	amod	17	SENT_71	[p4l1167t3495r1301b3543],
11	C-to-T	JJ	O	c-to-t	amod	17	SENT_71	[p4l1324t3498r1484b3543],
12	(	NN	O	(	nn	17	SENT_71	[p4l1507t3499r1774b3558],
13	antisense	JJ	O	antisense	amod	17	SENT_71	[p4l1507t3499r1774b3558],
14	G-to-A	NN	O	g-to-a	nn	17	SENT_71	[p4l1794t3498r1980b3558],
15	)	CD	NUMBER	)	num	17	SENT_71	[p4l1794t3498r1980b3558],
16	base-pair	NN	O	base-pair	nn	17	SENT_71	[p4l65t3575r304b3638],
17	change	NN	O	change	nsubj	19	SENT_71	[p4l321t3575r508b3639],
18	(	CD	NUMBER	(	num	19	SENT_71	[p4l533t3579r763b3638],
19	arrows	NNS	O	arrow	xcomp	8	SENT_71	[p4l533t3579r763b3638],
20	)	CD	NUMBER	)	dep	19	SENT_71	[p4l533t3579r763b3638],
21	.	.	O	.	_	0	SENT_71	[p4l533t3579r763b3638],

1	Raw	NN	O	raw	nn	2	SENT_72	[p4l789t3579r893b3623],
2	sequences	NNS	O	sequence	nsubj	3	SENT_72	[p4l911t3592r1184b3638],
3	ofthe	VBP	O	ofthe	_	0	SENT_72	[p4l1205t3574r1352b3623],
4	original	JJ	O	original	amod	6	SENT_72	[p4l1371t3575r1565b3639],
5	biopsy	NN	O	biopsy	nn	6	SENT_72	[p4l1590t3575r1758b3638],
6	specimen	NN	O	specimen	dobj	3	SENT_72	[p4l1777t3579r2026b3638],
7	and	CC	O	and	_	0	SENT_72	[p4l63t3655r155b3704],
8	the	DT	O	the	det	10	SENT_72	[p4l173t3655r255b3704],
9	biopsy	NN	O	biopsy	nn	10	SENT_72	[p4l275t3655r443b3719],
10	specimen	NN	O	specimen	nsubj	14	SENT_72	[p4l460t3660r708b3718],
11	obtained	VBN	O	obtain	partmod	10	SENT_72	[p4l729t3655r956b3704],
12	on	IN	O	on	_	0	SENT_72	[p4l975t3672r1037b3704],
13	relapse	NN	O	relapse	prep_on	11	SENT_72	[p4l1060t3655r1244b3718],
14	demonstrate	VBP	O	demonstrate	conj_and	3	SENT_72	[p4l1261t3655r1596b3704],
15	the	DT	O	the	det	16	SENT_72	[p4l1611t3655r1693b3704],
16	appearance	NN	O	appearance	dobj	14	SENT_72	[p4l1711t3672r2013b3718],
17	of	IN	O	of	_	0	SENT_72	[p4l2030t3655r2087b3704],
18	this	DT	O	this	det	19	SENT_72	[p4l61t3736r155b3784],
19	mutation	NN	O	mutation	prep_of	16	SENT_72	[p4l178t3740r429b3792],
20	,	,	O	,	_	0	SENT_72	[p4l178t3740r429b3792],
21	and	CC	O	and	_	0	SENT_72	[p4l450t3736r543b3784],
22	further	RB	O	further	advmod	24	SENT_72	[p4l563t3735r742b3784],
23	subcloning	NN	O	subcloning	nsubj	24	SENT_72	[p4l759t3736r1049b3799],
24	confirms	VBZ	O	confirm	conj_and	3	SENT_72	[p4l1066t3735r1296b3784],
25	the	DT	O	the	det	26	SENT_72	[p4l1314t3736r1396b3784],
26	presence	NN	O	presence	dobj	24	SENT_72	[p4l1417t3752r1649b3799],
27	of	IN	O	of	_	0	SENT_72	[p4l1667t3735r1725b3784],
28	both	CC	O	both	advmod	30	SENT_72	[p4l1736t3736r1849b3784],
29	the	DT	O	the	det	30	SENT_72	[p4l1868t3736r1950b3784],
30	wildL	NN	O	wildl	prep_of	26	SENT_72	[p4l1966t3736r2090b3784, p4l65t3825r162b3834],
31	,	,	O	,	_	0	SENT_72	[p4l1966t3736r2090b3784, p4l65t3825r162b3834],
32	,	,	O	,	_	0	SENT_72	[p4l1966t3736r2090b3784, p4l65t3825r162b3834],
33	-	:	O	-	_	0	SENT_72	[p4l1966t3736r2090b3784, p4l65t3825r162b3834],
34	_	CD	NUMBER	_	num	35	SENT_72	[p4l1966t3736r2090b3784, p4l65t3825r162b3834],
35	_	CD	NUMBER	_	dep	30	SENT_72	[p4l195t3833r243b3834],
36	,	,	O	,	_	0	SENT_72	[p4l195t3833r243b3834],
37	_	CD	NUMBER	_	num	38	SENT_72	[p4l195t3833r243b3834],
38	J	NN	O	j	appos	35	SENT_72	[p4l263t3816r281b3834],
39	,	,	O	,	_	0	SENT_72	[p4l306t3825r494b3834],
40	__	NN	O	__	appos	38	SENT_72	[p4l306t3825r494b3834],
41	,	,	O	,	_	0	SENT_72	[p4l306t3825r494b3834],
42	,	,	O	,	_	0	SENT_72	[p4l306t3825r494b3834],
43	L	NN	O	l	nn	44	SENT_72	[p4l306t3825r494b3834],
44	_	NN	O	_	appos	35	SENT_72	[p4l306t3825r494b3834],
45	,	,	O	,	_	0	SENT_72	[p4l306t3825r494b3834],
46	_	NN	O	_	nn	47	SENT_72	[p4l306t3825r494b3834],
47	L	NN	O	l	appos	44	SENT_72	[p4l306t3825r494b3834],
48	___	CD	NUMBER	___	dep	35	SENT_72	[p4l519t3833r782b3834],
49	,	,	O	,	_	0	SENT_72	[p4l519t3833r782b3834],
50	,	,	O	,	_	0	SENT_72	[p4l519t3833r782b3834],
51	_	RB	O	_	dep	30	SENT_72	[p4l519t3833r782b3834],
52	,	,	O	,	_	0	SENT_72	[p4l519t3833r782b3834],
53	____	IN	O	____	prep	24	SENT_72	[p4l519t3833r782b3834],

1	|	NN	O	|	nn	3	SENT_73	[p5l8t6r16b125],
2	type	NN	O	type	nn	3	SENT_73	[p5l61t6r169b51],
3	EIHO	NN	O	eiho	_	0	SENT_73	[p5l189t6r281b36],
4	mutant	JJ	O	mutant	amod	5	SENT_73	[p5l306t6r494b36],
5	sequences	NNS	O	sequence	dep	3	SENT_73	[p5l514t6r801b51],
6	.	.	O	.	_	0	SENT_73	[p5l514t6r801b51],

1	I	PRP	O	I	_	0	SENT_74	[p5l2142t6r2151b125],

1	with	IN	O	with	_	0	SENT_75	[p5l7t293r147b351],
2	random	JJ	O	random	amod	4	SENT_75	[p5l161t292r408b351],
3	hexamer	NN	O	hexamer	nn	4	SENT_75	[p5l422t293r692b351],
4	primers	NNS	O	primer	pobj	1	SENT_75	[p5l704t293r965b367],
5	.	.	O	.	_	0	SENT_75	[p5l704t293r965b367],

1	Ampliﬁcation	NN	O	ampliﬁcation	nsubj	23	SENT_76	[p5l981t292r1411b367],
2	of	IN	O	of	_	0	SENT_76	[p5l1426t292r1500b351],
3	the	DT	O	the	det	7	SENT_76	[p5l1502t293r1597b351],
4	CDNA	NNP	ORGANIZATION	CDNA	nn	7	SENT_76	[p5l11t392r202b446],
5	(	CD	NUMBER	(	num	7	SENT_76	[p5l223t393r418b455],
6	sense	NN	O	sense	nn	7	SENT_76	[p5l223t393r418b455],
7	primer	NN	O	primer	prep_of	1	SENT_76	[p5l438t388r672b462],
8	:	:	O	:	_	0	SENT_76	[p5l438t388r672b462],
9	5	CD	NUMBER	5	dep	7	SENT_76	[p5l697t392r1595b446, p5l8t487r269b553],
10	'	''	O	'	_	0	SENT_76	[p5l697t392r1595b446, p5l8t487r269b553],
11	GTTAAAATTCCCGTCGCTATC3	NN	O	gttaaaattcccgtcgctatc3	dep	1	SENT_76	[p5l697t392r1595b446, p5l8t487r269b553],
12	'	''	O	'	_	0	SENT_76	[p5l697t392r1595b446, p5l8t487r269b553],
13	,	,	O	,	_	0	SENT_76	[p5l697t392r1595b446, p5l8t487r269b553],
14	and	CC	O	and	_	0	SENT_76	[p5l294t483r412b541],
15	antisense	JJ	O	antisense	amod	16	SENT_76	[p5l432t483r733b541],
16	primer	NN	O	primer	dep	1	SENT_76	[p5l752t483r991b557],
17	:	:	O	:	_	0	SENT_76	[p5l752t483r991b557],
18	5	CD	NUMBER	5	dep	16	SENT_76	[p5l1016t487r1595b541, p5l11t582r601b645],
19	'	''	O	'	_	0	SENT_76	[p5l1016t487r1595b541, p5l11t582r601b645],
20	GGACATAGTCCAGGAGGCAG3	NN	O	ggacatagtccaggaggcag3	dep	1	SENT_76	[p5l1016t487r1595b541, p5l11t582r601b645],
21	’	CD	NUMBER	’	num	22	SENT_76	[p5l1016t487r1595b541, p5l11t582r601b645],
22	)	NN	O	)	dep	1	SENT_76	[p5l1016t487r1595b541, p5l11t582r601b645],
23	yielded	VBD	O	yield	_	0	SENT_76	[p5l617t578r837b652],
24	two	CD	NUMBER	two	num	25	SENT_76	[p5l852t590r964b636],
25	fragments	NNS	O	fragment	dobj	23	SENT_76	[p5l979t577r1312b652],
26	,	,	O	,	_	0	SENT_76	[p5l979t577r1312b652],
27	a	DT	O	a	det	32	SENT_76	[p5l1331t597r1364b636],
28	196-bp	JJ	O	196-bp	amod	32	SENT_76	[p5l1380t578r1596b652],
29	(	NN	O	(	nn	32	SENT_76	[p5l14t672r349b747],
30	wild	JJ	O	wild	amod	32	SENT_76	[p5l14t672r349b747],
31	—	NN	O	—	nn	32	SENT_76	[p5l14t672r349b747],
32	type	NN	O	type	dobj	23	SENT_76	[p5l14t672r349b747],
33	)	CD	NUMBER	)	num	34	SENT_76	[p5l14t672r349b747],
34	fragment	NN	O	fragment	dep	32	SENT_76	[p5l374t672r668b747],
35	and	CC	O	and	_	0	SENT_76	[p5l685t673r802b731],
36	a	DT	O	a	det	40	SENT_76	[p5l822t692r856b731],
37	178-bp	JJ	O	178-bp	amod	40	SENT_76	[p5l878t673r1098b747],
38	(	NN	O	(	nn	40	SENT_76	[p5l1124t672r1402b740],
39	deletion	NN	O	deletion	nn	40	SENT_76	[p5l1124t672r1402b740],
40	product	NN	O	product	dobj	23	SENT_76	[p5l1422t673r1595b747, p5l11t773r126b835],
41	)	CD	NUMBER	)	num	42	SENT_76	[p5l1422t673r1595b747, p5l11t773r126b835],
42	fragment	NN	O	fragment	dep	40	SENT_76	[p5l155t767r463b842],
43	.	.	O	.	_	0	SENT_76	[p5l155t767r463b842],

1	PCR	NN	O	pcr	nn	2	SENT_77	[p5l490t772r632b830],
2	products	NNS	O	product	nsubjpass	15	SENT_77	[p5l648t767r926b842],
3	were	VBD	O	be	auxpass	4	SENT_77	[p5l948t787r1099b826],
4	subcloned	VBN	O	subclon	_	0	SENT_77	[p5l1125t767r1448b827],
5	into	IN	O	into	_	0	SENT_77	[p5l1472t768r1595b826],
6	the	DT	O	the	det	7	SENT_77	[p5l11t863r107b921],
7	pGEM-T	NN	O	pgem-t	prep_into	4	SENT_77	[p5l135t867r407b937],
8	easy	JJ	O	easy	amod	13	SENT_77	[p5l434t882r567b937],
9	cloning	NN	O	cloning	nn	13	SENT_77	[p5l592t863r833b937],
10	vector	NN	O	vector	nn	13	SENT_77	[p5l855t875r1049b921],
11	(	CD	NUMBER	(	num	13	SENT_77	[p5l1078t863r1448b937],
12	lnvitrogen	NN	O	lnvitrogen	nn	13	SENT_77	[p5l1078t863r1448b937],
13	)	NN	O	)	dep	7	SENT_77	[p5l1078t863r1448b937],
14	and	CC	O	and	_	0	SENT_77	[p5l1480t863r1596b921],
15	sequenced	VBN	O	sequence	conj_and	4	SENT_77	[p5l12t958r360b1032],
16	.	.	O	.	_	0	SENT_77	[p5l12t958r360b1032],

1	ENGLJ	NNP	O	ENGLJ	nn	2	SENT_78	[p5l516t1113r600b1135],
2	MED	NNP	O	MED	_	0	SENT_78	[p5l615t1113r668b1128],
3	2	CD	NUMBER	2	num	2	SENT_78	[p5l708t1113r729b1133],
4	;	:	O	;	_	0	SENT_78	[p5l708t1113r729b1133],
5	WWW	NNP	O	WWW	dep	2	SENT_78	[p5l781t1113r992b1135],
6	.	.	O	.	_	0	SENT_78	[p5l781t1113r992b1135],

1	NE	NNS	O	ne	nsubj	2	SENT_79	[p5l781t1113r992b1135],
2	}	VBP	O	}	_	0	SENT_79	[p5l781t1113r992b1135],
3	M.ORG	NNP	O	M.ORG	nn	4	SENT_79	[p5l781t1113r992b1135],
4	FEBRUARY	NNP	DATE	FEBRUARY	nsubj	6	SENT_79	[p5l1032t1113r1159b1129],
5	24,2005	CD	NUMBER	24,2005	num	6	SENT_79	[p5l1171t1113r1285b1135],
6	787	CD	NUMBER	787	xcomp	2	SENT_79	[p5l1959t1111r2016b1133],

1	e	LS	O	e	dep	3	SENT_80	[p5l739t1154r752b1170],
2	New	NNP	LOCATION	New	nn	3	SENT_80	[p5l762t1147r824b1170],
3	England	NNP	LOCATION	England	_	0	SENT_80	[p5l833t1146r944b1177],
4	J	NNP	O	J	prep	3	SENT_80	[p5l952t1147r965b1170],
5	oumal	NN	O	oumal	dep	4	SENT_80	[p5l966t1146r1050b1170],
6	of	IN	O	of	_	0	SENT_80	[p5l1060t1146r1088b1170],
7	Medicine	NN	O	medicine	prep_of	3	SENT_80	[p5l1095t1146r1220b1170],

1	Downloaded	VBN	O	download	_	0	SENT_81	[p5l144t1187r314b1210],
2	from	IN	O	from	_	0	SENT_81	[p5l322t1187r387b1210],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_81	[p5l396t1187r514b1217],
4	at	IN	O	at	_	0	SENT_81	[p5l524t1191r547b1210],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_81	[p5l556t1187r738b1210],
6	on	IN	O	on	_	0	SENT_81	[p5l748t1194r780b1210],
7	January	NNP	DATE	January	prep_on	1	SENT_81	[p5l789t1187r891b1217],
8	5	CD	DATE	5	num	7	SENT_81	[p5l902t1187r924b1214],
9	,	,	DATE	,	_	0	SENT_81	[p5l902t1187r924b1214],
10	2014	CD	DATE	2014	num	7	SENT_81	[p5l935t1187r1007b1210],
11	.	.	O	.	_	0	SENT_81	[p5l935t1187r1007b1210],

1	For	IN	O	for	_	0	SENT_82	[p5l1018t1187r1064b1210],
2	personal	JJ	O	personal	amod	3	SENT_82	[p5l1072t1187r1184b1217],
3	use	NN	O	use	pobj	1	SENT_82	[p5l1194t1194r1237b1210],
4	only	RB	O	only	advmod	3	SENT_82	[p5l1247t1187r1312b1217],
5	.	.	O	.	_	0	SENT_82	[p5l1247t1187r1312b1217],

1	No	DT	O	no	det	3	SENT_83	[p5l1322t1187r1362b1210],
2	other	JJ	O	other	amod	3	SENT_83	[p5l1372t1187r1440b1210],
3	uses	NNS	O	use	_	0	SENT_83	[p5l1448t1194r1504b1210],
4	without	IN	O	without	_	0	SENT_83	[p5l1515t1187r1616b1210],
5	permission	NN	O	permission	prep_without	3	SENT_83	[p5l1624t1187r1777b1217],
6	.	.	O	.	_	0	SENT_83	[p5l1624t1187r1777b1217],

1	Copyright	NN	O	copyright	_	0	SENT_84	[p5l494t1228r628b1259],
2	©	CD	NUMBER	©	num	6	SENT_84	[p5l638t1228r661b1252],
3	2005	CD	DATE	2005	num	6	SENT_84	[p5l671t1228r735b1252],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_84	[p5l746t1228r937b1252],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_84	[p5l947t1228r1055b1252],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_84	[p5l1065t1228r1170b1259],
7	.	.	O	.	_	0	SENT_84	[p5l1065t1228r1170b1259],

1	All	DT	O	all	det	2	SENT_85	[p5l1181t1228r1222b1252],
2	rights	NNS	O	rights	nsubj	3	SENT_85	[p5l1232t1228r1306b1259],
3	reserved	VBN	O	reserve	_	0	SENT_85	[p5l1316t1228r1435b1252],
4	.	.	O	.	_	0	SENT_85	[p5l1316t1228r1435b1252],

1	The	DT	O	the	det	4	SENT_86	[p5l715t1334r752b1355],
2	NEW	NNP	O	NEW	nn	4	SENT_86	[p5l764t1336r845b1355],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_86	[p5l859t1336r1034b1355],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_86	[p5l1048t1336r1214b1362],
5	ofMEDICINE	NN	O	ofmedicine	dep	4	SENT_86	[p5l1228t1334r1444b1361],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_87	[p5l12t1557r219b1606],
2	EXPRESSION	NN	O	expression	nsubj	3	SENT_87	[p5l263t1557r772b1606],
3	CONSTRUCTS	VBZ	O	construct	dep	21	SENT_87	[p5l819t1557r1367b1606],
4	Constructs	NNS	O	construct	dobj	3	SENT_87	[p5l10t1661r467b1735],
5	with	IN	O	with	_	0	SENT_87	[p5l497t1656r686b1735],
6	the	DT	O	the	det	9	SENT_87	[p5l719t1656r848b1734],
7	full	JJ	O	full	amod	9	SENT_87	[p5l881t1655r1329b1756],
8	—	NN	O	—	nn	9	SENT_87	[p5l881t1655r1329b1756],
9	length	NN	O	length	prep_with	3	SENT_87	[p5l881t1655r1329b1756],
10	wild	JJ	O	wild	amod	13	SENT_87	[p5l1357t1655r1750b1756],
11	—	NN	O	—	nn	13	SENT_87	[p5l1357t1655r1750b1756],
12	type	NN	O	type	nn	13	SENT_87	[p5l1357t1655r1750b1756],
13	EGFR	NN	ORGANIZATION	egfr	dep	9	SENT_87	[p5l1781t1662r2011b1751],
14	,	,	O	,	_	0	SENT_87	[p5l1781t1662r2011b1751],
15	as	RB	O	as	_	0	SENT_87	[p5l2048t1682r2132b1734],
16	well	RB	O	well	_	0	SENT_87	[p5l6t1784r178b1863],
17	as	IN	O	as	_	0	SENT_87	[p5l197t1810r280b1862],
18	the	DT	O	the	det	20	SENT_87	[p5l302t1784r429b1862],
19	common	JJ	O	common	amod	20	SENT_87	[p5l450t1809r826b1862],
20	mutations	NNS	O	mutation	prep_with	3	SENT_87	[p5l846t1784r1269b1863],
21	L85	VBP	O	l85	_	0	SENT_87	[p5l1289t1789r1440b1862],
22	8Rand	NN	O	8rand	nn	23	SENT_87	[p5l1448t1784r1733b1867],
23	delL747	NN	O	dell747	dobj	21	SENT_87	[p5l1754t1784r2139b1862],
24	—	CD	NUMBER	—	num	25	SENT_87	[p5l1754t1784r2139b1862],
25	P753insS	NN	O	p753inss	nsubj	21	SENT_87	[p5l9t1912r423b2007],
26	,	,	O	,	_	0	SENT_87	[p5l9t1912r423b2007],
27	were	VBD	O	be	auxpass	29	SENT_87	[p5l462t1938r663b1991],
28	kindly	RB	O	kindly	advmod	29	SENT_87	[p5l701t1912r966b2012],
29	provided	VBN	O	provide	ccomp	21	SENT_87	[p5l998t1911r1370b2012],
30	by	IN	O	by	_	0	SENT_87	[p5l1408t1912r1505b2012],
31	Dr.	NNP	O	Dr.	nn	32	SENT_87	[p5l1537t1918r1663b1990],
32	Kwol	NNP	O	Kwol	agent	29	SENT_87	[p5l1705t1912r2135b1993],
33	<	JJR	O	<	amod	32	SENT_87	[p5l1705t1912r2135b1993],
34	.	.	O	.	_	0	SENT_87	[p5l1705t1912r2135b1993],

1	—	NN	O	—	_	0	SENT_88	[p5l1705t1912r2135b1993],
2	.	.	O	.	_	0	SENT_88	[p5l1705t1912r2135b1993],

1	Kin	NNP	O	Kin	nn	2	SENT_89	[p5l1705t1912r2135b1993],
2	Wong	NNP	PERSON	Wong	_	0	SENT_89	[p5l7t2047r281b2140],
3	.	.	O	.	_	0	SENT_89	[p5l7t2047r281b2140],

1	The	DT	O	the	det	2	SENT_90	[p5l302t2040r462b2118],
2	delL747	NN	O	dell747	_	0	SENT_90	[p5l483t2039r1072b2118],
3	.	.	O	.	_	0	SENT_90	[p5l483t2039r1072b2118],

1	—	NN	O	—	_	0	SENT_91	[p5l483t2039r1072b2118],
2	.	.	O	.	_	0	SENT_91	[p5l483t2039r1072b2118],

1	S752	NN	O	s752	nn	2	SENT_92	[p5l483t2039r1072b2118],
2	mutation	NN	O	mutation	nsubj	3	SENT_92	[p5l1092t2040r1476b2119],
3	(	VBD	O	(	dep	40	SENT_92	[p5l1500t2040r1656b2131],
4	the	DT	O	the	det	7	SENT_92	[p5l1500t2040r1656b2131],
5	initial	JJ	O	initial	amod	7	SENT_92	[p5l1676t2040r1914b2118],
6	EGFR	NN	ORGANIZATION	egfr	nn	7	SENT_92	[p5l1931t2046r2141b2119],
7	mutation	NN	O	mutation	dobj	3	SENT_92	[p5l10t2168r400b2247],
8	identiﬁed	VBN	O	identiﬁed	partmod	7	SENT_92	[p5l440t2167r844b2246],
9	in	IN	O	in	_	0	SENT_92	[p5l884t2168r966b2245],
10	our	PRP$	O	we	poss	11	SENT_92	[p5l1008t2193r1152b2247],
11	patient	NN	O	patient	prep_in	8	SENT_92	[p5l1189t2168r1511b2268],
12	)	CD	NUMBER	)	dep	11	SENT_92	[p5l1189t2168r1511b2268],
13	and	CC	O	and	_	0	SENT_92	[p5l1558t2167r1713b2246],
14	a	DT	DURATION	a	det	16	SENT_92	[p5l1754t2194r1798b2246],
15	second	JJ	DURATION	second	amod	16	SENT_92	[p5l1839t2168r2135b2246],
16	mutation	NN	O	mutation	conj_and	11	SENT_92	[p5l10t2296r400b2375],
17	in	IN	O	in	_	0	SENT_92	[p5l426t2296r507b2373],
18	which	WDT	O	which	rel	21	SENT_92	[p5l530t2296r790b2375],
19	methionine	NN	O	methionine	nsubjpass	21	SENT_92	[p5l817t2296r1305b2374],
20	was	VBD	O	be	auxpass	21	SENT_92	[p5l1328t2322r1489b2375],
21	substituted	VBN	O	substitute	rcmod	16	SENT_92	[p5l1519t2295r1988b2375],
22	for	IN	O	for	_	0	SENT_92	[p5l2015t2295r2137b2374],
23	threonine	NN	O	threonine	prep_for	21	SENT_92	[p5l11t2424r420b2502],
24	at	IN	O	at	_	0	SENT_92	[p5l460t2440r539b2502],
25	position	NN	O	position	prep_at	23	SENT_92	[p5l572t2424r921b2524],
26	790	CD	NUMBER	790	number	27	SENT_92	[p5l962t2429r1114b2502],
27	(	CD	NUMBER	(	dep	25	SENT_92	[p5l1159t2429r1488b2515],
28	T79OM	NN	O	t79om	dep	27	SENT_92	[p5l1159t2429r1488b2515],
29	—	CD	NUMBER	—	num	28	SENT_92	[p5l1526t2468r1633b2476],
30	the	DT	O	the	det	33	SENT_92	[p5l1669t2424r1798b2502],
31	second	JJ	ORDINAL	second	amod	33	SENT_92	[p5l1839t2424r2135b2502],
32	EGFR	NN	ORGANIZATION	egfr	nn	33	SENT_92	[p5l8t2558r219b2631],
33	mutation	NN	O	mutation	tmod	21	SENT_92	[p5l237t2552r622b2631],
34	identiﬁed	VBN	O	identiﬁed	partmod	33	SENT_92	[p5l644t2551r1043b2630],
35	in	IN	O	in	_	0	SENT_92	[p5l1066t2552r1147b2629],
36	our	PRP$	O	we	poss	37	SENT_92	[p5l1171t2577r1314b2631],
37	patient	NN	O	patient	prep_in	34	SENT_92	[p5l1333t2552r1652b2652],
38	)	CD	NUMBER	)	dep	33	SENT_92	[p5l1333t2552r1652b2652],
39	were	VBD	O	be	auxpass	40	SENT_92	[p5l1676t2578r1877b2631],
40	introduced	VBN	O	introduce	_	0	SENT_92	[p5l1900t2552r2134b2630, p5l11t2680r261b2759],
41	by	IN	O	by	_	0	SENT_92	[p5l292t2680r389b2780],
42	means	NNS	O	means	_	0	SENT_92	[p5l415t2705r688b2758],
43	of	IN	O	of	_	0	SENT_92	[p5l722t2679r822b2758],
44	a	DT	O	a	det	49	SENT_92	[p5l834t2706r878b2758],
45	site	NN	O	site	npadvmod	47	SENT_92	[p5l909t2679r1429b2758],
46	—	CD	NUMBER	—	num	45	SENT_92	[p5l909t2679r1429b2758],
47	directed	JJ	O	directed	amod	49	SENT_92	[p5l909t2679r1429b2758],
48	mutagenesis	NN	O	mutagenesis	nn	49	SENT_92	[p5l1460t2680r1994b2780],
49	kit	NN	O	kit	prep_by_means_of	40	SENT_92	[p5l2026t2680r2140b2759],
50	(	CD	NUMBER	(	num	52	SENT_92	[p5l15t2808r577b2908],
51	Quikchange	NNP	O	Quikchange	nn	52	SENT_92	[p5l15t2808r577b2908],
52	XL	NNP	O	XL	nsubjpass	40	SENT_92	[p5l608t2815r744b2903],
53	,	,	O	,	_	0	SENT_92	[p5l608t2815r744b2903],
54	Stratagene	NNP	O	Stratagene	appos	52	SENT_92	[p5l786t2813r1290b2908],
55	)	CD	NUMBER	)	num	54	SENT_92	[p5l786t2813r1290b2908],
56	.	.	O	.	_	0	SENT_92	[p5l786t2813r1290b2908],

1	All	DT	O	all	det	2	SENT_93	[p5l1327t2807r1446b2885],
2	fragments	NNS	O	fragment	nsubjpass	13	SENT_93	[p5l1481t2807r1911b2908],
3	containing	VBG	O	contain	partmod	2	SENT_93	[p5l1949t2833r2133b2886, p5l11t2936r315b3036],
4	point	NN	O	point	nn	5	SENT_93	[p5l333t2936r561b3036],
5	mutations	NNS	O	mutation	dobj	3	SENT_93	[p5l579t2936r1010b3015],
6	or	CC	O	or	_	0	SENT_93	[p5l1035t2961r1125b3014],
7	deletions	NNS	O	deletion	conj_or	5	SENT_93	[p5l1145t2936r1553b3031],
8	,	,	O	,	_	0	SENT_93	[p5l1145t2936r1553b3031],
9	or	CC	O	or	_	0	SENT_93	[p5l1582t2961r1672b3014],
10	both	DT	O	both	conj_or	5	SENT_93	[p5l1692t2935r1909b3031],
11	,	,	O	,	_	0	SENT_93	[p5l1692t2935r1909b3031],
12	were	VBD	O	be	auxpass	13	SENT_93	[p5l1933t2962r2135b3015],
13	swapped	VBN	O	swap	_	0	SENT_93	[p5l12t3063r383b3164],
14	with	IN	O	with	_	0	SENT_93	[p5l400t3063r589b3143],
15	the	DT	O	the	det	17	SENT_93	[p5l612t3064r741b3142],
16	corresponding	JJ	O	corresponding	amod	17	SENT_93	[p5l764t3063r1388b3164],
17	sequence	NN	O	sequence	prep_with	13	SENT_93	[p5l1408t3089r1796b3164],
18	in	IN	O	in	_	0	SENT_93	[p5l1817t3064r1899b3141],
19	wildtype	JJ	O	wildtype	amod	20	SENT_93	[p5l1916t3063r2133b3143, p5l11t3208r181b3292],
20	EGFR	NN	ORGANIZATION	egfr	prep_in	17	SENT_93	[p5l221t3198r433b3271],
21	that	WDT	O	that	nsubjpass	24	SENT_93	[p5l469t3192r636b3270],
22	had	VBD	O	have	aux	24	SENT_93	[p5l673t3191r828b3270],
23	been	VBN	O	be	auxpass	24	SENT_93	[p5l870t3192r1069b3270],
24	subcloned	VBN	O	subclon	rcmod	17	SENT_93	[p5l1112t3192r1545b3271],
25	into	IN	O	into	_	0	SENT_93	[p5l1586t3192r1752b3270],
26	plasmid	NN	O	plasmid	nn	29	SENT_93	[p5l1794t3191r2135b3292],
27	DNA	NN	O	dna	nn	29	SENT_93	[p5l9t3326r221b3398],
28	(	NN	O	(	nn	29	SENT_93	[p5l247t3325r779b3420],
29	pcDNA3	NN	O	pcdna3	prep_into	24	SENT_93	[p5l247t3325r779b3420],
30	.1	CD	NUMBER	.1	num	31	SENT_93	[p5l247t3325r779b3420],
31	)	NN	O	)	dep	29	SENT_93	[p5l247t3325r779b3420],
32	.	.	O	.	_	0	SENT_93	[p5l247t3325r779b3420],

1	A	DT	O	a	det	3	SENT_94	[p5l805t3327r871b3397],
2	hemagglutinin	NN	O	hemagglutinin	nn	3	SENT_94	[p5l892t3320r1518b3420],
3	tag	NN	O	tag	nsubjpass	5	SENT_94	[p5l1543t3336r1677b3420],
4	was	VBD	O	be	auxpass	5	SENT_94	[p5l1693t3346r1854b3399],
5	added	VBN	O	add	_	0	SENT_94	[p5l1880t3319r2135b3398],
6	to	TO	O	to	_	0	SENT_94	[p5l11t3464r90b3526],
7	the	DT	O	the	det	10	SENT_94	[p5l117t3447r246b3526],
8	3	CD	NUMBER	3	num	10	SENT_94	[p5l272t3453r340b3526],
9	'	''	O	'	_	0	SENT_94	[p5l272t3453r340b3526],
10	end	NN	O	end	prep_to	5	SENT_94	[p5l370t3448r523b3526],
11	of	IN	O	of	_	0	SENT_94	[p5l549t3447r649b3526],
12	the	DT	O	the	det	15	SENT_94	[p5l656t3448r785b3526],
13	EGFR	NN	ORGANIZATION	egfr	nn	15	SENT_94	[p5l809t3454r1021b3527],
14	coding	VBG	O	code	amod	15	SENT_94	[p5l1041t3447r1332b3548],
15	region	NN	O	region	prep_of	5	SENT_94	[p5l1354t3448r1650b3548],
16	.	.	O	.	_	0	SENT_94	[p5l1354t3448r1650b3548],

1	The	DT	O	the	det	3	SENT_95	[p5l1678t3448r1838b3526],
2	resulting	VBG	O	result	amod	3	SENT_95	[p5l1864t3448r2133b3527, p5l10t3576r148b3676],
3	constructs	NNS	O	construct	nsubjpass	5	SENT_95	[p5l171t3592r606b3655],
4	were	VBD	O	be	auxpass	5	SENT_95	[p5l629t3602r831b3655],
5	conﬁrmed	VBN	O	conﬁrmed	_	0	SENT_95	[p5l856t3575r1295b3654],
6	by	IN	O	by	_	0	SENT_95	[p5l1320t3576r1417b3676],
7	sequencing	NN	O	sequencing	agent	5	SENT_95	[p5l1439t3576r1944b3676],
8	.	.	O	.	_	0	SENT_95	[p5l1439t3576r1944b3676],

1	TRANSFECTION	NN	O	transfection	tmod	23	SENT_96	[p6l8t112r644b161],
2	AN	DT	O	a	det	6	SENT_96	[p6l688t112r795b161],
3	D	NN	O	d	nn	6	SENT_96	[p6l819t112r865b161],
4	WESTERN	JJ	O	western	amod	6	SENT_96	[p6l903t112r1285b161],
5	BLOTTI	NN	O	blottus	nn	6	SENT_96	[p6l1335t112r1612b161],
6	NG	NN	O	ng	dep	1	SENT_96	[p6l1636t112r1749b161],
7	For	IN	O	for	_	0	SENT_96	[p6l9t220r153b291],
8	transient	JJ	O	transient	amod	11	SENT_96	[p6l189t212r1109b291],
9	—	NN	O	—	nn	11	SENT_96	[p6l189t212r1109b291],
10	transfection	NN	O	transfection	nn	11	SENT_96	[p6l189t212r1109b291],
11	experiments	NNS	O	experiment	prep_for	23	SENT_96	[p6l1148t213r1691b313],
12	,	,	O	,	_	0	SENT_96	[p6l1148t213r1691b313],
13	COS	NN	O	cos	nn	14	SENT_96	[p6l1736t218r2008b291],
14	—	NN	O	—	nsubjpass	23	SENT_96	[p6l1736t218r2008b291],
15	7	CD	NUMBER	7	dep	14	SENT_96	[p6l1736t218r2008b291],
16	or	CC	O	or	_	0	SENT_96	[p6l2048t238r2138b291],
17	N	NN	O	n	nn	19	SENT_96	[p6l8t348r83b419],
18	IH	NN	O	ih	nn	19	SENT_96	[p6l85t346r388b419],
19	—	NN	O	—	conj_or	14	SENT_96	[p6l85t346r388b419],
20	3T3	NN	O	3t3	nn	21	SENT_96	[p6l85t346r388b419],
21	cells	NNS	O	cell	dep	19	SENT_96	[p6l438t340r620b419],
22	were	VBD	O	be	auxpass	23	SENT_96	[p6l663t367r864b420],
23	plated	VBN	O	plate	_	0	SENT_96	[p6l909t340r1169b441],
24	at	IN	O	at	_	0	SENT_96	[p6l1213t357r1292b419],
25	a	DT	O	a	det	26	SENT_96	[p6l1332t367r1376b419],
26	concentration	NN	O	concentration	prep_at	23	SENT_96	[p6l1420t341r2007b419],
27	of	IN	O	of	_	0	SENT_96	[p6l2052t340r2153b419],
28	5x104	NN	O	5x104	nn	29	SENT_96	[p6l12t474r262b547],
29	cells	NNS	O	cell	prep_of	26	SENT_96	[p6l283t469r462b547],
30	per	IN	O	per	prep	29	SENT_96	[p6l484t495r621b569],
31	well	RB	O	well	pcomp	30	SENT_96	[p6l635t468r807b548],
32	in	IN	O	in	_	0	SENT_96	[p6l828t469r908b546],
33	six	CD	NUMBER	six	prep_in	23	SENT_96	[p6l931t469r1246b548],
34	.	.	O	.	_	0	SENT_96	[p6l931t469r1246b548],

1	—	NN	O	—	_	0	SENT_97	[p6l931t469r1246b548],
2	.	.	O	.	_	0	SENT_97	[p6l931t469r1246b548],

1	Well	UH	O	well	dep	2	SENT_98	[p6l931t469r1246b548],
2	plates	NNS	O	plate	_	0	SENT_98	[p6l1266t469r1532b569],
3	.	.	O	.	_	0	SENT_98	[p6l1266t469r1532b569],

1	The	DT	DATE	the	det	3	SENT_99	[p6l1555t468r1715b547],
2	following	VBG	DATE	follow	amod	3	SENT_99	[p6l1737t468r2139b569],
3	day	NN	DATE	day	tmod	8	SENT_99	[p6l11t597r170b697],
4	,	,	O	,	_	0	SENT_99	[p6l11t597r170b697],
5	these	DT	O	these	det	6	SENT_99	[p6l211t597r433b675],
6	cells	NNS	O	cell	nsubjpass	35	SENT_99	[p6l469t597r656b675],
7	were	VBD	O	be	auxpass	8	SENT_99	[p6l688t623r894b676],
8	transfected	VBN	O	transfect	_	0	SENT_99	[p6l929t596r1408b675],
9	With	IN	O	with	_	0	SENT_99	[p6l1438t596r1630b676],
10	1	CD	NUMBER	1	num	11	SENT_99	[p6l1669t602r1713b674],
11	pg	NN	O	pg	prep_with	8	SENT_99	[p6l1750t622r1851b697],
12	of	IN	O	of	_	0	SENT_99	[p6l1883t596r1985b675],
13	the	DT	O	the	det	15	SENT_99	[p6l2002t597r2133b675],
14	expression	NN	O	expression	nn	15	SENT_99	[p6l11t725r474b825],
15	constructs	NNS	O	construct	prep_of	11	SENT_99	[p6l518t741r963b804],
16	with	IN	O	with	_	0	SENT_99	[p6l1005t725r1198b804],
17	the	DT	O	the	det	18	SENT_99	[p6l1242t725r1373b803],
18	use	NN	O	use	prep_with	8	SENT_99	[p6l1417t751r1558b804],
19	of	IN	O	of	_	0	SENT_99	[p6l1603t724r1704b803],
20	Fugene	NN	O	fugene	prep_of	18	SENT_99	[p6l1728t732r2042b825],
21	6	CD	NUMBER	6	num	20	SENT_99	[p6l2086t730r2132b803],
22	(	CD	NUMBER	(	num	24	SENT_99	[p6l15t851r362b946],
23	Roche	NNP	LOCATION	Roche	nn	24	SENT_99	[p6l15t851r362b946],
24	)	NN	O	)	xcomp	8	SENT_99	[p6l15t851r362b946],
25	,	,	O	,	_	0	SENT_99	[p6l15t851r362b946],
26	incubated	VBN	O	incubate	partmod	24	SENT_99	[p6l391t851r802b931],
27	for	IN	O	for	_	0	SENT_99	[p6l825t851r948b930],
28	12	CD	DURATION	12	num	29	SENT_99	[p6l971t857r1067b928],
29	hours	NNS	NUMBER	hour	prep_for	26	SENT_99	[p6l1092t852r1330b930],
30	in	IN	O	in	_	0	SENT_99	[p6l1355t852r1436b928],
31	serum	NN	O	serum	prep_in	29	SENT_99	[p6l1460t878r1744b946],
32	,	,	O	,	_	0	SENT_99	[p6l1460t878r1744b946],
33	and	CC	O	and	_	0	SENT_99	[p6l1772t851r1926b930],
34	then	RB	O	then	advmod	35	SENT_99	[p6l1950t852r2135b929],
35	incubated	VBN	O	incubate	conj_and	8	SENT_99	[p6l10t980r425b1059],
36	in	IN	O	in	_	0	SENT_99	[p6l452t980r534b1057],
37	serum	NN	O	serum	prep_in	35	SENT_99	[p6l563t979r1023b1059],
38	—	CD	NUMBER	—	num	40	SENT_99	[p6l563t979r1023b1059],
39	free	JJ	O	free	amod	40	SENT_99	[p6l563t979r1023b1059],
40	medium	NN	O	medium	dobj	8	SENT_99	[p6l1051t980r1404b1059],
41	for	IN	O	for	_	0	SENT_99	[p6l1432t979r1555b1058],
42	an	DT	O	a	det	45	SENT_99	[p6l1580t1005r1680b1058],
43	additional	JJ	O	additional	amod	45	SENT_99	[p6l1707t979r2135b1058],
44	12	CD	DURATION	12	num	45	SENT_99	[p6l14t1113r110b1185],
45	hours	NNS	NUMBER	hour	prep_for	40	SENT_99	[p6l141t1107r407b1187],
46	.	.	O	.	_	0	SENT_99	[p6l141t1107r407b1187],

1	The	DT	O	the	det	2	SENT_100	[p6l439t1107r601b1186],
2	cells	NNS	O	cell	nsubjpass	5	SENT_100	[p6l631t1108r814b1186],
3	Were	VBD	O	be	auxpass	5	SENT_100	[p6l841t1134r1042b1187],
4	then	RB	O	then	advmod	5	SENT_100	[p6l1073t1108r1260b1186],
5	stimulated	VBN	O	stimulate	_	0	SENT_100	[p6l1291t1107r1736b1187],
6	with	IN	O	with	_	0	SENT_100	[p6l1762t1108r1951b1187],
7	100	CD	NUMBER	100	num	8	SENT_100	[p6l1984t1113r2134b1186],
8	ng	NN	O	ng	prep_with	5	SENT_100	[p6l10t1261r121b1336],
9	of	IN	O	of	_	0	SENT_100	[p6l148t1235r249b1314],
10	epidermal	JJ	O	epidermal	amod	14	SENT_100	[p6l261t1235r687b1336],
11	growth	NN	O	growth	nn	14	SENT_100	[p6l717t1236r1020b1336],
12	factor	NN	O	factor	nn	14	SENT_100	[p6l1051t1235r1297b1314],
13	(	CD	NUMBER	(	num	14	SENT_100	[p6l1329t1241r1570b1327],
14	EGF	NN	ORGANIZATION	egf	prep_of	8	SENT_100	[p6l1329t1241r1570b1327],
15	)	CD	NUMBER	)	dobj	5	SENT_100	[p6l1329t1241r1570b1327],
16	per	IN	O	per	_	0	SENT_100	[p6l1604t1262r1743b1336],
17	milliliter	NN	O	milliliter	prep_per	15	SENT_100	[p6l1771t1235r2137b1314],
18	for	IN	O	for	_	0	SENT_100	[p6l10t1363r133b1442],
19	15	CD	DURATION	15	num	20	SENT_100	[p6l161t1369r255b1442],
20	minutes	NNS	NUMBER	minute	prep_for	17	SENT_100	[p6l286t1364r628b1443],
21	(	CD	NUMBER	(	num	23	SENT_100	[p6l661t1364r1013b1464],
22	Sigma	NNP	O	Sigma	nn	23	SENT_100	[p6l661t1364r1013b1464],
23	)	NN	O	)	dep	20	SENT_100	[p6l661t1364r1013b1464],
24	.	.	O	.	_	0	SENT_100	[p6l661t1364r1013b1464],

1	To	TO	O	to	aux	2	SENT_101	[p6l1043t1369r1148b1442],
2	determine	VB	O	determine	_	0	SENT_101	[p6l1177t1363r1606b1442],
3	Whether	IN	O	whether	complm	8	SENT_101	[p6l1629t1363r1980b1443],
4	the	DT	O	the	det	6	SENT_101	[p6l2005t1363r2135b1442],
5	mutant	JJ	O	mutant	amod	6	SENT_101	[p6l10t1508r320b1571],
6	receptors	NNS	O	receptor	nsubjpass	8	SENT_101	[p6l336t1508r722b1592],
7	were	VBD	O	be	auxpass	8	SENT_101	[p6l741t1518r941b1571],
8	inhibited	VBN	O	inhibit	ccomp	43	SENT_101	[p6l963t1492r1341b1570],
9	by	IN	O	by	_	0	SENT_101	[p6l1364t1492r1460b1592],
10	gefitinib	NN	O	gefitinib	agent	8	SENT_101	[p6l1478t1491r1828b1592],
11	(	CD	NUMBER	(	num	10	SENT_101	[p6l1856t1498r2134b1583, p6l8t1625r360b1713],
12	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	nn	13	SENT_101	[p6l1856t1498r2134b1583, p6l8t1625r360b1713],
13	)	NNP	O	)	dep	10	SENT_101	[p6l1856t1498r2134b1583, p6l8t1625r360b1713],
14	,	,	O	,	_	0	SENT_101	[p6l1856t1498r2134b1583, p6l8t1625r360b1713],
15	AG1478	NNP	O	AG1478	agent	8	SENT_101	[p6l394t1624r740b1697],
16	(	CD	NUMBER	(	num	18	SENT_101	[p6l780t1619r1375b1713],
17	Calbiochem	NNP	O	Calbiochem	nn	18	SENT_101	[p6l780t1619r1375b1713],
18	)	NN	O	)	dep	15	SENT_101	[p6l780t1619r1375b1713],
19	,	,	O	,	_	0	SENT_101	[p6l780t1619r1375b1713],
20	cetuximab	NN	O	cetuximab	nn	21	SENT_101	[p6l1415t1619r1850b1697],
21	(	NN	O	(	agent	8	SENT_101	[p6l1888t1625r2133b1709, p6l10t1747r324b1825],
22	commercial	JJ	O	commercial	amod	24	SENT_101	[p6l1888t1625r2133b1709, p6l10t1747r324b1825],
23	supply	NN	O	supply	nn	24	SENT_101	[p6l355t1746r687b1847],
24	)	NN	O	)	dep	21	SENT_101	[p6l355t1746r687b1847],
25	,	,	O	,	_	0	SENT_101	[p6l355t1746r687b1847],
26	erlotinib	NN	O	erlotinib	nn	27	SENT_101	[p6l724t1747r1082b1825],
27	(	NN	O	(	agent	8	SENT_101	[p6l1118t1747r1649b1838],
28	commercial	JJ	O	commercial	amod	30	SENT_101	[p6l1118t1747r1649b1838],
29	supply	NN	O	supply	nn	30	SENT_101	[p6l1680t1747r2012b1847],
30	)	NN	O	)	dep	27	SENT_101	[p6l1680t1747r2012b1847],
31	,	,	O	,	_	0	SENT_101	[p6l1680t1747r2012b1847],
32	or	CC	O	or	_	0	SENT_101	[p6l2048t1772r2138b1825],
33	CL	NN	O	cl	agent	8	SENT_101	[p6l10t1880r501b1970],
34	—	CD	NUMBER	—	num	33	SENT_101	[p6l10t1880r501b1970],
35	387,785	CD	NUMBER	387,785	number	36	SENT_101	[p6l10t1880r501b1970],
36	(	CD	NUMBER	(	num	38	SENT_101	[p6l533t1874r1129b1970],
37	Calbiochem	NN	O	calbiochem	nn	38	SENT_101	[p6l533t1874r1129b1970],
38	)	NN	O	)	dep	33	SENT_101	[p6l533t1874r1129b1970],
39	,	,	O	,	_	0	SENT_101	[p6l533t1874r1129b1970],
40	each	DT	O	each	det	41	SENT_101	[p6l1159t1875r1349b1953],
41	drug	NN	O	drug	nsubjpass	43	SENT_101	[p6l1373t1874r1573b1975],
42	was	VBD	O	be	auxpass	43	SENT_101	[p6l1589t1901r1750b1954],
43	added	VBN	O	add	ccomp	2	SENT_101	[p6l1776t1874r2030b1953],
44	to	TO	O	to	_	0	SENT_101	[p6l2054t1891r2133b1953],
45	the	DT	O	the	det	47	SENT_101	[p6l11t2003r140b2081],
46	culture	NN	O	culture	nn	47	SENT_101	[p6l181t2003r472b2082],
47	medium	NN	O	medium	prep_to	43	SENT_101	[p6l513t2003r866b2082],
48	three	CD	DURATION	three	num	49	SENT_101	[p6l906t2003r1119b2081],
49	hours	NNS	NUMBER	hour	tmod	43	SENT_101	[p6l1159t2003r1400b2082],
50	before	IN	O	before	_	0	SENT_101	[p6l1443t2002r1709b2081],
51	the	DT	O	the	det	52	SENT_101	[p6l1750t2003r1879b2081],
52	addition	NN	O	addition	prep_before	43	SENT_101	[p6l1919t2002r2133b2081, p6l11t2131r176b2209],
53	of	IN	O	of	_	0	SENT_101	[p6l203t2130r304b2209],
54	EGF	NN	O	egf	prep_of	52	SENT_101	[p6l310t2136r508b2209],
55	.	.	O	.	_	0	SENT_101	[p6l310t2136r508b2209],

1	Whole	JJ	O	whole	amod	4	SENT_102	[p6l536t2130r997b2209],
2	—	NN	O	—	nn	4	SENT_102	[p6l536t2130r997b2209],
3	cell	NN	O	cell	nn	4	SENT_102	[p6l536t2130r997b2209],
4	extracts	NNS	O	extract	nsubjpass	26	SENT_102	[p6l1024t2147r1344b2209],
5	were	VBD	O	be	auxpass	6	SENT_102	[p6l1368t2157r1570b2210],
6	separated	VBN	O	separate	_	0	SENT_102	[p6l1598t2130r2001b2231],
7	on	IN	O	on	_	0	SENT_102	[p6l2029t2156r2135b2209],
8	8	CD	PERCENT	8	num	9	SENT_102	[p6l11t2264r56b2337],
9	percent	NN	PERCENT	percent	prep_on	6	SENT_102	[p6l94t2275r414b2359],
10	sodium	NN	O	sodium	nn	12	SENT_102	[p6l447t2259r765b2338],
11	dodecyl	NN	O	dodecyl	nn	12	SENT_102	[p6l802t2258r1123b2359],
12	sulfate	NN	O	sulfate	tmod	6	SENT_102	[p6l1161t2258r2134b2359],
13	—	CD	NUMBER	—	num	15	SENT_102	[p6l1161t2258r2134b2359],
14	polyacrylamide	NN	O	polyacrylamide	nn	15	SENT_102	[p6l1161t2258r2134b2359],
15	gels	NNS	O	gel	dep	12	SENT_102	[p6l10t2386r200b2487],
16	,	,	O	,	_	0	SENT_102	[p6l10t2386r200b2487],
17	transferred	VBN	O	transfer	conj_and	6	SENT_102	[p6l232t2386r699b2465],
18	to	TO	O	to	_	0	SENT_102	[p6l724t2403r803b2465],
19	nitrocellulose	NN	O	nitrocellulose	nn	23	SENT_102	[p6l830t2386r1407b2466],
20	or	CC	O	or	_	0	SENT_102	[p6l1434t2412r1523b2465],
21	polyvinylidine	NN	O	polyvinylidine	conj_or	19	SENT_102	[p6l1544t2386r2135b2487],
22	diﬂuoride	NN	O	diﬂuoride	nn	23	SENT_102	[p6l11t2514r418b2594],
23	membranes	NNS	O	membrane	prep_to	17	SENT_102	[p6l440t2515r958b2610],
24	,	,	O	,	_	0	SENT_102	[p6l440t2515r958b2610],
25	and	CC	O	and	_	0	SENT_102	[p6l984t2514r1138b2593],
26	analyzed	VBN	O	analyze	conj_and	6	SENT_102	[p6l1159t2515r1520b2615],
27	with	IN	O	with	_	0	SENT_102	[p6l1537t2514r1723b2594],
28	the	DT	O	the	det	29	SENT_102	[p6l1745t2515r1873b2593],
29	use	NN	O	use	prep_with	26	SENT_102	[p6l1894t2541r2032b2594],
30	of	IN	O	of	_	0	SENT_102	[p6l2054t2514r2154b2593],
31	a	DT	O	a	det	33	SENT_102	[p6l10t2669r54b2721],
32	chemiluminescence	NN	O	chemiluminescence	nn	33	SENT_102	[p6l87t2643r914b2722],
33	reagent	NN	O	reagent	prep_of	29	SENT_102	[p6l948t2659r1263b2743],
34	(	CD	NUMBER	(	num	36	SENT_102	[p6l1296t2650r1665b2734],
35	Western	NNP	O	Western	nn	36	SENT_102	[p6l1296t2650r1665b2734],
36	Lightning	NNP	O	Lightning	dep	33	SENT_102	[p6l1697t2642r2130b2743],
37	,	,	O	,	_	0	SENT_102	[p6l1697t2642r2130b2743],
38	Perl	NNP	PERSON	Perl	dep	39	SENT_102	[p6l9t2771r535b2850],
39	<	JJR	O	<	appos	33	SENT_102	[p6l9t2771r535b2850],
40	inElmer	NNP	O	inElmer	nn	42	SENT_102	[p6l9t2771r535b2850],
41	Life	NNP	O	Life	nn	42	SENT_102	[p6l555t2770r709b2849],
42	Science	NNP	O	Science	dep	39	SENT_102	[p6l736t2771r1103b2862],
43	)	CD	NUMBER	)	num	42	SENT_102	[p6l736t2771r1103b2862],
44	.	.	O	.	_	0	SENT_102	[p6l736t2771r1103b2862],

1	Autophosphorylation	NN	O	autophosphorylation	nsubjpass	28	SENT_103	[p6l1129t2770r2029b2871],
2	of	IN	O	of	_	0	SENT_103	[p6l2054t2770r2154b2849],
3	EGFRwas	NN	O	egfrwa	prep_of	1	SENT_103	[p6l9t2904r432b2982],
4	detected	VBN	O	detect	partmod	3	SENT_103	[p6l455t2898r802b2977],
5	with	IN	O	with	_	0	SENT_103	[p6l818t2899r1006b2978],
6	antibody	NN	O	antibody	prep_with	4	SENT_103	[p6l1025t2898r1393b2999],
7	against	IN	O	against	_	0	SENT_103	[p6l1408t2899r1714b2999],
8	phospho	NN	O	phospho	nn	10	SENT_103	[p6l1728t2899r2134b2999],
9	—	CD	NUMBER	—	num	10	SENT_103	[p6l1728t2899r2134b2999],
10	tyrosine	NN	O	tyrosine	prep_against	6	SENT_103	[p6l11t3027r343b3127],
11	at	IN	O	at	_	0	SENT_103	[p6l364t3043r442b3105],
12	position	NN	O	position	prep_at	4	SENT_103	[p6l457t3027r807b3127],
13	1068	CD	DATE	1068	num	12	SENT_103	[p6l833t3032r1034b3105],
14	(	CD	NUMBER	(	number	15	SENT_103	[p6l1063t3032r1381b3118],
15	1:1000	CD	NUMBER	1:1000	num	16	SENT_103	[p6l1063t3032r1381b3118],
16	dilution	NN	O	dilution	dep	4	SENT_103	[p6l1404t3026r1761b3122],
17	;	:	O	;	_	0	SENT_103	[p6l1404t3026r1761b3122],
18	Cell	NN	O	cell	nn	21	SENT_103	[p6l1787t3026r1949b3105],
19	Signaling	NN	O	signaling	nn	21	SENT_103	[p6l1973t3027r2133b3127, p6l10t3155r286b3255],
20	Technology	NN	O	technology	nn	21	SENT_103	[p6l311t3154r873b3255],
21	)	NN	O	)	nsubjpass	28	SENT_103	[p6l311t3154r873b3255],
22	,	,	O	,	_	0	SENT_103	[p6l311t3154r873b3255],
23	and	CC	O	and	_	0	SENT_103	[p6l910t3154r1068b3233],
24	total	JJ	O	total	amod	26	SENT_103	[p6l1100t3155r1294b3233],
25	protein	NN	O	protein	nn	26	SENT_103	[p6l1324t3155r1637b3255],
26	expression	NN	O	expression	conj_and	1	SENT_103	[p6l1670t3155r2134b3255],
27	was	VBD	O	be	auxpass	28	SENT_103	[p6l6t3309r169b3362],
28	measured	VBN	O	measure	_	0	SENT_103	[p6l216t3282r636b3362],
29	with	IN	O	with	_	0	SENT_103	[p6l676t3283r868b3362],
30	the	DT	O	the	det	31	SENT_103	[p6l914t3283r1045b3361],
31	use	NN	O	use	prep_with	28	SENT_103	[p6l1090t3309r1232b3362],
32	of	IN	O	of	_	0	SENT_103	[p6l1277t3282r1379b3361],
33	antibody	NN	O	antibody	prep_of	31	SENT_103	[p6l1404t3282r1784b3383],
34	against	IN	O	against	_	0	SENT_103	[p6l1823t3283r2139b3383],
35	EGFR	NN	ORGANIZATION	egfr	prep_against	28	SENT_103	[p6l9t3416r266b3494],
36	(	CD	NUMBER	(	number	37	SENT_103	[p6l282t3416r597b3502],
37	1:1000	CD	NUMBER	1:1000	num	38	SENT_103	[p6l282t3416r597b3502],
38	dilution	NN	O	dilution	dep	35	SENT_103	[p6l620t3410r972b3506],
39	;	:	O	;	_	0	SENT_103	[p6l620t3410r972b3506],
40	Santa	NNP	ORGANIZATION	Santa	nn	42	SENT_103	[p6l1000t3416r1230b3489],
41	Cruz	NNP	ORGANIZATION	Cruz	nn	42	SENT_103	[p6l1250t3416r1448b3490],
42	Biotechnology	NNP	ORGANIZATION	Biotechnology	dep	35	SENT_103	[p6l1469t3411r2130b3511],
43	)	NN	O	)	dep	42	SENT_103	[p6l1469t3411r2130b3511],
44	.	.	O	.	_	0	SENT_103	[p6l1469t3411r2130b3511],

1	STRUCTURAL	JJ	O	structural	amod	2	SENT_104	[p6l11t3695r540b3744],
2	MODELING	NN	O	modeling	_	0	SENT_104	[p6l585t3695r1040b3744],

1	The	DT	O	the	det	3	SENT_105	[p7l7t33r167b111],
2	crystallographic	JJ	O	crystallographic	amod	3	SENT_105	[p7l191t32r863b133],
3	structure	NN	O	structure	nsubjpass	18	SENT_105	[p7l886t49r1256b112],
4	of	IN	O	of	_	0	SENT_105	[p7l1280t32r1380b111],
5	the	DT	O	the	det	9	SENT_105	[p7l1384t32r1512b111],
6	EGFR	NN	ORGANIZATION	egfr	nn	9	SENT_105	[p7l1534t38r1791b116],
7	tyrosine	NN	O	tyrosine	nn	9	SENT_105	[p7l1804t33r2135b133],
8	kinase	NN	O	kinase	nn	9	SENT_105	[p7l10t160r280b240],
9	domain	NN	O	domain	prep_of	3	SENT_105	[p7l318t161r665b256],
10	,	,	O	,	_	0	SENT_105	[p7l318t161r665b256],
11	solved	VBD	O	solve	partmod	3	SENT_105	[p7l710t161r973b240],
12	in	IN	O	in	_	0	SENT_105	[p7l1010t161r1091b238],
13	complex	JJ	O	complex	prep_in	11	SENT_105	[p7l1128t160r1489b261],
14	With	IN	O	with	_	0	SENT_105	[p7l1519t161r1708b240],
15	erlotinib	NN	O	erlotinib	prep_with	11	SENT_105	[p7l1746t160r2129b256],
16	,	,	O	,	_	0	SENT_105	[p7l1746t160r2129b256],
17	Was	VBD	O	be	auxpass	18	SENT_105	[p7l6t315r167b368],
18	used	VBN	O	use	_	0	SENT_105	[p7l203t288r398b368],
19	as	IN	O	as	_	0	SENT_105	[p7l431t315r516b367],
20	a	DT	O	a	det	21	SENT_105	[p7l551t315r595b367],
21	model	NN	O	model	prep_as	18	SENT_105	[p7l628t288r894b367],
22	for	IN	O	for	_	0	SENT_105	[p7l927t288r1051b367],
23	the	DT	O	the	det	24	SENT_105	[p7l1082t289r1211b367],
24	prediction	NN	O	prediction	prep_for	21	SENT_105	[p7l1244t289r1679b389],
25	of	IN	O	of	_	0	SENT_105	[p7l1714t288r1815b367],
26	l	NN	O	l	prep_of	24	SENT_105	[p7l1830t289r2133b368],
27	<	JJR	O	<	amod	26	SENT_105	[p7l1830t289r2133b368],
28	inase	CD	NUMBER	inase	num	31	SENT_105	[p7l1830t289r2133b368],
29	—	NN	O	—	nn	31	SENT_105	[p7l1830t289r2133b368],
30	inhibitor	NN	O	inhibitor	nn	31	SENT_105	[p7l10t417r376b495],
31	binding	NN	O	binding	dep	38	SENT_105	[p7l394t417r721b517],
32	(	CD	NUMBER	(	num	33	SENT_105	[p7l741t417r1067b508],
33	Protein	NN	ORGANIZATION	protein	dep	31	SENT_105	[p7l741t417r1067b508],
34	Data	NNP	ORGANIZATION	Data	nn	37	SENT_105	[p7l1084t423r1279b495],
35	Bank	NNP	ORGANIZATION	Bank	nn	37	SENT_105	[p7l1296t417r1513b496],
36	accession	NN	O	accession	nn	37	SENT_105	[p7l1527t417r1924b495],
37	code	NN	O	code	dep	38	SENT_105	[p7l1944t416r2136b495],
38	1M17	NN	O	1m17	dep	46	SENT_105	[p7l14t539r397b636],
39	)	CD	NUMBER	)	num	40	SENT_105	[p7l14t539r397b636],
40	.14	CD	NUMBER	.14	dep	38	SENT_105	[p7l14t539r397b636],
41	The	DT	O	the	det	42	SENT_105	[p7l428t545r589b623],
42	inhibitor	NN	O	inhibitor	nsubjpass	46	SENT_105	[p7l624t545r1000b623],
43	and	CC	O	and	_	0	SENT_105	[p7l1030t545r1186b623],
44	solvent	JJ	O	solvent	nsubjpass	46	SENT_105	[p7l1222t545r1524b624],
45	were	VBD	O	be	auxpass	46	SENT_105	[p7l1550t571r1751b624],
46	stripped	VBN	O	strip	ccomp	27	SENT_105	[p7l1788t545r2135b645],
47	from	IN	O	from	_	0	SENT_105	[p7l10t672r218b751],
48	the	DT	O	the	det	49	SENT_105	[p7l249t673r378b751],
49	model	NN	O	model	prep_from	46	SENT_105	[p7l408t672r698b751],
50	.	.	O	.	_	0	SENT_105	[p7l408t672r698b751],

1	We	PRP	O	we	nsubj	2	SENT_106	[p7l731t680r864b751],
2	used	VBD	O	use	_	0	SENT_106	[p7l895t672r1090b752],
3	the	DT	O	the	det	5	SENT_106	[p7l1121t673r1250b751],
4	AutoDock	NN	O	autodock	nn	5	SENT_106	[p7l1278t672r1711b752],
5	program	NN	O	program	nsubj	22	SENT_106	[p7l1736t698r2129b773],
6	,	,	O	,	_	0	SENT_106	[p7l1736t698r2129b773],
7	Version	NNP	O	Version	appos	5	SENT_106	[p7l6t802r309b880],
8	3.0	CD	NUMBER	3.0	num	7	SENT_106	[p7l331t795r564b896],
9	,	,	O	,	_	0	SENT_106	[p7l331t795r564b896],
10	”	CD	NUMBER	”	num	7	SENT_106	[p7l331t795r564b896],
11	to	TO	O	to	aux	12	SENT_106	[p7l589t817r667b879],
12	predict	VB	O	predict	infmod	7	SENT_106	[p7l688t801r983b901],
13	binding	NN	O	binding	dobj	12	SENT_106	[p7l999t801r1347b901],
14	,	,	O	,	_	0	SENT_106	[p7l999t801r1347b901],
15	first	RB	ORDINAL	first	advmod	16	SENT_106	[p7l1374t800r1543b879],
16	using	VBG	O	use	partmod	12	SENT_106	[p7l1559t802r1792b901],
17	a	DT	O	a	det	18	SENT_106	[p7l1810t827r1854b879],
18	model	NN	O	model	dobj	16	SENT_106	[p7l1873t801r2136b879],
19	of	IN	O	of	_	0	SENT_106	[p7l11t928r112b1007],
20	erlotinib	NN	O	erlotinib	prep_of	18	SENT_106	[p7l121t929r503b1024],
21	,	,	O	,	_	0	SENT_106	[p7l121t929r503b1024],
22	made	VBN	O	make	ccomp	2	SENT_106	[p7l536t928r766b1007],
23	by	IN	O	by	_	0	SENT_106	[p7l793t928r890b1029],
24	means	NNS	O	means	_	0	SENT_106	[p7l913t954r1187b1007],
25	of	IN	O	of	_	0	SENT_106	[p7l1216t928r1317b1007],
26	the	DT	O	the	det	29	SENT_106	[p7l1326t929r1454b1007],
27	JME	NN	ORGANIZATION	jme	nn	29	SENT_106	[p7l1471t936r1649b1020],
28	molecularediting	NN	O	molecularediting	nn	29	SENT_106	[p7l1678t929r2134b1008, p7l11t1056r308b1156],
29	feature	NN	O	feature	prep_by_means_of	22	SENT_106	[p7l338t1055r628b1135],
30	of	IN	O	of	_	0	SENT_106	[p7l662t1055r762b1134],
31	the	DT	O	the	det	34	SENT_106	[p7l777t1056r907b1134],
32	online	NN	O	online	nn	34	SENT_106	[p7l940t1056r1205b1134],
33	resource	NN	O	resource	nn	34	SENT_106	[p7l1238t1081r1597b1135],
34	PRODRG	NN	O	prodrg	prep_of	29	SENT_106	[p7l1629t1049r2134b1139],
35	.16	CD	NUMBER	.16	dobj	22	SENT_106	[p7l1629t1049r2134b1139],
36	The	DT	O	the	det	38	SENT_106	[p7l7t1184r169b1263],
37	erlotinib	NN	O	erlotinib	nn	38	SENT_106	[p7l200t1185r558b1263],
38	test	NN	O	test	nsubj	39	SENT_106	[p7l590t1201r742b1263],
39	yielded	VBD	O	yield	rcmod	35	SENT_106	[p7l763t1184r1064b1285],
40	a	DT	O	a	det	41	SENT_106	[p7l1094t1211r1138b1263],
41	model	NN	O	model	nsubj	46	SENT_106	[p7l1167t1185r1433b1263],
42	for	IN	O	for	_	0	SENT_106	[p7l1464t1184r1587b1263],
43	ligand	NN	O	ligand	nn	44	SENT_106	[p7l1613t1185r1879b1285],
44	binding	NN	O	binding	prep_for	41	SENT_106	[p7l1910t1185r2134b1263, p7l10t1313r148b1413],
45	highly	RB	O	highly	advmod	46	SENT_106	[p7l176t1313r443b1413],
46	similar	JJ	O	similar	xcomp	39	SENT_106	[p7l471t1313r766b1391],
47	to	TO	O	to	_	0	SENT_106	[p7l795t1329r873b1391],
48	that	DT	O	that	prep_to	46	SENT_106	[p7l906t1313r1073b1391],
49	seen	VBN	O	see	partmod	48	SENT_106	[p7l1100t1338r1287b1391],
50	in	IN	O	in	_	0	SENT_106	[p7l1318t1313r1398b1390],
51	the	DT	O	the	det	53	SENT_106	[p7l1430t1313r1559b1391],
52	crystal	NN	O	crystal	nn	53	SENT_106	[p7l1591t1313r1863b1413],
53	structure	NN	O	structure	prep_in	49	SENT_106	[p7l1895t1329r2134b1392, p7l11t1457r198b1520],
54	.	.	O	.	_	0	SENT_106	[p7l1895t1329r2134b1392, p7l11t1457r198b1520],

1	Using	VBG	O	use	partmod	7	SENT_107	[p7l224t1441r478b1541],
2	the	DT	O	the	det	4	SENT_107	[p7l496t1441r624b1519],
3	AutoDockTools	NNPS	O	AutoDockTools	nn	4	SENT_107	[p7l642t1441r1303b1520],
4	interface	NN	O	interface	dobj	1	SENT_107	[p7l1325t1440r1715b1536],
5	,	,	O	,	_	0	SENT_107	[p7l1325t1440r1715b1536],
6	we	PRP	O	we	nsubj	7	SENT_107	[p7l1737t1467r1855b1520],
7	used	VBD	O	use	_	0	SENT_107	[p7l1877t1441r2072b1520],
8	a	DT	O	a	det	10	SENT_107	[p7l2092t1467r2136b1519],
9	grid	NN	O	grid	nn	10	SENT_107	[p7l10t1570r180b1670],
10	spacing	NN	O	spacing	dobj	7	SENT_107	[p7l212t1570r540b1670],
11	of	IN	O	of	_	0	SENT_107	[p7l568t1569r669b1648],
12	0.37513	CD	NUMBER	0.37513	prep_of	10	SENT_107	[p7l682t1556r984b1648],
13	;	:	O	;	_	0	SENT_107	[p7l682t1556r984b1648],
14	and	CC	O	and	_	0	SENT_107	[p7l1012t1570r1167b1648],
15	60x50x4O	JJ	O	60x50x4o	amod	16	SENT_107	[p7l1199t1575r1629b1648],
16	points	NNS	O	point	conj_and	10	SENT_107	[p7l1659t1570r1924b1670],
17	centered	VBN	O	center	partmod	16	SENT_107	[p7l1958t1595r2134b1648, p7l11t1698r222b1776],
18	around	IN	O	around	_	0	SENT_107	[p7l259t1697r561b1777],
19	the	DT	O	the	det	21	SENT_107	[p7l600t1698r729b1776],
20	catalytic	JJ	O	catalytic	amod	21	SENT_107	[p7l768t1698r1111b1798],
21	cleft	NN	O	cleft	prep_around	17	SENT_107	[p7l1149t1697r1331b1776],
22	of	IN	O	of	_	0	SENT_107	[p7l1366t1697r1467b1776],
23	the	DT	O	the	det	24	SENT_107	[p7l1486t1698r1615b1776],
24	enzyme	NN	O	enzyme	prep_of	21	SENT_107	[p7l1655t1723r1976b1798],
25	for	IN	O	for	_	0	SENT_107	[p7l2015t1697r2138b1776],
26	docking	NN	O	docking	prep_for	24	SENT_107	[p7l11t1826r353b1926],
27	and	CC	O	and	_	0	SENT_107	[p7l371t1825r526b1904],
28	adopted	VBD	O	adopt	conj_and	7	SENT_107	[p7l548t1825r886b1926],
29	the	DT	O	the	det	31	SENT_107	[p7l909t1826r1037b1904],
30	genetic	JJ	O	genetic	amod	31	SENT_107	[p7l1059t1826r1360b1926],
31	algorithm	NN	O	algorithm	dobj	28	SENT_107	[p7l1381t1826r1797b1926],
32	with	IN	O	with	_	0	SENT_107	[p7l1815t1825r2002b1905],
33	local	JJ	O	local	amod	34	SENT_107	[p7l2024t1826r2134b1904, p7l11t1953r125b2032],
34	search	NN	O	search	prep_with	28	SENT_107	[p7l171t1954r446b2032],
35	using	VBG	O	use	partmod	34	SENT_107	[p7l495t1954r735b2054],
36	default	NN	O	default	nn	37	SENT_107	[p7l781t1953r1082b2033],
37	settings	NNS	O	setting	dobj	35	SENT_107	[p7l1127t1954r1487b2054],
38	.	.	O	.	_	0	SENT_107	[p7l1127t1954r1487b2054],

1	Geﬁtinib	NNP	O	Geﬁtinib	nsubjpass	8	SENT_108	[p7l1542t1953r1927b2032],
2	and	CC	O	and	_	0	SENT_108	[p7l1976t1953r2134b2032],
3	CL	NN	O	cl	nsubjpass	8	SENT_108	[p7l10t2086r504b2175],
4	—	CD	NUMBER	—	number	5	SENT_108	[p7l10t2086r504b2175],
5	387,785	CD	NUMBER	387,785	dep	3	SENT_108	[p7l10t2086r504b2175],
6	were	VBD	O	be	auxpass	8	SENT_108	[p7l537t2107r739b2160],
7	then	RB	O	then	advmod	8	SENT_108	[p7l774t2080r961b2158],
8	docked	VBN	O	dock	_	0	SENT_108	[p7l995t2080r1299b2160],
9	with	IN	O	with	_	0	SENT_108	[p7l1328t2081r1517b2160],
10	the	DT	O	the	det	11	SENT_108	[p7l1552t2081r1681b2158],
11	use	NN	O	use	prep_with	8	SENT_108	[p7l1715t2107r1854b2160],
12	of	IN	O	of	_	0	SENT_108	[p7l1889t2080r1989b2159],
13	the	DT	O	the	det	15	SENT_108	[p7l2006t2080r2134b2158],
14	same	JJ	O	same	amod	15	SENT_108	[p7l12t2235r232b2287],
15	protocol	NN	O	protocol	prep_of	11	SENT_108	[p7l283t2209r672b2309],
16	.	.	O	.	_	0	SENT_108	[p7l283t2209r672b2309],

1	To	TO	O	to	aux	2	SENT_109	[p7l727t2214r833b2287],
2	illustrate	VB	O	illustrate	purpcl	12	SENT_109	[p7l886t2208r1266b2288],
3	potential	JJ	O	potential	amod	5	SENT_109	[p7l1317t2209r1702b2309],
4	inhibitor	NN	O	inhibitor	nn	5	SENT_109	[p7l1753t2209r2137b2287],
5	clashes	NNS	O	clash	dobj	2	SENT_109	[p7l11t2337r320b2415],
6	with	IN	O	with	_	0	SENT_109	[p7l351t2337r540b2416],
7	the	DT	O	the	det	9	SENT_109	[p7l572t2337r702b2415],
8	T790M	NN	O	t790m	nn	9	SENT_109	[p7l731t2342r1034b2415],
9	mutant	NN	O	mutant	prep_with	2	SENT_109	[p7l1068t2353r1398b2432],
10	,	,	O	,	_	0	SENT_109	[p7l1068t2353r1398b2432],
11	We	PRP	O	we	nsubj	12	SENT_109	[p7l1431t2363r1549b2416],
12	prepared	VBD	O	prepare	_	0	SENT_109	[p7l1580t2337r1958b2437],
13	ﬁgures	NNS	O	ﬁgures	dobj	12	SENT_109	[p7l1990t2336r2134b2437, p7l10t2491r184b2544],
14	in	IN	O	in	_	0	SENT_109	[p7l221t2465r302b2542],
15	which	WDT	O	which	rel	24	SENT_109	[p7l332t2465r592b2544],
16	threonine	NN	O	threonine	nsubjpass	24	SENT_109	[p7l628t2464r1037b2543],
17	at	IN	O	at	_	0	SENT_109	[p7l1072t2481r1151b2543],
18	position	NN	O	position	prep_at	16	SENT_109	[p7l1179t2465r1528b2565],
19	790	CD	NUMBER	790	number	20	SENT_109	[p7l1563t2470r1716b2543],
20	(	CD	NUMBER	(	num	22	SENT_109	[p7l1756t2470r2028b2556],
21	T790	NN	O	t790	nn	22	SENT_109	[p7l1756t2470r2028b2556],
22	)	NN	O	)	dep	18	SENT_109	[p7l1756t2470r2028b2556],
23	is	VBZ	O	be	auxpass	24	SENT_109	[p7l2068t2465r2133b2543],
24	mutated	VBN	O	mutate	rcmod	13	SENT_109	[p7l10t2593r361b2672],
25	to	TO	O	to	_	0	SENT_109	[p7l392t2609r471b2671],
26	methionine	NN	O	methionine	prep_to	24	SENT_109	[p7l504t2593r1015b2671],
27	.	.	O	.	_	0	SENT_109	[p7l504t2593r1015b2671],

1	We	PRP	O	we	nsubj	3	SENT_110	[p7l1048t2600r1182b2671],
2	then	RB	O	then	advmod	3	SENT_110	[p7l1213t2593r1400b2671],
3	chose	VBD	O	choose	_	0	SENT_110	[p7l1432t2593r1672b2671],
4	the	DT	O	the	det	9	SENT_110	[p7l1704t2592r1832b2671],
5	lowest	JJS	O	lowest	amod	9	SENT_110	[p7l1862t2593r2140b2672],
6	free	JJ	O	free	amod	9	SENT_110	[p7l10t2720r490b2821],
7	—	NN	O	—	nn	9	SENT_110	[p7l10t2720r490b2821],
8	energy	NN	O	energy	nn	9	SENT_110	[p7l10t2720r490b2821],
9	cluster	NN	O	cluster	nsubj	21	SENT_110	[p7l513t2721r796b2800],
10	that	WDT	O	that	nsubj	11	SENT_110	[p7l820t2721r987b2799],
11	overlapped	VBD	O	overlap	rcmod	9	SENT_110	[p7l1008t2720r1472b2821],
12	in	IN	O	in	_	0	SENT_110	[p7l1497t2721r1578b2798],
13	the	DT	O	the	det	17	SENT_110	[p7l1605t2721r1734b2799],
14	quinazo	NN	O	quinazo	nn	17	SENT_110	[p7l1761t2721r2134b2821],
15	—	NN	O	—	nn	17	SENT_110	[p7l1761t2721r2134b2821],
16	line	NN	O	line	nn	17	SENT_110	[p7l9t2849r164b2927],
17	moiety	NN	O	moiety	prep_in	11	SENT_110	[p7l204t2849r493b2949],
18	with	IN	O	with	_	0	SENT_110	[p7l523t2849r713b2928],
19	the	DT	O	the	det	20	SENT_110	[p7l753t2849r882b2927],
20	crystallographic	JJ	O	crystallographic	prep_with	11	SENT_110	[p7l922t2849r1601b2949],
21	coordinates	VBZ	O	coordinate	ccomp	3	SENT_110	[p7l1641t2848r2133b2927],
22	found	VBN	O	find	dep	21	SENT_110	[p7l10t2976r261b3056],
23	for	IN	O	for	_	0	SENT_110	[p7l286t2976r409b3055],
24	erlotinib	NN	O	erlotinib	nn	25	SENT_110	[p7l432t2976r790b3055],
25	binding	NN	O	binding	prep_for	22	SENT_110	[p7l817t2977r1170b3077],
26	.	.	O	.	_	0	SENT_110	[p7l817t2977r1170b3077],

1	RESULTS	NNS	O	result	_	0	SENT_111	[p7l828t3292r1305b3351],

1	Exons	NNS	O	exon	nsubjpass	10	SENT_112	[p7l9t3494r263b3565],
2	18	CD	NUMBER	18	num	1	SENT_112	[p7l313t3492r408b3565],
3	through	IN	O	through	_	0	SENT_112	[p7l455t3487r796b3587],
4	21	CD	NUMBER	21	prep_through	1	SENT_112	[p7l839t3492r940b3564],
5	of	IN	O	of	_	0	SENT_112	[p7l985t3486r1086b3565],
6	the	DT	O	the	det	8	SENT_112	[p7l1111t3486r1240b3565],
7	EGFR	NN	ORGANIZATION	egfr	nn	8	SENT_112	[p7l1282t3493r1495b3566],
8	gene	NN	O	gene	prep_of	4	SENT_112	[p7l1531t3512r1730b3587],
9	were	VBD	O	be	auxpass	10	SENT_112	[p7l1770t3513r1971b3566],
10	sequenced	VBN	O	sequence	_	0	SENT_112	[p7l2017t3513r2133b3565, p7l11t3614r366b3715],
11	from	IN	O	from	_	0	SENT_112	[p7l389t3614r596b3693],
12	DNA	NN	O	dna	prep_from	10	SENT_112	[p7l619t3621r831b3694],
13	isolated	VBN	O	isolate	partmod	12	SENT_112	[p7l851t3614r1180b3693],
14	from	IN	O	from	_	0	SENT_112	[p7l1203t3614r1411b3693],
15	both	CC	O	both	dep	20	SENT_112	[p7l1435t3615r1628b3693],
16	the	DT	O	the	det	20	SENT_112	[p7l1652t3615r1782b3693],
17	original	JJ	O	original	amod	20	SENT_112	[p7l1806t3615r2135b3715],
18	diagnostic	JJ	O	diagnostic	amod	20	SENT_112	[p8l11t21r450b121],
19	biopsy	NN	O	biopsy	nn	20	SENT_112	[p8l483t21r762b121],
20	specimen	NN	O	specimen	prep_from	13	SENT_112	[p8l792t21r1195b121],
21	and	CC	O	and	_	0	SENT_112	[p8l1227t20r1383b99],
22	the	DT	O	the	det	24	SENT_112	[p8l1416t21r1545b99],
23	biopsy	NN	O	biopsy	nn	24	SENT_112	[p8l1580t21r1859b121],
24	specimen	NN	O	specimen	conj_and	12	SENT_112	[p8l1888t21r2134b121, p8l10t174r196b227],
25	obtained	VBN	O	obtain	partmod	24	SENT_112	[p8l230t148r602b227],
26	at	IN	O	at	_	0	SENT_112	[p8l634t165r713b227],
27	relapse	NN	O	relapse	prep_at	25	SENT_112	[p8l741t149r1063b249],
28	.	.	O	.	_	0	SENT_112	[p8l741t149r1063b249],

1	These	DT	O	these	det	2	SENT_113	[p8l1099t149r1349b227],
2	exons	NNS	O	exon	nsubj	3	SENT_113	[p8l1384t174r1624b227],
3	encompass	VBP	O	encompass	_	0	SENT_113	[p8l1660t174r2133b249],
4	most	JJS	O	most	dobj	3	SENT_113	[p8l10t293r225b355],
5	of	IN	O	of	_	0	SENT_113	[p8l242t276r342b355],
6	the	DT	O	the	det	10	SENT_113	[p8l345t277r473b355],
7	tyrosine	NN	O	tyrosine	nn	10	SENT_113	[p8l495t277r827b377],
8	kinase	NN	O	kinase	nn	10	SENT_113	[p8l848t277r1116b356],
9	binding	NN	O	binding	nn	10	SENT_113	[p8l1138t277r1468b377],
10	domain	NN	O	domain	prep_of	4	SENT_113	[p8l1487t277r1808b355],
11	of	IN	O	of	_	0	SENT_113	[p8l1830t276r1930b355],
12	EGFR	NN	ORGANIZATION	egfr	prep_of	10	SENT_113	[p8l1930t283r2141b356],
13	and	CC	O	and	_	0	SENT_113	[p8l10t405r164b483],
14	all	DT	O	all	det	17	SENT_113	[p8l183t405r280b483],
15	activating	VBG	O	activate	amod	17	SENT_113	[p8l298t405r700b505],
16	EGFR	NN	ORGANIZATION	egfr	nn	17	SENT_113	[p8l715t411r925b484],
17	mutations	NNS	O	mutation	nsubj	18	SENT_113	[p8l937t405r1361b484],
18	described	VBD	O	describe	conj_and	3	SENT_113	[p8l1384t404r1783b483],
19	thus	RB	O	thus	advmod	20	SENT_113	[p8l1802t404r1979b484],
20	far	RB	O	far	advmod	18	SENT_113	[p8l2001t404r2130b483],
21	.	.	O	.	_	0	SENT_113	[p8l2001t404r2130b483],

1	The	DT	O	the	det	5	SENT_114	[p8l7t533r167b611],
2	original	JJ	O	original	amod	5	SENT_114	[p8l192t533r517b633],
3	diagnostic	JJ	O	diagnostic	amod	5	SENT_114	[p8l542t532r976b633],
4	biopsy	NN	O	biopsy	nn	5	SENT_114	[p8l1000t533r1276b633],
5	specimen	NN	O	specimen	nsubj	6	SENT_114	[p8l1297t533r1696b633],
6	contained	VBD	O	contain	_	0	SENT_114	[p8l1721t532r2135b611],
7	a	DT	O	a	det	10	SENT_114	[p8l10t686r54b737],
8	small	JJ	O	small	amod	10	SENT_114	[p8l87t660r314b737],
9	deletion	NN	O	deletion	nn	10	SENT_114	[p8l348t659r688b738],
10	mutation	NN	O	mutation	dobj	6	SENT_114	[p8l721t660r1134b754],
11	,	,	O	,	_	0	SENT_114	[p8l721t660r1134b754],
12	delL747	NN	O	dell747	appos	10	SENT_114	[p8l1172t659r1795b754],
13	.	.	O	.	_	0	SENT_114	[p8l1172t659r1795b754],

1	—	NN	O	—	_	0	SENT_115	[p8l1172t659r1795b754],
2	.	.	O	.	_	0	SENT_115	[p8l1172t659r1795b754],

1	S752	NN	O	s752	_	0	SENT_116	[p8l1172t659r1795b754],
2	,	,	O	,	_	0	SENT_116	[p8l1172t659r1795b754],
3	consistent	JJ	O	consistent	appos	1	SENT_116	[p8l1834t660r2134b738, p8l11t804r176b866],
4	with	IN	O	with	_	0	SENT_116	[p8l203t788r393b867],
5	other	JJ	O	other	amod	10	SENT_116	[p8l430t787r671b883],
6	,	,	O	,	_	0	SENT_116	[p8l430t787r671b883],
7	commonly	RB	O	commonly	advmod	8	SENT_116	[p8l714t788r1169b888],
8	identiﬁed	JJ	O	identiﬁed	amod	10	SENT_116	[p8l1201t787r1605b866],
9	EGFR	NN	ORGANIZATION	egfr	nn	10	SENT_116	[p8l1639t794r1851b867],
10	mutations	NNS	O	mutation	prep_with	3	SENT_116	[p8l1882t804r2133b867, p8l11t916r239b994],
11	.	.	O	.	_	0	SENT_116	[p8l1882t804r2133b867, p8l11t916r239b994],

1	Examination	NN	O	examination	nsubj	8	SENT_117	[p8l264t916r794b994],
2	of	IN	O	of	_	0	SENT_117	[p8l815t915r915b994],
3	the	DT	O	the	det	4	SENT_117	[p8l917t916r1044b994],
4	sequences	NNS	O	sequence	prep_of	1	SENT_117	[p8l1066t941r1489b1016],
5	of	IN	O	of	_	0	SENT_117	[p8l1512t915r1611b994],
6	exon	NN	O	exon	prep_of	4	SENT_117	[p8l1614t941r1811b994],
7	19	CD	NUMBER	19	num	6	SENT_117	[p8l1834t921r1930b994],
8	conﬁrmed	VBD	O	conﬁrmed	_	0	SENT_117	[p8l1953t941r2134b994, p8l10t1043r288b1122],
9	the	DT	O	the	det	10	SENT_117	[p8l310t1044r437b1122],
10	persistence	NN	O	persistence	dobj	8	SENT_117	[p8l458t1044r925b1144],
11	of	IN	O	of	_	0	SENT_117	[p8l948t1043r1047b1122],
12	the	DT	O	the	det	14	SENT_117	[p8l1051t1044r1178b1122],
13	original	JJ	O	original	amod	14	SENT_117	[p8l1201t1044r1524b1144],
14	delL747	NN	O	dell747	prep_of	10	SENT_117	[p8l1546t1043r2135b1122],
15	.	.	O	.	_	0	SENT_117	[p8l1546t1043r2135b1122],

1	—	NN	O	—	_	0	SENT_118	[p8l1546t1043r2135b1122],
2	.	.	O	.	_	0	SENT_118	[p8l1546t1043r2135b1122],

1	S752	NN	O	s752	nn	2	SENT_119	[p8l1546t1043r2135b1122],
2	mutation	NN	O	mutation	_	0	SENT_119	[p8l10t1172r400b1251],
3	in	IN	O	in	_	0	SENT_119	[p8l424t1172r505b1249],
4	the	DT	O	the	det	7	SENT_119	[p8l531t1172r659b1250],
5	second	JJ	ORDINAL	second	amod	7	SENT_119	[p8l686t1171r982b1250],
6	biopsy	NN	O	biopsy	nn	7	SENT_119	[p8l1007t1171r1286b1272],
7	specimen	NN	O	specimen	prep_in	2	SENT_119	[p8l1308t1172r1734b1272],
8	.	.	O	.	_	0	SENT_119	[p8l1308t1172r1734b1272],

1	Comparison	NN	O	comparison	nsubj	17	SENT_120	[p8l139t1300r664b1400],
2	of	IN	O	of	_	0	SENT_120	[p8l712t1299r813b1378],
3	the	DT	O	the	det	5	SENT_120	[p8l841t1300r970b1378],
4	DNA	NN	O	dna	nn	5	SENT_120	[p8l1016t1306r1228b1378],
5	sequences	NNS	O	sequence	prep_of	1	SENT_120	[p8l1273t1325r1703b1400],
6	from	IN	O	from	_	0	SENT_120	[p8l1751t1299r1958b1378],
7	the	DT	O	the	det	11	SENT_120	[p8l2006t1299r2134b1378],
8	original	JJ	O	original	amod	11	SENT_120	[p8l11t1427r334b1528],
9	diagnostic	JJ	O	diagnostic	amod	11	SENT_120	[p8l356t1427r787b1528],
10	biopsy	NN	O	biopsy	nn	11	SENT_120	[p8l808t1428r1082b1528],
11	specimen	NN	O	specimen	prep_from	5	SENT_120	[p8l1101t1428r1498b1528],
12	and	CC	O	and	_	0	SENT_120	[p8l1518t1427r1672b1506],
13	the	DT	O	the	det	16	SENT_120	[p8l1694t1427r1822b1506],
14	second	JJ	ORDINAL	second	amod	16	SENT_120	[p8l1845t1428r2136b1506],
15	biopsy	NN	O	biopsy	nn	16	SENT_120	[p8l11t1556r290b1656],
16	specimen	NN	O	specimen	prep_from	5	SENT_120	[p8l325t1556r728b1656],
17	demonstrated	VBD	O	demonstrate	_	0	SENT_120	[p8l767t1555r1353b1634],
18	the	DT	O	the	det	19	SENT_120	[p8l1393t1556r1521b1634],
19	presence	NN	O	presence	nsubj	45	SENT_120	[p8l1559t1581r1933b1656],
20	of	IN	O	of	_	0	SENT_120	[p8l1972t1555r2073b1634],
21	a	DT	O	a	det	25	SENT_120	[p8l2092t1582r2136b1634],
22	new	JJ	O	new	amod	25	SENT_120	[p8l10t1709r198b1779],
23	,	,	O	,	_	0	SENT_120	[p8l10t1709r198b1779],
24	double	JJ	O	double	amod	25	SENT_120	[p8l227t1683r515b1763],
25	peak	NN	O	peak	prep_of	19	SENT_120	[p8l536t1684r740b1784],
26	in	IN	O	in	_	0	SENT_120	[p8l757t1684r838b1761],
27	exon	NN	O	exon	prep_in	25	SENT_120	[p8l861t1709r1061b1762],
28	20	CD	NUMBER	20	num	27	SENT_120	[p8l1083t1689r1208b1779],
29	,	,	O	,	_	0	SENT_120	[p8l1083t1689r1208b1779],
30	which	WDT	O	which	nsubjpass	32	SENT_120	[p8l1232t1684r1492b1763],
31	was	VBD	O	be	auxpass	32	SENT_120	[p8l1510t1710r1672b1763],
32	conﬁrmed	VBN	O	conﬁrmed	rcmod	27	SENT_120	[p8l1697t1683r2135b1762],
33	by	IN	O	by	_	0	SENT_120	[p8l11t1812r108b1912],
34	re	NN	O	re	nn	36	SENT_120	[p8l137t1811r820b1912],
35	—	NN	O	—	nn	36	SENT_120	[p8l137t1811r820b1912],
36	ampliﬁcation	NN	O	ampliﬁcation	agent	32	SENT_120	[p8l137t1811r820b1912],
37	and	CC	O	and	_	0	SENT_120	[p8l854t1812r1010b1890],
38	sequencing	NN	O	sequencing	agent	32	SENT_120	[p8l1046t1812r1530b1912],
39	in	IN	O	in	_	0	SENT_120	[p8l1561t1812r1641b1889],
40	both	CC	O	both	preconj	41	SENT_120	[p8l1677t1812r1869b1890],
41	sense	NN	O	sense	prep_in	32	SENT_120	[p8l1905t1837r2135b1890],
42	and	CC	O	and	_	0	SENT_120	[p8l10t1939r165b2018],
43	antisense	JJ	O	antisense	amod	44	SENT_120	[p8l195t1940r591b2018],
44	directions	NNS	O	direction	conj_and	41	SENT_120	[p8l623t1940r1041b2018],
45	(	VBP	O	(	ccomp	17	SENT_120	[p8l1079t1940r1263b2040],
46	Fig	NN	O	fig	dobj	45	SENT_120	[p8l1079t1940r1263b2040],
47	.	.	O	.	_	0	SENT_120	[p8l1079t1940r1263b2040],

1	1B	NN	O	1b	_	0	SENT_121	[p8l1303t1945r1466b2031],
2	)	NN	O	)	dep	1	SENT_121	[p8l1303t1945r1466b2031],
3	.	.	O	.	_	0	SENT_121	[p8l1303t1945r1466b2031],

1	The	DT	O	the	det	2	SENT_122	[p8l1499t1940r1660b2018],
2	product	NN	O	product	nsubjpass	8	SENT_122	[p8l1691t1939r2027b2040],
3	of	IN	O	of	_	0	SENT_122	[p8l2053t1939r2153b2018],
4	exon	NN	O	exon	nn	6	SENT_122	[p8l11t2093r210b2146],
5	20	CD	NUMBER	20	num	6	SENT_122	[p8l231t2073r332b2146],
6	ampliﬁcation	NN	O	ampliﬁcation	prep_of	2	SENT_122	[p8l353t2067r919b2168],
7	was	VBD	O	be	auxpass	8	SENT_122	[p8l936t2094r1097b2147],
8	subcloned	VBN	O	subclon	_	0	SENT_122	[p8l1122t2067r1578b2163],
9	,	,	O	,	_	0	SENT_122	[p8l1122t2067r1578b2163],
10	and	CC	O	and	_	0	SENT_122	[p8l1604t2067r1760b2146],
11	multiple	JJ	O	multiple	amod	12	SENT_122	[p8l1781t2067r2135b2168],
12	subclones	NNS	O	subclone	nsubjpass	14	SENT_122	[p8l12t2195r431b2275],
13	were	VBD	O	be	auxpass	14	SENT_122	[p8l457t2222r658b2275],
14	sequenced	VBN	O	sequence	conj_and	8	SENT_122	[p8l688t2196r1155b2296],
15	.	.	O	.	_	0	SENT_122	[p8l688t2196r1155b2296],

1	Whereas	IN	O	whereas	mark	6	SENT_123	[p8l1184t2196r1553b2274],
2	13	CD	TIME	13	nsubj	6	SENT_123	[p8l1586t2201r1681b2274],
3	of	IN	TIME	of	_	0	SENT_123	[p8l1713t2195r1813b2274],
4	17	CD	TIME	17	num	5	SENT_123	[p8l1826t2201r1922b2274],
5	subclones	NNS	O	subclone	prep_of	2	SENT_123	[p8l1953t2196r2134b2275, p8l11t2324r277b2402],
6	demonstrated	VBD	O	demonstrate	advcl	13	SENT_123	[p8l317t2323r903b2402],
7	wild	JJ	O	wild	amod	10	SENT_123	[p8l935t2323r1329b2424],
8	—	NN	O	—	nn	10	SENT_123	[p8l935t2323r1329b2424],
9	type	NN	O	type	nn	10	SENT_123	[p8l935t2323r1329b2424],
10	sequences	NNS	O	sequence	dobj	6	SENT_123	[p8l1367t2349r1822b2424],
11	,	,	O	,	_	0	SENT_123	[p8l1367t2349r1822b2424],
12	4	CD	NUMBER	4	nsubj	13	SENT_123	[p8l1862t2329r1912b2402],
13	contained	VBD	O	contain	_	0	SENT_123	[p8l1949t2349r2134b2402, p8l11t2452r271b2530],
14	an	DT	O	a	det	20	SENT_123	[p8l291t2477r392b2530],
15	identical	JJ	O	identical	amod	20	SENT_123	[p8l412t2452r770b2530],
16	single	JJ	O	single	amod	20	SENT_123	[p8l793t2452r1041b2552],
17	base	NN	O	base	nn	20	SENT_123	[p8l1064t2452r1451b2552],
18	—	NN	O	—	nn	20	SENT_123	[p8l1064t2452r1451b2552],
19	pair	NN	O	pair	nn	20	SENT_123	[p8l1064t2452r1451b2552],
20	change	NN	O	change	dobj	13	SENT_123	[p8l1471t2452r1770b2552],
21	from	IN	O	from	_	0	SENT_123	[p8l1792t2451r1997b2530],
22	cytosine	NN	O	cytosine	prep_from	13	SENT_123	[p8l2020t2478r2134b2552, p8l11t2580r264b2658],
23	to	TO	O	to	_	0	SENT_123	[p8l296t2596r375b2658],
24	thymidine	NN	O	thymidine	nn	26	SENT_123	[p8l408t2579r835b2680],
25	(	NN	O	(	nn	26	SENT_123	[p8l872t2585r959b2671],
26	C	NN	O	c	prep_to	13	SENT_123	[p8l872t2585r959b2671],
27	to	TO	O	to	_	0	SENT_123	[p8l994t2596r1073b2658],
28	T	NN	O	t	prep_to	26	SENT_123	[p8l1103t2585r1190b2671],
29	)	CD	NUMBER	)	num	28	SENT_123	[p8l1103t2585r1190b2671],
30	(	CD	NUMBER	(	num	31	SENT_123	[p8l1232t2580r1415b2680],
31	Fig	NN	O	fig	dep	28	SENT_123	[p8l1232t2580r1415b2680],
32	.	.	O	.	_	0	SENT_123	[p8l1232t2580r1415b2680],

1	1B	NN	O	1b	nn	2	SENT_124	[p8l1456t2585r1620b2675],
2	)	NN	O	)	_	0	SENT_124	[p8l1456t2585r1620b2675],
3	,	,	O	,	_	0	SENT_124	[p8l1456t2585r1620b2675],
4	conﬁrming	VBG	O	conﬁrming	partmod	2	SENT_124	[p8l1659t2579r2138b2680],
5	that	IN	O	that	complm	10	SENT_124	[p8l11t2708r178b2786],
6	the	DT	O	the	det	8	SENT_124	[p8l194t2708r323b2786],
7	new	JJ	O	new	amod	8	SENT_124	[p8l344t2733r520b2787],
8	peak	NN	O	peak	nsubjpass	10	SENT_124	[p8l536t2707r739b2808],
9	was	VBD	O	be	auxpass	10	SENT_124	[p8l752t2734r913b2787],
10	caused	VBN	O	cause	ccomp	4	SENT_124	[p8l937t2707r1223b2787],
11	by	IN	O	by	_	0	SENT_124	[p8l1245t2708r1342b2808],
12	a	DT	O	a	det	16	SENT_124	[p8l1358t2734r1402b2786],
13	base	NN	O	base	nn	16	SENT_124	[p8l1422t2708r1814b2808],
14	—	NN	O	—	nn	16	SENT_124	[p8l1422t2708r1814b2808],
15	pair	NN	O	pair	nn	16	SENT_124	[p8l1422t2708r1814b2808],
16	change	NN	O	change	agent	10	SENT_124	[p8l1833t2708r2134b2808],
17	at	IN	O	at	_	0	SENT_124	[p8l10t2852r89b2914],
18	this	DT	O	this	det	21	SENT_124	[p8l113t2836r266b2914],
19	position	NN	O	position	nn	21	SENT_124	[p8l295t2836r645b2936],
20	(	NN	O	(	nn	21	SENT_124	[p8l678t2836r1056b2936],
21	position	NN	O	position	prep_at	16	SENT_124	[p8l678t2836r1056b2936],
22	164208	CD	NUMBER	164208	tmod	10	SENT_124	[p8l1088t2841r1423b2931],
23	;	:	O	;	_	0	SENT_124	[p8l1088t2841r1423b2931],
24	GenBanl	NN	O	genbanl	dep	2	SENT_124	[p8l1456t2836r1855b2915],
25	<	JJR	O	<	amod	27	SENT_124	[p8l1456t2836r1855b2915],
26	accession	NN	O	accession	nn	27	SENT_124	[p8l1878t2862r2134b2914, p8l12t2965r188b3043],
27	number	NN	O	number	dep	24	SENT_124	[p8l214t2964r550b3044],
28	AY588246	CD	NUMBER	ay588246	num	29	SENT_124	[p8l568t2970r1058b3056],
29	)	NN	O	)	dep	24	SENT_124	[p8l568t2970r1058b3056],
30	.	.	O	.	_	0	SENT_124	[p8l568t2970r1058b3056],

1	To	TO	O	to	aux	2	SENT_125	[p8l136t3098r241b3171],
2	obtain	VB	O	obtain	purpcl	15	SENT_125	[p8l275t3093r546b3171],
3	further	JJ	O	further	amod	4	SENT_125	[p8l578t3092r873b3172],
4	evidence	NN	O	evidence	dobj	2	SENT_125	[p8l903t3093r1264b3172],
5	of	IN	O	of	_	0	SENT_125	[p8l1297t3092r1397b3171],
6	the	DT	O	the	det	7	SENT_125	[p8l1411t3093r1540b3171],
7	presence	NN	O	presence	prep_of	4	SENT_125	[p8l1572t3118r1945b3193],
8	of	IN	O	of	_	0	SENT_125	[p8l1979t3092r2079b3171],
9	a	DT	DURATION	a	det	11	SENT_125	[p8l2092t3119r2136b3171],
10	second	JJ	DURATION	second	amod	11	SENT_125	[p8l12t3220r307b3299],
11	mutation	NN	O	mutation	prep_of	7	SENT_125	[p8l336t3221r749b3316],
12	,	,	O	,	_	0	SENT_125	[p8l336t3221r749b3316],
13	cDNA	NN	O	cdna	nsubjpass	15	SENT_125	[p8l784t3227r1039b3299],
14	was	VBD	O	be	auxpass	15	SENT_125	[p8l1060t3247r1222b3300],
15	generated	VBN	O	generate	_	0	SENT_125	[p8l1252t3221r1669b3321],
16	from	IN	O	from	_	0	SENT_125	[p8l1697t3220r1905b3299],
17	RNA	NN	O	rna	prep_from	15	SENT_125	[p8l1932t3227r2138b3304],
18	isolated	VBN	O	isolate	partmod	17	SENT_125	[p8l10t3349r339b3427],
19	from	IN	O	from	_	0	SENT_125	[p8l362t3348r569b3427],
20	the	DT	O	the	det	22	SENT_125	[p8l593t3349r722b3427],
21	parafﬁn	NN	O	parafﬁn	nn	22	SENT_125	[p8l744t3348r1080b3449],
22	block	NN	O	block	prep_from	18	SENT_125	[p8l1104t3348r1339b3428],
23	of	IN	O	of	_	0	SENT_125	[p8l1358t3348r1459b3427],
24	the	DT	O	the	det	26	SENT_125	[p8l1464t3349r1593b3427],
25	biopsy	NN	O	biopsy	nn	26	SENT_125	[p8l1617t3349r1896b3449],
26	specimen	NN	O	specimen	prep_of	22	SENT_125	[p8l1917t3375r2134b3449, p8l10t3477r224b3555],
27	obtained	VBN	O	obtain	partmod	26	SENT_125	[p8l265t3476r637b3555],
28	at	IN	O	at	_	0	SENT_125	[p8l677t3493r757b3555],
29	the	DT	O	the	det	30	SENT_125	[p8l793t3477r922b3555],
30	time	NN	O	time	prep_at	27	SENT_125	[p8l963t3477r1150b3555],
31	of	IN	O	of	_	0	SENT_125	[p8l1192t3476r1292b3555],
32	relapse	NN	O	relapse	prep_of	30	SENT_125	[p8l1314t3477r1637b3577],
33	.	.	O	.	_	0	SENT_125	[p8l1314t3477r1637b3577],

1	The	DT	O	the	det	2	SENT_126	[p8l1679t3477r1841b3555],
2	cDNA	NN	O	cdna	_	0	SENT_126	[p8l1883t3483r2138b3555],

1	788	CD	NUMBER	788	num	4	SENT_127	[p8l149t3656r205b3678],
2	N	NN	O	n	nn	4	SENT_127	[p8l880t3658r894b3674],
3	ENGL	NN	ORGANIZATION	engl	nn	4	SENT_127	[p8l909t3658r976b3674],
4	MED	NN	O	med	_	0	SENT_127	[p8l1008t3658r1061b3673],
5	352	CD	NUMBER	352	dep	4	SENT_127	[p8l1073t3652r1139b3680],
6	;	:	O	;	_	0	SENT_127	[p8l1073t3652r1139b3680],
7	8	CD	NUMBER	8	num	8	SENT_127	[p8l1073t3652r1139b3680],
8	WWW	NN	O	www	dep	4	SENT_127	[p8l1174t3658r1294b3680],
9	.	.	O	.	_	0	SENT_127	[p8l1174t3658r1294b3680],

1	NEj	NN	O	nej	nn	3	SENT_128	[p8l1174t3658r1294b3680],
2	M.ORG	NN	O	m.org	nn	3	SENT_128	[p8l1302t3658r1385b3674],
3	FEBRUARY	NN	DATE	february	_	0	SENT_128	[p8l1425t3658r1552b3674],
4	24	CD	DATE	24	dep	3	SENT_128	[p8l1564t3658r1602b3680],
5	,	,	DATE	,	_	0	SENT_128	[p8l1564t3658r1602b3680],
6	2005	CD	DATE	2005	appos	4	SENT_128	[p8l1615t3658r1678b3680],

1	e	LS	O	e	dep	4	SENT_129	[p8l973t3699r987b3715],
2	New	NNP	O	New	nn	4	SENT_129	[p8l996t3692r1058b3715],
3	England	NNP	O	England	nn	4	SENT_129	[p8l1067t3691r1178b3722],
4	Journal	NNP	O	Journal	_	0	SENT_129	[p8l1187t3691r1284b3715],
5	of	IN	O	of	prep	4	SENT_129	[p8l1294t3691r1323b3715],
6	Medicine	NNP	O	Medicine	dep	4	SENT_129	[p8l1330t3691r1455b3715],

1	Downloaded	VBN	O	download	_	0	SENT_130	[p8l378t3732r548b3755],
2	from	IN	O	from	_	0	SENT_130	[p8l557t3732r621b3755],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_130	[p8l630t3732r748b3762],
4	at	IN	O	at	_	0	SENT_130	[p8l759t3736r782b3755],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_130	[p8l790t3732r973b3755],
6	on	IN	O	on	_	0	SENT_130	[p8l982t3739r1015b3755],
7	January	NNP	DATE	January	prep_on	1	SENT_130	[p8l1023t3732r1126b3762],
8	5	CD	DATE	5	num	7	SENT_130	[p8l1136t3732r1159b3759],
9	,	,	DATE	,	_	0	SENT_130	[p8l1136t3732r1159b3759],
10	2014	CD	DATE	2014	num	7	SENT_130	[p8l1169t3732r1242b3755],
11	.	.	O	.	_	0	SENT_130	[p8l1169t3732r1242b3755],

1	For	IN	O	for	_	0	SENT_131	[p8l1252t3732r1299b3755],
2	personal	JJ	O	personal	amod	3	SENT_131	[p8l1307t3732r1419b3762],
3	use	NN	O	use	pobj	1	SENT_131	[p8l1428t3739r1472b3755],
4	only	RB	O	only	advmod	3	SENT_131	[p8l1482t3732r1546b3762],
5	.	.	O	.	_	0	SENT_131	[p8l1482t3732r1546b3762],

1	No	DT	O	no	det	3	SENT_132	[p8l1557t3732r1597b3755],
2	other	JJ	O	other	amod	3	SENT_132	[p8l1607t3732r1675b3755],
3	uses	NNS	O	use	_	0	SENT_132	[p8l1683t3739r1739b3755],
4	without	IN	O	without	_	0	SENT_132	[p8l1749t3732r1850b3755],
5	permission	NN	O	permission	prep_without	3	SENT_132	[p8l1859t3732r2011b3762],
6	.	.	O	.	_	0	SENT_132	[p8l1859t3732r2011b3762],

1	Copyright	NN	O	copyright	_	0	SENT_133	[p8l728t3773r863b3804],
2	©	CD	NUMBER	©	num	6	SENT_133	[p8l872t3773r896b3797],
3	2005	CD	DATE	2005	num	6	SENT_133	[p8l906t3773r970b3797],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_133	[p8l980t3773r1171b3797],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_133	[p8l1181t3773r1289b3797],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_133	[p8l1300t3773r1405b3804],
7	.	.	O	.	_	0	SENT_133	[p8l1300t3773r1405b3804],

1	All	DT	O	all	det	2	SENT_134	[p8l1416t3773r1457b3797],
2	rights	NNS	O	rights	nsubj	3	SENT_134	[p8l1466t3773r1541b3804],
3	reserved	VBN	O	reserve	_	0	SENT_134	[p8l1551t3773r1670b3797],
4	.	.	O	.	_	0	SENT_134	[p8l1551t3773r1670b3797],

1	RRRRRRRRR	NNP	O	RRRRRRRRR	_	0	SENT_135	[p9l958t67r1156b86],
2	RT	NN	O	rt	dep	1	SENT_135	[p9l1162t67r1201b86],

1	Was	VBD	O	be	cop	2	SENT_136	[p9l6t307r166b360],
2	ampliﬁed	JJ	O	ampliﬁed	_	0	SENT_136	[p9l189t280r611b381],
3	,	,	O	,	_	0	SENT_136	[p9l189t280r611b381],
4	and	CC	O	and	_	0	SENT_136	[p9l638t280r792b359],
5	the	DT	O	the	det	6	SENT_136	[p9l814t280r942b359],
6	C	NN	O	c	conj_and	2	SENT_136	[p9l963t286r1233b359],
7	.	.	O	.	_	0	SENT_136	[p9l963t286r1233b359],

1	—	NN	O	—	_	0	SENT_137	[p9l963t286r1233b359],
2	.	.	O	.	_	0	SENT_137	[p9l963t286r1233b359],

1	to	TO	O	to	_	0	SENT_138	[p9l963t286r1233b359],
2	.	.	O	.	_	0	SENT_138	[p9l963t286r1233b359],

1	—	NN	O	—	_	0	SENT_139	[p9l963t286r1233b359],
2	.	.	O	.	_	0	SENT_139	[p9l963t286r1233b359],

1	T	NN	O	t	nn	2	SENT_140	[p9l963t286r1233b359],
2	base	NN	O	base	nsubjpass	7	SENT_140	[p9l1251t281r1639b381],
3	—	NN	O	—	nn	5	SENT_140	[p9l1251t281r1639b381],
4	pair	NN	O	pair	nn	5	SENT_140	[p9l1251t281r1639b381],
5	change	NN	O	change	dep	2	SENT_140	[p9l1658t281r1957b381],
6	was	VBD	O	be	auxpass	7	SENT_140	[p9l1974t307r2134b360],
7	conﬁrmed	VBN	O	conﬁrmed	_	0	SENT_140	[p9l11t408r450b487],
8	in	IN	O	in	_	0	SENT_140	[p9l475t409r557b486],
9	14	CD	NUMBER	14	prep_in	7	SENT_140	[p9l586t414r685b487],
10	of	IN	O	of	_	0	SENT_140	[p9l712t408r812b487],
11	40	CD	NUMBER	40	num	12	SENT_140	[p9l819t414r921b487],
12	subclones	NNS	O	subclone	prep_of	9	SENT_140	[p9l949t409r1394b488],
13	.	.	O	.	_	0	SENT_140	[p9l949t409r1394b488],

1	Interestingly	RB	O	interestingly	dep	4	SENT_141	[p9l1425t409r1973b509],
2	,	,	O	,	_	0	SENT_141	[p9l1425t409r1973b509],
3	the	DT	O	the	det	4	SENT_141	[p9l2006t409r2135b487],
4	C	NN	O	c	_	0	SENT_141	[p9l11t542r282b615],
5	.	.	O	.	_	0	SENT_141	[p9l11t542r282b615],

1	—	NN	O	—	_	0	SENT_142	[p9l11t542r282b615],
2	.	.	O	.	_	0	SENT_142	[p9l11t542r282b615],

1	to	TO	O	to	_	0	SENT_143	[p9l11t542r282b615],
2	.	.	O	.	_	0	SENT_143	[p9l11t542r282b615],

1	—	NN	O	—	_	0	SENT_144	[p9l11t542r282b615],
2	.	.	O	.	_	0	SENT_144	[p9l11t542r282b615],

1	T	NN	O	t	nn	2	SENT_145	[p9l11t542r282b615],
2	base	NN	O	base	nsubjpass	8	SENT_145	[p9l305t537r698b637],
3	—	NN	O	—	nn	5	SENT_145	[p9l305t537r698b637],
4	pair	NN	O	pair	nn	5	SENT_145	[p9l305t537r698b637],
5	change	NN	O	change	dep	2	SENT_145	[p9l721t537r1022b637],
6	was	VBD	O	be	auxpass	8	SENT_145	[p9l1043t563r1204b616],
7	consistently	RB	O	consistently	advmod	8	SENT_145	[p9l1232t537r1739b637],
8	observed	VBN	O	observe	_	0	SENT_145	[p9l1761t537r2135b616],
9	with	IN	O	with	_	0	SENT_145	[p9l6t665r196b744],
10	either	CC	O	either	preconj	13	SENT_145	[p9l228t665r472b743],
11	Wild	NNP	O	Wild	nn	13	SENT_145	[p9l496t664r890b765],
12	—	CD	NUMBER	—	num	13	SENT_145	[p9l496t664r890b765],
13	type	NN	O	type	prep_with	8	SENT_145	[p9l496t664r890b765],
14	or	CC	O	or	_	0	SENT_145	[p9l923t690r1012b743],
15	delL747	NN	O	dell747	conj_or	13	SENT_145	[p9l1042t665r1640b743],
16	.	.	O	.	_	0	SENT_145	[p9l1042t665r1640b743],

1	—	NN	O	—	_	0	SENT_146	[p9l1042t665r1640b743],
2	.	.	O	.	_	0	SENT_146	[p9l1042t665r1640b743],

1	S752	NN	O	s752	nsubj	4	SENT_147	[p9l1042t665r1640b743],
2	sequences	NNS	O	sequence	dep	1	SENT_147	[p9l1675t690r2130b765],
3	,	,	O	,	_	0	SENT_147	[p9l1675t690r2130b765],
4	suggesting	VBG	O	suggest	_	0	SENT_147	[p9l12t793r471b892],
5	that	IN	O	that	complm	10	SENT_147	[p9l508t793r673b870],
6	the	DT	O	the	det	7	SENT_147	[p9l709t793r837b870],
7	mutation	NN	O	mutation	nsubj	10	SENT_147	[p9l877t793r1263b871],
8	is	VBZ	O	be	cop	10	SENT_147	[p9l1302t793r1366b870],
9	either	CC	O	either	advmod	10	SENT_147	[p9l1409t793r1649b870],
10	biallelic	JJ	O	biallelic	ccomp	4	SENT_147	[p9l1687t793r2010b870],
11	or	CC	O	or	_	0	SENT_147	[p9l2050t817r2139b870],
12	that	IN	O	that	complm	15	SENT_147	[p9l11t921r176b999],
13	the	DT	O	the	det	14	SENT_147	[p9l194t921r322b999],
14	tumor	NN	O	tumor	nsubj	15	SENT_147	[p9l345t937r605b1000],
15	has	VBZ	O	have	ccomp	4	SENT_147	[p9l625t921r765b999],
16	two	CD	NUMBER	two	num	18	SENT_147	[p9l789t937r940b1000],
17	distinct	JJ	O	distinct	amod	18	SENT_147	[p9l965t921r1280b999],
18	populations	NNS	O	population	dobj	15	SENT_147	[p9l1296t921r1796b1021],
19	of	IN	O	of	_	0	SENT_147	[p9l1821t920r1921b999],
20	cells	NNS	O	cell	prep_of	18	SENT_147	[p9l1926t921r2130b999],
21	.	.	O	.	_	0	SENT_147	[p9l1926t921r2130b999],

1	The	DT	O	the	det	2	SENT_148	[p9l136t1049r298b1127],
2	C	NN	O	c	_	0	SENT_148	[p9l354t1054r625b1127],
3	.	.	O	.	_	0	SENT_148	[p9l354t1054r625b1127],

1	—	NN	O	—	_	0	SENT_149	[p9l354t1054r625b1127],
2	.	.	O	.	_	0	SENT_149	[p9l354t1054r625b1127],

1	to	TO	O	to	_	0	SENT_150	[p9l354t1054r625b1127],
2	.	.	O	.	_	0	SENT_150	[p9l354t1054r625b1127],

1	—	NN	O	—	_	0	SENT_151	[p9l354t1054r625b1127],
2	.	.	O	.	_	0	SENT_151	[p9l354t1054r625b1127],

1	T	NN	O	t	nn	2	SENT_152	[p9l354t1054r625b1127],
2	base	NN	O	base	nsubjpass	7	SENT_152	[p9l679t1049r1071b1149],
3	—	NN	O	—	nn	5	SENT_152	[p9l679t1049r1071b1149],
4	pair	NN	O	pair	nn	5	SENT_152	[p9l679t1049r1071b1149],
5	change	NN	O	change	dep	2	SENT_152	[p9l1124t1049r1426b1149],
6	is	VBZ	O	be	auxpass	7	SENT_152	[p9l1481t1049r1546b1127],
7	predicted	VBN	O	predict	_	0	SENT_152	[p9l1602t1049r1999b1149],
8	to	TO	O	to	aux	9	SENT_152	[p9l2055t1065r2134b1127],
9	change	VB	O	change	xcomp	7	SENT_152	[p9l11t1177r313b1277],
10	threonine	NN	O	threonine	dobj	9	SENT_152	[p9l358t1177r767b1255],
11	to	TO	O	to	_	0	SENT_152	[p9l813t1193r892b1255],
12	methionine	NN	O	methionine	prep_to	9	SENT_152	[p9l938t1177r1426b1255],
13	at	IN	O	at	_	0	SENT_152	[p9l1470t1193r1549b1255],
14	position	NN	O	position	prep_at	12	SENT_152	[p9l1588t1177r1936b1277],
15	790	CD	NUMBER	790	number	16	SENT_152	[p9l1982t1182r2134b1255],
16	(	CD	NUMBER	(	num	18	SENT_152	[p9l15t1310r375b1396],
17	T790M	NN	O	t790m	nn	18	SENT_152	[p9l15t1310r375b1396],
18	)	NN	O	)	npadvmod	9	SENT_152	[p9l15t1310r375b1396],
19	in	IN	O	in	_	0	SENT_152	[p9l414t1305r495b1382],
20	the	DT	O	the	det	22	SENT_152	[p9l530t1304r658b1383],
21	catalytic	JJ	O	catalytic	amod	22	SENT_152	[p9l693t1305r1036b1405],
22	cleft	NN	O	cleft	prep_in	9	SENT_152	[p9l1070t1304r1253b1383],
23	of	IN	O	of	_	0	SENT_152	[p9l1282t1304r1383b1383],
24	the	DT	O	the	det	28	SENT_152	[p9l1398t1305r1527b1383],
25	EGFR	NN	ORGANIZATION	egfr	nn	28	SENT_152	[p9l1559t1311r1771b1384],
26	tyrosine	NN	O	tyrosine	nn	28	SENT_152	[p9l1799t1305r2134b1405],
27	kinase	NN	O	kinase	nn	28	SENT_152	[p9l10t1433r276b1512],
28	domain	NN	O	domain	prep_of	22	SENT_152	[p9l299t1433r641b1511],
29	.	.	O	.	_	0	SENT_152	[p9l299t1433r641b1511],

1	Structural	JJ	MISC	structural	amod	2	SENT_153	[p9l670t1433r1075b1512],
2	modeling	NN	O	modeling	nsubjpass	4	SENT_153	[p9l1096t1433r1499b1533],
3	was	VBD	O	be	auxpass	4	SENT_153	[p9l1513t1459r1672b1512],
4	performed	VBN	O	perform	_	0	SENT_153	[p9l1694t1432r2136b1533],
5	on	IN	O	on	_	0	SENT_153	[p9l11t1586r117b1639],
6	the	DT	O	the	det	7	SENT_153	[p9l138t1560r265b1639],
7	basis	NN	O	basis	prep_on	4	SENT_153	[p9l287t1561r493b1639],
8	of	IN	O	of	_	0	SENT_153	[p9l516t1560r615b1639],
9	a	DT	O	a	det	11	SENT_153	[p9l617t1587r662b1639],
10	cocrystallization	NN	O	cocrystallization	nn	11	SENT_153	[p9l681t1561r1360b1661],
11	model	NN	O	model	prep_of	7	SENT_153	[p9l1380t1561r1644b1639],
12	of	IN	O	of	_	0	SENT_153	[p9l1664t1560r1764b1639],
13	the	DT	O	the	det	16	SENT_153	[p9l1766t1561r1894b1639],
14	bind	NN	O	bind	nn	16	SENT_153	[p9l1915t1561r2135b1639],
15	—	NN	O	—	nn	16	SENT_153	[p9l1915t1561r2135b1639],
16	ing	NN	O	ing	prep_of	11	SENT_153	[p9l10t1689r148b1789],
17	of	IN	O	of	_	0	SENT_153	[p9l188t1688r288b1767],
18	erlotinib	NN	O	erlotinib	prep_of	16	SENT_153	[p9l313t1689r671b1767],
19	to	TO	O	to	_	0	SENT_153	[p9l717t1705r795b1767],
20	the	DT	O	the	det	24	SENT_153	[p9l841t1689r969b1767],
21	EGFR	NN	ORGANIZATION	egfr	nn	24	SENT_153	[p9l1011t1694r1271b1772],
22	tyrosine	NN	O	tyrosine	nn	24	SENT_153	[p9l1304t1689r1638b1789],
23	kinase	NN	O	kinase	nn	24	SENT_153	[p9l1682t1689r1952b1768],
24	domain	NN	O	domain	prep_to	4	SENT_153	[p9l1997t1689r2134b1767, p9l11t1811r337b1895],
25	.	.	O	.	_	0	SENT_153	[p9l1997t1689r2134b1767, p9l11t1811r337b1895],

1	“	NN	O	“	nsubj	4	SENT_154	[p9l1997t1689r2134b1767, p9l11t1811r337b1895],
2	Using	VBG	O	use	partmod	1	SENT_154	[p9l357t1818r611b1917],
3	the	DT	O	the	dobj	2	SENT_154	[p9l630t1817r759b1895],
4	coordinates	VBZ	O	coordinate	ccomp	10	SENT_154	[p9l782t1817r1274b1895],
5	from	IN	O	from	_	0	SENT_154	[p9l1298t1816r1505b1895],
6	this	DT	O	this	det	7	SENT_154	[p9l1527t1817r1680b1895],
7	model	NN	O	model	prep_from	4	SENT_154	[p9l1704t1817r1993b1912],
8	,	,	O	,	_	0	SENT_154	[p9l1704t1817r1993b1912],
9	We	PRP	O	we	nsubj	27	SENT_154	[p9l2016t1843r2135b1896],
10	found	VBD	O	find	_	0	SENT_154	[p9l11t1944r262b2024],
11	that	IN	O	that	complm	13	SENT_154	[p9l287t1945r454b2023],
12	T790	NN	O	t790	nsubj	13	SENT_154	[p9l472t1950r688b2023],
13	appears	VBZ	O	appear	ccomp	10	SENT_154	[p9l714t1971r1041b2045],
14	to	TO	O	to	aux	16	SENT_154	[p9l1069t1961r1148b2023],
15	be	VB	O	be	cop	16	SENT_154	[p9l1176t1945r1272b2023],
16	critical	JJ	O	critical	xcomp	13	SENT_154	[p9l1299t1945r1583b2023],
17	for	IN	O	for	_	0	SENT_154	[p9l1608t1944r1731b2023],
18	the	DT	O	the	det	21	SENT_154	[p9l1755t1945r1884b2023],
19	bind	NN	O	bind	nn	21	SENT_154	[p9l1910t1945r2134b2023],
20	—	NN	O	—	nn	21	SENT_154	[p9l1910t1945r2134b2023],
21	ing	NN	O	ing	prep_for	16	SENT_154	[p9l10t2073r148b2173],
22	of	IN	O	of	_	0	SENT_154	[p9l177t2072r278b2151],
23	erlotinib	NN	O	erlotinib	prep_of	21	SENT_154	[p9l291t2073r650b2151],
24	to	TO	O	to	_	0	SENT_154	[p9l683t2089r762b2151],
25	EGFR	NN	ORGANIZATION	egfr	prep_to	16	SENT_154	[p9l793t2078r1052b2156],
26	and	CC	O	and	_	0	SENT_154	[p9l1072t2073r1228b2151],
27	is	VBZ	O	be	conj_and	10	SENT_154	[p9l1259t2073r1323b2151],
28	in	IN	O	in	_	0	SENT_154	[p9l1356t2073r1437b2150],
29	juxtaposition	NN	O	juxtaposition	prep_in	27	SENT_154	[p9l1455t2073r2023b2173],
30	to	TO	O	to	_	0	SENT_154	[p9l2055t2089r2134b2151],
31	the	DT	O	the	det	34	SENT_154	[p9l11t2201r140b2279],
32	acetylene	NN	O	acetylene	nn	34	SENT_154	[p9l174t2201r558b2301],
33	side	NN	O	side	nn	34	SENT_154	[p9l593t2201r759b2279],
34	chain	NN	O	chain	prep_to	29	SENT_154	[p9l794t2201r1023b2279],
35	of	IN	O	of	_	0	SENT_154	[p9l1057t2200r1157b2279],
36	the	DT	O	the	det	40	SENT_154	[p9l1173t2200r1302b2279],
37	aniline	NN	O	aniline	nn	40	SENT_154	[p9l1335t2201r1623b2279],
38	group	NN	O	group	nn	40	SENT_154	[p9l1656t2226r1907b2301],
39	(	CD	NUMBER	(	num	40	SENT_154	[p9l1946t2201r2130b2301],
40	Fig	NN	O	fig	prep_of	34	SENT_154	[p9l1946t2201r2130b2301],
41	.	.	O	.	_	0	SENT_154	[p9l1946t2201r2130b2301],

1	2A	NN	O	2a	_	0	SENT_155	[p9l11t2334r179b2419],
2	)	NN	O	)	dep	1	SENT_155	[p9l11t2334r179b2419],
3	.	.	O	.	_	0	SENT_155	[p9l11t2334r179b2419],

1	Because	IN	O	because	mark	5	SENT_156	[p9l206t2335r543b2407],
2	the	DT	O	the	det	4	SENT_156	[p9l566t2329r694b2406],
3	methionine	NN	O	methionine	nn	4	SENT_156	[p9l717t2329r1200b2406],
4	substitution	NN	O	substitution	nsubj	5	SENT_156	[p9l1224t2329r1725b2407],
5	introduces	VBZ	O	introduce	advcl	24	SENT_156	[p9l1746t2329r2135b2407, p9l11t2483r93b2535],
6	a	DT	O	a	det	11	SENT_156	[p9l119t2483r164b2535],
7	bulkier	JJR	O	bulkier	dep	8	SENT_156	[p9l188t2456r488b2536],
8	amino	NN	O	amino	amod	11	SENT_156	[p9l509t2457r778b2535],
9	acid	NN	O	acid	nn	11	SENT_156	[p9l803t2456r974b2535],
10	side	NN	O	side	nn	11	SENT_156	[p9l1001t2457r1166b2535],
11	chain	NN	O	chain	dobj	5	SENT_156	[p9l1193t2457r1422b2535],
12	than	IN	O	than	mark	13	SENT_156	[p9l1447t2457r1635b2535],
13	does	VBZ	O	do	advcl	5	SENT_156	[p9l1661t2457r1852b2535],
14	threonine	NN	O	threonine	dobj	13	SENT_156	[p9l1879t2457r2134b2535, p9l11t2585r194b2663],
15	at	IN	O	at	_	0	SENT_156	[p9l220t2601r298b2663],
16	this	DT	O	this	det	17	SENT_156	[p9l319t2585r472b2663],
17	position	NN	O	position	prep_at	13	SENT_156	[p9l498t2585r871b2685],
18	,	,	O	,	_	0	SENT_156	[p9l498t2585r871b2685],
19	the	DT	O	the	det	22	SENT_156	[p9l903t2585r1032b2663],
20	resulting	VBG	O	result	amod	22	SENT_156	[p9l1057t2585r1436b2685],
21	steric	JJ	O	steric	amod	22	SENT_156	[p9l1460t2585r1685b2663],
22	hindrance	NN	O	hindrance	nsubj	24	SENT_156	[p9l1709t2585r2135b2663],
23	may	MD	O	may	aux	24	SENT_156	[p9l11t2739r187b2813],
24	interfere	VB	O	interfere	_	0	SENT_156	[p9l227t2712r584b2791],
25	with	IN	O	with	_	0	SENT_156	[p9l625t2713r814b2792],
26	the	DT	O	the	det	27	SENT_156	[p9l860t2713r988b2791],
27	binding	NN	O	binding	prep_with	24	SENT_156	[p9l1034t2713r1367b2813],
28	of	IN	O	of	_	0	SENT_156	[p9l1410t2712r1510b2791],
29	erlotinib	NN	O	erlotinib	nn	31	SENT_156	[p9l1537t2713r1895b2791],
30	(	CD	NUMBER	(	num	31	SENT_156	[p9l1946t2713r2130b2813],
31	Fig	NN	O	fig	prep_of	27	SENT_156	[p9l1946t2713r2130b2813],
32	.	.	O	.	_	0	SENT_156	[p9l1946t2713r2130b2813],

1	2B	NN	O	2b	_	0	SENT_157	[p9l11t2846r178b2932],
2	)	NN	O	)	dep	1	SENT_157	[p9l11t2846r178b2932],
3	.	.	O	.	_	0	SENT_157	[p9l11t2846r178b2932],

1	Moreover	RB	O	moreover	advmod	14	SENT_158	[p9l203t2848r626b2936],
2	,	,	O	,	_	0	SENT_158	[p9l203t2848r626b2936],
3	high	JJ	O	high	amod	6	SENT_158	[p9l653t2840r1184b2941],
4	—	NN	O	—	nn	6	SENT_158	[p9l653t2840r1184b2941],
5	afﬁnity	NN	O	afﬁnity	nn	6	SENT_158	[p9l653t2840r1184b2941],
6	binding	NN	O	binding	nsubj	14	SENT_158	[p9l1203t2841r1536b2941],
7	of	IN	O	of	_	0	SENT_158	[p9l1556t2840r1656b2919],
8	erlotinib	NN	O	erlotinib	prep_of	6	SENT_158	[p9l1660t2841r2019b2919],
9	by	IN	O	by	_	0	SENT_158	[p9l2043t2841r2140b2941],
10	means	NNS	O	means	_	0	SENT_158	[p9l11t2994r289b3047],
11	of	IN	O	of	_	0	SENT_158	[p9l315t2968r415b3047],
12	Water	NN	O	water	nn	13	SENT_158	[p9l415t2969r1080b3048],
13	—	NN	O	—	prep_by_means_of	8	SENT_158	[p9l415t2969r1080b3048],
14	mediated	VBD	O	mediate	_	0	SENT_158	[p9l415t2969r1080b3048],
15	hydrogen	NN	O	hydrogen	nn	16	SENT_158	[p9l1101t2969r1502b3069],
16	bonding	NN	O	bonding	nsubj	19	SENT_158	[p9l1524t2969r1884b3069],
17	could	MD	O	could	aux	19	SENT_158	[p9l1904t2969r2135b3048],
18	not	RB	O	not	neg	19	SENT_158	[p9l11t3113r156b3175],
19	take	VB	O	take	ccomp	14	SENT_158	[p9l199t3096r377b3176],
20	place	NN	O	place	dobj	19	SENT_158	[p9l423t3097r645b3197],
21	with	IN	O	with	_	0	SENT_158	[p9l688t3097r881b3176],
22	the	DT	O	the	det	25	SENT_158	[p9l928t3096r1059b3175],
23	methionine	NN	O	methionine	nn	25	SENT_158	[p9l1107t3097r1605b3175],
24	side	NN	O	side	nn	25	SENT_158	[p9l1653t3097r1823b3175],
25	chain	NN	O	chain	prep_with	19	SENT_158	[p9l1870t3097r2129b3192],
26	,	,	O	,	_	0	SENT_158	[p9l1870t3097r2129b3192],
27	Whereas	IN	O	whereas	mark	35	SENT_158	[p9l6t3225r361b3304],
28	the	DT	O	the	det	30	SENT_158	[p9l389t3225r518b3303],
29	hydroxyl	NN	O	hydroxyl	nn	30	SENT_158	[p9l544t3224r904b3325],
30	group	NN	O	group	nsubj	35	SENT_158	[p9l928t3250r1179b3325],
31	of	IN	O	of	_	0	SENT_158	[p9l1206t3224r1307b3303],
32	T	NN	O	t	prep_of	30	SENT_158	[p9l1309t3230r1371b3302],
33	790	CD	NUMBER	790	npadvmod	34	SENT_158	[p9l1374t3230r1526b3303],
34	likely	JJ	O	likely	amod	32	SENT_158	[p9l1550t3225r1777b3325],
35	contributes	VBZ	O	contribute	dep	19	SENT_158	[p9l1798t3225r2134b3303, p9l11t3369r179b3432],
36	to	TO	O	to	_	0	SENT_158	[p9l207t3369r286b3431],
37	high	JJ	O	high	amod	40	SENT_158	[p9l312t3352r844b3453],
38	—	NN	O	—	nn	40	SENT_158	[p9l312t3352r844b3453],
39	afﬁnity	NN	O	afﬁnity	nn	40	SENT_158	[p9l312t3352r844b3453],
40	binding	NN	O	binding	prep_to	35	SENT_158	[p9l865t3353r1198b3453],
41	of	IN	O	of	_	0	SENT_158	[p9l1220t3352r1321b3431],
42	erlotinib	NN	O	erlotinib	prep_of	40	SENT_158	[p9l1328t3353r1712b3431],
43	.	.	O	.	_	0	SENT_158	[p9l1328t3353r1712b3431],

1	Although	IN	O	although	mark	14	SENT_159	[p9l136t3480r537b3581],
2	a	DT	O	a	det	4	SENT_159	[p9l584t3507r628b3559],
3	crystal	NN	O	crystal	nn	4	SENT_159	[p9l675t3481r947b3581],
4	structure	NN	O	structure	nsubjpass	14	SENT_159	[p9l996t3497r1370b3560],
5	of	IN	O	of	_	0	SENT_159	[p9l1420t3480r1520b3559],
6	the	DT	O	the	det	7	SENT_159	[p9l1550t3481r1679b3559],
7	geﬁtinib	NN	O	geﬁtinib	prep_of	4	SENT_159	[p9l1727t3480r2139b3581],
8	—	CD	NUMBER	—	num	10	SENT_159	[p9l1727t3480r2139b3581],
9	EGFR	NN	ORGANIZATION	egfr	nn	10	SENT_159	[p9l9t3614r268b3692],
10	complex	NN	O	complex	dep	7	SENT_159	[p9l283t3609r644b3709],
11	has	VBZ	O	have	aux	14	SENT_159	[p9l666t3609r807b3687],
12	not	RB	O	not	neg	14	SENT_159	[p9l834t3625r978b3687],
13	been	VBN	O	be	auxpass	14	SENT_159	[p9l998t3609r1197b3687],
14	published	VBN	O	publish	advcl	21	SENT_159	[p9l1220t3608r1664b3709],
15	,	,	O	,	_	0	SENT_159	[p9l1220t3608r1664b3709],
16	a	DT	O	a	det	17	SENT_159	[p9l1695t3635r1739b3687],
17	model	NN	O	model	nsubj	21	SENT_159	[p9l1762t3609r2028b3687],
18	of	IN	O	of	_	0	SENT_159	[p9l2053t3608r2153b3687],
19	this	DT	O	this	det	20	SENT_159	[p10l11t21r164b99],
20	complex	NN	O	complex	prep_of	17	SENT_159	[p10l215t21r576b121],
21	suggested	VBD	O	suggest	_	0	SENT_159	[p10l623t20r1045b121],
22	that	IN	O	that	advmod	21	SENT_159	[p10l1094t21r1279b116],
23	,	,	O	,	_	0	SENT_159	[p10l1094t21r1279b116],
24	in	IN	O	in	_	0	SENT_159	[p10l1332t21r1414b98],
25	a	DT	O	a	det	26	SENT_159	[p10l1462t47r1506b99],
26	conformation	NN	O	conformation	prep_in	21	SENT_159	[p10l1554t20r2135b99],
27	similar	JJ	O	similar	amod	26	SENT_159	[p10l12t149r307b227],
28	to	TO	O	to	_	0	SENT_159	[p10l342t165r421b227],
29	the	DT	O	the	det	30	SENT_159	[p10l460t149r589b227],
30	erlotinib	NN	O	erlotinib	prep_to	27	SENT_159	[p10l628t148r1302b232],
31	.	.	O	.	_	0	SENT_159	[p10l628t148r1302b232],

1	—	NN	O	—	_	0	SENT_160	[p10l628t148r1302b232],
2	.	.	O	.	_	0	SENT_160	[p10l628t148r1302b232],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_161	[p10l628t148r1302b232],
2	complex	NN	O	complex	nsubj	14	SENT_161	[p10l1330t149r1711b249],
3	,	,	O	,	_	0	SENT_161	[p10l1330t149r1711b249],
4	the	DT	O	the	det	5	SENT_161	[p10l1754t149r1884b227],
5	chloride	NN	O	chloride	appos	2	SENT_161	[p10l1922t149r2134b227, p10l11t277r172b355],
6	at	IN	O	at	_	0	SENT_161	[p10l193t293r272b355],
7	the	DT	O	the	det	9	SENT_161	[p10l289t277r418b355],
8	3	CD	NUMBER	3	num	9	SENT_161	[p10l441t282r485b355],
9	position	NN	O	position	prep_at	5	SENT_161	[p10l508t277r858b377],
10	of	IN	O	of	_	0	SENT_161	[p10l879t276r980b355],
11	the	DT	O	the	det	13	SENT_161	[p10l984t277r1112b355],
12	aniline	NN	O	aniline	nn	13	SENT_161	[p10l1134t277r1421b355],
13	group	NN	O	group	prep_of	9	SENT_161	[p10l1442t302r1693b377],
14	lies	VBZ	O	lie	_	0	SENT_161	[p10l1715t277r1854b355],
15	in	IN	O	in	_	0	SENT_161	[p10l1877t277r1958b354],
16	juxtaposition	NN	O	juxtaposition	prep_in	14	SENT_161	[p10l1966t277r2134b377, p10l11t405r440b505],
17	to	TO	O	to	_	0	SENT_161	[p10l473t421r552b483],
18	the	DT	O	the	det	20	SENT_161	[p10l588t405r717b483],
19	T790	NN	O	t790	nn	20	SENT_161	[p10l747t410r963b483],
20	moiety	NN	O	moiety	prep_to	14	SENT_161	[p10l997t405r1298b505],
21	.	.	O	.	_	0	SENT_161	[p10l997t405r1298b505],

1	A	DT	O	a	det	3	SENT_162	[p10l1333t412r1399b482],
2	T79OM	NN	O	t79om	nn	3	SENT_162	[p10l1426t410r1729b483],
3	substitution	NN	O	substitution	nsubjpass	5	SENT_162	[p10l1765t405r2134b484, p10l11t533r175b611],
4	is	VBZ	O	be	auxpass	5	SENT_162	[p10l197t533r261b611],
5	predicted	VBN	O	predict	_	0	SENT_162	[p10l284t532r676b633],
6	to	TO	O	to	aux	7	SENT_162	[p10l699t549r777b611],
7	lead	VB	O	lead	xcomp	5	SENT_162	[p10l799t532r970b611],
8	to	TO	O	to	_	0	SENT_162	[p10l993t549r1071b611],
9	a	DT	O	a	det	12	SENT_162	[p10l1095t559r1139b611],
10	similar	JJ	O	similar	amod	12	SENT_162	[p10l1161t533r1453b611],
11	steric	JJ	O	steric	amod	12	SENT_162	[p10l1473t533r1695b611],
12	clash	NN	O	clash	prep_to	7	SENT_162	[p10l1718t533r1931b611],
13	With	IN	O	with	_	0	SENT_162	[p10l1949t533r2136b612],
14	the	DT	O	the	det	18	SENT_162	[p10l11t661r140b739],
15	geﬁtinib	NN	O	geﬁtinib	nn	18	SENT_162	[p10l177t660r532b761],
16	molecule	NN	O	molecule	nn	18	SENT_162	[p10l571t661r955b740],
17	(	CD	NUMBER	(	num	18	SENT_162	[p10l998t661r1180b761],
18	Fig	NN	O	fig	prep_with	12	SENT_162	[p10l998t661r1180b761],
19	.	.	O	.	_	0	SENT_162	[p10l998t661r1180b761],

1	2C	NN	O	2c	_	0	SENT_163	[p10l1224t666r1395b752],
2	)	NN	O	)	dep	1	SENT_163	[p10l1224t666r1395b752],
3	.	.	O	.	_	0	SENT_163	[p10l1224t666r1395b752],

1	This	DT	O	this	det	4	SENT_164	[p10l1434t661r1619b739],
2	amino	NN	O	amino	nn	4	SENT_164	[p10l1658t661r1926b739],
3	acid	NN	O	acid	nn	4	SENT_164	[p10l1964t661r2135b739],
4	change	NN	O	change	nsubjpass	24	SENT_164	[p10l11t789r313b889],
5	is	VBZ	O	be	auxpass	7	SENT_164	[p10l340t789r405b867],
6	not	RB	O	not	neg	7	SENT_164	[p10l435t805r578b867],
7	expected	VBN	O	expect	_	0	SENT_164	[p10l602t789r969b889],
8	to	TO	O	to	aux	9	SENT_164	[p10l997t805r1076b867],
9	interfere	VB	O	interfere	xcomp	7	SENT_164	[p10l1104t788r1462b867],
10	with	IN	O	with	mark	14	SENT_164	[p10l1486t789r1675b868],
11	AT	IN	O	at	_	0	SENT_164	[p10l1699t794r1820b866],
12	P	NN	O	p	prep_at	14	SENT_164	[p10l1820t789r2134b867],
13	—	CD	NUMBER	—	nsubj	14	SENT_164	[p10l1820t789r2134b867],
14	bind	VBP	O	bind	advcl	9	SENT_164	[p10l1820t789r2134b867],
15	—	RB	O	—	advmod	14	SENT_164	[p10l1820t789r2134b867],
16	ing	VBG	O	ing	xcomp	14	SENT_164	[p10l10t917r148b1017],
17	itself	PRP	O	itself	dobj	16	SENT_164	[p10l169t916r393b995],
18	and	CC	O	and	_	0	SENT_164	[p10l398t917r578b1012],
19	,	,	O	,	_	0	SENT_164	[p10l398t917r578b1012],
20	therefore	RB	O	therefore	dep	7	SENT_164	[p10l608t916r1015b1012],
21	,	,	O	,	_	0	SENT_164	[p10l608t916r1015b1012],
22	is	VBZ	O	be	auxpass	24	SENT_164	[p10l1044t917r1109b995],
23	not	RB	O	not	neg	24	SENT_164	[p10l1136t933r1280b995],
24	expected	VBN	O	expect	conj_and	7	SENT_164	[p10l1300t917r1667b1017],
25	to	TO	O	to	aux	26	SENT_164	[p10l1692t933r1770b995],
26	alter	VB	O	alter	xcomp	24	SENT_164	[p10l1796t917r1984b995],
27	the	DT	O	the	det	28	SENT_164	[p10l2006t917r2135b995],
28	activity	NN	O	activity	dobj	26	SENT_164	[p10l10t1045r306b1145],
29	of	IN	O	of	_	0	SENT_164	[p10l327t1044r428b1123],
30	the	DT	O	the	det	31	SENT_164	[p10l434t1045r564b1123],
31	kinase	NN	O	kinase	prep_of	28	SENT_164	[p10l589t1045r859b1124],
32	on	IN	O	on	_	0	SENT_164	[p10l885t1070r992b1123],
33	ligand	NN	O	ligand	nn	34	SENT_164	[p10l1015t1045r1282b1145],
34	stimulation	NN	O	stimulation	prep_on	31	SENT_164	[p10l1308t1045r1815b1124],
35	.	.	O	.	_	0	SENT_164	[p10l1308t1045r1815b1124],

1	To	TO	O	to	aux	2	SENT_165	[p10l136t1178r241b1251],
2	confirm	VB	O	confirm	purpcl	17	SENT_165	[p10l282t1172r619b1251],
3	the	DT	O	the	det	5	SENT_165	[p10l659t1173r787b1251],
4	functional	JJ	O	functional	amod	5	SENT_165	[p10l826t1172r1259b1252],
5	effects	NNS	O	effect	dobj	2	SENT_165	[p10l1297t1172r1567b1251],
6	predicted	VBN	O	predict	partmod	5	SENT_165	[p10l1607t1173r2004b1273],
7	by	IN	O	by	_	0	SENT_165	[p10l2043t1173r2140b1273],
8	our	PRP$	O	we	poss	10	SENT_165	[p10l11t1325r156b1378],
9	structural	JJ	O	structural	amod	10	SENT_165	[p10l185t1300r589b1379],
10	model	NN	O	model	agent	6	SENT_165	[p10l619t1299r909b1394],
11	,	,	O	,	_	0	SENT_165	[p10l619t1299r909b1394],
12	the	DT	O	the	det	15	SENT_165	[p10l945t1300r1075b1377],
13	T	NN	O	t	nn	15	SENT_165	[p10l1102t1305r1164b1376],
14	790M	NN	O	790m	nn	15	SENT_165	[p10l1167t1305r1405b1378],
15	substitution	NN	O	substitution	nsubjpass	17	SENT_165	[p10l1439t1300r1945b1379],
16	was	VBD	O	be	auxpass	17	SENT_165	[p10l1972t1326r2133b1378],
17	introduced	VBN	O	introduce	_	0	SENT_165	[p10l10t1428r471b1507],
18	into	IN	O	into	_	0	SENT_165	[p10l532t1428r698b1506],
19	the	DT	O	the	det	20	SENT_165	[p10l763t1428r892b1506],
20	sequence	NN	O	sequence	prep_into	17	SENT_165	[p10l957t1453r1344b1528],
21	of	IN	O	of	_	0	SENT_165	[p10l1408t1427r1508b1506],
22	the	DT	O	the	det	26	SENT_165	[p10l1553t1428r1682b1506],
23	wild	JJ	O	wild	amod	26	SENT_165	[p10l1741t1427r2135b1528],
24	—	NN	O	—	nn	26	SENT_165	[p10l1741t1427r2135b1528],
25	type	NN	O	type	nn	26	SENT_165	[p10l1741t1427r2135b1528],
26	EGFR	NN	ORGANIZATION	egfr	prep_of	20	SENT_165	[p10l9t1560r281b1649],
27	,	,	O	,	_	0	SENT_165	[p10l9t1560r281b1649],
28	delL747	NN	O	dell747	appos	26	SENT_165	[p10l345t1555r1125b1633],
29	.	.	O	.	_	0	SENT_165	[p10l345t1555r1125b1633],

1	—	NN	O	—	_	0	SENT_166	[p10l345t1555r1125b1633],
2	.	.	O	.	_	0	SENT_166	[p10l345t1555r1125b1633],

1	P753insS	NN	O	p753inss	nn	3	SENT_167	[p10l345t1555r1125b1633],
2	mutant	JJ	O	mutant	amod	3	SENT_167	[p10l1185t1571r1497b1633],
3	EGFR	NN	ORGANIZATION	egfr	nsubj	4	SENT_167	[p10l1549t1560r1807b1638],
4	(	VBD	O	(	_	0	SENT_167	[p10l1860t1561r1933b1645],
5	a	DT	O	a	dep	6	SENT_167	[p10l1860t1561r1933b1645],
6	frequently	RB	O	frequently	advmod	7	SENT_167	[p10l1989t1554r2134b1632, p10l11t1683r326b1783],
7	identiﬁed	VBN	O	identiﬁed	dep	4	SENT_167	[p10l341t1682r745b1761],
8	deletion	NN	O	deletion	nn	10	SENT_167	[p10l767t1683r1107b1761],
9	mutant	JJ	O	mutant	amod	10	SENT_167	[p10l1128t1690r1493b1778],
10	)	NN	O	)	tmod	7	SENT_167	[p10l1128t1690r1493b1778],
11	,	,	O	,	_	0	SENT_167	[p10l1128t1690r1493b1778],
12	the	DT	O	the	det	14	SENT_167	[p10l1520t1683r1649b1761],
13	L858Rmu	NN	O	l858rmu	nn	14	SENT_167	[p10l1669t1688r2134b1766],
14	—	NN	O	—	appos	10	SENT_167	[p10l1669t1688r2134b1766],
15	tant	JJ	O	tant	amod	16	SENT_167	[p10l11t1826r180b1888],
16	EGFR	NN	ORGANIZATION	egfr	nsubj	17	SENT_167	[p10l221t1816r480b1893],
17	(	VBD	O	(	rcmod	14	SENT_167	[p10l521t1811r680b1901],
18	the	DT	O	the	det	23	SENT_167	[p10l521t1811r680b1901],
19	most	RBS	O	most	advmod	20	SENT_167	[p10l727t1826r944b1888],
20	common	JJ	O	common	amod	23	SENT_167	[p10l986t1835r1366b1888],
21	point	NN	O	point	nn	23	SENT_167	[p10l1412t1811r1641b1910],
22	mutation	NN	O	mutation	nn	23	SENT_167	[p10l1682t1811r2130b1905],
23	)	NN	O	)	dobj	17	SENT_167	[p10l1682t1811r2130b1905],
24	,	,	O	,	_	0	SENT_167	[p10l1682t1811r2130b1905],
25	and	CC	O	and	_	0	SENT_167	[p10l10t1939r165b2017],
26	the	DT	O	the	det	27	SENT_167	[p10l189t1939r317b2017],
27	delL747	NN	O	dell747	dobj	17	SENT_167	[p10l341t1938r934b2017],
28	.	.	O	.	_	0	SENT_167	[p10l341t1938r934b2017],

1	—	NN	O	—	_	0	SENT_168	[p10l341t1938r934b2017],
2	.	.	O	.	_	0	SENT_168	[p10l341t1938r934b2017],

1	S752	NN	O	s752	nsubj	2	SENT_169	[p10l341t1938r934b2017],
2	mutant	NN	O	mutant	_	0	SENT_169	[p10l958t1955r1286b2018],
3	.	.	O	.	_	0	SENT_169	[p10l958t1955r1286b2018],

1	We	PRP	O	we	nsubj	2	SENT_170	[p10l1311t1946r1444b2017],
2	performed	VBD	O	perform	_	0	SENT_170	[p10l1466t1938r1912b2039],
3	transient	JJ	O	transient	amod	6	SENT_170	[p10l1936t1955r2134b2017, p10l12t2066r755b2145],
4	—	NN	O	—	nn	6	SENT_170	[p10l1936t1955r2134b2017, p10l12t2066r755b2145],
5	transfection	NN	O	transfection	nn	6	SENT_170	[p10l1936t1955r2134b2017, p10l12t2066r755b2145],
6	experiments	NNS	O	experiment	dobj	2	SENT_170	[p10l783t2067r1300b2167],
7	in	IN	O	in	_	0	SENT_170	[p10l1328t2067r1410b2144],
8	COS	NN	O	cos	nn	9	SENT_170	[p10l1437t2072r1709b2145],
9	—	NN	O	—	prep_in	2	SENT_170	[p10l1437t2072r1709b2145],
10	7	CD	NUMBER	7	num	9	SENT_170	[p10l1437t2072r1709b2145],
11	and	CC	O	and	_	0	SENT_170	[p10l1737t2067r1893b2145],
12	N	NN	O	n	nn	16	SENT_170	[p10l1917t2074r1992b2146],
13	IH	NN	O	ih	nn	16	SENT_170	[p10l1994t2074r2134b2144],
14	—	NN	O	—	nn	16	SENT_170	[p10l1994t2074r2134b2144],
15	3T3	NN	O	3t3	nn	16	SENT_170	[p10l11t2200r168b2273],
16	cells	NNS	O	cell	nsubj	17	SENT_170	[p10l216t2194r398b2273],
17	using	VBG	O	use	conj_and	2	SENT_170	[p10l444t2195r681b2295],
18	all	DT	O	all	det	21	SENT_170	[p10l721t2195r820b2273],
19	four	CD	NUMBER	four	num	21	SENT_170	[p10l863t2194r1041b2274],
20	construct	NN	O	construct	nn	21	SENT_170	[p10l1083t2211r1482b2274],
21	pairs	NNS	O	pair	nsubj	22	SENT_170	[p10l1519t2195r1726b2295],
22	(	VBP	O	(	ccomp	17	SENT_170	[p10l1776t2195r2136b2295],
23	original	JJ	O	original	amod	24	SENT_170	[p10l1776t2195r2136b2295],
24	construct	NN	O	construct	dobj	22	SENT_170	[p10l11t2339r411b2402],
25	vs.	CC	O	vs.	prep	24	SENT_170	[p10l448t2349r557b2402],
26	original	JJ	O	original	amod	27	SENT_170	[p10l610t2323r939b2423],
27	construct	NN	O	construct	dep	25	SENT_170	[p10l986t2339r1385b2402],
28	with	IN	O	with	_	0	SENT_170	[p10l1422t2323r1611b2402],
29	the	DT	O	the	det	32	SENT_170	[p10l1659t2323r1787b2401],
30	T79OM	NN	O	t79om	nn	32	SENT_170	[p10l1831t2328r2134b2401],
31	mutation	NN	O	mutation	nn	32	SENT_170	[p10l11t2451r458b2542],
32	)	NN	O	)	prep_with	27	SENT_170	[p10l11t2451r458b2542],
33	.	.	O	.	_	0	SENT_170	[p10l11t2451r458b2542],

1	All	DT	O	all	det	4	SENT_171	[p10l499t2451r618b2528],
2	four	CD	NUMBER	four	num	4	SENT_171	[p10l656t2450r833b2530],
3	construct	NN	O	construct	nn	4	SENT_171	[p10l870t2467r1269b2530],
4	pairs	NNS	O	pair	nsubj	5	SENT_171	[p10l1301t2451r1508b2551],
5	demonstrated	VBD	O	demonstrate	_	0	SENT_171	[p10l1549t2451r2135b2529],
6	identical	JJ	O	identical	amod	7	SENT_171	[p10l10t2578r372b2657],
7	levels	NNS	O	level	dobj	5	SENT_171	[p10l416t2579r645b2658],
8	of	IN	O	of	_	0	SENT_171	[p10l693t2578r794b2657],
9	expression	NN	O	expression	prep_of	7	SENT_171	[p10l823t2579r1276b2679],
10	of	IN	O	of	_	0	SENT_171	[p10l1323t2578r1423b2657],
11	total	JJ	O	total	amod	12	SENT_171	[p10l1451t2579r1641b2657],
12	EGFR	NN	ORGANIZATION	egfr	prep_of	9	SENT_171	[p10l1686t2584r1944b2662],
13	and	CC	O	and	_	0	SENT_171	[p10l1980t2579r2135b2657],
14	phosphorylated	JJ	O	phosphorylated	amod	16	SENT_171	[p10l10t2706r673b2807],
15	EGFR	NN	ORGANIZATION	egfr	nn	16	SENT_171	[p10l697t2712r957b2790],
16	(	NN	O	(	conj_and	12	SENT_171	[p10l977t2707r1669b2807],
17	phosphorylated	VBN	O	phosphorylate	partmod	12	SENT_171	[p10l977t2707r1669b2807],
18	EGFR	NN	ORGANIZATION	egfr	nsubj	19	SENT_171	[p10l1694t2712r1953b2790],
19	corresponds	VBZ	O	correspond	ccomp	17	SENT_171	[p10l1970t2732r2134b2785, p10l11t2834r397b2935],
20	to	TO	O	to	_	0	SENT_171	[p10l431t2851r510b2913],
21	activated	VBN	O	activate	amod	25	SENT_171	[p10l542t2834r912b2914],
22	EGFR	NN	ORGANIZATION	egfr	nn	25	SENT_171	[p10l941t2840r1200b2918],
23	tyrosine	NN	O	tyrosine	nn	25	SENT_171	[p10l1221t2835r1556b2935],
24	kinase	NN	O	kinase	nn	25	SENT_171	[p10l1588t2835r1916b2930],
25	)	NN	O	)	prep_to	19	SENT_171	[p10l1588t2835r1916b2930],
26	,	,	O	,	_	0	SENT_171	[p10l1588t2835r1916b2930],
27	suggesting	VBG	O	suggest	partmod	5	SENT_171	[p10l1955t2861r2134b2935, p10l10t2963r324b3063],
28	that	IN	O	that	complm	38	SENT_171	[p10l356t2963r522b3041],
29	the	DT	O	the	det	30	SENT_171	[p10l553t2963r682b3041],
30	presence	NN	O	presence	nsubj	38	SENT_171	[p10l717t2988r1090b3063],
31	of	IN	O	of	_	0	SENT_171	[p10l1127t2962r1227b3041],
32	the	DT	O	the	det	34	SENT_171	[p10l1245t2963r1374b3041],
33	T79OM	NN	O	t79om	nn	34	SENT_171	[p10l1406t2968r1709b3041],
34	mutation	NN	O	mutation	prep_of	30	SENT_171	[p10l1746t2963r2135b3042],
35	does	VBZ	O	do	aux	38	SENT_171	[p10l11t3091r202b3169],
36	not	RB	O	not	neg	38	SENT_171	[p10l234t3107r378b3169],
37	substantially	RB	O	substantially	advmod	38	SENT_171	[p10l403t3091r942b3191],
38	alter	VB	O	alter	ccomp	27	SENT_171	[p10l966t3091r1153b3169],
39	the	DT	O	the	det	40	SENT_171	[p10l1180t3091r1309b3169],
40	production	NN	O	production	dobj	38	SENT_171	[p10l1337t3091r1831b3191],
41	,	,	O	,	_	0	SENT_171	[p10l1337t3091r1831b3191],
42	degraFigure	NN	O	degrafigure	appos	40	SENT_171	[p10l1867t3091r2134b3191, p11l66t2287r228b2349],

1	2	LS	NUMBER	2	_	0	SENT_172	[p11l245t2290r289b2334],
2	.	.	O	.	_	0	SENT_172	[p11l245t2290r289b2334],

1	Mechanism	NN	O	mechanism	_	0	SENT_173	[p11l312t2286r616b2334],
2	of	IN	O	of	_	0	SENT_173	[p11l636t2285r696b2334],
3	Drug	NN	O	drug	nn	4	SENT_173	[p11l707t2290r836b2349],
4	Resistance	NN	O	resistance	prep_of	1	SENT_173	[p11l857t2287r1150b2334],
5	.	.	O	.	_	0	SENT_173	[p11l857t2287r1150b2334],

1	Panel	NN	O	panel	nn	2	SENT_174	[p11l67t2382r202b2431],
2	A	NN	O	a	nsubj	3	SENT_174	[p11l220t2385r257b2430],
3	shows	VBZ	O	show	_	0	SENT_174	[p11l273t2382r435b2431],
4	the	DT	O	the	det	8	SENT_174	[p11l452t2382r534b2431],
5	crystallographically	RB	O	crystallographically	advmod	6	SENT_174	[p11l551t2382r1053b2446],
6	determined	VBN	O	determine	amod	8	SENT_174	[p11l1069t2382r1368b2431],
7	binding	NN	O	binding	nn	8	SENT_174	[p11l1390t2382r1587b2446],
8	oferlotinib	NN	O	oferlotinib	dobj	3	SENT_174	[p11l1603t2382r1884b2431],
9	to	TO	O	to	_	0	SENT_174	[p11l1900t2391r1951b2431],
10	wildtype	JJ	O	wildtype	amod	12	SENT_174	[p11l1966t2382r2090b2431, p11l61t2472r169b2526],
11	EG	NN	O	eg	nn	12	SENT_174	[p11l192t2466r260b2511],
12	FR	NN	O	fr	prep_to	8	SENT_174	[p11l272t2467r348b2519],
13	,	,	O	,	_	0	SENT_174	[p11l272t2467r348b2519],
14	whereas	IN	O	whereas	mark	17	SENT_174	[p11l368t2462r583b2511],
15	Panel	NN	O	panel	nn	16	SENT_174	[p11l608t2462r743b2511],
16	B	NN	O	b	nsubj	17	SENT_174	[p11l770t2467r797b2510],
17	shows	VBZ	O	show	advcl	3	SENT_174	[p11l819t2462r981b2511],
18	how	WRB	O	how	advmod	22	SENT_174	[p11l1004t2462r1111b2511],
19	the	DT	O	the	det	21	SENT_174	[p11l1127t2462r1208b2511],
20	T79OM	NN	O	t79om	nn	21	SENT_174	[p11l1225t2465r1406b2511],
21	mutation	NN	O	mutation	nsubj	22	SENT_174	[p11l1433t2467r1667b2511],
22	leads	VBZ	O	lead	ccomp	17	SENT_174	[p11l1692t2462r1823b2511],
23	to	TO	O	to	_	0	SENT_174	[p11l1842t2472r1893b2511],
24	steric	JJ	O	steric	amod	27	SENT_174	[p11l1914t2467r2054b2511],
25	hindrance	NN	O	hindrance	nn	27	SENT_174	[p11l65t2543r324b2591],
26	oferlotinib	NN	O	oferlotinib	nn	27	SENT_174	[p11l343t2542r627b2591],
27	binding	NN	O	binding	prep_to	22	SENT_174	[p11l649t2543r846b2606],
28	owing	VBG	O	owe	partmod	27	SENT_174	[p11l864t2547r1022b2606],
29	to	TO	O	to	_	0	SENT_174	[p11l1038t2552r1089b2591],
30	the	DT	O	the	det	32	SENT_174	[p11l1107t2543r1189b2591],
31	presence	NN	O	presence	nn	32	SENT_174	[p11l1211t2560r1443b2605],
32	ofthe	NN	O	ofthe	prep_to	28	SENT_174	[p11l1462t2542r1610b2591],
33	bulkier	JJR	O	bulkier	amod	36	SENT_174	[p11l1631t2542r1807b2591],
34	methionine	NN	O	methionine	nn	36	SENT_174	[p11l1827t2542r2026b2591, p11l65t2627r174b2671],
35	side	NN	O	side	nn	36	SENT_174	[p11l191t2623r295b2671],
36	chain	NN	O	chain	dep	32	SENT_174	[p11l311t2623r448b2671],
37	(	CD	NUMBER	(	num	39	SENT_174	[p11l472t2627r687b2687],
38	orange	JJ	O	orange	amod	39	SENT_174	[p11l472t2627r687b2687],
39	)	NN	O	)	dobj	22	SENT_174	[p11l472t2627r687b2687],
40	in	IN	O	in	_	0	SENT_174	[p11l711t2627r753b2671],
41	the	DT	O	the	det	45	SENT_174	[p11l770t2623r851b2671],
42	ATP-kinase	NN	O	atp-kinase	nn	45	SENT_174	[p11l865t2623r1390b2687],
43	—	NN	O	—	nn	45	SENT_174	[p11l865t2623r1390b2687],
44	binding	NN	O	binding	nn	45	SENT_174	[p11l865t2623r1390b2687],
45	pocket	NN	O	pocket	prep_in	39	SENT_174	[p11l1407t2623r1591b2686],
46	.	.	O	.	_	0	SENT_174	[p11l1407t2623r1591b2686],

1	Panel	NN	O	panel	nn	2	SENT_175	[p11l1613t2623r1749b2671],
2	C	NN	O	c	nsubj	3	SENT_175	[p11l1768t2627r1803b2672],
3	shows	VBZ	O	show	_	0	SENT_175	[p11l1819t2623r1981b2672],
4	the	DT	O	the	det	6	SENT_175	[p11l1997t2623r2079b2671],
5	steric	JJ	O	steric	amod	6	SENT_175	[p11l64t2708r204b2752],
6	hindrance	NN	O	hindrance	dobj	3	SENT_175	[p11l224t2703r483b2752],
7	in	IN	O	in	_	0	SENT_175	[p11l505t2708r546b2751],
8	the	DT	O	the	det	11	SENT_175	[p11l566t2703r648b2752],
9	predicted	VBN	O	predict	amod	11	SENT_175	[p11l670t2703r911b2766],
10	complex	NN	O	complex	nn	11	SENT_175	[p11l933t2703r1153b2766],
11	ofgeﬁtinib	NN	O	ofgeﬁtinib	prep_in	6	SENT_175	[p11l1171t2702r1450b2767],
12	and	CC	O	and	_	0	SENT_175	[p11l1471t2703r1563b2752],
13	EG	NN	O	eg	nn	14	SENT_175	[p11l1589t2707r1657b2752],
14	FR	NN	O	fr	conj_and	11	SENT_175	[p11l1669t2708r1732b2751],
15	with	IN	O	with	_	0	SENT_175	[p11l1749t2703r1857b2752],
16	the	DT	O	the	det	18	SENT_175	[p11l1877t2703r1959b2752],
17	T79OM	NN	O	t79om	nn	18	SENT_175	[p11l60t2787r240b2832],
18	mutation	NN	O	mutation	prep_with	11	SENT_175	[p11l267t2788r519b2832],
19	.	.	O	.	_	0	SENT_175	[p11l267t2788r519b2832],

1	Panel	NN	O	panel	nn	2	SENT_176	[p11l544t2783r680b2832],
2	D	NN	O	d	nsubj	3	SENT_176	[p11l706t2788r742b2831],
3	shows	VBZ	O	show	_	0	SENT_176	[p11l763t2783r925b2832],
4	the	DT	O	the	dobj	3	SENT_176	[p11l944t2783r1026b2832],
5	predicted	VBN	O	predict	partmod	4	SENT_176	[p11l1048t2783r1288b2846],
6	binding	NN	O	binding	nn	7	SENT_176	[p11l1313t2783r1510b2847],
7	ofCL-387	NN	O	ofcl-387	dobj	5	SENT_176	[p11l1528t2783r1885b2840],
8	,785	CD	NUMBER	,785	num	7	SENT_176	[p11l1528t2783r1885b2840],
9	to	TO	O	to	_	0	SENT_176	[p11l1906t2793r1957b2832],
10	EG	NNP	O	EG	nn	11	SENT_176	[p11l67t2868r134b2912],
11	FR	NN	O	fr	prep_to	5	SENT_176	[p11l146t2868r209b2911],
12	with	IN	O	with	_	0	SENT_176	[p11l226t2864r334b2912],
13	the	DT	O	the	det	18	SENT_176	[p11l354t2864r436b2912],
14	T79OM	NN	O	t79om	nn	18	SENT_176	[p11l453t2867r633b2912],
15	mutation	NN	O	mutation	nn	18	SENT_176	[p11l660t2868r894b2912],
16	(	CD	NUMBER	(	num	18	SENT_176	[p11l922t2864r1188b2927],
17	structural	JJ	O	structural	amod	18	SENT_176	[p11l922t2864r1188b2927],
18	change	NN	O	change	prep_with	5	SENT_176	[p11l1210t2864r1396b2928],
19	introduced	VBN	O	introduce	partmod	18	SENT_176	[p11l1417t2864r1697b2912],
20	by	IN	O	by	_	0	SENT_176	[p11l1721t2864r1776b2927],
21	the	DT	O	the	det	23	SENT_176	[p11l1792t2864r1874b2912],
22	T79OM	NN	O	t79om	nn	23	SENT_176	[p11l1890t2867r2071b2912],
23	mutation	NN	O	mutation	agent	19	SENT_176	[p11l65t2949r299b2992],
24	shown	VBN	O	show	partmod	23	SENT_176	[p11l323t2944r490b2992],
25	in	IN	O	in	_	0	SENT_176	[p11l514t2949r555b2992],
26	orange	JJ	O	orange	amod	27	SENT_176	[p11l578t2948r794b3008],
27	)	NN	O	)	prep_in	24	SENT_176	[p11l578t2948r794b3008],
28	.	.	O	.	_	0	SENT_176	[p11l578t2948r794b3008],

1	dation	NN	O	dation	_	0	SENT_177	[p11l11t3249r229b3319],
2	,	,	O	,	_	0	SENT_177	[p11l11t3249r229b3319],
3	activation	NN	O	activation	conj_or	1	SENT_177	[p11l263t3249r585b3319],
4	,	,	O	,	_	0	SENT_177	[p11l263t3249r585b3319],
5	or	CC	O	or	_	0	SENT_177	[p11l621t3267r687b3307],
6	deactivation	NN	O	deactivation	conj_or	1	SENT_177	[p11l717t3248r1096b3307],
7	of	IN	O	of	_	0	SENT_177	[p11l1127t3248r1202b3307],
8	the	DT	O	the	det	11	SENT_177	[p11l1219t3249r1316b3307],
9	scaffold	NN	O	scaffold	nn	11	SENT_177	[p11l1348t3248r1597b3307],
10	EGFR	NN	ORGANIZATION	egfr	nn	11	SENT_177	[p11l9t3348r201b3406],
11	molecule	NN	O	molecule	prep_of	1	SENT_177	[p11l208t3344r507b3402],
12	.	.	O	.	_	0	SENT_177	[p11l208t3344r507b3402],

1	In	IN	O	in	_	0	SENT_178	[p11l526t3349r590b3401],
2	contrast	NN	O	contrast	prep_in	25	SENT_178	[p11l605t3355r873b3414],
3	,	,	O	,	_	0	SENT_178	[p11l605t3355r873b3414],
4	when	WRB	O	when	advmod	10	SENT_178	[p11l888t3344r1061b3402],
5	transiently	RB	O	transiently	advmod	6	SENT_178	[p11l1076t3343r1405b3418],
6	transfected	VBN	O	transfect	csubjpass	10	SENT_178	[p11l1417t3356r1596b3402, p11l11t3438r195b3497],
7	COS-7	NN	O	cos-7	nn	8	SENT_178	[p11l211t3443r412b3497],
8	cells	NNS	O	cell	dobj	6	SENT_178	[p11l430t3439r563b3497],
9	Were	VBD	O	be	auxpass	10	SENT_178	[p11l577t3458r726b3498],
10	treated	VBN	O	treat	advcl	25	SENT_178	[p11l743t3438r954b3497],
11	with	IN	O	with	_	0	SENT_178	[p11l967t3438r1106b3498],
12	increasing	VBG	O	increase	amod	13	SENT_178	[p11l1121t3439r1446b3513],
13	concentrations	NNS	O	concentration	prep_with	10	SENT_178	[p11l1460t3457r1596b3497, p11l11t3534r358b3592],
14	of	IN	O	of	_	0	SENT_178	[p11l375t3533r449b3592],
15	gefitinib	NN	O	gefitinib	prep_of	13	SENT_178	[p11l450t3533r715b3608],
16	before	IN	O	before	_	0	SENT_178	[p11l733t3533r932b3592],
17	EGF	NN	ORGANIZATION	egf	nn	18	SENT_178	[p11l947t3538r1082b3592],
18	stimulation	NN	O	stimulation	prep_before	15	SENT_178	[p11l1101t3534r1480b3604],
19	,	,	O	,	_	0	SENT_178	[p11l1101t3534r1480b3604],
20	the	DT	O	the	det	22	SENT_178	[p11l1500t3534r1596b3592],
21	original	JJ	O	original	amod	22	SENT_178	[p11l11t3629r257b3703],
22	constructs	NNS	O	construct	nsubjpass	25	SENT_178	[p11l273t3640r598b3687],
23	were	VBD	O	be	auxpass	25	SENT_178	[p11l612t3648r762b3687],
24	fully	RB	O	fully	advmod	25	SENT_178	[p11l777t3628r917b3703],
25	inhibited	VBN	O	inhibit	_	0	SENT_178	[p11l929t3628r1214b3687],
26	at	IN	O	at	_	0	SENT_178	[p11l1228t3641r1288b3687],
27	a	DT	O	a	det	28	SENT_178	[p11l1299t3648r1332b3687],
28	concentration	NN	O	concentration	prep_at	25	SENT_178	[p11l1347t3647r1595b3687, p11l11t3724r221b3782],
29	of	IN	O	of	_	0	SENT_178	[p11l239t3723r314b3782],
30	20	CD	NUMBER	20	num	31	SENT_178	[p11l319t3728r394b3782],
31	nM	NN	O	nm	prep_of	28	SENT_178	[p11l412t3729r534b3795],
32	,	,	O	,	_	0	SENT_178	[p11l412t3729r534b3795],
33	Whereas	IN	O	whereas	_	0	SENT_178	[p11l553t3724r813b3782],
34	all	DT	O	all	det	36	SENT_178	[p11l832t3723r907b3782],
35	four	CD	NUMBER	four	num	36	SENT_178	[p11l924t3723r1057b3782],
36	constructs	NNS	O	construct	prep_whereas	25	SENT_178	[p11l1073t3735r1399b3782],
37	carrying	VBG	O	carry	partmod	36	SENT_178	[p11l1419t3743r1596b3798, p12l10t17r112b91],

1	the	DT	O	the	det	5	SENT_179	[p12l125t17r220b75],
2	T790M	NN	O	t790m	nn	5	SENT_179	[p12l233t21r457b75],
3	amino	NN	O	amino	nn	5	SENT_179	[p12l473t17r671b75],
4	acid	NN	O	acid	nn	5	SENT_179	[p12l687t17r812b75],
5	substitution	NN	O	substitution	nsubj	6	SENT_179	[p12l829t17r1200b75],
6	demonstrated	VBD	O	demonstrate	_	0	SENT_179	[p12l1216t17r1596b75, p12l11t112r82b170],
7	high-level	JJ	O	high-level	amod	8	SENT_179	[p12l97t111r409b186],
8	resistance	NN	O	resistance	dobj	6	SENT_179	[p12l424t112r757b182],
9	,	,	O	,	_	0	SENT_179	[p12l424t112r757b182],
10	with	IN	O	with	_	0	SENT_179	[p12l774t112r916b171],
11	persistent	JJ	O	persistent	amod	12	SENT_179	[p12l930t112r1245b186],
12	generation	NN	O	generation	prep_with	6	SENT_179	[p12l1257t112r1596b186],
13	of	IN	O	of	_	0	SENT_179	[p12l11t206r86b265],
14	phosphorylated	JJ	O	phosphorylated	amod	15	SENT_179	[p12l91t207r586b281],
15	EGFR	NN	ORGANIZATION	egfr	prep_of	12	SENT_179	[p12l604t211r798b269],
16	at	IN	O	at	_	0	SENT_179	[p12l808t219r867b265],
17	concentrations	NNS	O	concentration	prep_at	6	SENT_179	[p12l883t207r1352b265],
18	of	IN	O	of	_	0	SENT_179	[p12l1374t206r1449b265],
19	geﬁtinib	NN	O	geﬁtinib	prep_of	17	SENT_179	[p12l1454t206r1596b281, p12l11t302r155b360],
20	as	RB	O	as	advmod	21	SENT_179	[p12l186t321r249b360],
21	high	JJ	O	high	advmod	6	SENT_179	[p12l281t301r425b376],
22	as	IN	O	as	_	0	SENT_179	[p12l456t321r519b360],
23	2	CD	NUMBER	2	num	24	SENT_179	[p12l551t306r586b359],
24	uM	NN	O	um	prep_as	21	SENT_179	[p12l619t307r714b376],
25	(	CD	NUMBER	(	num	26	SENT_179	[p12l750t302r887b376],
26	Fig	NN	O	fig	dep	21	SENT_179	[p12l750t302r887b376],
27	.	.	O	.	_	0	SENT_179	[p12l750t302r887b376],

1	3A	NN	O	3a	_	0	SENT_180	[p12l923t306r1049b369],
2	)	NN	O	)	dep	1	SENT_180	[p12l923t306r1049b369],
3	.	.	O	.	_	0	SENT_180	[p12l923t306r1049b369],

1	Identical	JJ	O	identical	amod	2	SENT_181	[p12l1083t302r1358b360],
2	results	NNS	O	result	nsubjpass	4	SENT_181	[p12l1388t302r1595b360],
3	were	VBD	O	be	auxpass	4	SENT_181	[p12l7t416r158b455],
4	obtained	VBN	O	obtain	_	0	SENT_181	[p12l177t397r455b455],
5	in	IN	O	in	_	0	SENT_181	[p12l473t397r533b454],
6	N	NN	O	n	nn	8	SENT_181	[p12l550t402r606b455],
7	IH	NN	O	ih	nn	8	SENT_181	[p12l608t401r835b455],
8	—	NN	O	—	prep_in	4	SENT_181	[p12l608t401r835b455],
9	3T3	NN	O	3t3	nn	10	SENT_181	[p12l608t401r835b455],
10	cells	NNS	O	cell	nsubj	11	SENT_181	[p12l856t397r993b455],
11	(	VBP	O	(	rcmod	8	SENT_181	[p12l1016t397r1173b464],
12	data	NNS	O	datum	dobj	11	SENT_181	[p12l1016t397r1173b464],
13	not	RB	O	not	neg	14	SENT_181	[p12l1190t409r1298b455],
14	shown	VBN	O	show	rcmod	12	SENT_181	[p12l1314t397r1566b464],
15	)	NN	O	)	dobj	14	SENT_181	[p12l1314t397r1566b464],
16	.	.	O	.	_	0	SENT_181	[p12l1314t397r1566b464],

1	To	TO	O	to	aux	2	SENT_182	[p12l104t497r182b551],
2	determine	VB	O	determine	purpcl	23	SENT_182	[p12l198t493r512b551],
3	whether	IN	O	whether	complm	8	SENT_182	[p12l524t493r781b552],
4	the	DT	O	the	det	7	SENT_182	[p12l794t493r889b551],
5	T	NN	O	t	nn	7	SENT_182	[p12l901t497r947b550],
6	790M	NN	O	790m	nn	7	SENT_182	[p12l949t497r1124b551],
7	mutation	NN	O	mutation	nsubj	8	SENT_182	[p12l1140t493r1425b552],
8	leads	VBZ	O	lead	ccomp	2	SENT_182	[p12l1439t493r1596b551],
9	to	TO	O	to	_	0	SENT_182	[p12l11t601r69b647],
10	resistance	NN	O	resistance	prep_to	8	SENT_182	[p12l92t589r400b647],
11	to	TO	O	to	_	0	SENT_182	[p12l423t601r481b647],
12	EGFR	NN	ORGANIZATION	egfr	nn	13	SENT_182	[p12l503t593r694b651],
13	inhibitors	NNS	O	inhibitor	prep_to	8	SENT_182	[p12l707t589r1009b647],
14	that	WDT	O	that	nsubj	15	SENT_182	[p12l1033t589r1155b647],
15	have	VBP	O	have	rcmod	13	SENT_182	[p12l1173t588r1311b648],
16	different	JJ	O	different	amod	18	SENT_182	[p12l1334t588r1601b647],
17	molecular	JJ	O	molecular	amod	18	SENT_182	[p12l11t684r323b742],
18	structures	NNS	O	structure	dobj	15	SENT_182	[p12l338t696r643b742],
19	and	CC	O	and	_	0	SENT_182	[p12l660t684r775b742],
20	mechanisms	NNS	O	mechanism	conj_and	18	SENT_182	[p12l791t684r1203b754],
21	,	,	O	,	_	0	SENT_182	[p12l791t684r1203b754],
22	we	PRP	O	we	nsubj	23	SENT_182	[p12l1220t703r1308b742],
23	screened	VBD	O	screen	_	0	SENT_182	[p12l1325t684r1597b742],
24	four	CD	NUMBER	four	num	28	SENT_182	[p12l11t778r146b837],
25	commercially	RB	O	commercially	advmod	26	SENT_182	[p12l203t779r640b853],
26	available	JJ	O	available	amod	28	SENT_182	[p12l695t779r974b838],
27	EGFR	NN	ORGANIZATION	egfr	nn	28	SENT_182	[p12l1032t783r1228b841],
28	inhibitors	NNS	O	inhibitor	nsubj	29	SENT_182	[p12l1278t778r1594b837],
29	(	VBP	O	(	ccomp	23	SENT_182	[p12l14t878r317b944],
30	AG1478	NN	O	ag1478	nsubj	40	SENT_182	[p12l14t878r317b944],
31	,	,	O	,	_	0	SENT_182	[p12l14t878r317b944],
32	cetuximab	NN	O	cetuximab	nsubj	40	SENT_182	[p12l348t874r698b944],
33	,	,	O	,	_	0	SENT_182	[p12l348t874r698b944],
34	erlotinib	NN	O	erlotinib	nsubj	40	SENT_182	[p12l727t873r1021b944],
35	,	,	O	,	_	0	SENT_182	[p12l727t873r1021b944],
36	and	CC	O	and	_	0	SENT_182	[p12l1050t874r1168b932],
37	CL-387	NN	O	cl-387	nsubj	40	SENT_182	[p12l1193t878r1592b944],
38	,785	CD	NUMBER	,785	num	39	SENT_182	[p12l1193t878r1592b944],
39	)	NN	O	)	dep	30	SENT_182	[p12l1193t878r1592b944],
40	using	VBG	O	use	dep	29	SENT_182	[p12l11t969r185b1043],
41	cells	NNS	O	cell	dobj	40	SENT_182	[p12l198t969r333b1027],
42	that	WDT	O	that	nsubjpass	45	SENT_182	[p12l350t969r473b1027],
43	were	VBD	O	be	auxpass	45	SENT_182	[p12l481t988r630b1027],
44	transiently	RB	O	transiently	advmod	45	SENT_182	[p12l646t969r977b1043],
45	transfected	VBN	O	transfect	rcmod	41	SENT_182	[p12l989t968r1334b1027],
46	with	IN	O	with	_	0	SENT_182	[p12l1346t969r1486b1027],
47	the	DT	O	the	det	48	SENT_182	[p12l1501t969r1597b1027],
48	delL747	NN	O	dell747	prep_with	45	SENT_182	[p12l11t1065r467b1123],
49	.	.	O	.	_	0	SENT_182	[p12l11t1065r467b1123],

1	—	NN	O	—	_	0	SENT_183	[p12l11t1065r467b1123],
2	.	.	O	.	_	0	SENT_183	[p12l11t1065r467b1123],

1	S752	NN	O	s752	_	0	SENT_184	[p12l11t1065r467b1123],
2	construct	NN	O	construct	dep	1	SENT_184	[p12l495t1077r800b1124],
3	and	CC	O	and	_	0	SENT_184	[p12l823t1065r941b1123],
4	the	DT	O	the	det	5	SENT_184	[p12l968t1065r1066b1123],
5	delL747	NN	O	dell747	dep	1	SENT_184	[p12l1094t1064r1595b1123],
6	.	.	O	.	_	0	SENT_184	[p12l1094t1064r1595b1123],

1	—	NN	O	—	_	0	SENT_185	[p12l1094t1064r1595b1123],
2	.	.	O	.	_	0	SENT_185	[p12l1094t1064r1595b1123],

1	S752	NN	O	s752	_	0	SENT_186	[p12l1094t1064r1595b1123],
2	+	CC	O	+	cc	1	SENT_186	[p12l1094t1064r1595b1123],

1	N	NN	O	n	nn	3	SENT_187	[p12l487t1205r501b1221],
2	ENGLJ	NN	O	englj	nn	3	SENT_187	[p12l516t1205r600b1227],
3	MED	NN	O	med	_	0	SENT_187	[p12l615t1205r668b1220],
4	352	CD	NUMBER	352	dep	3	SENT_187	[p12l680t1199r746b1227],
5	;	:	O	;	_	0	SENT_187	[p12l680t1199r746b1227],
6	8	CD	NUMBER	8	num	7	SENT_187	[p12l680t1199r746b1227],
7	WWW	NN	O	www	dep	3	SENT_187	[p12l781t1205r875b1221],
8	.	.	O	.	_	0	SENT_187	[p12l781t1205r875b1221],

1	N	NN	O	n	nn	2	SENT_188	[p12l781t1205r875b1221],
2	E	NN	O	e	_	0	SENT_188	[p12l883t1205r901b1227],
3	}	CD	NUMBER	}	num	5	SENT_188	[p12l883t1205r901b1227],
4	M.ORG	NNP	O	M.ORG	nn	5	SENT_188	[p12l909t1205r992b1221],
5	FEBRUARY	NNP	DATE	FEBRUARY	dep	2	SENT_188	[p12l1032t1205r1159b1221],
6	24	CD	DATE	24	num	5	SENT_188	[p12l1171t1205r1209b1227],
7	,	,	O	,	_	0	SENT_188	[p12l1171t1205r1209b1227],
8	2oo5	CD	NUMBER	2oo5	number	9	SENT_188	[p12l1222t1205r1285b1227],
9	789	CD	NUMBER	789	appos	5	SENT_188	[p12l1959t1203r2016b1226],

1	The	DT	O	the	det	4	SENT_189	[p12l702t1238r752b1262],
2	New	NNP	O	New	nn	4	SENT_189	[p12l762t1239r824b1262],
3	England	NNP	O	England	nn	4	SENT_189	[p12l833t1238r944b1269],
4	Journal	NNP	O	Journal	_	0	SENT_189	[p12l952t1238r1050b1262],
5	of	IN	O	of	_	0	SENT_189	[p12l1060t1238r1088b1262],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_189	[p12l1095t1238r1220b1262],

1	Downloaded	VBN	O	download	_	0	SENT_190	[p12l144t1279r314b1302],
2	from	IN	O	from	_	0	SENT_190	[p12l322t1279r387b1302],
3	nejmorg	NN	O	nejmorg	prep_from	1	SENT_190	[p12l396t1279r514b1309],
4	at	IN	O	at	_	0	SENT_190	[p12l524t1283r547b1302],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_190	[p12l556t1279r738b1302],
6	on	IN	O	on	_	0	SENT_190	[p12l748t1286r780b1302],
7	January	NNP	DATE	January	prep_on	1	SENT_190	[p12l789t1279r891b1309],
8	5	CD	DATE	5	num	7	SENT_190	[p12l902t1279r924b1306],
9	,	,	DATE	,	_	0	SENT_190	[p12l902t1279r924b1306],
10	2014	CD	DATE	2014	num	7	SENT_190	[p12l935t1279r1007b1302],
11	.	.	O	.	_	0	SENT_190	[p12l935t1279r1007b1302],

1	For	IN	O	for	_	0	SENT_191	[p12l1018t1279r1064b1302],
2	personal	JJ	O	personal	amod	3	SENT_191	[p12l1072t1279r1184b1309],
3	use	NN	O	use	pobj	1	SENT_191	[p12l1194t1286r1237b1302],
4	only	RB	O	only	advmod	3	SENT_191	[p12l1247t1279r1312b1309],
5	.	.	O	.	_	0	SENT_191	[p12l1247t1279r1312b1309],

1	No	DT	O	no	det	3	SENT_192	[p12l1322t1279r1362b1302],
2	other	JJ	O	other	amod	3	SENT_192	[p12l1372t1279r1440b1302],
3	uses	NNS	O	use	_	0	SENT_192	[p12l1448t1286r1504b1302],
4	without	IN	O	without	_	0	SENT_192	[p12l1515t1279r1616b1302],
5	permission	NN	O	permission	prep_without	3	SENT_192	[p12l1624t1279r1777b1309],
6	.	.	O	.	_	0	SENT_192	[p12l1624t1279r1777b1309],

1	Copyright	NN	O	copyright	_	0	SENT_193	[p12l494t1320r628b1351],
2	©	CD	NUMBER	©	num	6	SENT_193	[p12l638t1320r661b1344],
3	2005	CD	DATE	2005	num	6	SENT_193	[p12l671t1320r735b1344],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_193	[p12l746t1320r937b1344],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_193	[p12l947t1320r1055b1344],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_193	[p12l1065t1320r1170b1351],
7	.	.	O	.	_	0	SENT_193	[p12l1065t1320r1170b1351],

1	All	DT	O	all	det	2	SENT_194	[p12l1181t1320r1222b1344],
2	rights	NNS	O	rights	nsubj	3	SENT_194	[p12l1232t1320r1306b1351],
3	reserved	VBN	O	reserve	_	0	SENT_194	[p12l1316t1320r1435b1344],
4	.	.	O	.	_	0	SENT_194	[p12l1316t1320r1435b1344],

1	The	DT	O	the	det	3	SENT_195	[p12l715t1362r752b1383],
2	NEW	NNP	O	NEW	nn	3	SENT_195	[p12l764t1364r844b1383],
3	ENGLAND	NNP	O	ENGLAND	_	0	SENT_195	[p12l858t1364r1033b1383],
4	JOURNAL	NNP	O	JOURNAL	nn	5	SENT_195	[p12l1047t1364r1213b1390],
5	afMEDICINE	NNP	O	afMEDICINE	dep	3	SENT_195	[p12l1227t1362r1443b1389],

1	Anti	JJ	O	anti	amod	4	SENT_196	[p12l763t1535r933b1565],
2	—	NN	O	—	nn	4	SENT_196	[p12l763t1535r933b1565],
3	p-EGFR	NN	O	p-egfr	nn	4	SENT_196	[p12l763t1535r933b1565],
4	Anti-EGFR	NN	O	anti-egfr	_	0	SENT_196	[p12l1401t1535r1535b1558],
5	(	CD	NUMBER	(	num	6	SENT_196	[p12l1546t1535r1651b1566],
6	control	NN	O	control	dep	4	SENT_196	[p12l1546t1535r1651b1566],
7	)	CD	NUMBER	)	num	14	SENT_196	[p12l1546t1535r1651b1566],
8	Geﬁtinib	NNP	O	Geﬁtinib	nn	14	SENT_196	[p12l763t1574r865b1596],
9	(	CD	NUMBER	(	num	14	SENT_196	[p12l877t1576r931b1603],
10	yM	NNP	O	yM	nn	14	SENT_196	[p12l877t1576r931b1603],
11	)	CD	NUMBER	)	num	14	SENT_196	[p12l877t1576r931b1603],
12	Geﬁtinib	NNP	O	Geﬁtinib	nn	14	SENT_196	[p12l1442t1574r1544b1596],
13	(	CD	NUMBER	(	num	14	SENT_196	[p12l1556t1576r1610b1603],
14	pm	NN	O	pm	rcmod	6	SENT_196	[p12l1556t1576r1610b1603],
15	)	NN	O	)	dep	4	SENT_196	[p12l1556t1576r1610b1603],

1	_	NNP	O	_	nn	2	SENT_197	[p12l904t1730r917b1731],
2	J.	NNP	O	J.	_	0	SENT_197	[p12l1259t1713r1310b1730],
3	.	.	O	.	_	0	SENT_197	[p12l1259t1713r1310b1730],

1	.	.	O	.	_	0	SENT_198	[p12l1259t1713r1310b1730],

1	m	NN	O	m	_	0	SENT_199	[p12l1343t1716r1390b1730],
2	_	CD	NUMBER	_	num	1	SENT_199	[p12l1343t1716r1390b1730],
3	A	DT	O	a	det	4	SENT_199	[p12l1403t1720r1550b1730],
4	_	NN	O	_	dep	1	SENT_199	[p12l1403t1720r1550b1730],
5	.	.	O	.	_	0	SENT_199	[p12l1403t1720r1550b1730],

1	‘	NN	O	‘	nn	3	SENT_200	[p12l1403t1720r1550b1730],
2	....	CD	NUMBER	....	num	3	SENT_200	[p12l1403t1720r1550b1730],
3	_	NN	O	_	_	0	SENT_200	[p12l1403t1720r1550b1730],
4	;	:	O	;	_	0	SENT_200	[p12l1403t1720r1550b1730],
5	1	CD	NUMBER	1	num	6	SENT_200	[p12l1604t1720r1612b1730],
6	A	NN	O	a	dep	3	SENT_200	[p12l1667t1715r1676b1730],
7	.	.	O	.	_	0	SENT_200	[p12l1734t1726r1738b1730],

1	I	PRP	O	I	_	0	SENT_201	[p12l1794t1722r1800b1730],

1	L858R	NNP	O	L858R	nn	5	SENT_202	[p12l427t1779r498b1800],
2	W.	NNP	O	W.	nn	5	SENT_202	[p12l602t1789r635b1806],
3	“	NNP	O	“	nn	5	SENT_202	[p12l865t1754r1169b1818],
4	I.	NNP	O	I.	nn	5	SENT_202	[p12l865t1754r1169b1818],
5	”	NNP	O	”	_	0	SENT_202	[p12l865t1754r1169b1818],
6	.	.	O	.	_	0	SENT_202	[p12l1650t1801r1653b1802],

1	A	DT	O	a	det	4	SENT_203	[p12l1726t1788r1746b1829],
2	de	FW	O	de	nn	3	SENT_203	[p12l276t1858r497b1880],
3	|	FW	O	|	amod	4	SENT_203	[p12l276t1858r497b1880],
4	L747	NN	O	l747	_	0	SENT_203	[p12l276t1858r497b1880],
5	.	.	O	.	_	0	SENT_203	[p12l276t1858r497b1880],

1	—	NN	O	—	_	0	SENT_204	[p12l276t1858r497b1880],
2	.	.	O	.	_	0	SENT_204	[p12l276t1858r497b1880],

1	P753insS	NN	O	p753inss	_	0	SENT_205	[p12l276t1858r497b1880],
2	.	.	O	.	_	0	SENT_205	[p12l663t1879r667b1880],

1	cz	NN	O	cz	_	0	SENT_206	[p12l866t1856r1173b1915],
2	*	NN	O	*	dep	1	SENT_206	[p12l866t1856r1173b1915],
3	.	.	O	.	_	0	SENT_206	[p12l1300t1876r1303b1877],

1	.	.	O	.	_	0	SENT_207	[p12l1430t1878r1433b1879],

1	z	SYM	O	z	dep	2	SENT_208	[p12l1508t1880r1525b1881],
2	*	CD	NUMBER	*	_	0	SENT_208	[p12l1508t1880r1525b1881],
3	~	NN	O	~	dep	2	SENT_208	[p12l1562t1870r1569b1871],
4	'	''	O	'	_	0	SENT_208	[p12l1758t1870r1761b1871],

1	mutant	JJ	O	mutant	_	0	SENT_209	[p12l413t1896r498b1914],
2	-	:	O	-	_	0	SENT_209	[p12l1273t1921r1293b1924],
3	—	NN	O	—	nn	7	SENT_209	[p12l1341t1923r1364b1924],
4	r	NN	O	r	nn	7	SENT_209	[p12l1341t1923r1364b1924],
5	—	NN	O	—	nn	7	SENT_209	[p12l1407t1923r1417b1924],
6	A	NN	O	a	nn	7	SENT_209	[p12l1471t1919r1482b1924],
7	A	NN	O	a	dep	1	SENT_209	[p12l1534t1918r1544b1924],
8	,	,	O	,	_	0	SENT_209	[p12l1668t1923r1672b1924],

1	de	IN	O	de	dep	4	SENT_210	[p12l329t1972r497b1994],
2	“	CD	NUMBER	“	pobj	1	SENT_210	[p12l329t1972r497b1994],
3	-747	CD	NUMBER	-747	num	4	SENT_210	[p12l329t1972r497b1994],
4	-5752	CD	NUMBER	-5752	_	0	SENT_210	[p12l329t1972r497b1994],
5	-	:	O	-	_	0	SENT_210	[p12l1204t1962r1858b2008],
6	ll	NN	O	ll	dep	9	SENT_210	[p12l1204t1962r1858b2008],
7	_	NN	O	_	dep	6	SENT_210	[p12l1204t1962r1858b2008],
8	‘	CD	NUMBER	‘	dep	9	SENT_210	[p12l1204t1962r1858b2008],
9	i	FW	O	i	dep	17	SENT_210	[p12l1204t1962r1858b2008],
10	3	CD	NUMBER	3	number	11	SENT_210	[p12l682t2038r693b2058],
11	4	CD	NUMBER	4	num	13	SENT_210	[p12l747t2038r759b2058],
12	5	CD	NUMBER	5	number	13	SENT_210	[p12l812t2038r823b2058],
13	6	CD	NUMBER	6	dep	9	SENT_210	[p12l884t2038r896b2058],
14	7	CD	NUMBER	7	number	15	SENT_210	[p12l948t2038r959b2058],
15	8	CD	NUMBER	8	amod	13	SENT_210	[p12l1010t2038r1022b2058],
16	9	CD	NUMBER	9	num	17	SENT_210	[p12l1074t2038r1086b2058],
17	10	CD	NUMBER	10	dep	27	SENT_210	[p12l1131t2038r1157b2058],
18	1	CD	NUMBER	1	number	19	SENT_210	[p12l1236t2038r1246b2058],
19	2	CD	NUMBER	2	num	21	SENT_210	[p12l1300t2038r1312b2058],
20	3	CD	NUMBER	3	number	21	SENT_210	[p12l1366t2038r1376b2058],
21	4	CD	NUMBER	4	dep	17	SENT_210	[p12l1430t2038r1443b2058],
22	5	CD	NUMBER	5	number	23	SENT_210	[p12l1497t2038r1507b2058],
23	6	CD	NUMBER	6	num	25	SENT_210	[p12l1564t2038r1576b2058],
24	7	CD	NUMBER	7	number	25	SENT_210	[p12l1629t2038r1640b2058],
25	8	CD	DATE	8	dep	21	SENT_210	[p12l1692t2038r1704b2058],
26	9	CD	DATE	9	num	27	SENT_210	[p12l1756t2038r1768b2058],
27	10	CD	DATE	10	dep	4	SENT_210	[p12l1814t2038r1840b2058],

1	1	CD	NUMBER	1	num	2	SENT_211	[p12l554t2038r563b2058],
2	2	CD	NUMBER	2	_	0	SENT_211	[p12l617t2038r629b2058],
3	Without	IN	O	without	dep	2	SENT_211	[p12l587t2083r691b2106],
4	T790M	NN	O	t790m	pobj	3	SENT_211	[p12l699t2084r787b2106],
5	With	IN	O	with	_	0	SENT_211	[p12l936t2083r995b2106],
6	T790M	NN	O	t790m	prep_with	4	SENT_211	[p12l1005t2084r1093b2106],
7	Without	IN	O	without	dep	2	SENT_211	[p12l1270t2083r1374b2106],
8	T790M	NN	O	t790m	pobj	7	SENT_211	[p12l1382t2084r1470b2106],
9	With	IN	O	with	_	0	SENT_211	[p12l1618t2083r1677b2106],
10	T790M	NN	O	t790m	prep_with	8	SENT_211	[p12l1687t2084r1775b2106],

1	CL	NN	O	cl	_	0	SENT_212	[p12l885t2220r1016b2244],
2	—	CD	NUMBER	—	num	1	SENT_212	[p12l885t2220r1016b2244],
3	387,785	CD	NUMBER	387,785	number	4	SENT_212	[p12l885t2220r1016b2244],
4	(	CD	NUMBER	(	num	5	SENT_212	[p12l1030t2220r1085b2247],
5	nM	NN	O	nm	dep	1	SENT_212	[p12l1030t2220r1085b2247],
6	)	CD	NUMBER	)	num	7	SENT_212	[p12l1030t2220r1085b2247],
7	CL	NN	O	cl	dep	1	SENT_212	[p12l1326t2220r1458b2244],
8	—	CD	NUMBER	—	number	9	SENT_212	[p12l1326t2220r1458b2244],
9	387,785	CD	NUMBER	387,785	dep	7	SENT_212	[p12l1326t2220r1458b2244],
10	(	CD	NUMBER	(	num	12	SENT_212	[p12l1471t2220r1527b2247],
11	nM	NN	O	nm	nn	12	SENT_212	[p12l1471t2220r1527b2247],
12	)	NN	O	)	dep	9	SENT_212	[p12l1471t2220r1527b2247],

1	o	NN	O	o	dep	6	SENT_213	[p12l807t2257r820b2278],
2	0.3	CD	NUMBER	0.3	num	3	SENT_213	[p12l887t2257r920b2278],
3	3.0	CD	NUMBER	3.0	dep	1	SENT_213	[p12l968t2257r1002b2278],
4	30	CD	NUMBER	30	dep	6	SENT_213	[p12l1052t2257r1079b2278],
5	300	CD	NUMBER	300	num	6	SENT_213	[p12l1125t2257r1167b2278],
6	o	NN	O	o	dep	10	SENT_213	[p12l1263t2257r1276b2278],
7	0.3	CD	NUMBER	0.3	num	8	SENT_213	[p12l1342t2257r1375b2278],
8	3.0	CD	NUMBER	3.0	dep	6	SENT_213	[p12l1422t2257r1456b2278],
9	30	CD	NUMBER	30	num	10	SENT_213	[p12l1504t2257r1531b2278],
10	300	CD	NUMBER	300	_	0	SENT_213	[p12l1576t2257r1617b2278],

1	9	CD	NUMBER	9	num	2	SENT_214	[p12l1511t2504r1523b2525],
2	10	CD	NUMBER	10	_	0	SENT_214	[p12l1584t2504r1610b2525],
3	del	DT	O	del	det	4	SENT_214	[p12l899t2556r935b2579],
4	L747	NN	O	l747	dep	2	SENT_214	[p12l940t2558r1078b2579],
5	.	.	O	.	_	0	SENT_214	[p12l940t2558r1078b2579],

1	—	NN	O	—	_	0	SENT_215	[p12l940t2558r1078b2579],
2	.	.	O	.	_	0	SENT_215	[p12l940t2558r1078b2579],

1	S752	NN	O	s752	_	0	SENT_216	[p12l940t2558r1078b2579],
2	delL747	NN	O	dell747	dep	1	SENT_216	[p12l1291t2556r1576b2580],
3	.	.	O	.	_	0	SENT_216	[p12l1291t2556r1576b2580],

1	—	NN	O	—	_	0	SENT_217	[p12l1291t2556r1576b2580],
2	.	.	O	.	_	0	SENT_217	[p12l1291t2556r1576b2580],

1	S752	NN	O	s752	_	0	SENT_218	[p12l1291t2556r1576b2580],
2	+	CC	O	+	cc	3	SENT_218	[p12l1291t2556r1576b2580],
3	T790M	NN	O	t790m	dep	1	SENT_218	[p12l1291t2556r1576b2580],

1	Figure	NNP	O	Figure	_	0	SENT_219	[p12l264t2643r348b2675],
2	3	CD	NUMBER	3	dep	1	SENT_219	[p12l356t2644r378b2667],
3	.	.	O	.	_	0	SENT_219	[p12l356t2644r378b2667],

1	Resistance	NN	O	resistance	_	0	SENT_220	[p12l389t2643r534b2667],
2	of	IN	O	of	_	0	SENT_220	[p12l542t2642r573b2667],
3	EGFR	NN	ORGANIZATION	egfr	prep_of	1	SENT_220	[p12l577t2644r652b2667],
4	with	IN	O	with	_	0	SENT_220	[p12l660t2642r718b2667],
5	the	DT	O	the	det	7	SENT_220	[p12l726t2642r770b2667],
6	T790M	NN	MISC	t790m	nn	7	SENT_220	[p12l777t2644r871b2667],
7	Mutation	NN	MISC	mutation	prep_with	1	SENT_220	[p12l884t2643r1006b2667],
8	to	TO	MISC	to	_	0	SENT_220	[p12l1015t2646r1042b2667],
9	Geﬁtinib	NNP	MISC	Geﬁtinib	nn	13	SENT_220	[p12l1050t2642r1168b2667],
10	(	NNP	O	(	nn	13	SENT_220	[p12l1177t2642r1260b2675],
11	Panel	NNP	O	Panel	nn	13	SENT_220	[p12l1177t2642r1260b2675],
12	A	NNP	O	A	nn	13	SENT_220	[p12l1268t2644r1296b2675],
13	)	NN	O	)	prep_to	7	SENT_220	[p12l1268t2644r1296b2675],
14	and	CC	O	and	_	0	SENT_220	[p12l1306t2642r1355b2667],
15	Susceptibility	NN	O	susceptibility	prep_with	1	SENT_220	[p12l1364t2642r1547b2675],
16	of	IN	O	of	_	0	SENT_220	[p12l1555t2642r1586b2667],
17	EGFR	NN	ORGANIZATION	egfr	prep_of	15	SENT_220	[p12l1590t2644r1665b2667],
18	with	IN	O	with	_	0	SENT_220	[p12l1673t2642r1731b2667],
19	the	DT	O	the	det	21	SENT_220	[p12l1739t2642r1783b2667],
20	T790M	NN	MISC	t790m	nn	21	SENT_220	[p12l1790t2644r1884b2667],
21	Mutation	NN	MISC	mutation	prep_with	1	SENT_220	[p12l264t2684r386b2709],
22	to	TO	O	to	_	0	SENT_220	[p12l396t2688r423b2709],
23	an	DT	O	a	det	29	SENT_220	[p12l432t2692r463b2709],
24	Alternative	JJ	MISC	alternative	amod	29	SENT_220	[p12l473t2684r621b2709],
25	Inhibitor	NN	MISC	inhibitor	nn	29	SENT_220	[p12l632t2684r748b2709],
26	(	NN	O	(	nn	29	SENT_220	[p12l758t2684r841b2717],
27	Panel	NN	O	panel	nn	29	SENT_220	[p12l758t2684r841b2717],
28	3	CD	NUMBER	3	num	29	SENT_220	[p12l853t2686r887b2717],
29	)	NN	O	)	prep_to	21	SENT_220	[p12l853t2686r887b2717],
30	.	.	O	.	_	0	SENT_220	[p12l853t2686r887b2717],

1	Panel	NN	O	panel	nn	2	SENT_221	[p12l264t2734r335b2759],
2	A	NN	O	a	nsubj	3	SENT_221	[p12l345t2735r364b2758],
3	shows	VBZ	O	show	_	0	SENT_221	[p12l374t2734r458b2759],
4	the	DT	O	the	det	7	SENT_221	[p12l468t2734r511b2759],
5	inhibition	NN	O	inhibition	nn	7	SENT_221	[p12l522t2734r650b2759],
6	ofthe	NN	O	ofthe	nn	7	SENT_221	[p12l661t2733r738b2759],
7	activation	NN	O	activation	dobj	3	SENT_221	[p12l748t2736r878b2759],
8	of	IN	O	of	_	0	SENT_221	[p12l890t2733r919b2759],
9	EGFR	NN	ORGANIZATION	egfr	prep_of	7	SENT_221	[p12l927t2736r1001b2759],
10	by	IN	O	by	_	0	SENT_221	[p12l1012t2734r1040b2767],
11	geﬁtinib	NN	O	geﬁtinib	prep_by	3	SENT_221	[p12l1050t2733r1167b2767],
12	.	.	O	.	_	0	SENT_221	[p12l1050t2733r1167b2767],

1	Autophosphorylation	NN	O	autophosphorylation	_	0	SENT_222	[p12l1177t2734r1466b2767],
2	ofwild-type	JJ	O	ofwild-type	amod	5	SENT_222	[p12l1477t2733r1633b2767],
3	EGFR	NN	ORGANIZATION	egfr	nn	5	SENT_222	[p12l1645t2736r1719b2759],
4	(	NN	O	(	nn	5	SENT_222	[p12l1732t2736r1849b2767],
5	tyrosine	NN	O	tyrosine	nsubjpass	14	SENT_222	[p12l1732t2736r1849b2767],
6	at	IN	O	at	_	0	SENT_222	[p12l1859t2738r1884b2759],
7	position	NN	O	position	prep_at	5	SENT_222	[p12l263t2778r372b2808],
8	1068	CD	DATE	1068	number	9	SENT_222	[p12l385t2777r447b2801],
9	[	CD	NUMBER	[	num	10	SENT_222	[p12l459t2777r566b2808],
10	T1068	NN	O	t1068	dep	7	SENT_222	[p12l459t2777r566b2808],
11	]	CD	NUMBER	]	num	12	SENT_222	[p12l459t2777r566b2808],
12	)	NN	O	)	dep	10	SENT_222	[p12l459t2777r566b2808],
13	is	VBZ	O	be	auxpass	14	SENT_222	[p12l580t2778r599b2800],
14	detected	VBN	O	detect	rcmod	1	SENT_222	[p12l610t2775r724b2800],
15	by	IN	O	by	_	0	SENT_222	[p12l737t2775r765b2808],
16	immunoblots	NNS	O	immunoblot	agent	14	SENT_222	[p12l775t2775r958b2800],
17	ofwhole-cell	JJ	O	ofwhole-cell	amod	18	SENT_222	[p12l969t2775r1138b2800],
18	extracts	NNS	O	extract	dep	1	SENT_222	[p12l1149t2780r1252b2800],
19	isolated	VBN	O	isolate	partmod	18	SENT_222	[p12l1264t2775r1368b2800],
20	from	IN	O	from	_	0	SENT_222	[p12l1379t2775r1443b2800],
21	transfected	VBN	O	transfect	prepc_from	19	SENT_222	[p12l1453t2775r1605b2800],
22	COS-7	NN	O	cos-7	nn	23	SENT_222	[p12l1616t2777r1703b2800],
23	cells	NNS	O	cell	dobj	21	SENT_222	[p12l1713t2775r1771b2800],
24	after	IN	O	after	_	0	SENT_222	[p12l1782t2775r1843b2800],
25	a	DT	O	a	det	27	SENT_222	[p12l1852t2784r1865b2800],
26	three-hour	JJ	DURATION	three-hour	amod	27	SENT_222	[p12l261t2817r406b2842],
27	incubation	NN	O	incubation	prep_after	21	SENT_222	[p12l416t2817r558b2842],
28	with	IN	O	with	_	0	SENT_222	[p12l568t2817r624b2842],
29	various	JJ	O	various	amod	31	SENT_222	[p12l635t2819r734b2842],
30	concentrations	NNS	O	concentration	nn	31	SENT_222	[p12l745t2819r948b2842],
31	ofgefitinib	NN	O	ofgefitinib	prep_with	21	SENT_222	[p12l958t2817r1111b2850],
32	.	.	O	.	_	0	SENT_222	[p12l958t2817r1111b2850],

1	On	IN	O	on	_	0	SENT_223	[p12l1122t2819r1162b2842],
2	the	DT	O	the	det	3	SENT_223	[p12l1172t2817r1215b2842],
3	left	NN	O	left	prep_on	13	SENT_223	[p12l1226t2817r1273b2847],
4	,	,	O	,	_	0	SENT_223	[p12l1226t2817r1273b2847],
5	four	CD	NUMBER	four	num	7	SENT_223	[p12l1284t2817r1340b2842],
6	different	JJ	O	different	amod	7	SENT_223	[p12l1349t2817r1463b2842],
7	constructs	NNS	O	construct	nsubjpass	13	SENT_223	[p12l1472t2822r1615b2842],
8	without	IN	O	without	_	0	SENT_223	[p12l1624t2817r1728b2842],
9	the	DT	O	the	det	11	SENT_223	[p12l1737t2817r1779b2842],
10	T790M	NN	O	t790m	nn	11	SENT_223	[p12l1788t2819r1882b2842],
11	mutation	NN	O	mutation	prep_without	7	SENT_223	[p12l263t2861r385b2884],
12	are	VBP	O	be	auxpass	13	SENT_223	[p12l396t2867r436b2884],
13	shown	VBN	O	show	_	0	SENT_223	[p12l446t2859r532b2884],
14	in	IN	O	in	_	0	SENT_223	[p12l544t2861r566b2883],
15	lanes	NNS	O	lane	prep_in	13	SENT_223	[p12l577t2859r646b2884],
16	1	CD	NUMBER	1	num	15	SENT_223	[p12l657t2861r668b2883],
17	through	IN	O	through	_	0	SENT_223	[p12l678t2859r785b2892],
18	5	CD	NUMBER	5	prep_through	15	SENT_223	[p12l796t2861r808b2884],
19	and	CC	O	and	_	0	SENT_223	[p12l819t2859r867b2884],
20	four	CD	NUMBER	four	num	21	SENT_223	[p12l877t2858r933b2884],
21	constructs	NNS	O	construct	nsubjpass	27	SENT_223	[p12l941t2863r1083b2884],
22	with	IN	O	with	_	0	SENT_223	[p12l1092t2859r1148b2884],
23	the	DT	O	the	det	25	SENT_223	[p12l1157t2859r1200b2884],
24	T790M	NN	O	t790m	nn	25	SENT_223	[p12l1208t2860r1302b2884],
25	mutation	NN	O	mutation	prep_with	21	SENT_223	[p12l1314t2861r1436b2884],
26	are	VBP	O	be	auxpass	27	SENT_223	[p12l1447t2867r1487b2884],
27	shown	VBN	O	show	conj_and	13	SENT_223	[p12l1497t2859r1583b2884],
28	in	IN	O	in	_	0	SENT_223	[p12l1595t2861r1616b2883],
29	lanes	NNS	O	lane	prep_in	27	SENT_223	[p12l1628t2859r1696b2884],
30	6	CD	NUMBER	6	num	29	SENT_223	[p12l1707t2861r1721b2884],
31	through	IN	O	through	_	0	SENT_223	[p12l1729t2859r1836b2892],
32	10	CD	NUMBER	10	prep_through	29	SENT_223	[p12l1848t2860r1885b2884],
33	.	.	O	.	_	0	SENT_223	[p12l1848t2860r1885b2884],

1	Total	JJ	O	total	amod	3	SENT_224	[p12l261t2900r325b2925],
2	EGFR	NN	ORGANIZATION	egfr	nn	3	SENT_224	[p12l337t2902r412b2925],
3	expression	NN	O	expression	nsubjpass	5	SENT_224	[p12l420t2903r565b2933],
4	is	VBZ	O	be	auxpass	5	SENT_224	[p12l576t2903r595b2925],
5	shown	VBN	O	show	_	0	SENT_224	[p12l606t2900r692b2925],
6	on	IN	O	on	_	0	SENT_224	[p12l703t2909r735b2925],
7	the	DT	O	the	det	10	SENT_224	[p12l744t2900r787b2925],
8	right	JJ	O	right	amod	10	SENT_224	[p12l797t2900r859b2933],
9	(	NN	O	(	nn	10	SENT_224	[p12l870t2900r994b2933],
10	control	NN	O	control	prep_on	5	SENT_224	[p12l870t2900r994b2933],
11	)	CD	NUMBER	)	dep	10	SENT_224	[p12l870t2900r994b2933],
12	.	.	O	.	_	0	SENT_224	[p12l870t2900r994b2933],

1	Panel	NN	O	panel	nn	2	SENT_225	[p12l1006t2900r1077b2925],
2	B	NN	O	b	nsubj	3	SENT_225	[p12l1089t2903r1104b2925],
3	shows	VBZ	O	show	_	0	SENT_225	[p12l1114t2900r1198b2925],
4	the	DT	O	the	det	7	SENT_225	[p12l1207t2900r1250b2925],
5	inhibition	NN	O	inhibition	nn	7	SENT_225	[p12l1260t2900r1388b2925],
6	ofEGFR	NN	O	ofegfr	nn	7	SENT_225	[p12l1398t2900r1508b2925],
7	autophosphorylation	NN	O	autophosphorylation	dobj	3	SENT_225	[p12l1517t2900r1801b2933],
8	by	IN	O	by	_	0	SENT_225	[p12l1812t2900r1841b2933],
9	CL387	NN	O	cl387	prep_by	3	SENT_225	[p12l1849t2902r1892b2925, p12l262t2944r375b2972],
10	,785	CD	NUMBER	,785	num	9	SENT_225	[p12l1849t2902r1892b2925, p12l262t2944r375b2972],
11	.	.	O	.	_	0	SENT_225	[p12l1849t2902r1892b2925, p12l262t2944r375b2972],

1	In	IN	O	in	_	0	SENT_226	[p12l388t2944r411b2967],
2	both	DT	O	both	det	3	SENT_226	[p12l423t2942r482b2967],
3	panels	NNS	O	panel	prep_in	9	SENT_226	[p12l494t2942r588b2975],
4	,	,	O	,	_	0	SENT_226	[p12l494t2942r588b2975],
5	autophosphorylation	NN	O	autophosphorylation	nsubjpass	9	SENT_226	[p12l600t2942r883b2975],
6	of	IN	O	of	_	0	SENT_226	[p12l894t2942r924b2967],
7	EGFR	NN	ORGANIZATION	egfr	prep_of	5	SENT_226	[p12l931t2944r1005b2967],
8	was	VBD	O	be	auxpass	9	SENT_226	[p12l1013t2951r1064b2967],
9	detected	VBN	O	detect	_	0	SENT_226	[p12l1075t2942r1189b2967],
10	with	IN	O	with	_	0	SENT_226	[p12l1199t2942r1255b2967],
11	antibody	NN	O	antibody	prep_with	9	SENT_226	[p12l1267t2942r1384b2975],
12	against	IN	O	against	_	0	SENT_226	[p12l1394t2944r1492b2975],
13	phosphotyrosine	NN	O	phosphotyrosine	prep_against	11	SENT_226	[p12l1502t2942r1731b2975],
14	at	IN	O	at	_	0	SENT_226	[p12l1741t2947r1765b2967],
15	position	NN	O	position	prep_at	9	SENT_226	[p12l1775t2944r1884b2975],
16	1068	CD	DATE	1068	num	15	SENT_226	[p12l264t2985r326b3009],
17	(	CD	NUMBER	(	number	18	SENT_226	[p12l339t2985r438b3017],
18	1:1000	CD	NUMBER	1:1000	num	19	SENT_226	[p12l339t2985r438b3017],
19	dilution	NN	O	dilution	dep	15	SENT_226	[p12l447t2984r559b3013],
20	;	:	O	;	_	0	SENT_226	[p12l447t2984r559b3013],
21	anti	JJ	O	anti	amod	15	SENT_226	[p12l570t2986r761b3017],
22	—	NN	O	—	nn	24	SENT_226	[p12l570t2986r761b3017],
23	p-EGFR	NN	O	p-egfr	nn	24	SENT_226	[p12l570t2986r761b3017],
24	)	NN	O	)	dep	15	SENT_226	[p12l570t2986r761b3017],
25	,	,	O	,	_	0	SENT_226	[p12l570t2986r761b3017],
26	and	CC	O	and	_	0	SENT_226	[p12l772t2984r820b3009],
27	total	JJ	O	total	amod	29	SENT_226	[p12l830t2984r890b3009],
28	protein	NN	O	protein	nn	29	SENT_226	[p12l902t2986r996b3016],
29	expression	NN	O	expression	nsubjpass	31	SENT_226	[p12l1007t2986r1152b3016],
30	was	VBD	O	be	auxpass	31	SENT_226	[p12l1162t2992r1213b3009],
31	measured	VBN	O	measure	conj_and	9	SENT_226	[p12l1224t2984r1357b3009],
32	with	IN	O	with	_	0	SENT_226	[p12l1367t2984r1423b3009],
33	the	DT	O	the	det	35	SENT_226	[p12l1433t2984r1475b3009],
34	use	NN	O	use	nn	35	SENT_226	[p12l1486t2992r1531b3009],
35	ofantibody	NN	O	ofantibody	prep_with	31	SENT_226	[p12l1541t2983r1693b3017],
36	against	IN	O	against	_	0	SENT_226	[p12l1702t2986r1800b3017],
37	EGFR	NN	ORGANIZATION	egfr	prep_against	35	SENT_226	[p12l1811t2986r1885b3009],
38	(	CD	NUMBER	(	number	39	SENT_226	[p12l265t3027r364b3058],
39	1:1000	CD	NUMBER	1:1000	num	40	SENT_226	[p12l265t3027r364b3058],
40	dilution	NN	O	dilution	dep	37	SENT_226	[p12l373t3025r485b3055],
41	;	:	O	;	_	0	SENT_226	[p12l373t3025r485b3055],
42	anti-EGFR	JJ	O	anti-egfr	amod	43	SENT_226	[p12l497t3027r654b3058],
43	)	NN	O	)	dep	37	SENT_226	[p12l497t3027r654b3058],
44	.	.	O	.	_	0	SENT_226	[p12l497t3027r654b3058],

1	T790M	NN	O	t790m	nsubj	2	SENT_227	[p12l7t3308r314b3381],
2	construct	NN	O	construct	_	0	SENT_227	[p12l352t3319r770b3382],
3	.	.	O	.	_	0	SENT_227	[p12l352t3319r770b3382],

1	We	PRP	O	we	nsubj	3	SENT_228	[p12l805t3310r938b3381],
2	consistently	RB	O	consistently	advmod	3	SENT_228	[p12l972t3303r1480b3403],
3	found	VBD	O	find	_	0	SENT_228	[p12l1508t3302r1759b3382],
4	that	IN	O	that	complm	20	SENT_228	[p12l1793t3303r1959b3381],
5	CL387	NN	O	cl387	nsubj	20	SENT_228	[p12l1988t3308r2134b3381, p12l11t3436r372b3526],
6	,785	CD	NUMBER	,785	num	5	SENT_228	[p12l1988t3308r2134b3381, p12l11t3436r372b3526],
7	,	,	O	,	_	0	SENT_228	[p12l1988t3308r2134b3381, p12l11t3436r372b3526],
8	a	DT	O	a	det	13	SENT_228	[p12l400t3457r445b3509],
9	specific	JJ	O	specific	amod	13	SENT_228	[p12l468t3430r782b3531],
10	and	CC	O	and	_	0	SENT_228	[p12l803t3431r958b3509],
11	irreversible	JJ	O	irreversible	amod	13	SENT_228	[p12l980t3431r1445b3510],
12	anilinoquinazo	NN	O	anilinoquinazo	nn	13	SENT_228	[p12l1468t3431r2134b3531],
13	—	NN	O	—	appos	5	SENT_228	[p12l1468t3431r2134b3531],
14	line	NN	O	line	nn	16	SENT_228	[p12l10t3559r164b3637],
15	EGFR	NN	ORGANIZATION	egfr	nn	16	SENT_228	[p12l224t3564r482b3642],
16	inhibitor	NN	O	inhibitor	dep	13	SENT_228	[p12l532t3553r1010b3654],
17	,	,	O	,	_	0	SENT_228	[p12l532t3553r1010b3654],
18	“	CD	NUMBER	“	npadvmod	19	SENT_228	[p12l532t3553r1010b3654],
19	strongly	RB	O	strongly	advmod	20	SENT_228	[p12l1073t3559r1419b3659],
20	inhibited	VBD	O	inhibit	ccomp	3	SENT_228	[p12l1475t3559r1858b3637],
21	EGFinduced	JJ	O	egfinduced	amod	22	SENT_228	[p12l1917t3564r2133b3637, p12l10t3687r344b3766],
22	phosphorylation	NN	O	phosphorylation	dobj	20	SENT_228	[p12l363t3687r1058b3787],
23	of	IN	O	of	_	0	SENT_228	[p12l1078t3686r1178b3765],
24	both	CC	O	both	advmod	26	SENT_228	[p12l1181t3687r1372b3765],
25	the	DT	O	the	det	26	SENT_228	[p12l1393t3687r1521b3765],
26	delL747	NN	O	dell747	prep_of	22	SENT_228	[p12l1542t3687r2134b3765],
27	.	.	O	.	_	0	SENT_228	[p12l1542t3687r2134b3765],

1	—	NN	O	—	_	0	SENT_229	[p12l1542t3687r2134b3765],
2	.	.	O	.	_	0	SENT_229	[p12l1542t3687r2134b3765],

1	S752	NN	O	s752	_	0	SENT_230	[p12l1542t3687r2134b3765],

1	construct	NN	O	construct	_	0	SENT_231	[p13l11t36r410b99],
2	(	CD	NUMBER	(	num	1	SENT_231	[p13l442t27r850b120],
3	apparent	JJ	O	apparent	amod	10	SENT_231	[p13l442t27r850b120],
4	50	CD	PERCENT	50	num	5	SENT_231	[p13l878t26r976b98],
5	percent	NN	PERCENT	percent	npadvmod	6	SENT_231	[p13l1007t36r1327b120],
6	inhibitory	JJ	O	inhibitory	amod	10	SENT_231	[p13l1353t21r1773b120],
7	concentration	NN	O	concentration	nn	10	SENT_231	[p13l1801t45r2134b98, p13l11t149r292b227],
8	[	CD	NUMBER	[	num	10	SENT_231	[p13l339t154r571b249],
9	IC50	NN	O	ic50	nn	10	SENT_231	[p13l339t154r571b249],
10	]	NN	O	]	dep	1	SENT_231	[p13l339t154r571b249],
11	of	IN	O	of	_	0	SENT_231	[p13l619t148r719b227],
12	0.3	CD	NUMBER	0.3	num	14	SENT_231	[p13l738t154r864b227],
13	nM	NN	O	nm	nn	14	SENT_231	[p13l905t156r1074b240],
14	)	NN	O	)	prep_of	10	SENT_231	[p13l905t156r1074b240],
15	and	CC	O	and	_	0	SENT_231	[p13l1116t149r1272b227],
16	the	DT	O	the	det	17	SENT_231	[p13l1309t149r1438b227],
17	delL747	NN	O	dell747	prep_of	10	SENT_231	[p13l1477t149r2134b227],
18	.	.	O	.	_	0	SENT_231	[p13l1477t149r2134b227],

1	—	NN	O	—	_	0	SENT_232	[p13l1477t149r2134b227],
2	.	.	O	.	_	0	SENT_232	[p13l1477t149r2134b227],

1	S752	NN	O	s752	_	0	SENT_233	[p13l1477t149r2134b227],
2	+	CC	O	+	_	0	SENT_233	[p13l1477t149r2134b227],
3	T790	NN	O	t790	nn	4	SENT_233	[p13l7t282r223b355],
4	M	NN	O	m	conj_+	1	SENT_233	[p13l243t284r326b355],
5	double	JJ	O	double	amod	8	SENT_233	[p13l351t277r990b356],
6	—	NN	O	—	nn	8	SENT_233	[p13l351t277r990b356],
7	mutant	JJ	O	mutant	amod	8	SENT_233	[p13l351t277r990b356],
8	construct	NN	O	construct	dep	4	SENT_233	[p13l1008t293r1407b356],
9	(	RB	O	(	advmod	10	SENT_233	[p13l1429t284r1837b377],
10	apparent	JJ	O	apparent	amod	11	SENT_233	[p13l1429t284r1837b377],
11	IC50	NN	O	ic50	dep	1	SENT_233	[p13l1852t282r2028b377],
12	of	IN	O	of	_	0	SENT_233	[p13l2052t276r2153b355],
13	3.0	CD	NUMBER	3.0	num	14	SENT_233	[p13l11t410r139b483],
14	nM	NN	O	nm	prep_of	11	SENT_233	[p13l180t412r349b496],
15	)	CD	NUMBER	)	number	16	SENT_233	[p13l180t412r349b496],
16	(	CD	NUMBER	(	num	17	SENT_233	[p13l399t405r582b505],
17	Fig	NN	O	fig	dep	11	SENT_233	[p13l399t405r582b505],
18	.	.	O	.	_	0	SENT_233	[p13l399t405r582b505],

1	3B	NN	O	3b	_	0	SENT_234	[p13l628t410r795b496],
2	)	NN	O	)	dep	1	SENT_234	[p13l628t410r795b496],
3	.	.	O	.	_	0	SENT_234	[p13l628t410r795b496],

1	When	WRB	O	when	advmod	2	SENT_235	[p13l836t405r1090b483],
2	tested	VBN	O	test	advcl	13	SENT_235	[p13l1130t404r1378b483],
3	with	IN	O	with	_	0	SENT_235	[p13l1413t405r1602b484],
4	the	DT	O	the	det	6	SENT_235	[p13l1642t405r1771b483],
5	doublemutant	JJ	O	doublemutant	amod	6	SENT_235	[p13l1812t405r2134b484, p13l10t548r322b611],
6	construct	NN	O	construct	prep_with	2	SENT_235	[p13l354t548r771b626],
7	,	,	O	,	_	0	SENT_235	[p13l354t548r771b626],
8	the	DT	O	the	det	12	SENT_235	[p13l813t531r943b609],
9	CL	NN	O	cl	nn	12	SENT_235	[p13l979t537r1469b626],
10	—	NN	O	—	nn	12	SENT_235	[p13l979t537r1469b626],
11	387,785	CD	NUMBER	387,785	num	12	SENT_235	[p13l979t537r1469b626],
12	inhibitor	NN	O	inhibitor	nsubj	13	SENT_235	[p13l1509t532r1884b610],
13	demonstrated	VBD	O	demonstrate	_	0	SENT_235	[p13l1918t532r2134b610, p13l11t659r409b738],
14	1/10th	IN	O	1/10th	_	0	SENT_235	[p13l446t660r716b750],
15	its	PRP$	O	its	poss	16	SENT_235	[p13l750t660r846b738],
16	potency	NN	O	potency	prep_1/10th	13	SENT_235	[p13l881t676r1215b760],
17	against	IN	O	against	_	0	SENT_235	[p13l1243t660r1553b760],
18	the	DT	O	the	det	22	SENT_235	[p13l1583t660r1712b738],
19	delL747	NN	O	dell747	nn	22	SENT_235	[p13l1747t660r2138b738],
20	—	CD	NUMBER	—	num	22	SENT_235	[p13l1747t660r2138b738],
21	S752	NN	O	s752	nn	22	SENT_235	[p13l12t793r215b865],
22	construct	NN	O	construct	prep_against	13	SENT_235	[p13l240t803r658b882],
23	,	,	O	,	_	0	SENT_235	[p13l240t803r658b882],
24	whereas	IN	O	whereas	mark	30	SENT_235	[p13l681t788r1029b866],
25	the	DT	O	the	det	26	SENT_235	[p13l1054t788r1183b865],
26	other	JJ	O	other	nsubj	30	SENT_235	[p13l1206t788r1430b865],
27	tested	VBN	O	test	partmod	26	SENT_235	[p13l1450t788r1698b865],
28	inhibitors	NNS	O	inhibitor	dobj	27	SENT_235	[p13l1719t788r2133b865],
29	were	VBD	O	be	cop	30	SENT_235	[p13l6t942r207b995],
30	ineffective	JJ	O	ineffective	dep	22	SENT_235	[p13l255t915r687b995],
31	against	IN	O	against	_	0	SENT_235	[p13l735t916r1044b1016],
32	the	DT	O	the	det	36	SENT_235	[p13l1087t916r1216b994],
33	double	JJ	O	double	amod	36	SENT_235	[p13l1266t916r1905b995],
34	—	NN	O	—	nn	36	SENT_235	[p13l1266t916r1905b995],
35	mutant	JJ	O	mutant	amod	36	SENT_235	[p13l1266t916r1905b995],
36	construct	NN	O	construct	prep_against	30	SENT_235	[p13l1949t941r2133b994, p13l12t1059r253b1122],
37	(	CD	NUMBER	(	num	38	SENT_235	[p13l295t1044r504b1134],
38	data	NNS	O	datum	npadvmod	39	SENT_235	[p13l295t1044r504b1134],
39	not	RB	O	not	neg	40	SENT_235	[p13l544t1059r688b1121],
40	shown	VBN	O	show	partmod	36	SENT_235	[p13l726t1044r1063b1134],
41	)	NN	O	)	dobj	40	SENT_235	[p13l726t1044r1063b1134],
42	.	.	O	.	_	0	SENT_235	[p13l726t1044r1063b1134],

1	A	DT	O	a	det	2	SENT_236	[p13l1107t1050r1173b1120],
2	model	NN	O	model	nsubjpass	4	SENT_236	[p13l1211t1044r1478b1121],
3	was	VBD	O	be	auxpass	4	SENT_236	[p13l1514t1070r1676b1122],
4	generated	VBN	O	generate	_	0	SENT_236	[p13l1719t1044r2135b1143],
5	with	IN	O	with	_	0	SENT_236	[p13l6t1172r195b1251],
6	CL	NN	O	cl	prep_with	4	SENT_236	[p13l230t1177r721b1266],
7	—	CD	NUMBER	—	number	8	SENT_236	[p13l230t1177r721b1266],
8	387,785	CD	NUMBER	387,785	dep	6	SENT_236	[p13l230t1177r721b1266],
9	and	CC	O	and	_	0	SENT_236	[p13l758t1172r914b1249],
10	EGFR	NN	ORGANIZATION	egfr	prep_with	4	SENT_236	[p13l948t1177r1206b1254],
11	(	CD	NUMBER	(	num	12	SENT_236	[p13l1235t1172r1419b1271],
12	Fig	NN	O	fig	dep	10	SENT_236	[p13l1235t1172r1419b1271],
13	.	.	O	.	_	0	SENT_236	[p13l1235t1172r1419b1271],

1	2D	NN	O	2d	_	0	SENT_237	[p13l1459t1177r1637b1262],
2	)	NN	O	)	dep	1	SENT_237	[p13l1459t1177r1637b1262],
3	.	.	O	.	_	0	SENT_237	[p13l1459t1177r1637b1262],

1	The	DT	O	the	det	4	SENT_238	[p13l1674t1172r1836b1249],
2	3	CD	NUMBER	3	num	4	SENT_238	[p13l1872t1172r2134b1249],
3	—	NN	O	—	nn	4	SENT_238	[p13l1872t1172r2134b1249],
4	bro	NN	O	bro	nsubj	6	SENT_238	[p13l1872t1172r2134b1249],
5	—	CD	NUMBER	—	dep	4	SENT_238	[p13l1872t1172r2134b1249],
6	mine	JJ	O	mine	_	0	SENT_238	[p13l10t1300r223b1378],
7	side	NN	O	side	nn	8	SENT_238	[p13l267t1300r433b1378],
8	chain	NN	O	chain	dobj	6	SENT_238	[p13l476t1300r705b1378],
9	in	IN	O	in	_	0	SENT_238	[p13l746t1300r827b1377],
10	this	DT	O	this	det	12	SENT_238	[p13l869t1300r1022b1378],
11	model	NN	O	model	nn	12	SENT_238	[p13l1066t1299r1332b1378],
12	points	NNS	O	point	prep_in	8	SENT_238	[p13l1372t1300r1637b1400],
13	away	RB	O	away	advmod	8	SENT_238	[p13l1681t1326r1890b1400],
14	from	IN	O	from	_	0	SENT_238	[p13l1927t1299r2135b1378],
15	T790	NN	O	t790	prep_from	6	SENT_238	[p13l7t1433r247b1523],
16	,	,	O	,	_	0	SENT_238	[p13l7t1433r247b1523],
17	as	IN	O	as	_	0	SENT_238	[p13l280t1454r364b1506],
18	opposed	VBN	O	oppose	prepc_as	6	SENT_238	[p13l395t1428r755b1528],
19	to	TO	O	to	_	0	SENT_238	[p13l783t1444r862b1506],
20	its	PRP$	O	its	poss	21	SENT_238	[p13l891t1428r987b1506],
21	orientation	NN	O	orientation	prep_to	18	SENT_238	[p13l1017t1428r1486b1506],
22	with	IN	O	with	_	0	SENT_238	[p13l1510t1428r1699b1507],
23	respect	NN	O	respect	prep_with	21	SENT_238	[p13l1727t1444r2032b1528],
24	to	TO	O	to	_	0	SENT_238	[p13l2055t1444r2134b1506],
25	erlotinib	NN	O	erlotinib	prep_to	18	SENT_238	[p13l11t1556r365b1634],
26	and	CC	O	and	_	0	SENT_238	[p13l389t1556r544b1634],
27	geﬁtinib	NN	O	geﬁtinib	conj_and	25	SENT_238	[p13l567t1555r942b1656],
28	,	,	O	,	_	0	SENT_238	[p13l567t1555r942b1656],
29	thereby	RB	O	thereby	advmod	31	SENT_238	[p13l972t1556r1284b1656],
30	potentially	RB	O	potentially	advmod	31	SENT_238	[p13l1301t1556r1747b1656],
31	reducing	VBG	O	reduce	ccomp	18	SENT_238	[p13l1766t1556r2139b1656],
32	the	DT	O	the	det	34	SENT_238	[p13l11t1684r140b1762],
33	steric	JJ	O	steric	amod	34	SENT_238	[p13l168t1684r392b1762],
34	hindrance	NN	O	hindrance	dobj	31	SENT_238	[p13l417t1683r841b1762],
35	to	TO	O	to	_	0	SENT_238	[p13l868t1700r947b1762],
36	binding	NN	O	binding	prep_to	31	SENT_238	[p13l976t1684r1308b1784],
37	of	IN	O	of	_	0	SENT_238	[p13l1331t1683r1432b1762],
38	the	DT	O	the	det	40	SENT_238	[p13l1440t1684r1569b1762],
39	mutated	VBN	O	mutate	amod	40	SENT_238	[p13l1596t1684r1945b1763],
40	protein	NN	O	protein	prep_of	36	SENT_238	[p13l1970t1709r2147b1784, p13l11t1812r191b1890],
41	.	.	O	.	_	0	SENT_238	[p13l1970t1709r2147b1784, p13l11t1812r191b1890],

1	The	DT	O	the	det	2	SENT_239	[p13l232t1812r394b1890],
2	sensitivity	NN	O	sensitivity	_	0	SENT_239	[p13l433t1812r855b1912],
3	of	IN	O	of	_	0	SENT_239	[p13l889t1811r990b1890],
4	the	DT	O	the	det	5	SENT_239	[p13l1009t1811r1139b1890],
5	delL747	NN	O	dell747	prep_of	2	SENT_239	[p13l1178t1812r2146b1890],
6	.	.	O	.	_	0	SENT_239	[p13l1178t1812r2146b1890],

1	—	NN	O	—	_	0	SENT_240	[p13l1178t1812r2146b1890],
2	.	.	O	.	_	0	SENT_240	[p13l1178t1812r2146b1890],

1	S752	NN	O	s752	nsubjpass	11	SENT_241	[p13l1178t1812r2146b1890],
2	+	CC	O	+	_	0	SENT_241	[p13l1178t1812r2146b1890],
3	T790M	NN	O	t790m	nn	4	SENT_241	[p13l1178t1812r2146b1890],
4	construct	NN	O	construct	nsubjpass	11	SENT_241	[p13l11t1957r413b2020],
5	to	TO	O	to	_	0	SENT_241	[p13l437t1956r516b2019],
6	CL	NN	O	cl	nn	8	SENT_241	[p13l547t1946r1041b2036],
7	—	CD	NUMBER	—	num	8	SENT_241	[p13l547t1946r1041b2036],
8	387,785	NN	NUMBER	387,785	prep_to	1	SENT_241	[p13l547t1946r1041b2036],
9	might	MD	O	might	aux	11	SENT_241	[p13l1074t1941r1334b2041],
10	be	VB	O	be	auxpass	11	SENT_241	[p13l1358t1941r1454b2019],
11	explained	VBN	O	explain	_	0	SENT_241	[p13l1484t1941r1892b2041],
12	by	IN	O	by	prep	11	SENT_241	[p13l1922t1941r2019b2041],
13	either	CC	O	either	dep	12	SENT_241	[p13l2044t1941r2147b2019, p13l11t2069r181b2147],
14	its	PRP$	O	its	poss	16	SENT_241	[p13l206t2069r302b2147],
15	altered	JJ	O	altered	amod	16	SENT_241	[p13l333t2069r621b2147],
16	binding	NN	O	binding	conj	12	SENT_241	[p13l650t2068r985b2169],
17	to	TO	O	to	_	0	SENT_241	[p13l1011t2085r1090b2147],
18	the	DT	O	the	det	20	SENT_241	[p13l1120t2069r1250b2147],
19	kinase	NN	O	kinase	nn	20	SENT_241	[p13l1278t2069r1551b2148],
20	domain	NN	O	domain	prep_to	12	SENT_241	[p13l1580t2069r1905b2147],
21	or	CC	O	or	_	0	SENT_241	[p13l1935t2094r2025b2147],
22	its	PRP$	O	its	poss	24	SENT_241	[p13l2049t2069r2145b2147],
23	covalent	JJ	O	covalent	amod	24	SENT_241	[p13l11t2197r364b2276],
24	binding	NN	O	binding	conj_or	20	SENT_241	[p13l385t2197r720b2297],
25	to	TO	O	to	_	0	SENT_241	[p13l743t2213r822b2275],
26	EGFR	NN	ORGANIZATION	egfr	prep_to	11	SENT_241	[p13l847t2202r1121b2280],
27	.	.	O	.	_	0	SENT_241	[p13l847t2202r1121b2280],

1	DISCUSSION	NN	O	discussion	_	0	SENT_242	[p13l721t2513r1424b2573],

1	We	PRP	O	we	nsubj	2	SENT_243	[p13l7t2718r141b2789],
2	identiﬁed	VBD	O	identiﬁed	_	0	SENT_243	[p13l164t2710r571b2789],
3	a	DT	O	a	det	7	SENT_243	[p13l595t2737r639b2789],
4	novel	JJ	O	novel	amod	7	SENT_243	[p13l662t2711r911b2806],
5	,	,	O	,	_	0	SENT_243	[p13l662t2711r911b2806],
6	second	JJ	ORDINAL	second	amod	7	SENT_243	[p13l942t2711r1239b2789],
7	mutation	NN	O	mutation	dobj	2	SENT_243	[p13l1264t2711r1655b2790],
8	of	IN	O	of	_	0	SENT_243	[p13l1680t2710r1782b2789],
9	the	DT	O	the	det	11	SENT_243	[p13l1788t2711r1917b2789],
10	EGFR	NN	ORGANIZATION	egfr	nn	11	SENT_243	[p13l1940t2717r2153b2791],
11	gene	NN	O	gene	prep_of	7	SENT_243	[p13l10t2866r210b2941],
12	in	IN	O	in	_	0	SENT_243	[p13l244t2841r326b2918],
13	a	DT	O	a	det	14	SENT_243	[p13l359t2867r404b2919],
14	tumor	NN	O	tumor	prep_in	2	SENT_243	[p13l437t2856r702b2920],
15	with	IN	O	with	_	0	SENT_243	[p13l729t2841r919b2920],
16	the	DT	O	the	det	17	SENT_243	[p13l954t2841r1084b2919],
17	delL747	NN	O	dell747	prep_with	14	SENT_243	[p13l1119t2841r1721b2919],
18	.	.	O	.	_	0	SENT_243	[p13l1119t2841r1721b2919],

1	—	NN	O	—	_	0	SENT_244	[p13l1119t2841r1721b2919],
2	.	.	O	.	_	0	SENT_244	[p13l1119t2841r1721b2919],

1	S752	NN	O	s752	nn	2	SENT_245	[p13l1119t2841r1721b2919],
2	mutation	NN	O	mutation	_	0	SENT_245	[p13l1756t2841r2148b2920],
3	of	IN	O	of	_	0	SENT_245	[p13l11t2968r112b3047],
4	EGFR	NN	ORGANIZATION	egfr	prep_of	2	SENT_245	[p13l118t2975r349b3048],
5	.	.	O	.	_	0	SENT_245	[p13l118t2975r349b3048],

1	The	DT	O	the	det	2	SENT_246	[p13l378t2969r540b3047],
2	delL747	NN	O	dell747	_	0	SENT_246	[p13l568t2969r1170b3047],
3	.	.	O	.	_	0	SENT_246	[p13l568t2969r1170b3047],

1	—	NN	O	—	_	0	SENT_247	[p13l568t2969r1170b3047],
2	.	.	O	.	_	0	SENT_247	[p13l568t2969r1170b3047],

1	S752	NN	O	s752	nn	2	SENT_248	[p13l568t2969r1170b3047],
2	mutation	NN	O	mutation	nsubjpass	4	SENT_248	[p13l1197t2969r1590b3048],
3	is	VBZ	O	be	auxpass	4	SENT_248	[p13l1615t2969r1681b3047],
4	associated	VBN	O	associate	_	0	SENT_248	[p13l1709t2969r2148b3047],
5	with	IN	O	with	_	0	SENT_248	[p13l6t3097r196b3176],
6	susceptibility	NN	O	susceptibility	prep_with	4	SENT_248	[p13l219t3096r781b3197],
7	of	IN	O	of	_	0	SENT_248	[p13l799t3096r899b3175],
8	non	JJ	O	non	amod	14	SENT_248	[p13l903t3097r1538b3175],
9	—	JJ	O	—	amod	14	SENT_248	[p13l903t3097r1538b3175],
10	small	JJ	O	small	amod	14	SENT_248	[p13l903t3097r1538b3175],
11	—	NN	O	—	nn	14	SENT_248	[p13l903t3097r1538b3175],
12	cell	NN	O	cell	nn	14	SENT_248	[p13l903t3097r1538b3175],
13	lung	NN	O	lung	nn	14	SENT_248	[p13l1558t3097r1753b3197],
14	cancer	NN	O	cancer	prep_of	6	SENT_248	[p13l1772t3122r2049b3175],
15	to	TO	O	to	_	0	SENT_248	[p13l2067t3113r2147b3175],
16	geﬁtinib	NN	O	geﬁtinib	prep_to	4	SENT_248	[p13l10t3224r392b3325],
17	,	,	O	,	_	0	SENT_248	[p13l10t3224r392b3325],
18	and	CC	O	and	_	0	SENT_248	[p13l426t3225r583b3303],
19	in	IN	O	in	_	0	SENT_248	[p13l611t3225r693b3302],
20	our	PRP$	O	we	poss	21	SENT_248	[p13l722t3250r867b3304],
21	patient	NN	O	patient	prep_in	27	SENT_248	[p13l891t3225r1211b3325],
22	,	,	O	,	_	0	SENT_248	[p13l891t3225r1211b3325],
23	the	DT	O	the	det	24	SENT_248	[p13l1245t3225r1376b3303],
24	tumor	NN	O	tumor	nsubj	27	SENT_248	[p13l1405t3241r1669b3304],
25	was	VBD	O	be	cop	27	SENT_248	[p13l1691t3251r1853b3304],
26	highly	RB	O	highly	advmod	27	SENT_248	[p13l1884t3225r2153b3325],
27	responsive	JJ	O	responsive	conj_and	4	SENT_248	[p13l10t3353r463b3453],
28	to	TO	O	to	_	0	SENT_248	[p13l494t3369r572b3431],
29	the	DT	O	the	det	30	SENT_248	[p13l604t3353r734b3431],
30	drug	NN	O	drug	prep_to	27	SENT_248	[p13l765t3352r986b3453],
31	.	.	O	.	_	0	SENT_248	[p13l765t3352r986b3453],

1	After	IN	O	after	_	0	SENT_249	[p13l1018t3352r1233b3431],
2	a	DT	O	a	det	6	SENT_249	[p13l1259t3379r1304b3431],
3	tvvo	NN	O	tvvo	nn	6	SENT_249	[p13l1332t3369r1699b3453],
4	—	CD	NUMBER	—	num	6	SENT_249	[p13l1332t3369r1699b3453],
5	year	NN	NUMBER	year	nn	6	SENT_249	[p13l1332t3369r1699b3453],
6	remission	NN	O	remission	prep_after	16	SENT_249	[p13l1726t3353r2148b3431],
7	while	IN	O	while	mark	9	SENT_249	[p13l6t3481r239b3560],
8	still	RB	O	still	advmod	9	SENT_249	[p13l271t3481r424b3559],
9	receiving	VBG	O	receive	dep	6	SENT_249	[p13l454t3481r839b3581],
10	geﬁtinib	NN	O	geﬁtinib	dobj	9	SENT_249	[p13l866t3480r1248b3581],
11	,	,	O	,	_	0	SENT_249	[p13l866t3480r1248b3581],
12	however	RB	O	however	advmod	16	SENT_249	[p13l1284t3480r1657b3576],
13	,	,	O	,	_	0	SENT_249	[p13l1284t3480r1657b3576],
14	the	DT	O	the	det	15	SENT_249	[p13l1694t3481r1824b3559],
15	patient	NN	O	patient	nsubj	16	SENT_249	[p13l1853t3481r2153b3581],
16	had	VBD	O	have	_	0	SENT_249	[p13l10t3608r166b3687],
17	a	DT	O	a	det	18	SENT_249	[p13l197t3635r241b3687],
18	relapse	NN	O	relapse	nsubj	29	SENT_249	[p13l271t3609r595b3709],
19	,	,	O	,	_	0	SENT_249	[p13l271t3609r595b3709],
20	and	CC	O	and	_	0	SENT_249	[p13l631t3609r788b3687],
21	analysis	NN	O	analysis	conj_and	18	SENT_249	[p13l819t3609r1151b3709],
22	of	IN	O	of	_	0	SENT_249	[p13l1186t3608r1286b3687],
23	a	DT	O	a	det	24	SENT_249	[p13l1299t3635r1343b3687],
24	biopsy	NN	O	biopsy	prep_of	18	SENT_249	[p13l1373t3609r1653b3709],
25	of	IN	O	of	_	0	SENT_249	[p13l1681t3608r1782b3687],
26	the	DT	O	the	det	28	SENT_249	[p13l1795t3609r1925b3687],
27	geﬁtinib	NN	O	geﬁtinib	nn	28	SENT_249	[p13l1956t3608r2147b3709, p14l11t21r616b99],
28	—	NN	O	—	prep_of	24	SENT_249	[p13l1956t3608r2147b3709, p14l11t21r616b99],
29	resistant	JJ	O	resistant	xcomp	16	SENT_249	[p13l1956t3608r2147b3709, p14l11t21r616b99],

1	tumor	NN	O	tumor	nsubj	2	SENT_250	[p14l651t37r915b100],
2	revealed	VBD	O	reveal	_	0	SENT_250	[p14l952t21r1297b100],
3	a	DT	DURATION	a	det	5	SENT_250	[p14l1336t47r1381b99],
4	second	JJ	DURATION	second	amod	5	SENT_250	[p14l1420t20r1717b99],
5	mutation	NN	O	mutation	dobj	2	SENT_250	[p14l1757t21r2148b100],

1	790	CD	NUMBER	790	num	4	SENT_251	[p14l149t180r206b202],
2	N	NN	O	n	nn	4	SENT_251	[p14l880t181r894b197],
3	ENGL	NN	ORGANIZATION	engl	nn	4	SENT_251	[p14l909t181r976b197],
4	MED	NN	O	med	_	0	SENT_251	[p14l1008t181r1061b196],
5	352	CD	NUMBER	352	dep	4	SENT_251	[p14l1073t175r1139b203],
6	;	:	O	;	_	0	SENT_251	[p14l1073t175r1139b203],
7	8	CD	NUMBER	8	num	8	SENT_251	[p14l1073t175r1139b203],
8	WWW	NN	O	www	dep	4	SENT_251	[p14l1174t181r1294b203],
9	.	.	O	.	_	0	SENT_251	[p14l1174t181r1294b203],

1	NEJ	NN	O	nej	nn	3	SENT_252	[p14l1174t181r1294b203],
2	M.ORG	NN	O	m.org	nn	3	SENT_252	[p14l1302t181r1385b197],
3	FEBRUARY	NN	DATE	february	_	0	SENT_252	[p14l1425t181r1552b197],
4	24	CD	DATE	24	dep	3	SENT_252	[p14l1564t181r1602b203],
5	,	,	DATE	,	_	0	SENT_252	[p14l1564t181r1602b203],
6	2005	CD	DATE	2005	appos	4	SENT_252	[p14l1615t181r1678b203],

1	e	LS	O	e	dep	4	SENT_253	[p14l973t222r987b238],
2	New	NNP	O	New	nn	4	SENT_253	[p14l996t215r1058b238],
3	England	NNP	O	England	nn	4	SENT_253	[p14l1067t214r1178b245],
4	Journal	NNP	O	Journal	_	0	SENT_253	[p14l1187t214r1284b238],
5	of	IN	O	of	prep	4	SENT_253	[p14l1294t214r1323b238],
6	Medicine	NNP	O	Medicine	dep	4	SENT_253	[p14l1330t214r1455b238],

1	Downloaded	VBN	O	download	_	0	SENT_254	[p14l378t255r548b278],
2	from	IN	O	from	_	0	SENT_254	[p14l557t255r621b278],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_254	[p14l630t255r748b285],
4	at	IN	O	at	_	0	SENT_254	[p14l759t259r782b278],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_254	[p14l790t255r973b278],
6	on	IN	O	on	_	0	SENT_254	[p14l982t262r1015b278],
7	January	NNP	DATE	January	prep_on	1	SENT_254	[p14l1023t255r1126b285],
8	5	CD	DATE	5	num	7	SENT_254	[p14l1136t255r1159b282],
9	,	,	DATE	,	_	0	SENT_254	[p14l1136t255r1159b282],
10	2014	CD	DATE	2014	num	7	SENT_254	[p14l1170t255r1242b278],
11	.	.	O	.	_	0	SENT_254	[p14l1170t255r1242b278],

1	For	IN	O	for	_	0	SENT_255	[p14l1252t255r1299b278],
2	personal	JJ	O	personal	amod	3	SENT_255	[p14l1307t255r1419b285],
3	use	NN	O	use	pobj	1	SENT_255	[p14l1428t262r1472b278],
4	only	RB	O	only	advmod	3	SENT_255	[p14l1482t255r1546b285],
5	.	.	O	.	_	0	SENT_255	[p14l1482t255r1546b285],

1	No	DT	O	no	det	3	SENT_256	[p14l1557t255r1597b278],
2	other	JJ	O	other	amod	3	SENT_256	[p14l1607t255r1675b278],
3	uses	NNS	O	use	_	0	SENT_256	[p14l1683t262r1739b278],
4	without	IN	O	without	_	0	SENT_256	[p14l1749t255r1850b278],
5	permission	NN	O	permission	prep_without	3	SENT_256	[p14l1859t255r2011b285],
6	.	.	O	.	_	0	SENT_256	[p14l1859t255r2011b285],

1	Copyright	NN	O	copyright	_	0	SENT_257	[p14l728t296r863b327],
2	©	CD	NUMBER	©	num	6	SENT_257	[p14l872t296r896b320],
3	2005	CD	DATE	2005	num	6	SENT_257	[p14l906t296r970b320],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_257	[p14l980t296r1171b320],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_257	[p14l1181t296r1289b320],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_257	[p14l1300t296r1405b327],
7	.	.	O	.	_	0	SENT_257	[p14l1300t296r1405b327],

1	All	DT	O	all	det	2	SENT_258	[p14l1416t296r1457b320],
2	rights	NNS	O	rights	nsubj	3	SENT_258	[p14l1466t296r1541b327],
3	reserved	VBN	O	reserve	_	0	SENT_258	[p14l1551t296r1670b320],
4	.	.	O	.	_	0	SENT_258	[p14l1551t296r1670b320],

1	BRIEF	JJ	O	brief	amod	2	SENT_259	[p14l958t402r1056b421],
2	REPORT	NN	O	report	_	0	SENT_259	[p14l1070t402r1201b421],

1	in	IN	O	in	_	0	SENT_260	[p14l10t616r91b693],
2	the	DT	O	the	det	5	SENT_260	[p14l117t616r246b694],
3	tyrosine	NN	O	tyrosine	nn	5	SENT_260	[p14l272t616r606b716],
4	kinase	NN	O	kinase	nn	5	SENT_260	[p14l632t615r902b695],
5	domain	NN	O	domain	pobj	1	SENT_260	[p14l928t615r1252b694],
6	of	IN	O	of	_	0	SENT_260	[p14l1278t615r1379b694],
7	EGFR	NN	ORGANIZATION	egfr	prep_of	5	SENT_260	[p14l1383t622r1612b695],
8	.	.	O	.	_	0	SENT_260	[p14l1383t622r1612b695],

1	Insertion	NN	O	insertion	nsubj	8	SENT_261	[p14l1642t616r2027b694],
2	of	IN	O	of	_	0	SENT_261	[p14l2053t615r2153b694],
3	this	DT	O	this	det	4	SENT_261	[p14l11t744r164b822],
4	mutation	NN	O	mutation	prep_of	1	SENT_261	[p14l203t744r592b823],
5	into	IN	O	into	_	0	SENT_261	[p14l629t744r794b822],
6	test	NN	O	test	nn	7	SENT_261	[p14l834t760r985b822],
7	cells	NNS	O	cell	prep_into	4	SENT_261	[p14l1019t744r1201b822],
8	rendered	VBD	O	render	_	0	SENT_261	[p14l1240t744r1616b822],
9	them	PRP	O	they	dobj	8	SENT_261	[p14l1653t744r1870b822],
10	resistant	JJ	O	resistant	amod	9	SENT_261	[p14l1907t744r2134b822, p14l11t888r180b950],
11	to	TO	O	to	_	0	SENT_261	[p14l202t888r281b950],
12	geﬁtinib	NN	O	geﬁtinib	prep_to	10	SENT_261	[p14l308t871r662b972],
13	in	FW	O	in	nn	14	SENT_261	[p14l689t872r770b949],
14	vitro	FW	O	vitro	advmod	8	SENT_261	[p14l791t872r1008b951],
15	.	.	O	.	_	0	SENT_261	[p14l791t872r1008b951],

1	The	DT	O	the	det	2	SENT_262	[p14l1036t872r1197b950],
2	development	NN	O	development	nsubj	16	SENT_262	[p14l1224t871r1774b972],
3	of	IN	O	of	_	0	SENT_262	[p14l1795t871r1896b950],
4	a	DT	DURATION	a	det	6	SENT_262	[p14l1902t898r1947b950],
5	second	JJ	DURATION	second	amod	6	SENT_262	[p14l1973t898r2134b950, p14l11t999r173b1078],
6	mutation	NN	O	mutation	prep_of	2	SENT_262	[p14l206t1000r594b1079],
7	in	IN	O	in	_	0	SENT_262	[p14l626t1000r707b1077],
8	the	DT	O	the	det	10	SENT_262	[p14l740t1000r869b1078],
9	EGFR	NN	ORGANIZATION	egfr	nn	10	SENT_262	[p14l900t1006r1112b1079],
10	gene	NN	O	gene	prep_in	6	SENT_262	[p14l1137t1025r1336b1100],
11	that	WDT	O	that	nsubj	12	SENT_262	[p14l1369t999r1536b1078],
12	confers	VBZ	O	confer	rcmod	10	SENT_262	[p14l1564t999r1873b1078],
13	resistance	NN	O	resistance	dobj	12	SENT_262	[p14l1907t1000r2133b1078, p14l11t1144r239b1206],
14	to	TO	O	to	_	0	SENT_262	[p14l286t1144r366b1206],
15	geﬁtinib	NN	O	geﬁtinib	prep_to	12	SENT_262	[p14l414t1127r777b1228],
16	suggests	VBZ	O	suggest	_	0	SENT_262	[p14l826t1144r1196b1228],
17	that	IN	O	that	complm	22	SENT_262	[p14l1244t1128r1415b1206],
18	the	DT	O	the	det	20	SENT_262	[p14l1456t1128r1588b1206],
19	tumor	NN	O	tumor	nn	20	SENT_262	[p14l1634t1144r1901b1207],
20	cells	NNS	O	cell	nsubj	22	SENT_262	[p14l1945t1127r2132b1206],
21	remain	VBP	O	remain	cop	22	SENT_262	[p14l11t1256r314b1334],
22	dependent	JJ	O	dependent	ccomp	16	SENT_262	[p14l347t1255r797b1356],
23	on	IN	O	on	_	0	SENT_262	[p14l824t1281r930b1334],
24	an	DT	O	a	det	27	SENT_262	[p14l959t1281r1060b1334],
25	active	JJ	O	active	amod	27	SENT_262	[p14l1091t1256r1326b1335],
26	EGFR	NN	ORGANIZATION	egfr	nn	27	SENT_262	[p14l1355t1261r1614b1339],
27	pathway	NN	O	pathway	prep_on	22	SENT_262	[p14l1633t1255r1989b1356],
28	for	IN	O	for	_	0	SENT_262	[p14l2015t1255r2138b1334],
29	their	PRP$	O	they	poss	30	SENT_262	[p14l11t1384r209b1462],
30	proliferation	NN	O	proliferation	prep_for	27	SENT_262	[p14l229t1383r787b1484],
31	.	.	O	.	_	0	SENT_262	[p14l229t1383r787b1484],

1	In	IN	O	in	_	0	SENT_263	[p14l138t1519r225b1589],
2	chronic	JJ	O	chronic	amod	4	SENT_263	[p14l256t1512r576b1590],
3	myeloid	JJ	O	myeloid	amod	4	SENT_263	[p14l606t1511r942b1612],
4	leukemia	NN	O	leukemia	prep_in	20	SENT_263	[p14l971t1512r1359b1591],
5	and	CC	O	and	_	0	SENT_263	[p14l1387t1512r1543b1590],
6	gastrointestinal	JJ	O	gastrointestinal	amod	8	SENT_263	[p14l1572t1512r2134b1612, p14l11t1638r139b1716],
7	stromal	JJ	O	stromal	amod	8	SENT_263	[p14l172t1639r494b1717],
8	tumors	NNS	O	tumor	prep_in	20	SENT_263	[p14l526t1655r852b1733],
9	,	,	O	,	_	0	SENT_263	[p14l526t1655r852b1733],
10	the	DT	O	the	det	13	SENT_263	[p14l890t1639r1019b1716],
11	two	CD	NUMBER	two	num	13	SENT_263	[p14l1052t1655r1204b1718],
12	main	JJ	O	main	amod	13	SENT_263	[p14l1237t1639r1451b1716],
13	mechanisms	NNS	O	mechanism	nsubj	20	SENT_263	[p14l1483t1638r2019b1716],
14	of	IN	O	of	_	0	SENT_263	[p14l2053t1638r2154b1717],
15	resistance	NN	O	resistance	prep_of	13	SENT_263	[p14l11t1767r433b1845],
16	to	TO	O	to	_	0	SENT_263	[p14l465t1783r544b1845],
17	imatinib	NN	O	imatinib	prep_to	15	SENT_263	[p14l575t1767r931b1845],
18	are	VBP	O	be	cop	20	SENT_263	[p14l963t1793r1089b1845],
19	point	NN	O	point	nn	20	SENT_263	[p14l1119t1767r1347b1867],
20	mutations	NNS	O	mutation	_	0	SENT_263	[p14l1373t1767r1803b1846],
21	or	CC	O	or	_	0	SENT_263	[p14l1838t1792r1943b1862],
22	,	,	O	,	_	0	SENT_263	[p14l1838t1792r1943b1862],
23	less	JJR	O	less	dep	20	SENT_263	[p14l1978t1766r2133b1845],
24	commonly	RB	O	commonly	dep	23	SENT_263	[p14l11t1895r478b1995],
25	,	,	O	,	_	0	SENT_263	[p14l11t1895r478b1995],
26	ampliﬁcation	NN	O	ampliﬁcation	conj_or	20	SENT_263	[p14l505t1894r1071b1995],
27	of	IN	O	of	_	0	SENT_263	[p14l1094t1894r1194b1973],
28	the	DT	O	the	det	29	SENT_263	[p14l1198t1895r1327b1973],
29	BCR	NN	O	bcr	prep_of	20	SENT_263	[p14l1348t1900r1698b1975],
30	.	.	O	.	_	0	SENT_263	[p14l1348t1900r1698b1975],

1	—	NN	O	—	_	0	SENT_264	[p14l1348t1900r1698b1975],
2	.	.	O	.	_	0	SENT_264	[p14l1348t1900r1698b1975],

1	ABL	NN	ORGANIZATION	abl	nn	2	SENT_265	[p14l1348t1900r1698b1975],
2	gene	NN	O	gene	nsubj	12	SENT_265	[p14l1717t1889r2134b1995],
3	.18	CD	NUMBER	.18	num	4	SENT_265	[p14l1717t1889r2134b1995],
4	’	NN	O	’	dep	2	SENT_265	[p14l1717t1889r2134b1995],
5	2	CD	NUMBER	2	number	6	SENT_265	[p14l1717t1889r2134b1995],
6	°	CD	NUMBER	°	num	7	SENT_265	[p14l1717t1889r2134b1995],
7	Knowledge	NN	O	knowledge	dep	2	SENT_265	[p14l10t2022r487b2123],
8	of	IN	O	of	_	0	SENT_265	[p14l513t2022r614b2101],
9	these	DT	O	these	det	10	SENT_265	[p14l621t2023r839b2101],
10	mechanisms	NNS	O	mechanism	prep_of	7	SENT_265	[p14l864t2023r1399b2101],
11	has	VBZ	O	have	aux	12	SENT_265	[p14l1426t2023r1567b2101],
12	led	VBN	O	lead	_	0	SENT_265	[p14l1594t2023r1719b2101],
13	to	TO	O	to	_	0	SENT_265	[p14l1744t2039r1823b2101],
14	the	DT	O	the	det	15	SENT_265	[p14l1850t2023r1979b2101],
15	development	NN	O	development	prep_to	12	SENT_265	[p14l2005t2022r2134b2101, p14l6t2151r460b2251],
16	of	IN	O	of	_	0	SENT_265	[p14l488t2150r589b2229],
17	second	JJ	ORDINAL	second	amod	20	SENT_265	[p14l605t2151r1394b2251],
18	—	NN	O	—	nn	20	SENT_265	[p14l605t2151r1394b2251],
19	generation	NN	O	generation	nn	20	SENT_265	[p14l605t2151r1394b2251],
20	BCR	NN	O	bcr	prep_of	15	SENT_265	[p14l1425t2156r1821b2234],
21	.	.	O	.	_	0	SENT_265	[p14l1425t2156r1821b2234],

1	—	NN	O	—	_	0	SENT_266	[p14l1425t2156r1821b2234],
2	.	.	O	.	_	0	SENT_266	[p14l1425t2156r1821b2234],

1	ABL	NN	ORGANIZATION	abl	nn	2	SENT_267	[p14l1425t2156r1821b2234],
2	inhibitors	NNS	O	inhibitor	_	0	SENT_267	[p14l1851t2151r2134b2229, p14l11t2273r289b2357],
3	.	.	O	.	_	0	SENT_267	[p14l1851t2151r2134b2229, p14l11t2273r289b2357],

1	”	NN	O	”	_	0	SENT_268	[p14l1851t2151r2134b2229, p14l11t2273r289b2357],
2	Interestingly	RB	O	interestingly	advmod	1	SENT_268	[p14l339t2279r900b2379],
3	,	,	O	,	_	0	SENT_268	[p14l339t2279r900b2379],
4	one	CD	NUMBER	one	appos	1	SENT_268	[p14l958t2304r1112b2357],
5	of	IN	O	of	_	0	SENT_268	[p14l1164t2278r1266b2357],
6	the	DT	O	the	det	11	SENT_268	[p14l1299t2279r1430b2357],
7	most	RBS	O	most	advmod	8	SENT_268	[p14l1482t2295r1701b2357],
8	common	JJ	O	common	amod	11	SENT_268	[p14l1749t2304r2134b2357],
9	imatinib	NN	O	imatinib	nn	11	SENT_268	[p14l10t2407r366b2484],
10	resistance	NN	O	resistance	nn	11	SENT_268	[p14l396t2407r818b2484],
11	mutations	NNS	O	mutation	prep_of	4	SENT_268	[p14l847t2407r1277b2485],
12	in	IN	O	in	_	0	SENT_268	[p14l1308t2407r1388b2483],
13	BCR	NN	O	bcr	prep_in	11	SENT_268	[p14l1415t2412r1766b2486],
14	.	.	O	.	_	0	SENT_268	[p14l1415t2412r1766b2486],

1	—	NN	O	—	_	0	SENT_269	[p14l1415t2412r1766b2486],
2	.	.	O	.	_	0	SENT_269	[p14l1415t2412r1766b2486],

1	ABL	NNP	ORGANIZATION	ABL	nsubj	2	SENT_270	[p14l1415t2412r1766b2486],
2	replaces	VBZ	O	replace	_	0	SENT_270	[p14l1790t2407r2132b2506],
3	threonine	NN	O	threonine	dobj	2	SENT_270	[p14l11t2535r428b2613],
4	at	IN	O	at	_	0	SENT_270	[p14l452t2551r531b2613],
5	position	NN	O	position	prep_at	2	SENT_270	[p14l548t2535r897b2635],
6	315	CD	NUMBER	315	number	7	SENT_270	[p14l921t2540r1071b2613],
7	(	CD	NUMBER	(	num	10	SENT_270	[p14l1102t2535r1261b2626],
8	the	DT	O	the	det	10	SENT_270	[p14l1102t2535r1261b2626],
9	amino	NN	O	amino	nn	10	SENT_270	[p14l1284t2535r1553b2613],
10	acid	NN	O	acid	nsubjpass	68	SENT_270	[p14l1576t2535r1748b2613],
11	structurally	RB	O	structurally	advmod	12	SENT_270	[p14l1772t2551r2134b2614, p14l10t2663r156b2763],
12	corresponding	VBG	O	correspond	partmod	10	SENT_270	[p14l185t2662r810b2763],
13	to	TO	O	to	_	0	SENT_270	[p14l840t2679r919b2741],
14	T790	NN	O	t790	prep_to	12	SENT_270	[p14l950t2668r1167b2741],
15	of	IN	O	of	_	0	SENT_270	[p14l1202t2662r1303b2741],
16	EGFR	NN	ORGANIZATION	egfr	nn	17	SENT_270	[p14l1316t2668r1594b2754],
17	)	NN	O	)	prep_of	14	SENT_270	[p14l1316t2668r1594b2754],
18	with	IN	O	with	_	0	SENT_270	[p14l1629t2662r1817b2742],
19	isoleu	NN	O	isoleu	prep_with	17	SENT_270	[p14l1851t2663r2134b2742],
20	—	CD	NUMBER	—	num	21	SENT_270	[p14l1851t2663r2134b2742],
21	cine	NN	O	cine	dobj	12	SENT_270	[p14l11t2791r182b2869],
22	in	IN	O	in	_	0	SENT_270	[p14l226t2791r308b2868],
23	the	DT	O	the	det	30	SENT_270	[p14l354t2791r482b2869],
24	ABL	NNP	ORGANIZATION	ABL	nn	30	SENT_270	[p14l522t2796r681b2868],
25	tyrosine	NN	O	tyrosine	nn	30	SENT_270	[p14l724t2791r1059b2891],
26	kinase	NN	O	kinase	nn	30	SENT_270	[p14l1104t2790r1375b2870],
27	domain	NN	O	domain	nn	30	SENT_270	[p14l1421t2791r1745b2869],
28	(	CD	NUMBER	(	num	30	SENT_270	[p14l1795t2796r2129b2886],
29	T3151	NN	O	t3151	nn	30	SENT_270	[p14l1795t2796r2129b2886],
30	)	NN	O	)	prep_in	21	SENT_270	[p14l1795t2796r2129b2886],
31	,	,	O	,	_	0	SENT_270	[p14l1795t2796r2129b2886],
32	leading	VBG	O	lead	appos	30	SENT_270	[p14l10t2918r325b3019],
33	to	TO	O	to	_	0	SENT_270	[p14l357t2935r436b2997],
34	a	DT	O	a	det	36	SENT_270	[p14l473t2945r517b2997],
35	structural	JJ	O	structural	amod	36	SENT_270	[p14l552t2919r956b2998],
36	change	NN	O	change	prep_to	32	SENT_270	[p14l992t2918r1293b3019],
37	very	RB	O	very	advmod	38	SENT_270	[p14l1324t2945r1497b3019],
38	similar	JJ	O	similar	rcmod	36	SENT_270	[p14l1529t2919r1824b2997],
39	to	TO	O	to	_	0	SENT_270	[p14l1857t2935r1936b2997],
40	that	DT	O	that	prep_to	38	SENT_270	[p14l1973t2919r2140b2997],
41	observed	VBN	O	observe	partmod	40	SENT_270	[p14l11t3046r387b3125],
42	with	IN	O	with	_	0	SENT_270	[p14l406t3046r595b3126],
43	EGFRT790M	NN	O	egfrt790m	prep_with	41	SENT_270	[p14l617t3040r1300b3129],
44	.13	CD	NUMBER	.13	num	43	SENT_270	[p14l617t3040r1300b3129],
45	In	IN	O	in	dep	38	SENT_270	[p14l1323t3053r1410b3123],
46	fact	NN	O	fact	pobj	45	SENT_270	[p14l1434t3045r1609b3141],
47	,	,	O	,	_	0	SENT_270	[p14l1434t3045r1609b3141],
48	on	IN	O	on	_	0	SENT_270	[p14l1639t3071r1745b3124],
49	the	DT	O	the	det	50	SENT_270	[p14l1769t3046r1899b3124],
50	basis	NN	O	basis	prep_on	32	SENT_270	[p14l1923t3046r2132b3124],
51	of	IN	O	of	_	0	SENT_270	[p14l11t3174r112b3253],
52	the	DT	O	the	det	54	SENT_270	[p14l121t3174r249b3253],
53	structural	JJ	O	structural	amod	54	SENT_270	[p14l278t3174r682b3254],
54	similarity	NN	O	similarity	prep_of	50	SENT_270	[p14l709t3174r1108b3275],
55	between	IN	O	between	_	0	SENT_270	[p14l1131t3175r1480b3254],
56	ABL	NNP	ORGANIZATION	ABL	nn	60	SENT_270	[p14l1502t3181r1682b3253],
57	and	CC	O	and	_	0	SENT_270	[p14l1706t3174r1861b3253],
58	EGFR	NN	ORGANIZATION	egfr	conj_and	56	SENT_270	[p14l1887t3180r2145b3258],
59	tyrosine	NN	O	tyrosine	nn	60	SENT_270	[p14l11t3303r346b3402],
60	kinases	NNS	O	kinase	prep_between	54	SENT_270	[p14l382t3303r720b3397],
61	,	,	O	,	_	0	SENT_270	[p14l382t3303r720b3397],
62	the	DT	O	the	det	65	SENT_270	[p14l762t3303r891b3380],
63	T	NN	O	t	nn	65	SENT_270	[p14l924t3308r985b3379],
64	790M	NN	O	790m	nn	65	SENT_270	[p14l989t3308r1228b3380],
65	change	NN	O	change	appos	60	SENT_270	[p14l1266t3303r1567b3402],
66	has	VBZ	O	have	aux	68	SENT_270	[p14l1604t3303r1745b3380],
67	been	VBN	O	be	auxpass	68	SENT_270	[p14l1785t3303r1984b3380],
68	introduced	VBN	O	introduce	rcmod	5	SENT_270	[p14l2020t3303r2134b3379, p14l11t3431r385b3510],
69	into	IN	O	into	_	0	SENT_270	[p14l423t3431r588b3509],
70	wild	JJ	O	wild	amod	73	SENT_270	[p14l624t3431r1017b3531],
71	—	NN	O	—	nn	73	SENT_270	[p14l624t3431r1017b3531],
72	type	NN	O	type	nn	73	SENT_270	[p14l624t3431r1017b3531],
73	EGFR	NN	ORGANIZATION	egfr	prep_into	68	SENT_270	[p14l1055t3436r1328b3526],
74	;	:	O	;	_	0	SENT_270	[p14l1055t3436r1328b3526],
75	this	DT	O	this	det	77	SENT_270	[p14l1371t3431r1523b3509],
76	altered	JJ	O	altered	amod	77	SENT_270	[p14l1563t3430r1850b3509],
77	EGFR	NN	ORGANIZATION	egfr	nsubj	78	SENT_270	[p14l1887t3436r2145b3514],
78	has	VBZ	O	have	parataxis	2	SENT_270	[p14l11t3559r152b3637],
79	high	JJ	O	high	amod	82	SENT_270	[p14l183t3558r601b3659],
80	—	NN	O	—	nn	82	SENT_270	[p14l183t3558r601b3659],
81	level	NN	O	level	nn	82	SENT_270	[p14l183t3558r601b3659],
82	resistance	NN	O	resistance	dobj	78	SENT_270	[p14l629t3559r1051b3637],
83	to	TO	O	to	_	0	SENT_270	[p14l1082t3575r1161b3637],
84	anilinoquinazoline	NN	O	anilinoquinazoline	nn	85	SENT_270	[p14l1190t3558r1990b3659],
85	inhibitors	NNS	O	inhibitor	prep_to	82	SENT_270	[p14l2020t3559r2134b3636, p14l11t3681r451b3763],
86	.	.	O	.	_	0	SENT_270	[p14l2020t3559r2134b3636, p14l11t3681r451b3763],

1	”	NNP	O	”	nn	4	SENT_271	[p14l2020t3559r2134b3636, p14l11t3681r451b3763],
2	Daily	NNP	SET	Daily	nn	4	SENT_271	[p14l478t3686r696b3785],
3	oral	JJ	O	oral	amod	4	SENT_271	[p14l721t3686r883b3763],
4	administration	NN	O	administration	nsubj	10	SENT_271	[p14l910t3686r1539b3763],
5	of	IN	O	of	_	0	SENT_271	[p14l1567t3685r1668b3763],
6	geﬁtinib	NN	O	geﬁtinib	prep_of	4	SENT_271	[p14l1678t3685r2032b3785],
7	at	IN	O	at	_	0	SENT_271	[p14l2061t3702r2140b3763],
8	recommended	VBN	O	recommend	amod	9	SENT_271	[p15l11t21r623b100],
9	doses	NNS	O	dose	prep_at	6	SENT_271	[p15l661t22r895b100],
10	results	VBZ	O	result	_	0	SENT_271	[p15l935t21r1211b101],
11	in	IN	O	in	_	0	SENT_271	[p15l1250t22r1331b99],
12	mean	JJ	O	mean	amod	17	SENT_271	[p15l1368t47r1601b100],
13	steady	JJ	O	steady	amod	17	SENT_271	[p15l1640t21r2135b122],
14	—	NN	O	—	nn	17	SENT_271	[p15l1640t21r2135b122],
15	state	NN	O	state	nn	17	SENT_271	[p15l1640t21r2135b122],
16	plasma	NN	O	plasma	nn	17	SENT_271	[p15l9t148r316b248],
17	concentrations	NNS	O	concentration	prep_in	10	SENT_271	[p15l344t149r971b226],
18	of	IN	O	of	_	0	SENT_271	[p15l1003t148r1103b226],
19	0.4	CD	NUMBER	0.4	prep_of	17	SENT_271	[p15l1113t154r1243b226],
20	to	TO	O	to	_	0	SENT_271	[p15l1273t165r1351b226],
21	1.4	CD	NUMBER	1.4	num	22	SENT_271	[p15l1384t154r1512b226],
22	pM	NN	O	pm	prep_to	10	SENT_271	[p15l1541t144r1779b248],
23	.	.	O	.	_	0	SENT_271	[p15l1541t144r1779b248],
24	"	''	O	"	punct	10	SENT_271	[p15l1541t144r1779b248],

1	-3	CD	NUMBER	-3	_	0	SENT_272	[p15l1541t144r1779b248],
2	Since	IN	O	since	dep	1	SENT_272	[p15l1811t149r2033b226],
3	at	IN	O	at	pcomp	2	SENT_272	[p15l2061t165r2140b226],
4	these	DT	O	these	det	5	SENT_272	[p15l11t277r229b355],
5	levels	NNS	O	level	pobj	3	SENT_272	[p15l252t277r480b356],
6	the	DT	O	the	det	8	SENT_272	[p15l505t277r634b355],
7	T79OM	NN	O	t79om	nn	8	SENT_272	[p15l654t282r957b355],
8	mutation	NN	O	mutation	nsubj	10	SENT_272	[p15l981t277r1370b356],
9	still	RB	O	still	advmod	10	SENT_272	[p15l1394t277r1547b355],
10	allows	VBZ	O	allow	rcmod	5	SENT_272	[p15l1568t276r1836b356],
11	the	DT	O	the	det	12	SENT_272	[p15l1861t277r1990b355],
12	activation	NN	O	activation	dobj	10	SENT_272	[p15l2013t303r2134b355, p15l11t405r326b484],

1	of	IN	O	of	_	0	SENT_273	[p15l356t404r456b483],
2	EGFR	NN	ORGANIZATION	egfr	prep_of	11	SENT_273	[p15l466t410r739b500],
3	,	,	O	,	_	0	SENT_273	[p15l466t410r739b500],
4	the	DT	O	the	det	5	SENT_273	[p15l775t404r903b483],
5	presence	NN	O	presence	nsubj	11	SENT_273	[p15l932t430r1305b505],
6	of	IN	O	of	_	0	SENT_273	[p15l1336t404r1437b483],
7	such	PDT	O	such	predet	9	SENT_273	[p15l1450t405r1644b484],
8	a	DT	O	a	det	9	SENT_273	[p15l1673t431r1718b483],
9	mutation	NN	O	mutation	prep_of	5	SENT_273	[p15l1746t405r2135b484],
10	might	MD	O	might	aux	11	SENT_273	[p15l11t533r269b633],
11	result	VB	O	result	_	0	SENT_273	[p15l288t533r530b612],
12	in	IN	O	in	_	0	SENT_273	[p15l549t533r630b610],
13	clinical	JJ	O	clinical	amod	14	SENT_273	[p15l656t532r957b611],
14	resistance	NN	O	resistance	prep_in	11	SENT_273	[p15l981t533r1427b611],
15	.	.	O	.	_	0	SENT_273	[p15l981t533r1427b611],

1	Although	IN	O	although	mark	7	SENT_274	[p15l136t660r537b761],
2	the	DT	O	the	det	4	SENT_274	[p15l594t661r723b739],
3	T3151	NN	O	t3151	nn	4	SENT_274	[p15l778t666r1029b739],
4	substitution	NN	O	substitution	nsubj	7	SENT_274	[p15l1087t661r1594b740],
5	in	IN	O	in	_	0	SENT_274	[p15l1651t661r1731b738],
6	BCR-ABL	NN	O	bcr-abl	prep_in	4	SENT_274	[p15l1787t666r2137b740],
7	confers	VBZ	O	confer	_	0	SENT_274	[p15l11t788r321b867],
8	high	JJ	O	high	amod	11	SENT_274	[p15l352t789r769b889],
9	—	NN	O	—	nn	11	SENT_274	[p15l352t789r769b889],
10	level	NN	O	level	nn	11	SENT_274	[p15l352t789r769b889],
11	resistance	NN	O	resistance	dobj	7	SENT_274	[p15l798t789r1220b867],
12	to	TO	O	to	_	0	SENT_274	[p15l1250t805r1328b867],
13	all	DT	O	all	prep_to	7	SENT_274	[p15l1358t789r1458b867],
14	tested	VBN	O	test	partmod	13	SENT_274	[p15l1487t788r1735b867],
15	inhibitor	NN	O	inhibitor	nn	16	SENT_274	[p15l1763t789r2138b867],
16	compounds	NNS	O	compound	dobj	14	SENT_274	[p15l11t916r538b1017],
17	,	,	O	,	_	0	SENT_274	[p15l11t916r538b1017],
18	the	DT	O	the	det	21	SENT_274	[p15l581t917r710b995],
19	corresponding	JJ	O	corresponding	amod	21	SENT_274	[p15l749t917r1373b1017],
20	T79OM	NN	O	t79om	nn	21	SENT_274	[p15l1404t922r1707b995],
21	mutation	NN	O	mutation	appos	16	SENT_274	[p15l1746t917r2135b996],

1	REFERENCES	NNS	O	reference	_	0	SENT_275	[p15l14t1211r484b1252],

1	1	LS	NUMBER	1	_	0	SENT_276	[p15l13t1309r49b1348],
2	.	.	O	.	_	0	SENT_276	[p15l13t1309r49b1348],

1	Jemal	NNP	PERSON	Jemal	nn	2	SENT_277	[p15l101t1304r238b1355],
2	A	NNP	PERSON	A	_	0	SENT_277	[p15l249t1308r297b1357],
3	,	,	O	,	_	0	SENT_277	[p15l249t1308r297b1357],
4	Tiwari	NNP	ORGANIZATION	Tiwari	nn	5	SENT_277	[p15l311t1304r464b1348],
5	RC	NNP	ORGANIZATION	RC	appos	2	SENT_277	[p15l475t1307r557b1357],
6	,	,	O	,	_	0	SENT_277	[p15l475t1307r557b1357],
7	Murray	NNP	PERSON	Murray	nn	8	SENT_277	[p15l571t1308r745b1360],
8	T	NN	O	t	appos	2	SENT_277	[p15l753t1307r794b1357],
9	,	,	O	,	_	0	SENT_277	[p15l753t1307r794b1357],
10	et	FW	O	et	nn	11	SENT_277	[p15l811t1313r854b1348],
11	al.	FW	O	al.	appos	2	SENT_277	[p15l863t1304r916b1348],
12	.	.	O	.	_	0	SENT_277	[p15l863t1304r916b1348],

1	Cancer	NN	O	cancer	nn	2	SENT_278	[p15l932t1307r1043b1348, p15l11t1390r82b1420],
2	statistics	NNS	O	statistics	_	0	SENT_278	[p15l99t1376r319b1429],
3	,	,	O	,	_	0	SENT_278	[p15l99t1376r319b1429],
4	2004	CD	DATE	2004	appos	2	SENT_278	[p15l341t1379r470b1420],
5	.	.	O	.	_	0	SENT_278	[p15l341t1379r470b1420],

1	CA	NNP	O	CA	nn	3	SENT_279	[p15l492t1379r563b1420],
2	Cancerl	NNP	O	Cancerl	nn	3	SENT_279	[p15l580t1379r779b1427],
3	Clin	NNP	O	Clin	_	0	SENT_279	[p15l796t1376r893b1420],
4	2004	CD	DATE	2004	num	3	SENT_279	[p15l912t1379r1042b1429],
5	;	:	O	;	_	0	SENT_279	[p15l912t1379r1042b1429],
6	54:8	CD	NUMBER	54:8	number	7	SENT_279	[p15l12t1450r205b1491],
7	—	CD	NUMBER	—	dep	3	SENT_279	[p15l12t1450r205b1491],
8	29	CD	NUMBER	29	dep	7	SENT_279	[p15l12t1450r205b1491],
9	.	.	O	.	_	0	SENT_279	[p15l12t1450r205b1491],

1	2	LS	NUMBER	2	_	0	SENT_280	[p15l10t1522r49b1561],
2	.	.	O	.	_	0	SENT_280	[p15l10t1522r49b1561],

1	Schiller	NNP	PERSON	Schiller	nn	2	SENT_281	[p15l108t1517r286b1561],
2	JH	NNP	O	JH	_	0	SENT_281	[p15l296t1521r373b1570],
3	,	,	O	,	_	0	SENT_281	[p15l296t1521r373b1570],
4	Harrington	NNP	PERSON	Harrington	nn	5	SENT_281	[p15l393t1517r660b1573],
5	D	NNP	O	D	appos	2	SENT_281	[p15l677t1520r727b1570],
6	,	,	O	,	_	0	SENT_281	[p15l677t1520r727b1570],
7	Belani	NNP	PERSON	Belani	nn	8	SENT_281	[p15l746t1517r894b1561],
8	CP	NNP	O	CP	appos	2	SENT_281	[p15l911t1520r983b1570],
9	,	,	O	,	_	0	SENT_281	[p15l911t1520r983b1570],
10	et	FW	O	et	nn	11	SENT_281	[p15l1003t1526r1046b1561],
11	al.	FW	O	al.	appos	2	SENT_281	[p15l10t1588r63b1632],
12	.	.	O	.	_	0	SENT_281	[p15l10t1588r63b1632],

1	Comparison	NN	O	comparison	_	0	SENT_282	[p15l85t1588r379b1644],
2	of	IN	O	of	_	0	SENT_282	[p15l398t1587r454b1632],
3	four	CD	NUMBER	four	num	5	SENT_282	[p15l462t1587r562b1632],
4	chemotherapy	NN	O	chemotherapy	nn	5	SENT_282	[p15l579t1588r919b1644],
5	regimens	NNS	O	regimen	prep_of	1	SENT_282	[p15l935t1588r1044b1644, p15l11t1673r138b1703],
6	for	IN	O	for	_	0	SENT_282	[p15l151t1658r220b1703],
7	advanced	JJ	O	advanced	amod	9	SENT_282	[p15l229t1659r449b1703],
8	non	JJ	O	non	amod	9	SENT_282	[p15l461t1659r815b1703],
9	—	NN	O	—	prep_for	1	SENT_282	[p15l461t1659r815b1703],
10	small	JJ	O	small	amod	14	SENT_282	[p15l461t1659r815b1703],
11	—	NN	O	—	nn	14	SENT_282	[p15l461t1659r815b1703],
12	cell	NN	O	cell	nn	14	SENT_282	[p15l461t1659r815b1703],
13	lung	NN	O	lung	nn	14	SENT_282	[p15l825t1659r934b1715],
14	cancer	NN	O	cancer	dep	9	SENT_282	[p15l944t1673r1044b1703, p15l11t1744r91b1774],
15	.	.	O	.	_	0	SENT_282	[p15l944t1673r1044b1703, p15l11t1744r91b1774],

1	N	NN	O	n	nn	3	SENT_283	[p15l107t1734r149b1774],
2	Engll	NNP	O	Engll	nn	3	SENT_283	[p15l161t1730r299b1786],
3	Med	NNP	O	Med	_	0	SENT_283	[p15l310t1730r414b1774],
4	2002	CD	DATE	2002	num	3	SENT_283	[p15l428t1733r787b1783],
5	;	:	O	;	_	0	SENT_283	[p15l428t1733r787b1783],
6	346:92	CD	NUMBER	346:92	number	7	SENT_283	[p15l428t1733r787b1783],
7	—	CD	NUMBER	—	dep	3	SENT_283	[p15l428t1733r787b1783],
8	8	CD	NUMBER	8	dep	7	SENT_283	[p15l428t1733r787b1783],
9	.	.	O	.	_	0	SENT_283	[p15l428t1733r787b1783],

1	3	LS	NUMBER	3	_	0	SENT_284	[p15l11t1806r49b1845],
2	.	.	O	.	_	0	SENT_284	[p15l11t1806r49b1845],

1	Scagliotti	NNP	PERSON	Scagliotti	nn	2	SENT_285	[p15l108t1801r329b1857],
2	GV	NNP	O	GV	_	0	SENT_285	[p15l348t1804r427b1854],
3	,	,	O	,	_	0	SENT_285	[p15l348t1804r427b1854],
4	De	NNP	PERSON	De	nn	6	SENT_285	[p15l449t1804r514b1845],
5	Marinis	NNP	PERSON	Marinis	nn	6	SENT_285	[p15l532t1801r713b1845],
6	F	NN	O	f	appos	2	SENT_285	[p15l733t1805r769b1854],
7	,	,	O	,	_	0	SENT_285	[p15l733t1805r769b1854],
8	Rinaldi	NNP	PERSON	Rinaldi	nn	9	SENT_285	[p15l791t1801r962b1848],
9	M	NNP	O	M	appos	2	SENT_285	[p15l980t1805r1041b1854],
10	,	,	O	,	_	0	SENT_285	[p15l980t1805r1041b1854],
11	et	FW	O	et	nn	12	SENT_285	[p15l11t1881r54b1916],
12	al.	FW	O	al.	appos	2	SENT_285	[p15l69t1872r122b1916],
13	.	.	O	.	_	0	SENT_285	[p15l69t1872r122b1916],

1	Phase	NN	O	phase	npadvmod	3	SENT_286	[p15l143t1872r280b1916],
2	III	CD	NUMBER	iii	num	1	SENT_286	[p15l298t1876r352b1915],
3	randomized	JJ	O	randomized	amod	4	SENT_286	[p15l369t1872r656b1916],
4	trial	NN	O	trial	nsubj	9	SENT_286	[p15l674t1872r767b1916],
5	comparing	VBG	O	compare	partmod	4	SENT_286	[p15l786t1872r1046b1928],
6	three	CD	NUMBER	three	num	8	SENT_286	[p15l11t1943r130b1987],
7	platinum	NN	O	platinum	nn	8	SENT_286	[p15l148t1943r522b1999],
8	—	NN	O	—	dobj	5	SENT_286	[p15l148t1943r522b1999],
9	based	VBN	O	base	_	0	SENT_286	[p15l148t1943r522b1999],
10	doublets	NNS	O	doublet	dobj	9	SENT_286	[p15l540t1943r742b1987],
11	in	IN	O	in	_	0	SENT_286	[p15l761t1943r807b1986],
12	advanced	JJ	O	advanced	amod	14	SENT_286	[p15l825t1943r1044b1987],
13	non	JJ	O	non	amod	14	SENT_286	[p15l11t2014r355b2058],
14	—	NN	O	—	prep_in	10	SENT_286	[p15l11t2014r355b2058],
15	small	JJ	O	small	amod	19	SENT_286	[p15l11t2014r355b2058],
16	—	NN	O	—	nn	19	SENT_286	[p15l11t2014r355b2058],
17	cell	NN	O	cell	nn	19	SENT_286	[p15l11t2014r355b2058],
18	lung	NN	O	lung	nn	19	SENT_286	[p15l386t2014r495b2070],
19	cancer	NN	O	cancer	dep	14	SENT_286	[p15l526t2028r689b2058],
20	.	.	O	.	_	0	SENT_286	[p15l526t2028r689b2058],

1	J	NNP	O	J	nn	3	SENT_287	[p15l719t2018r740b2065],
2	Clin	NNP	O	Clin	nn	3	SENT_287	[p15l772t2014r869b2058],
3	Oncol	NNP	O	Oncol	_	0	SENT_287	[p15l902t2014r1044b2058],
4	2002	CD	DATE	2002	num	3	SENT_287	[p15l11t2088r429b2138],
5	;	:	O	;	_	0	SENT_287	[p15l11t2088r429b2138],
6	20:4285	CD	NUMBER	20:4285	number	7	SENT_287	[p15l11t2088r429b2138],
7	—	CD	NUMBER	—	dep	3	SENT_287	[p15l11t2088r429b2138],
8	91	CD	NUMBER	91	dep	7	SENT_287	[p15l11t2088r429b2138],
9	.	.	O	.	_	0	SENT_287	[p15l11t2088r429b2138],

1	4	LS	NUMBER	4	_	0	SENT_288	[p15l10t2161r49b2200],
2	.	.	O	.	_	0	SENT_288	[p15l10t2161r49b2200],

1	Mendelsohn	NNP	PERSON	Mendelsohn	nn	2	SENT_289	[p15l105t2156r403b2200],
2	J	NNP	PERSON	J	_	0	SENT_289	[p15l417t2160r450b2209],
3	,	,	O	,	_	0	SENT_289	[p15l417t2160r450b2209],
4	Baselga	NNP	O	Baselga	nn	6	SENT_289	[p15l473t2156r655b2212],
5	J.	NNP	O	J.	nn	6	SENT_289	[p15l668t2160r701b2207],
6	Status	NNP	O	Status	appos	2	SENT_289	[p15l725t2159r867b2200],
7	of	IN	O	of	_	0	SENT_289	[p15l889t2155r945b2200],
8	epidermal	JJ	O	epidermal	amod	12	SENT_289	[p15l955t2156r1043b2212, p15l11t2227r177b2271],
9	growth	NN	O	growth	nn	12	SENT_289	[p15l199t2227r369b2283],
10	factor	NN	O	factor	nn	12	SENT_289	[p15l392t2226r529b2271],
11	receptor	NN	O	receptor	nn	12	SENT_289	[p15l551t2236r748b2283],
12	antagonists	NNS	O	antagonist	prep_of	6	SENT_289	[p15l768t2227r1043b2283],
13	in	IN	O	in	_	0	SENT_289	[p15l11t2298r56b2341],
14	the	DT	O	the	det	15	SENT_289	[p15l69t2298r141b2342],
15	biology	NN	O	biology	prep_in	12	SENT_289	[p15l154t2298r331b2354],
16	and	CC	O	and	_	0	SENT_289	[p15l340t2298r428b2342],
17	treatment	NN	O	treatment	conj_and	15	SENT_289	[p15l441t2307r673b2342],
18	of	IN	O	of	_	0	SENT_289	[p15l683t2297r739b2342],
19	cancer	NN	O	cancer	prep_of	15	SENT_289	[p15l742t2302r936b2349],
20	.	.	O	.	_	0	SENT_289	[p15l742t2302r936b2349],

1	J	NNP	O	J	nn	3	SENT_290	[p15l742t2302r936b2349],
2	Clin	NNP	O	Clin	nn	3	SENT_290	[p15l947t2298r1044b2342],
3	Oncol	NNP	O	Oncol	_	0	SENT_290	[p15l11t2369r153b2413],
4	2003	CD	DATE	2003	num	3	SENT_290	[p15l167t2372r586b2422],
5	;	:	O	;	_	0	SENT_290	[p15l167t2372r586b2422],
6	21:2787	CD	NUMBER	21:2787	number	7	SENT_290	[p15l167t2372r586b2422],
7	—	CD	NUMBER	—	dep	3	SENT_290	[p15l167t2372r586b2422],
8	99	CD	NUMBER	99	dep	7	SENT_290	[p15l167t2372r586b2422],
9	.	.	O	.	_	0	SENT_290	[p15l167t2372r586b2422],

1	5	CD	NUMBER	5	_	0	SENT_291	[p15l12t2445r49b2484],
2	.	.	O	.	_	0	SENT_291	[p15l12t2445r49b2484],

1	Fukuoka	NNP	LOCATION	Fukuoka	nn	2	SENT_292	[p15l106t2440r313b2484],
2	M	NNP	O	M	_	0	SENT_292	[p15l331t2444r392b2493],
3	,	,	O	,	_	0	SENT_292	[p15l331t2444r392b2493],
4	Yano	NNP	PERSON	Yano	nn	5	SENT_292	[p15l412t2444r528b2484],
5	S	NNP	O	S	appos	2	SENT_292	[p15l550t2443r588b2493],
6	,	,	O	,	_	0	SENT_292	[p15l550t2443r588b2493],
7	Giaccone	NNP	PERSON	Giaccone	nn	8	SENT_292	[p15l611t2440r832b2484],
8	G	NNP	O	G	appos	2	SENT_292	[p15l852t2443r905b2493],
9	,	,	O	,	_	0	SENT_292	[p15l852t2443r905b2493],
10	et	FW	O	et	nn	11	SENT_292	[p15l929t2449r971b2484],
11	al.	FW	O	al.	appos	2	SENT_292	[p15l988t2440r1041b2484],
12	.	.	O	.	_	0	SENT_292	[p15l988t2440r1041b2484],

1	Multi-institutional	JJ	O	multi-institutional	nsubj	21	SENT_293	[p15l9t2511r447b2555],
2	randomized	VBN	O	randomize	partmod	1	SENT_293	[p15l464t2511r751b2555],
3	phase	NN	O	phase	nn	5	SENT_293	[p15l767t2511r905b2567],
4	II	CD	NUMBER	ii	num	5	SENT_293	[p15l922t2515r957b2554],
5	trial	NN	O	trial	dobj	2	SENT_293	[p15l974t2511r1044b2555, p15l10t2582r50b2626],
6	of	IN	O	of	_	0	SENT_293	[p15l66t2581r122b2626],
7	geﬁtinib	NN	O	geﬁtinib	prep_of	5	SENT_293	[p15l127t2581r326b2638],
8	for	IN	O	for	_	0	SENT_293	[p15l341t2581r411b2626],
9	previously	RB	DATE	previously	advmod	10	SENT_293	[p15l423t2582r667b2638],
10	treated	VBN	O	treat	amod	11	SENT_293	[p15l679t2582r841b2626],
11	patients	NNS	O	patient	prep_for	2	SENT_293	[p15l855t2582r1043b2638],
12	with	IN	O	with	_	0	SENT_293	[p15l8t2653r114b2697],
13	advanced	JJ	O	advanced	amod	15	SENT_293	[p15l141t2653r360b2697],
14	non	JJ	O	non	amod	15	SENT_293	[p15l387t2653r731b2697],
15	—	NN	O	—	prep_with	11	SENT_293	[p15l387t2653r731b2697],
16	small	JJ	O	small	amod	20	SENT_293	[p15l387t2653r731b2697],
17	—	NN	O	—	nn	20	SENT_293	[p15l387t2653r731b2697],
18	cell	NN	O	cell	nn	20	SENT_293	[p15l387t2653r731b2697],
19	lung	NN	O	lung	nn	20	SENT_293	[p15l758t2653r866b2709],
20	cancer	NN	O	cancer	dep	15	SENT_293	[p15l892t2667r1046b2697],
21	(	VBD	O	(	_	0	SENT_293	[p15l14t2724r103b2775],
22	the	DT	O	the	det	26	SENT_293	[p15l14t2724r103b2775],
23	IDEAL	NNP	O	IDEAL	nn	26	SENT_293	[p15l124t2727r281b2767],
24	1	CD	NUMBER	1	num	26	SENT_293	[p15l304t2727r329b2767],
25	Trial	NN	O	trial	nn	26	SENT_293	[p15l349t2724r490b2775],
26	)	NN	O	)	dobj	21	SENT_293	[p15l349t2724r490b2775],
27	.	.	O	.	_	0	SENT_293	[p15l349t2724r490b2775],

1	J	NNP	O	J	nn	3	SENT_294	[p15l510t2728r531b2775],
2	Clin	NNP	O	Clin	nn	3	SENT_294	[p15l552t2724r649b2768],
3	Oncol	NNP	O	Oncol	_	0	SENT_294	[p15l672t2724r814b2768],
4	2003	CD	DATE	2003	num	3	SENT_294	[p15l836t2727r1042b2777],
5	;	:	O	;	_	0	SENT_294	[p15l836t2727r1042b2777],
6	21	CD	NUMBER	21	num	8	SENT_294	[p15l836t2727r1042b2777],
7	:	:	O	:	_	0	SENT_294	[p15l836t2727r1042b2777],
8	2237-46	CD	NUMBER	2237-46	dep	3	SENT_294	[p15l1118t1307r1326b1348],
9	.	.	O	.	_	0	SENT_294	[p15l1118t1307r1326b1348],

1	[	NNP	O	[	nn	6	SENT_295	[p15l1360t1307r1584b1357],
2	Erratum	NNP	O	Erratum	nn	6	SENT_295	[p15l1360t1307r1584b1357],
3	,	,	O	,	_	0	SENT_295	[p15l1360t1307r1584b1357],
4	J	NNP	O	J	appos	6	SENT_295	[p15l1608t1308r1629b1355],
5	Clin	NNP	O	Clin	nn	6	SENT_295	[p15l1653t1304r1750b1348],
6	Oncol	NNP	O	Oncol	_	0	SENT_295	[p15l1776t1304r1918b1348],
7	2004	CD	DATE	2004	num	6	SENT_295	[p15l1944t1307r2150b1357],
8	;	:	O	;	_	0	SENT_295	[p15l1944t1307r2150b1357],
9	22	CD	NUMBER	22	dep	6	SENT_295	[p15l1944t1307r2150b1357],
10	:	:	O	:	_	0	SENT_295	[p15l1944t1307r2150b1357],
11	4811	CD	NUMBER	4811	dep	9	SENT_295	[p15l1117t1379r1267b1426],
12	.	.	O	.	_	0	SENT_295	[p15l1117t1379r1267b1426],
13	]	SYM	O	]	dep	6	SENT_295	[p15l1117t1379r1267b1426],

1	6	CD	NUMBER	6	_	0	SENT_296	[p15l1118t1452r1156b1491],
2	.	.	O	.	_	0	SENT_296	[p15l1118t1452r1156b1491],

1	Kris	NNP	PERSON	Kris	nn	2	SENT_297	[p15l1214t1447r1309b1492],
2	MG	NN	PERSON	mg	_	0	SENT_297	[p15l1321t1450r1425b1500],
3	,	,	O	,	_	0	SENT_297	[p15l1321t1450r1425b1500],
4	Natale	NNP	PERSON	Natale	nn	5	SENT_297	[p15l1438t1447r1592b1491],
5	RB	NN	O	rb	appos	2	SENT_297	[p15l1604t1450r1686b1500],
6	,	,	O	,	_	0	SENT_297	[p15l1604t1450r1686b1500],
7	Herbst	NNP	ORGANIZATION	Herbst	nn	8	SENT_297	[p15l1700t1447r1864b1491],
8	RS	NN	ORGANIZATION	r	appos	2	SENT_297	[p15l1872t1450r1950b1500],
9	,	,	O	,	_	0	SENT_297	[p15l1872t1450r1950b1500],
10	et	FW	O	et	nn	11	SENT_297	[p15l1965t1456r2008b1491],
11	al.	FW	O	al.	appos	2	SENT_297	[p15l2017t1447r2069b1491],
12	.	.	O	.	_	0	SENT_297	[p15l2017t1447r2069b1491],

1	Efﬁcacy	NN	O	efﬁcacy	_	0	SENT_298	[p15l2084t1446r2151b1490, p15l1118t1516r1253b1573],
2	of	IN	O	of	_	0	SENT_298	[p15l1264t1516r1320b1561],
3	geﬁtinib	NN	O	geﬁtinib	prep_of	1	SENT_298	[p15l1322t1516r1535b1573],
4	,	,	O	,	_	0	SENT_298	[p15l1322t1516r1535b1573],
5	an	DT	O	a	det	6	SENT_298	[p15l1551t1531r1607b1561],
6	inhibitor	NN	O	inhibitor	appos	3	SENT_298	[p15l1619t1517r1829b1561],
7	of	IN	O	of	_	0	SENT_298	[p15l1841t1516r1897b1561],
8	the	DT	O	the	det	14	SENT_298	[p15l1900t1517r1972b1561],
9	epidermal	JJ	O	epidermal	amod	14	SENT_298	[p15l1985t1517r2151b1573, p15l1118t1588r1207b1632],
10	growth	NN	O	growth	nn	14	SENT_298	[p15l1224t1588r1394b1644],
11	factor	NN	O	factor	nn	14	SENT_298	[p15l1412t1587r1550b1632],
12	receptor	NN	O	receptor	nn	14	SENT_298	[p15l1566t1597r1763b1644],
13	tyrosine	NN	O	tyrosine	nn	14	SENT_298	[p15l1779t1588r1966b1644],
14	kinase	NN	O	kinase	prep_of	6	SENT_298	[p15l1984t1588r2149b1641],
15	,	,	O	,	_	0	SENT_298	[p15l1984t1588r2149b1641],
16	in	IN	O	in	_	0	SENT_298	[p15l1118t1659r1164b1702],
17	symptomatic	JJ	O	symptomatic	amod	18	SENT_298	[p15l1178t1659r1485b1715],
18	patients	NNS	O	patient	prep_in	3	SENT_298	[p15l1497t1659r1685b1715],
19	with	IN	O	with	_	0	SENT_298	[p15l1697t1659r1803b1703],
20	non	JJ	O	non	amod	25	SENT_298	[p15l1817t1659r2059b1703],
21	—	JJ	O	—	amod	25	SENT_298	[p15l1817t1659r2059b1703],
22	small	JJ	O	small	amod	25	SENT_298	[p15l1817t1659r2059b1703],
23	cell	NN	O	cell	nn	25	SENT_298	[p15l2073t1659r2152b1703],
24	lung	NN	O	lung	nn	25	SENT_298	[p15l1118t1730r1227b1786],
25	cancer	NN	O	cancer	prep_with	18	SENT_298	[p15l1237t1744r1404b1774],
26	:	:	O	:	_	0	SENT_298	[p15l1237t1744r1404b1774],
27	a	DT	O	a	det	29	SENT_298	[p15l1417t1744r1442b1774],
28	randomized	JJ	O	randomized	amod	29	SENT_298	[p15l1453t1730r1740b1774],
29	trial	NN	O	trial	dep	1	SENT_298	[p15l1752t1730r1858b1774],
30	.	.	O	.	_	0	SENT_298	[p15l1752t1730r1858b1774],

1	JAMA	NNP	O	JAMA	_	0	SENT_299	[p15l1867t1734r2009b1781],
2	2003	CD	DATE	2003	num	1	SENT_299	[p15l2020t1733r2150b1783],
3	;	:	O	;	_	0	SENT_299	[p15l2020t1733r2150b1783],
4	290:2149	CD	NUMBER	290:2149	number	5	SENT_299	[p15l1118t1804r1432b1845],
5	—	CD	NUMBER	—	dep	1	SENT_299	[p15l1118t1804r1432b1845],
6	58	CD	NUMBER	58	dep	5	SENT_299	[p15l1118t1804r1432b1845],
7	.	.	O	.	_	0	SENT_299	[p15l1118t1804r1432b1845],

1	7	CD	NUMBER	7	_	0	SENT_300	[p15l1119t1877r1156b1916],
2	.	.	O	.	_	0	SENT_300	[p15l1119t1877r1156b1916],

1	Perez	NNP	PERSON	Perez	_	0	SENT_301	[p15l1214t1872r1485b1916],
2	.	.	O	.	_	0	SENT_301	[p15l1214t1872r1485b1916],

1	—	NN	O	—	_	0	SENT_302	[p15l1214t1872r1485b1916],
2	.	.	O	.	_	0	SENT_302	[p15l1214t1872r1485b1916],

1	Soler	NNP	PERSON	Soler	nn	2	SENT_303	[p15l1214t1872r1485b1916],
2	R	NNP	PERSON	R	_	0	SENT_303	[p15l1501t1875r1548b1925],
3	,	,	O	,	_	0	SENT_303	[p15l1501t1875r1548b1925],
4	Chachoua	NNP	O	Chachoua	nn	5	SENT_303	[p15l1570t1872r1808b1916],
5	A	NNP	O	A	appos	2	SENT_303	[p15l1824t1876r1872b1925],
6	,	,	O	,	_	0	SENT_303	[p15l1824t1876r1872b1925],
7	Hammond	NNP	ORGANIZATION	Hammond	nn	8	SENT_303	[p15l1893t1872r2152b1916],
8	LA	NNP	ORGANIZATION	LA	appos	2	SENT_303	[p15l1118t1947r1195b1996],
9	,	,	O	,	_	0	SENT_303	[p15l1118t1947r1195b1996],
10	et	FW	O	et	nn	11	SENT_303	[p15l1219t1952r1262b1987],
11	al.	FW	O	al.	appos	2	SENT_303	[p15l1281t1943r1334b1987],
12	.	.	O	.	_	0	SENT_303	[p15l1281t1943r1334b1987],

1	Determinants	NNS	O	determinant	_	0	SENT_304	[p15l1357t1943r1682b1987],
2	of	IN	O	of	_	0	SENT_304	[p15l1705t1942r1761b1987],
3	tumor	NN	O	tumor	nn	4	SENT_304	[p15l1772t1952r1920b1987],
4	response	NN	O	response	prep_of	1	SENT_304	[p15l1939t1957r2152b1999],
5	and	CC	O	and	_	0	SENT_304	[p15l1118t2014r1205b2058],
6	survival	NN	O	survival	prep_of	1	SENT_304	[p15l1227t2014r1405b2058],
7	with	IN	O	with	_	0	SENT_304	[p15l1424t2014r1530b2058],
8	erlotinib	NN	O	erlotinib	prep_with	1	SENT_304	[p15l1551t2014r1752b2058],
9	in	IN	O	in	_	0	SENT_304	[p15l1773t2014r1819b2057],
10	patients	NNS	O	patient	prep_in	1	SENT_304	[p15l1839t2014r2026b2070],
11	with	IN	O	with	_	0	SENT_304	[p15l2046t2014r2152b2058],
12	non	JJ	O	non	amod	18	SENT_304	[p15l1118t2085r1462b2129],
13	—	JJ	O	—	amod	18	SENT_304	[p15l1118t2085r1462b2129],
14	small	JJ	O	small	amod	18	SENT_304	[p15l1118t2085r1462b2129],
15	—	NN	O	—	nn	18	SENT_304	[p15l1118t2085r1462b2129],
16	cell	NN	O	cell	nn	18	SENT_304	[p15l1118t2085r1462b2129],
17	lung	NN	O	lung	nn	18	SENT_304	[p15l1494t2085r1603b2141],
18	cancer	NN	O	cancer	prep_with	10	SENT_304	[p15l1634t2099r1797b2129],
19	.	.	O	.	_	0	SENT_304	[p15l1634t2099r1797b2129],

1	J	NNP	O	J	nn	3	SENT_305	[p15l1827t2089r1848b2136],
2	Clin	NNP	O	Clin	nn	3	SENT_305	[p15l1879t2085r1977b2129],
3	Oncol	NNP	O	Oncol	_	0	SENT_305	[p15l2009t2085r2152b2129],
4	2004	CD	DATE	2004	num	3	SENT_305	[p15l1118t2159r1537b2209],
5	;	:	O	;	_	0	SENT_305	[p15l1118t2159r1537b2209],
6	22:3238	CD	NUMBER	22:3238	number	7	SENT_305	[p15l1118t2159r1537b2209],
7	—	CD	NUMBER	—	dep	3	SENT_305	[p15l1118t2159r1537b2209],
8	47	CD	NUMBER	47	dep	7	SENT_305	[p15l1118t2159r1537b2209],
9	.	.	O	.	_	0	SENT_305	[p15l1118t2159r1537b2209],

1	8	CD	NUMBER	8	_	0	SENT_306	[p15l1118t2231r1156b2271],
2	.	.	O	.	_	0	SENT_306	[p15l1118t2231r1156b2271],

1	Miller	NNP	ORGANIZATION	Miller	nn	2	SENT_307	[p15l1213t2227r1356b2271],
2	VA	NNP	ORGANIZATION	VA	_	0	SENT_307	[p15l1367t2231r1445b2280],
3	,	,	O	,	_	0	SENT_307	[p15l1367t2231r1445b2280],
4	Kris	NNP	PERSON	Kris	nn	5	SENT_307	[p15l1462t2227r1557b2272],
5	MG	NN	PERSON	mg	appos	2	SENT_307	[p15l1571t2230r1675b2280],
6	,	,	O	,	_	0	SENT_307	[p15l1571t2230r1675b2280],
7	Shah	NNP	PERSON	Shah	nn	8	SENT_307	[p15l1693t2227r1809b2271],
8	N	NNP	O	N	appos	2	SENT_307	[p15l1823t2231r1875b2280],
9	,	,	O	,	_	0	SENT_307	[p15l1823t2231r1875b2280],
10	et	FW	O	et	nn	11	SENT_307	[p15l1893t2236r1935b2271],
11	al.	FW	O	al.	appos	2	SENT_307	[p15l1947t2227r1999b2271],
12	.	.	O	.	_	0	SENT_307	[p15l1947t2227r1999b2271],

1	Bronchioloalveolar	JJ	PERSON	bronchioloalveolar	amod	3	SENT_308	[p15l2016t2230r2151b2271, p15l1119t2298r1452b2342],
2	pathologic	JJ	O	pathologic	amod	3	SENT_308	[p15l1509t2298r1763b2354],
3	subtype	NN	O	subtype	nsubj	7	SENT_308	[p15l1824t2298r2005b2354],
4	and	CC	O	and	_	0	SENT_308	[p15l2064t2298r2152b2342],
5	smoking	NN	O	smoking	nn	6	SENT_308	[p15l1119t2369r1330b2425],
6	history	NN	O	history	conj_and	3	SENT_308	[p15l1350t2369r1515b2425],
7	predict	VBP	O	predict	_	0	SENT_308	[p15l1534t2369r1702b2425],
8	sensitivity	NN	O	sensitivity	dobj	7	SENT_308	[p15l1722t2369r1957b2425],
9	to	TO	O	to	dep	11	SENT_308	[p15l1978t2378r2022b2413],
10	geﬁtinib	NN	O	geﬁtinib	pobj	9	SENT_308	[p15l2045t2368r2151b2425, p15l1119t2440r1227b2484],
11	in	IN	O	in	rcmod	8	SENT_308	[p15l1249t2440r1295b2483],
12	advanced	JJ	O	advanced	amod	14	SENT_308	[p15l1316t2440r1536b2484],
13	non	JJ	O	non	amod	14	SENT_308	[p15l1558t2440r1902b2484],
14	—	NN	O	—	pobj	11	SENT_308	[p15l1558t2440r1902b2484],
15	small	JJ	O	small	amod	19	SENT_308	[p15l1558t2440r1902b2484],
16	—	NN	O	—	nn	19	SENT_308	[p15l1558t2440r1902b2484],
17	cell	NN	O	cell	nn	19	SENT_308	[p15l1558t2440r1902b2484],
18	lung	NN	O	lung	nn	19	SENT_308	[p15l1923t2440r2032b2496],
19	cancer	NN	O	cancer	dep	14	SENT_308	[p15l2052t2454r2151b2484, p15l1119t2525r1198b2555],
20	.	.	O	.	_	0	SENT_308	[p15l2052t2454r2151b2484, p15l1119t2525r1198b2555],
21	]	SYM	O	]	dep	8	SENT_308	[p15l1210t2515r1231b2562],

1	Clin	NNP	O	Clin	nn	2	SENT_309	[p15l1243t2511r1340b2555],
2	Oncol	NNP	O	Oncol	_	0	SENT_309	[p15l1354t2511r1497b2555],
3	2004	CD	DATE	2004	num	2	SENT_309	[p15l1511t2514r1899b2564],
4	;	:	O	;	_	0	SENT_309	[p15l1511t2514r1899b2564],
5	22:1103	CD	NUMBER	22:1103	number	6	SENT_309	[p15l1511t2514r1899b2564],
6	—	CD	NUMBER	—	dep	2	SENT_309	[p15l1511t2514r1899b2564],
7	9	CD	NUMBER	9	dep	6	SENT_309	[p15l1511t2514r1899b2564],
8	.	.	O	.	_	0	SENT_309	[p15l1511t2514r1899b2564],

1	9	CD	NUMBER	9	_	0	SENT_310	[p15l1118t2587r1156b2626],
2	.	.	O	.	_	0	SENT_310	[p15l1118t2587r1156b2626],

1	Lynch	NNP	PERSON	Lynch	nn	2	SENT_311	[p15l1214t2582r1356b2638],
2	TJ	NNP	PERSON	TJ	_	0	SENT_311	[p15l1365t2585r1428b2635],
3	,	,	O	,	_	0	SENT_311	[p15l1365t2585r1428b2635],
4	Bell	NNP	ORGANIZATION	Bell	nn	5	SENT_311	[p15l1442t2582r1532b2626],
5	DVV	NNP	ORGANIZATION	DVV	appos	2	SENT_311	[p15l1543t2585r1639b2635],
6	,	,	O	,	_	0	SENT_311	[p15l1543t2585r1639b2635],
7	Sordella	NNP	PERSON	Sordella	nn	8	SENT_311	[p15l1656t2582r1848b2626],
8	R	NNP	PERSON	R	appos	2	SENT_311	[p15l1858t2585r1906b2635],
9	,	,	O	,	_	0	SENT_311	[p15l1858t2585r1906b2635],
10	et	FW	O	et	nn	11	SENT_311	[p15l1921t2591r1964b2626],
11	al.	FW	O	al.	appos	2	SENT_311	[p15l1973t2582r2026b2626],
12	.	.	O	.	_	0	SENT_311	[p15l1973t2582r2026b2626],

1	Activating	VBG	O	activate	_	0	SENT_312	[p15l2039t2582r2151b2626, p15l1116t2653r1264b2709],
2	mutations	NNS	O	mutation	dobj	1	SENT_312	[p15l1286t2653r1527b2697],
3	in	IN	O	in	_	0	SENT_312	[p15l1552t2653r1598b2696],
4	the	DT	O	the	det	7	SENT_312	[p15l1622t2653r1695b2697],
5	epidermal	JJ	O	epidermal	amod	7	SENT_312	[p15l1719t2653r1958b2709],
6	growth	NN	O	growth	nn	7	SENT_312	[p15l1982t2653r2152b2709],
7	factor	NN	O	factor	prep_in	1	SENT_312	[p15l1118t2723r1256b2768],
8	receptor	NN	O	receptor	nn	10	SENT_312	[p15l1284t2733r1481b2780],
9	underlying	VBG	O	underlie	amod	10	SENT_312	[p15l1508t2724r1766b2780],
10	responsiveness	NN	O	responsiveness	nsubj	15	SENT_312	[p15l1793t2724r2151b2780],
11	of	IN	O	of	_	0	SENT_312	[p15l16t2973r117b3052],
12	EGFR	NN	ORGANIZATION	egfr	prep_of	10	SENT_312	[p15l119t2979r378b3057],
13	does	VBZ	O	do	aux	15	SENT_312	[p15l391t2974r582b3052],
14	not	RB	O	not	neg	15	SENT_312	[p15l607t2990r750b3052],
15	seem	VB	O	seem	rcmod	7	SENT_312	[p15l769t3000r985b3052],
16	to	TO	O	to	aux	17	SENT_312	[p15l1008t2990r1087b3052],
17	confer	VB	O	confer	xcomp	15	SENT_312	[p15l1112t2973r1382b3052],
18	such	JJ	O	such	amod	20	SENT_312	[p15l1403t2974r1597b3053],
19	universal	JJ	O	universal	amod	20	SENT_312	[p15l1620t2974r1999b3053],
20	resistance	NN	O	resistance	dobj	17	SENT_312	[p15l2022t3000r2133b3052, p15l17t3099r377b3193],
21	,	,	O	,	_	0	SENT_312	[p15l2022t3000r2133b3052, p15l17t3099r377b3193],

1	given	VBN	O	give	_	0	SENT_313	[p15l422t3099r645b3198],
2	the	DT	O	the	det	3	SENT_313	[p15l686t3099r814b3176],
3	fact	NN	O	fact	npadvmod	4	SENT_313	[p15l855t3098r1011b3176],
4	that	IN	O	that	advmod	1	SENT_313	[p15l1046t3099r1212b3176],
5	in	IN	O	in	_	0	SENT_313	[p15l1246t3099r1327b3175],
6	the	DT	O	the	det	7	SENT_313	[p15l1367t3099r1496b3176],
7	context	NN	O	context	prep_in	1	SENT_313	[p15l1537t3115r1848b3176],
8	of	IN	O	of	_	0	SENT_313	[p15l1883t3098r1983b3176],
9	the	DT	O	the	det	10	SENT_313	[p15l2005t3099r2134b3176],
10	delL747	NN	O	dell747	prep_of	7	SENT_313	[p15l16t3224r613b3301],
11	.	.	O	.	_	0	SENT_313	[p15l16t3224r613b3301],

1	—	NN	O	—	_	0	SENT_314	[p15l16t3224r613b3301],
2	.	.	O	.	_	0	SENT_314	[p15l16t3224r613b3301],

1	S752	NN	O	s752	nn	2	SENT_315	[p15l16t3224r613b3301],
2	mutation	NN	O	mutation	nsubjpass	8	SENT_315	[p15l637t3224r1048b3318],
3	,	,	O	,	_	0	SENT_315	[p15l637t3224r1048b3318],
4	it	PRP	O	it	nsubjpass	8	SENT_315	[p15l1076t3224r1136b3301],
5	can	MD	O	can	aux	8	SENT_315	[p15l1155t3249r1299b3301],
6	effectively	RB	O	effectively	advmod	8	SENT_315	[p15l1322t3223r1741b3323],
7	be	VB	O	be	auxpass	8	SENT_315	[p15l1761t3224r1856b3301],
8	inhibited	VBN	O	inhibit	_	0	SENT_315	[p15l1879t3223r2133b3301, p15l15t3349r169b3426],
9	by	IN	O	by	_	0	SENT_315	[p15l191t3348r287b3448],
10	CL	NN	O	cl	agent	8	SENT_315	[p15l304t3354r815b3443],
11	—	CD	NUMBER	—	number	12	SENT_315	[p15l304t3354r815b3443],
12	387,785	CD	NUMBER	387,785	num	10	SENT_315	[p15l304t3354r815b3443],
13	.	.	O	.	_	0	SENT_315	[p15l304t3354r815b3443],

1	Our	PRP$	O	we	poss	2	SENT_316	[p15l842t3354r1005b3427],
2	results	NNS	O	result	nsubj	4	SENT_316	[p15l1023t3349r1296b3427],
3	should	MD	O	should	aux	4	SENT_316	[p15l1322t3348r1605b3427],
4	motivate	VB	O	motivate	_	0	SENT_316	[p15l1627t3349r1985b3427],
5	the	DT	O	the	det	6	SENT_316	[p15l2007t3349r2135b3426],
6	development	NN	O	development	dobj	4	SENT_316	[p15l16t3474r564b3573],
7	of	IN	O	of	_	0	SENT_316	[p15l592t3473r693b3551],
8	alternative	JJ	O	alternative	amod	10	SENT_316	[p15l706t3474r1142b3552],
9	EGFR	NN	ORGANIZATION	egfr	nn	10	SENT_316	[p15l1174t3479r1432b3556],
10	inhibitors	NNS	O	inhibitor	prep_of	6	SENT_316	[p15l1453t3474r1866b3551],
11	or	CC	O	or	_	0	SENT_316	[p15l1901t3499r1990b3551],
12	inhibitors	NNS	O	inhibitor	conj_or	10	SENT_316	[p15l2019t3474r2133b3550, p15l16t3598r343b3676],
13	of	IN	O	of	_	0	SENT_316	[p15l386t3598r486b3676],
14	downstream	JJ	O	downstream	amod	15	SENT_316	[p15l509t3598r1034b3677],
15	targets	NNS	O	target	prep_of	10	SENT_316	[p15l1075t3615r1360b3698],
16	of	IN	O	of	_	0	SENT_316	[p15l1403t3598r1504b3676],
17	EGFR	NN	ORGANIZATION	egfr	prep_of	15	SENT_316	[p15l1524t3604r1783b3681],
18	such	JJ	O	such	_	0	SENT_316	[p15l1814t3599r2008b3677],
19	as	IN	O	as	_	0	SENT_316	[p15l2048t3625r2132b3676],
20	phosphatidylinositol	NN	O	phosphatidylinositol	prep_such_as	17	SENT_316	[p16l14t19r890b119],
21	3	CD	NUMBER	3	num	20	SENT_316	[p16l941t20r1321b99],
22	'	''	O	'	_	0	SENT_316	[p16l941t20r1321b99],
23	.	.	O	.	_	0	SENT_316	[p16l941t20r1321b99],

1	—	NN	O	—	_	0	SENT_317	[p16l941t20r1321b99],
2	.	.	O	.	_	0	SENT_317	[p16l941t20r1321b99],

1	kinase	NN	O	kinase	_	0	SENT_318	[p16l941t20r1321b99],
2	or	CC	O	or	_	0	SENT_318	[p16l1372t45r1461b97],
3	STAT5	NN	O	stat5	conj_or	1	SENT_318	[p16l1510t25r1779b97],
4	for	IN	O	for	_	0	SENT_318	[p16l1832t19r1955b97],
5	patients	NNS	O	patient	prep_for	1	SENT_318	[p16l2001t45r2133b119, p16l16t145r245b222],
6	with	IN	O	with	_	0	SENT_318	[p16l268t145r457b223],
7	EGFR-mutant	JJ	O	egfr-mutant	amod	8	SENT_318	[p16l482t150r1074b227],
8	tumors	NNS	O	tumor	prep_with	5	SENT_318	[p16l1095t161r1395b223],
9	with	IN	O	with	_	0	SENT_318	[p16l1419t145r1608b223],
10	acquired	VBN	O	acquire	amod	11	SENT_318	[p16l1633t145r1996b244],
11	resistance	NN	O	resistance	prep_with	8	SENT_318	[p16l2022t171r2133b222, p16l17t270r353b347],
12	to	TO	O	to	_	0	SENT_318	[p16l379t286r458b347],
13	anilinoquinazoline	NN	O	anilinoquinazoline	nn	14	SENT_318	[p16l484t269r1281b369],
14	inhibitors	NNS	O	inhibitor	prep_to	11	SENT_318	[p16l1306t270r1744b347],
15	.	.	O	.	_	0	SENT_318	[p16l1306t270r1744b347],

1	Our	PRP$	O	we	poss	2	SENT_319	[p16l144t400r307b473],
2	ﬁndings	NNS	O	ﬁndings	nsubj	17	SENT_319	[p16l326t394r696b494],
3	,	,	O	,	_	0	SENT_319	[p16l326t394r696b494],
4	and	CC	O	and	cc	5	SENT_319	[p16l723t394r877b472],
5	results	VBZ	O	result	dep	2	SENT_319	[p16l900t394r1173b473],
6	in	IN	O	in	_	0	SENT_319	[p16l1197t395r1277b471],
7	patients	NNS	O	patient	prep_in	5	SENT_319	[p16l1297t395r1627b494],
8	with	IN	O	with	_	0	SENT_319	[p16l1647t395r1834b473],
9	chronic	JJ	O	chronic	amod	11	SENT_319	[p16l1857t395r2133b472, p16l15t520r84b597],
10	myeloid	JJ	O	myeloid	amod	11	SENT_319	[p16l123t519r458b619],
11	leukemia	NN	O	leukemia	prep_with	7	SENT_319	[p16l496t520r883b598],
12	and	CC	O	and	_	0	SENT_319	[p16l920t520r1075b597],
13	gastrointestinal	JJ	O	gastrointestinal	amod	15	SENT_319	[p16l1114t520r1772b619],
14	stromal	JJ	O	stromal	amod	15	SENT_319	[p16l1813t520r2134b597],
15	tumors	NNS	O	tumor	prep_with	7	SENT_319	[p16l16t661r342b739],
16	,	,	O	,	_	0	SENT_319	[p16l16t661r342b739],
17	suggest	VBP	O	suggest	_	0	SENT_319	[p16l380t661r705b744],
18	that	IN	O	that	complm	42	SENT_319	[p16l731t645r898b722],
19	when	WRB	O	when	advmod	22	SENT_319	[p16l919t645r1152b724],
20	a	DT	O	a	det	21	SENT_319	[p16l1183t671r1227b722],
21	relapse	NN	O	relapse	nsubj	22	SENT_319	[p16l1256t644r1554b744],
22	occurs	VBZ	O	occur	advcl	42	SENT_319	[p16l1586t670r1857b723],
23	in	IN	O	in	_	0	SENT_319	[p16l1890t645r1971b721],
24	patients	NNS	O	patient	prep_in	22	SENT_319	[p16l2001t671r2133b744, p16l16t770r241b847],
25	with	IN	O	with	_	0	SENT_319	[p16l260t770r446b848],
26	anilinoquinazoline	NN	O	anilinoquinazoline	nn	27	SENT_319	[p16l467t769r1729b869],
27	—	NN	O	—	nn	30	SENT_319	[p16l467t769r1729b869],
28	responsive	JJ	O	responsive	amod	30	SENT_319	[p16l467t769r1729b869],
29	lung	NN	O	lung	nn	30	SENT_319	[p16l1750t770r1941b869],
30	cancer	NN	O	cancer	prep_with	24	SENT_319	[p16l1960t795r2134b847, p16l16t921r141b972],
31	with	IN	O	with	_	0	SENT_319	[p16l162t895r350b973],
32	a	DT	O	a	det	36	SENT_319	[p16l379t921r423b972],
33	drug	NN	O	drug	nn	36	SENT_319	[p16l451t894r1245b994],
34	—	NN	O	—	nn	36	SENT_319	[p16l451t894r1245b994],
35	susceptibility	NN	O	susceptibility	nn	36	SENT_319	[p16l451t894r1245b994],
36	mutation	NN	O	mutation	prep_with	22	SENT_319	[p16l1269t895r1681b989],
37	,	,	O	,	_	0	SENT_319	[p16l1269t895r1681b989],
38	the	DT	O	the	det	40	SENT_319	[p16l1717t894r1845b972],
39	tumor	NN	O	tumor	nn	40	SENT_319	[p16l1875t911r2137b973],
40	cells	NNS	O	cell	nsubj	42	SENT_319	[p16l16t1020r198b1098],
41	will	MD	O	will	aux	42	SENT_319	[p16l218t1019r375b1099],
42	contain	VB	O	contain	ccomp	17	SENT_319	[p16l398t1020r715b1098],
43	other	JJ	O	other	amod	44	SENT_319	[p16l738t1020r961b1098],
44	mutations	NNS	O	mutation	dobj	42	SENT_319	[p16l981t1020r1410b1099],
45	in	IN	O	in	_	0	SENT_319	[p16l1434t1020r1515b1097],
46	EGFR	NN	ORGANIZATION	egfr	prep_in	42	SENT_319	[p16l1535t1026r1747b1099],
47	that	WDT	O	that	nsubj	48	SENT_319	[p16l1764t1020r1930b1098],
48	confer	VBP	O	confer	rcmod	46	SENT_319	[p16l1948t1045r2132b1098, p16l16t1144r129b1222],

1	resistance	NN	O	resistance	_	0	SENT_320	[p16l168t1145r589b1222],
2	to	TO	O	to	_	0	SENT_320	[p16l631t1161r710b1222],
3	the	DT	O	the	det	4	SENT_320	[p16l753t1145r882b1222],
4	drug	NN	O	drug	prep_to	1	SENT_320	[p16l924t1145r1143b1244],
5	.	.	O	.	_	0	SENT_320	[p16l924t1145r1143b1244],

1	Our	PRP$	O	we	poss	2	SENT_321	[p16l1189t1150r1353b1223],
2	work	NN	O	work	nsubj	4	SENT_321	[p16l1387t1145r1609b1224],
3	also	RB	O	also	advmod	4	SENT_321	[p16l1645t1145r1812b1222],
4	underscores	VBZ	O	underscore	_	0	SENT_321	[p16l1854t1144r2133b1223, p16l17t1295r277b1347],
5	the	DT	O	the	det	6	SENT_321	[p16l304t1270r433b1347],
6	need	NN	O	need	dobj	4	SENT_321	[p16l457t1270r657b1347],
7	to	TO	O	to	aux	8	SENT_321	[p16l681t1286r760b1347],
8	consider	VB	O	consider	infmod	6	SENT_321	[p16l785t1270r1148b1347],
9	incorporating	VBG	O	incorporate	xcomp	8	SENT_321	[p16l1169t1270r1754b1369],
10	repeated	VBN	O	repeat	amod	11	SENT_321	[p16l1775t1269r2134b1369],
11	biopsies	NNS	O	biopsy	dobj	9	SENT_321	[p16l16t1394r362b1494],
12	into	IN	O	into	_	0	SENT_321	[p16l385t1395r550b1472],
13	clinical	JJ	O	clinical	amod	14	SENT_321	[p16l575t1395r875b1472],
14	studies	NNS	O	study	prep_into	9	SENT_321	[p16l898t1395r1191b1473],
15	of	IN	O	of	_	0	SENT_321	[p16l1216t1394r1317b1472],
16	novel	JJ	O	novel	dep	17	SENT_321	[p16l1320t1395r1544b1473],
17	targeted	VBN	O	target	amod	18	SENT_321	[p16l1566t1395r1911b1494],
18	therapies	NNS	O	therapy	prep_of	14	SENT_321	[p16l1934t1395r2133b1472, p16l15t1520r254b1619],
19	,	,	O	,	_	0	SENT_321	[p16l1934t1395r2133b1472, p16l15t1520r254b1619],
20	such	JJ	O	such	_	0	SENT_321	[p16l294t1520r487b1598],
21	as	IN	O	as	_	0	SENT_321	[p16l520t1546r603b1597],
22	those	DT	O	those	prep_such_as	18	SENT_321	[p16l639t1520r865b1597],
23	involving	VBG	O	involve	partmod	22	SENT_321	[p16l897t1520r1288b1619],
24	mutant	JJ	O	mutant	amod	26	SENT_321	[p16l1318t1536r1628b1598],
25	tyrosine	NN	O	tyrosine	nn	26	SENT_321	[p16l1657t1520r1991b1619],
26	kinases	NNS	O	kinase	dobj	23	SENT_321	[p16l2023t1520r2133b1599, p16l16t1670r271b1722],
27	.	.	O	.	_	0	SENT_321	[p16l2023t1520r2133b1599, p16l16t1670r271b1722],

1	Such	JJ	O	such	amod	2	SENT_322	[p16l301t1644r503b1723],
2	information	NN	O	information	nsubj	4	SENT_322	[p16l524t1644r1034b1722],
3	may	MD	O	may	aux	4	SENT_322	[p16l1057t1671r1232b1744],
4	guide	VB	O	guide	_	0	SENT_322	[p16l1250t1644r1483b1744],
5	the	DT	O	the	det	6	SENT_322	[p16l1506t1645r1634b1722],
6	selection	NN	O	selection	dobj	4	SENT_322	[p16l1658t1645r2030b1722],
7	of	IN	O	of	_	0	SENT_322	[p16l2052t1644r2153b1722],
8	second	JJ	ORDINAL	second	amod	10	SENT_322	[p16l17t1769r504b1847],
9	—	NN	O	—	nn	10	SENT_322	[p16l17t1769r504b1847],
10	line	NN	O	line	prep_of	6	SENT_322	[p16l17t1769r504b1847],
11	EGFR	NN	O	egfr	nn	14	SENT_322	[p16l528t1769r1183b1852],
12	—	CD	NUMBER	—	num	14	SENT_322	[p16l528t1769r1183b1852],
13	inhibitor	NN	O	inhibitor	nn	14	SENT_322	[p16l528t1769r1183b1852],
14	therapy	NN	O	therapy	dep	10	SENT_322	[p16l1206t1770r1533b1869],
15	.	.	O	.	_	0	SENT_322	[p16l1206t1770r1533b1869],

1	Supported	VBN	O	support	_	0	SENT_323	[p16l102t1947r429b2022],
2	by	IN	O	by	_	0	SENT_323	[p16l471t1947r545b2022],
3	a	DT	O	a	det	5	SENT_323	[p16l583t1966r617b2005],
4	Specialized	NNP	ORGANIZATION	Specialized	nn	5	SENT_323	[p16l659t1947r1013b2022],
5	Program	NN	ORGANIZATION	program	prep_by	1	SENT_323	[p16l1054t1952r1330b2022],
6	of	IN	ORGANIZATION	of	_	0	SENT_323	[p16l1372t1946r1448b2006],
7	Research	NN	ORGANIZATION	research	nn	8	SENT_323	[p16l1475t1947r1763b2009],
8	Excellence	NN	ORGANIZATION	excellence	prep_of	5	SENT_323	[p16l1804t1947r2135b2006],
9	(	CD	NUMBER	(	num	8	SENT_323	[p16l18t2026r285b2090],
10	SPORE	NN	O	spore	nn	12	SENT_323	[p16l18t2026r285b2090],
11	)	CD	NUMBER	)	num	12	SENT_323	[p16l18t2026r285b2090],
12	Grant	NNP	O	Grant	dobj	1	SENT_323	[p16l327t2026r514b2081],
13	in	IN	O	in	_	0	SENT_323	[p16l548t2022r609b2080],
14	Lun	NNP	O	Lun	nn	15	SENT_323	[p16l646t2027r768b2082],
15	Cancer	NNP	O	Cancer	prep_in	12	SENT_323	[p16l847t2026r1069b2081],
16	(	CD	NUMBER	(	num	17	SENT_323	[p16l1108t2026r1861b2093],
17	PA20	NN	O	pa20	dep	15	SENT_323	[p16l1108t2026r1861b2093],
18	.	.	O	.	_	0	SENT_323	[p16l1108t2026r1861b2093],

1	—	NN	O	—	_	0	SENT_324	[p16l1108t2026r1861b2093],
2	.	.	O	.	_	0	SENT_324	[p16l1108t2026r1861b2093],

1	CA090578-01A1	NN	O	ca090578-01a1	dep	11	SENT_325	[p16l1108t2026r1861b2093],
2	,	,	O	,	_	0	SENT_325	[p16l1108t2026r1861b2093],
3	to	TO	O	to	_	0	SENT_325	[p16l1904t2034r1963b2081],
4	Drs.	NNP	O	Drs.	nn	5	SENT_325	[p16l2001t2027r2131b2081],
5	Johnson	NNP	PERSON	Johnson	prep_to	1	SENT_325	[p16l7t2097r277b2165],
6	and	CC	O	and	_	0	SENT_325	[p16l303t2097r420b2156],
7	Tenen	NNP	PERSON	Tenen	prep_to	1	SENT_325	[p16l443t2101r659b2165],
8	)	CD	NUMBER	)	num	7	SENT_325	[p16l443t2101r659b2165],
9	an	DT	O	a	predet	11	SENT_325	[p16l689t2116r765b2155],
10	a	DT	O	a	det	11	SENT_325	[p16l832t2116r865b2155],
11	grant	NN	O	grant	_	0	SENT_325	[p16l891t2109r1061b2172],
12	(	CD	NUMBER	(	num	13	SENT_325	[p16l1087t2101r1693b2168],
13	1K12CA87723	NN	O	1k12ca87723	dep	11	SENT_325	[p16l1087t2101r1693b2168],
14	.	.	O	.	_	0	SENT_325	[p16l1087t2101r1693b2168],

1	—	NN	O	—	_	0	SENT_326	[p16l1087t2101r1693b2168],
2	.	.	O	.	_	0	SENT_326	[p16l1087t2101r1693b2168],

1	O1	NN	O	o1	_	0	SENT_327	[p16l1087t2101r1693b2168],
2	,	,	O	,	_	0	SENT_327	[p16l1087t2101r1693b2168],
3	to	TO	O	to	dep	1	SENT_327	[p16l1724t2110r1784b2156],
4	Dr.	NNP	O	Dr.	nn	6	SENT_327	[p16l1810t2102r1903b2156],
5	Janne	NNP	PERSON	Janne	nn	6	SENT_327	[p16l1926t2101r2130b2165],
6	)	NNP	O	)	pobj	3	SENT_327	[p16l1926t2101r2130b2165],
7	from	IN	O	from	_	0	SENT_327	[p16l14t2174r170b2234],
8	the	DT	O	the	det	10	SENT_327	[p16l195t2175r291b2233],
9	National	NNP	ORGANIZATION	National	nn	10	SENT_327	[p16l314t2175r589b2235],
10	Institutes	NNPS	ORGANIZATION	Institutes	prep_from	6	SENT_327	[p16l611t2176r906b2235],
11	of	IN	ORGANIZATION	of	_	0	SENT_327	[p16l933t2174r1008b2234],
12	Health	NNP	ORGANIZATION	Health	prep_of	10	SENT_327	[p16l1018t2175r1247b2234],
13	.	.	O	.	_	0	SENT_327	[p16l1018t2175r1247b2234],

1	Dr.	NNP	O	Dr.	nn	2	SENT_328	[p16l1275t2180r1368b2234],
2	Halmos	NNP	PERSON	Halmos	nsubjpass	4	SENT_328	[p16l1396t2175r1644b2234],
3	was	VBD	O	be	auxpass	4	SENT_328	[p16l1666t2194r1787b2235],
4	supported	VBN	O	support	conj_and	4	SENT_328	[p16l1814t2175r2135b2250],
5	by	IN	O	by	_	0	SENT_328	[p16l15t2251r88b2326],
6	an	DT	O	a	det	8	SENT_328	[p16l109t2270r185b2309],
7	American	NNP	ORGANIZATION	American	nn	8	SENT_328	[p16l206t2252r514b2309],
8	Association	NNP	ORGANIZATION	Association	agent	4	SENT_328	[p16l537t2252r907b2310],
9	for	IN	ORGANIZATION	for	_	0	SENT_328	[p16l932t2250r1025b2310],
10	Cancer	NNP	ORGANIZATION	Cancer	nn	13	SENT_328	[p16l1047t2255r1269b2310],
11	Research/Cancer	NNP	ORGANIZATION	Research/Cancer	nn	13	SENT_328	[p16l1291t2251r1826b2318],
12	Research	NNP	ORGANIZATION	Research	nn	13	SENT_328	[p16l1848t2251r2135b2313],
13	Foundation	NNP	ORGANIZATION	Foundation	prep_for	8	SENT_328	[p16l13t2327r380b2387],
14	of	IN	ORGANIZATION	of	_	0	SENT_328	[p16l406t2326r482b2386],
15	America/AstraZeneca	NNP	ORGANIZATION	America/AstraZeneca	nn	18	SENT_328	[p16l490t2328r1169b2394],
16	Young	NNP	ORGANIZATION	Young	nn	18	SENT_328	[p16l1191t2332r1392b2402],
17	Investigator	NNP	ORGANIZATION	Investigator	nn	18	SENT_328	[p16l1414t2328r1793b2402],
18	Award	NN	ORGANIZATION	award	prep_of	13	SENT_328	[p16l1813t2327r2019b2387],
19	for	IN	ORGANIZATION	for	_	0	SENT_328	[p16l2045t2326r2137b2386],
20	Translational	JJ	ORGANIZATION	translational	amod	23	SENT_328	[p16l12t2404r432b2463],
21	Lung	NN	ORGANIZATION	lung	nn	23	SENT_328	[p16l449t2409r613b2479],
22	Cancer	NNP	ORGANIZATION	Cancer	nn	23	SENT_328	[p16l629t2408r851b2463],
23	Research	NNP	ORGANIZATION	Research	prep_for	4	SENT_328	[p16l866t2404r1154b2466],
24	as	RB	O	as	_	0	SENT_328	[p16l1171t2423r1235b2462],
25	well	RB	O	well	_	0	SENT_328	[p16l1251t2404r1382b2463],
26	as	IN	O	as	_	0	SENT_328	[p16l1400t2423r1463b2462],
27	by	IN	O	by	_	0	SENT_328	[p16l1484t2404r1556b2479],
28	a	DT	O	a	det	29	SENT_328	[p16l1570t2423r1604b2462],
29	Flight	NN	ORGANIZATION	flight	nn	37	SENT_328	[p16l1620t2404r1810b2479],
30	Attendant	NNP	ORGANIZATION	Attendant	nn	37	SENT_328	[p16l1821t2404r2139b2463],
31	Medical	NNP	ORGANIZATION	Medical	nn	37	SENT_328	[p16l12t2481r261b2540],
32	Research	NNP	ORGANIZATION	Research	nn	37	SENT_328	[p16l275t2481r560b2543],
33	Institute	NNP	ORGANIZATION	Institute	nn	37	SENT_328	[p16l574t2481r836b2541],
34	Young	NNP	ORGANIZATION	Young	nn	37	SENT_328	[p16l848t2486r1049b2556],
35	Clinical	JJ	ORGANIZATION	clinical	amod	37	SENT_328	[p16l1062t2481r1300b2540],
36	Scientist	NN	O	scientist	nn	37	SENT_328	[p16l1318t2481r1584b2540],
37	Award	NN	O	award	agent	4	SENT_328	[p16l1593t2481r1815b2541],
38	.	.	O	.	_	0	SENT_328	[p16l1593t2481r1815b2541],

1	Dr.	NNP	O	Dr.	nn	2	SENT_329	[p16l1834t2486r1926b2540],
2	Koba	NNP	O	Koba	nsubjpass	6	SENT_329	[p16l1946t2481r2134b2542],
3	—	NN	O	—	nn	4	SENT_329	[p16l1946t2481r2134b2542],
4	yashi	NN	O	yashus	dep	2	SENT_329	[p16l11t2558r174b2633],
5	was	VBD	O	be	auxpass	6	SENT_329	[p16l192t2577r312b2618],
6	supported	VBN	O	support	_	0	SENT_329	[p16l338t2558r655b2633],
7	by	IN	O	by	_	0	SENT_329	[p16l678t2558r751b2633],
8	the	DT	O	the	det	11	SENT_329	[p16l770t2558r866b2616],
9	Uehara	NNP	ORGANIZATION	Uehara	nn	11	SENT_329	[p16l889t2558r1114b2617],
10	Memorial	NNP	ORGANIZATION	Memorial	nn	11	SENT_329	[p16l1134t2558r1440b2617],
11	Foundation	NNP	ORGANIZATION	Foundation	agent	6	SENT_329	[p16l1462t2558r1842b2617],
12	.	.	O	.	_	0	SENT_329	[p16l1462t2558r1842b2617],

1	Dr.	NNP	O	Dr.	nn	2	SENT_330	[p16l1868t2563r1960b2617],
2	Boggon	NNP	PERSON	Boggon	nsubj	6	SENT_330	[p16l1986t2563r2134b2633, p16l15t2653r135b2709],
3	is	VBZ	O	be	cop	6	SENT_330	[p16l152t2635r200b2692],
4	an	DT	O	a	det	6	SENT_330	[p16l219t2653r294b2692],
5	American	JJ	ORGANIZATION	american	amod	6	SENT_330	[p16l309t2635r614b2693],
6	Society	NNP	ORGANIZATION	Society	_	0	SENT_330	[p16l633t2635r854b2709],
7	of	IN	ORGANIZATION	of	_	0	SENT_330	[p16l869t2633r943b2693],
8	Hematolo	NNP	ORGANIZATION	Hematolo	nn	12	SENT_330	[p16l946t2634r1258b2693],
9	gy	NNP	O	gy	nn	12	SENT_330	[p16l1262t2654r1335b2709],
10	Basic	NNP	O	Basic	nn	12	SENT_330	[p16l1348t2635r1512b2692],
11	Research	NNP	O	Research	nn	12	SENT_330	[p16l1529t2634r1814b2696],
12	Fellow	NNP	O	Fellow	prep_of	6	SENT_330	[p16l1830t2634r2047b2694],
13	.	.	O	.	_	0	SENT_330	[p16l1830t2634r2047b2694],

1	We	PRP	O	we	nsubj	21	SENT_331	[p16l98t2739r198b2792],
2	are	VBP	O	be	cop	3	SENT_331	[p16l220t2753r315b2792],
3	indebted	JJ	O	indebted	_	0	SENT_331	[p16l337t2734r614b2793],
4	to	TO	O	to	_	0	SENT_331	[p16l637t2747r697b2793],
5	Drs.	NN	O	dr.	nn	7	SENT_331	[p16l720t2739r849b2793],
6	Gang	NN	PERSON	gang	nn	7	SENT_331	[p16l876t2738r1051b2810],
7	Huang	NNP	PERSON	Huang	prep_to	3	SENT_331	[p16l1071t2739r1289b2810],
8	and	CC	O	and	_	0	SENT_331	[p16l1308t2734r1425b2793],
9	Hideyo	NNP	PERSON	Hideyo	nn	10	SENT_331	[p16l1448t2734r1671b2809],
10	Hirai	NNP	PERSON	Hirai	npadvmod	21	SENT_331	[p16l1694t2735r1854b2792],
11	for	IN	O	for	_	0	SENT_331	[p16l1876t2734r1969b2793],
12	their	PRP$	O	they	poss	13	SENT_331	[p16l1990t2734r2138b2792],
13	scientiﬁc	NN	O	scientiﬁc	prep_for	10	SENT_331	[p16l16t2811r299b2869],
14	and	CC	O	and	_	0	SENT_331	[p16l322t2811r438b2870],
15	technical	JJ	O	technical	amod	16	SENT_331	[p16l461t2811r746b2869],
16	advice	NN	O	advice	prep_for	10	SENT_331	[p16l768t2811r980b2883],
17	,	,	O	,	_	0	SENT_331	[p16l768t2811r980b2883],
18	to	TO	O	to	_	0	SENT_331	[p16l1008t2824r1067b2870],
19	Dr.	NNP	O	Dr.	nn	20	SENT_331	[p16l1090t2816r1183b2870],
20	Kwol	NNP	O	Kwol	prep_to	13	SENT_331	[p16l1210t2811r1531b2872],
21	<	JJR	O	<	conj_and	3	SENT_331	[p16l1210t2811r1531b2872],
22	.	.	O	.	_	0	SENT_331	[p16l1210t2811r1531b2872],

1	—	NN	O	—	_	0	SENT_332	[p16l1210t2811r1531b2872],
2	.	.	O	.	_	0	SENT_332	[p16l1210t2811r1531b2872],

1	Kin	NNP	PERSON	Kin	nn	2	SENT_333	[p16l1210t2811r1531b2872],
2	Wong	NNP	PERSON	Wong	conj_and	2	SENT_333	[p16l1551t2816r1744b2887],
3	for	IN	O	for	_	0	SENT_333	[p16l1764t2811r1856b2870],
4	his	PRP$	O	he	poss	6	SENT_333	[p16l1877t2811r1968b2869],
5	kind	NN	O	kind	nn	6	SENT_333	[p16l1992t2811r2135b2871],
6	gift	NN	O	gift	prep_for	2	SENT_333	[p16l15t2888r124b2964],
7	of	IN	O	of	_	0	SENT_333	[p16l139t2888r215b2947],
8	EGFR	NN	ORGANIZATION	egfr	nn	9	SENT_333	[p16l218t2893r377b2948],
9	constructs	NNS	O	construct	prep_of	6	SENT_333	[p16l391t2900r736b2959],
10	,	,	O	,	_	0	SENT_333	[p16l391t2900r736b2959],
11	and	CC	O	and	_	0	SENT_333	[p16l758t2888r875b2946],
12	to	TO	O	to	_	0	SENT_333	[p16l893t2901r953b2946],
13	Dr.	NNP	O	Dr.	nn	16	SENT_333	[p16l971t2893r1064b2946],
14	D.	NNP	PERSON	D.	nn	16	SENT_333	[p16l1086t2893r1152b2946],
15	Gary	NNP	PERSON	Gary	nn	16	SENT_333	[p16l1175t2892r1327b2963],
16	Gilliland	NNP	PERSON	Gilliland	prep_to	2	SENT_333	[p16l1341t2888r1619b2946],
17	as	RB	O	as	_	0	SENT_333	[p16l1637t2907r1699b2946],
18	well	RB	O	well	_	0	SENT_333	[p16l1716t2888r1847b2947],
19	as	IN	O	as	_	0	SENT_333	[p16l1865t2907r1928b2946],
20	members	NNS	O	member	prep_to	2	SENT_333	[p16l1948t2907r2134b2946, p16l15t2966r146b3053],
21	of	IN	O	of	_	0	SENT_333	[p16l164t2965r239b3025],
22	the	DT	O	the	det	24	SENT_333	[p16l242t2966r339b3024],
23	Tenen	NNP	PERSON	Tenen	nn	24	SENT_333	[p16l353t2970r546b3025],
24	laboratory	NN	O	laboratory	prep_of	2	SENT_333	[p16l561t2966r887b3041],
25	for	IN	O	for	_	0	SENT_333	[p16l900t2965r993b3025],
26	their	PRP$	O	they	poss	28	SENT_333	[p16l1007t2966r1155b3024],
27	helpful	JJ	O	helpful	amod	28	SENT_333	[p16l1169t2965r1393b3041],
28	comments	NNS	O	comment	prep_for	2	SENT_333	[p16l1409t2979r1741b3025],
29	and	CC	O	and	_	0	SENT_333	[p16l1759t2966r1875b3025],
30	suggestions	NNS	O	suggestion	prep_for	2	SENT_333	[p16l1892t2985r2133b3041, p16l15t3054r189b3100],
31	.	.	O	.	_	0	SENT_333	[p16l1892t2985r2133b3041, p16l15t3054r189b3100],

1	of	IN	O	of	_	0	SENT_334	[p16l8t3398r125b3489],
2	non	JJ	O	non	amod	8	SENT_334	[p16l151t3400r881b3489],
3	—	JJ	O	—	amod	8	SENT_334	[p16l151t3400r881b3489],
4	small	JJ	O	small	amod	8	SENT_334	[p16l151t3400r881b3489],
5	—	NN	O	—	nn	8	SENT_334	[p16l151t3400r881b3489],
6	cell	NN	O	cell	nn	8	SENT_334	[p16l151t3400r881b3489],
7	lung	NN	O	lung	nn	8	SENT_334	[p16l926t3400r1151b3515],
8	cancer	NN	O	cancer	pobj	1	SENT_334	[p16l1195t3428r1513b3489],
9	to	TO	O	to	_	0	SENT_334	[p16l1556t3418r1648b3489],
10	geﬁtinib	NN	O	geﬁtinib	prep_to	8	SENT_334	[p16l1696t3398r2135b3515],
11	.	.	O	.	_	0	SENT_334	[p16l1696t3398r2135b3515],

1	N	NN	O	n	nn	2	SENT_335	[p16l6t3557r92b3640],
2	EnglJ	NN	O	englj	nsubj	3	SENT_335	[p16l119t3549r404b3664],
3	Med	VBD	O	med	_	0	SENT_335	[p16l425t3549r642b3638],
4	2004	CD	DATE	2004	dobj	3	SENT_335	[p16l670t3555r1596b3658],
5	;	:	O	;	_	0	SENT_335	[p16l670t3555r1596b3658],
6	350:2129	CD	NUMBER	350:2129	number	7	SENT_335	[p16l670t3555r1596b3658],
7	—	CD	NUMBER	—	dep	4	SENT_335	[p16l670t3555r1596b3658],
8	39	CD	NUMBER	39	dep	7	SENT_335	[p16l670t3555r1596b3658],
9	.	.	O	.	_	0	SENT_335	[p16l670t3555r1596b3658],

1	10	CD	NUMBER	10	_	0	SENT_336	[p16l12t3706r145b3787],
2	.	.	O	.	_	0	SENT_336	[p16l12t3706r145b3787],

1	Paez	NNP	PERSON	Paez	nn	2	SENT_337	[p16l205t3704r426b3787],
2	JG	NNP	O	JG	_	0	SENT_337	[p16l459t3704r614b3807],
3	,	,	O	,	_	0	SENT_337	[p16l459t3704r614b3807],
4	Janne	NNP	PERSON	Janne	nn	5	SENT_337	[p16l652t3706r934b3801],
5	PA	NN	PERSON	pa	appos	2	SENT_337	[p16l976t3704r1131b3807],
6	,	,	O	,	_	0	SENT_337	[p16l976t3704r1131b3807],
7	Lee	NNP	PERSON	Lee	nn	8	SENT_337	[p16l1179t3706r1342b3787],
8	JC	NNP	PERSON	JC	appos	2	SENT_337	[p16l1375t3704r1519b3807],
9	,	,	O	,	_	0	SENT_337	[p16l1375t3704r1519b3807],
10	et	FW	O	et	nn	11	SENT_337	[p16l1569t3716r1658b3787],
11	al.	FW	O	al.	appos	2	SENT_337	[p16l1696t3698r1803b3787],
12	.	.	O	.	_	0	SENT_337	[p16l1696t3698r1803b3787],

1	EGFR	NN	ORGANIZATION	egfr	_	0	SENT_338	[p16l1853t3704r2153b3793],

1	mutations	NNS	O	mutation	_	0	SENT_339	[p17l8t33r505b124],
2	in	IN	O	in	_	0	SENT_339	[p17l552t33r646b121],
3	lung	NN	O	lung	nn	4	SENT_339	[p17l690t33r915b148],
4	cancer	NN	O	cancer	prep_in	1	SENT_339	[p17l956t61r1300b122],
5	:	:	O	:	_	0	SENT_339	[p17l956t61r1300b122],
6	correlation	NN	O	correlation	dep	1	SENT_339	[p17l1350t33r1883b122],
7	with	IN	O	with	_	0	SENT_339	[p17l1922t33r2141b124],
8	clinical	JJ	O	clinical	amod	9	SENT_339	[p17l8t182r356b271],
9	response	NN	O	response	prep_with	6	SENT_339	[p17l411t210r849b297],
10	to	TO	O	to	_	0	SENT_339	[p17l906t200r996b271],
11	geﬁtinib	NN	O	geﬁtinib	nn	12	SENT_339	[p17l1053t180r1463b297],
12	therapy	NN	O	therapy	prep_to	9	SENT_339	[p17l1521t182r1899b297],
13	.	.	O	.	_	0	SENT_339	[p17l1521t182r1899b297],

1	Science	NNP	O	Science	_	0	SENT_340	[p17l1964t182r2137b271, p17l8t360r227b420],
2	2004	CD	DATE	2004	num	1	SENT_340	[p17l256t337r1243b440],
3	;	:	O	;	_	0	SENT_340	[p17l256t337r1243b440],
4	304:1497	CD	NUMBER	304:1497	number	5	SENT_340	[p17l256t337r1243b440],
5	-500	CD	NUMBER	-500	dep	1	SENT_340	[p17l256t337r1243b440],
6	.	.	O	.	_	0	SENT_340	[p17l256t337r1243b440],

1	11	CD	NUMBER	11	_	0	SENT_341	[p17l12t490r145b569],
2	.	.	O	.	_	0	SENT_341	[p17l12t490r145b569],

1	Pao	NNP	O	Pao	nn	2	SENT_342	[p17l205t486r380b569],
2	W	NNP	O	W	_	0	SENT_342	[p17l409t488r529b589],
3	,	,	O	,	_	0	SENT_342	[p17l409t488r529b589],
4	Miller	NNP	PERSON	Miller	nn	5	SENT_342	[p17l565t480r861b569],
5	V	NNP	O	V	appos	2	SENT_342	[p17l885t488r966b589],
6	,	,	O	,	_	0	SENT_342	[p17l885t488r966b589],
7	Zakowski	NNP	O	Zakowski	nn	8	SENT_342	[p17l1004t480r1475b571],
8	M	NNP	O	M	appos	2	SENT_342	[p17l1503t488r1628b589],
9	,	,	O	,	_	0	SENT_342	[p17l1503t488r1628b589],
10	et	FW	O	et	nn	11	SENT_342	[p17l1668t498r1756b569],
11	al.	FW	O	al.	appos	2	SENT_342	[p17l1783t480r1891b569],
12	.	.	O	.	_	0	SENT_342	[p17l1783t480r1891b569],

1	EGF	NN	ORGANIZATION	egf	nn	4	SENT_343	[p17l1928t486r2139b569],
2	receptor	NN	O	receptor	nn	4	SENT_343	[p17l8t647r414b744],
3	gene	NN	O	gene	nn	4	SENT_343	[p17l475t658r704b744],
4	mutations	NNS	O	mutation	nsubjpass	17	SENT_343	[p17l769t629r1267b720],
5	are	VBP	O	be	cop	6	SENT_343	[p17l1332t659r1477b718],
6	common	JJ	O	common	_	0	SENT_343	[p17l1543t657r1984b718],
7	in	IN	O	in	_	0	SENT_343	[p17l2046t629r2141b717],
8	lung	NN	O	lung	nn	9	SENT_343	[p17l6t778r231b893],
9	cancers	NNS	O	cancer	prep_in	6	SENT_343	[p17l261t807r624b867],
10	from	IN	O	from	_	0	SENT_343	[p17l660t776r899b867],
11	“	CD	NUMBER	“	prep_from	9	SENT_343	[p17l936t782r1249b869],
12	never	RB	O	never	advmod	9	SENT_343	[p17l936t782r1249b869],
13	smokers	NNS	O	smoker	dep	9	SENT_343	[p17l1281t778r1746b869],
14	”	CD	NUMBER	”	tmod	6	SENT_343	[p17l1281t778r1746b869],
15	and	CC	O	and	_	0	SENT_343	[p17l1783t778r1962b867],
16	are	VBP	O	be	auxpass	17	SENT_343	[p17l1996t808r2141b867],
17	associated	VBN	O	associate	conj_and	6	SENT_343	[p17l8t927r513b1016],
18	with	IN	O	with	_	0	SENT_343	[p17l535t927r755b1018],
19	sensitivity	NN	O	sensitivity	prep_with	17	SENT_343	[p17l785t927r1271b1042],
20	of	IN	O	of	_	0	SENT_343	[p17l1294t925r1412b1016],
21	tumors	NNS	O	tumor	prep_of	19	SENT_343	[p17l1419t945r1767b1018],
22	to	TO	O	to	aux	23	SENT_343	[p17l1799t945r1891b1016],
23	geﬁ	VB	O	geﬁ	xcomp	17	SENT_343	[p17l1920t925r2139b1042],
24	tinib	NN	O	tinib	dobj	23	SENT_343	[p17l8t1075r231b1164],
25	and	CC	O	and	_	0	SENT_343	[p17l264t1075r444b1164],
26	erlotinib	NN	O	erlotinib	conj_and	24	SENT_343	[p17l475t1075r919b1164],
27	.	.	O	.	_	0	SENT_343	[p17l475t1075r919b1164],

1	Proc	NNP	O	Proc	nn	7	SENT_344	[p17l954t1081r1171b1164],
2	Natl	NNP	O	Natl	nn	7	SENT_344	[p17l1199t1075r1408b1164],
3	Acad	NNP	O	Acad	nn	7	SENT_344	[p17l1433t1075r1678b1164],
4	Sci	NNP	O	Sci	nn	7	SENT_344	[p17l1710t1075r1849b1164],
5	U	NNP	O	U	nn	7	SENT_344	[p17l1878t1083r1958b1164],
6	S	NNP	O	S	nn	7	SENT_344	[p17l1990t1081r2038b1164],
7	A	NNP	O	A	_	0	SENT_344	[p17l2068t1083r2145b1162],

1	2004	CD	DATE	2004	_	0	SENT_345	[p17l8t1230r994b1333],
2	;	:	O	;	_	0	SENT_345	[p17l8t1230r994b1333],
3	101:13306	CD	NUMBER	101:13306	number	4	SENT_345	[p17l8t1230r994b1333],
4	—	CD	NUMBER	—	dep	1	SENT_345	[p17l8t1230r994b1333],
5	11	CD	NUMBER	11	dep	4	SENT_345	[p17l8t1230r994b1333],
6	.	.	O	.	_	0	SENT_345	[p17l8t1230r994b1333],

1	12	CD	NUMBER	12	_	0	SENT_346	[p17l12t1383r145b1462],
2	.	.	O	.	_	0	SENT_346	[p17l12t1383r145b1462],

1	Sordella	NN	O	sordellum	nn	2	SENT_347	[p17l209t1373r606b1462],
2	R	NN	O	r	_	0	SENT_347	[p17l646t1379r744b1482],
3	,	,	O	,	_	0	SENT_347	[p17l646t1379r744b1482],
4	Bell	NNP	ORGANIZATION	Bell	nn	5	SENT_347	[p17l791t1373r976b1462],
5	DW	NNP	ORGANIZATION	DW	appos	2	SENT_347	[p17l1018t1381r1217b1482],
6	,	,	O	,	_	0	SENT_347	[p17l1018t1381r1217b1482],
7	Haber	NNP	ORGANIZATION	Haber	nn	8	SENT_347	[p17l1266t1373r1569b1462],
8	DA	NNP	ORGANIZATION	DA	appos	2	SENT_347	[p17l1606t1379r1785b1482],
9	,	,	O	,	_	0	SENT_347	[p17l1606t1379r1785b1482],
10	Settleman	NNP	O	Settleman	nn	12	SENT_347	[p17l1837t1373r2137b1462, p17l8t1550r225b1611],
11	J.	NNP	O	J.	nn	12	SENT_347	[p17l278t1530r346b1625],
12	Gefitinib	NNP	O	Gefitinib	appos	2	SENT_347	[p17l418t1520r1436b1637],
13	—	CD	NUMBER	—	num	16	SENT_347	[p17l418t1520r1436b1637],
14	sensitizing	VBG	O	sensitize	amod	16	SENT_347	[p17l418t1520r1436b1637],
15	EGFR	NN	ORGANIZATION	egfr	nn	16	SENT_347	[p17l1497t1528r1795b1617],
16	mutations	NNS	O	mutation	nsubj	20	SENT_347	[p17l1849t1540r2137b1613, p17l8t1671r248b1760],
17	in	IN	O	in	_	0	SENT_347	[p17l292t1671r386b1759],
18	lung	NN	O	lung	nn	19	SENT_347	[p17l426t1671r650b1786],
19	cancer	NN	O	cancer	prep_in	16	SENT_347	[p17l690t1700r1008b1760],
20	activate	VBP	O	activate	rcmod	12	SENT_347	[p17l1046t1671r1409b1762],
21	anti-apoptotic	JJ	O	anti-apoptotic	amod	22	SENT_347	[p17l1451t1671r2141b1786],
22	pathways	NNS	O	pathway	dobj	20	SENT_347	[p17l6t1820r489b1935],
23	.	.	O	.	_	0	SENT_347	[p17l6t1820r489b1935],

1	Science	NNP	O	Science	_	0	SENT_348	[p17l527t1820r889b1909],
2	2004	CD	DATE	2004	num	1	SENT_348	[p17l918t1826r1781b1929],
3	;	:	O	;	_	0	SENT_348	[p17l918t1826r1781b1929],
4	305:1163	CD	NUMBER	305:1163	number	5	SENT_348	[p17l918t1826r1781b1929],
5	-7	CD	NUMBER	-7	dep	1	SENT_348	[p17l918t1826r1781b1929],
6	.	.	O	.	_	0	SENT_348	[p17l918t1826r1781b1929],

1	13	CD	NUMBER	13	_	0	SENT_349	[p17l12t1979r145b2058],
2	.	.	O	.	_	0	SENT_349	[p17l12t1979r145b2058],

1	Cho	NN	O	cho	nn	2	SENT_350	[p17l207t1969r403b2058],
2	D	NN	O	d	_	0	SENT_350	[p17l441t1975r543b2078],
3	,	,	O	,	_	0	SENT_350	[p17l441t1975r543b2078],
4	Kocher	NNP	PERSON	Kocher	nn	5	SENT_350	[p17l586t1969r938b2061],
5	O	NNP	PERSON	O	appos	2	SENT_350	[p17l972t1975r1075b2078],
6	,	,	O	,	_	0	SENT_350	[p17l972t1975r1075b2078],
7	Tenen	NNP	PERSON	Tenen	nn	8	SENT_350	[p17l1115t1975r1412b2058],
8	DG	NNS	O	dg	appos	2	SENT_350	[p17l1447t1975r1642b2078],
9	,	,	O	,	_	0	SENT_350	[p17l1447t1975r1642b2078],
10	et	FW	O	et	nn	11	SENT_350	[p17l1688t1987r1775b2058],
11	al.	FW	O	al.	appos	2	SENT_350	[p17l1807t1969r1915b2058],
12	.	.	O	.	_	0	SENT_350	[p17l1807t1969r1915b2058],

1	Unusual	JJ	O	unusual	amod	2	SENT_351	[p17l1958t1977r2139b2058, p17l8t2118r265b2209],
2	cases	NNS	O	case	_	0	SENT_351	[p17l302t2148r551b2207],
3	in	IN	O	in	_	0	SENT_351	[p17l590t2118r684b2206],
4	multiple	JJ	O	multiple	amod	5	SENT_351	[p17l721t2118r1125b2233],
5	myeloma	NN	O	myeloma	prep_in	2	SENT_351	[p17l1163t2118r1610b2233],
6	and	CC	O	and	_	0	SENT_351	[p17l1646t2118r1823b2207],
7	a	DT	O	a	det	9	SENT_351	[p17l1861t2148r1913b2207],
8	dramatic	JJ	O	dramatic	amod	9	SENT_351	[p17l1948t2118r2139b2207, p17l8t2267r276b2356],
9	response	NN	O	response	prep_in	2	SENT_351	[p17l330t2295r765b2382],
10	in	IN	O	in	_	0	SENT_351	[p17l819t2267r913b2355],
11	metastatic	JJ	O	metastatic	amod	13	SENT_351	[p17l968t2267r1467b2356],
12	lung	NN	O	lung	nn	13	SENT_351	[p17l1521t2267r1744b2382],
13	cancer	NN	O	cancer	prep_in	9	SENT_351	[p17l1797t2296r2135b2356],
14	:	:	O	:	_	0	SENT_351	[p17l1797t2296r2135b2356],
15	case	NN	O	case	dep	9	SENT_351	[p17l8t2446r211b2505],
16	4	CD	NUMBER	4	dep	15	SENT_351	[p17l262t2422r348b2505],
17	:	:	O	:	_	0	SENT_351	[p17l262t2422r348b2505],
18	mutation	NN	O	mutation	dep	9	SENT_351	[p17l405t2416r851b2507],
19	of	IN	O	of	_	0	SENT_351	[p17l904t2414r1020b2505],
20	the	DT	O	the	det	24	SENT_351	[p17l1052t2416r1201b2505],
21	epidermal	JJ	O	epidermal	amod	24	SENT_351	[p17l1254t2416r1742b2531],
22	growth	NN	O	growth	nn	24	SENT_351	[p17l1793t2416r2141b2531],
23	factor	NN	O	factor	nn	24	SENT_351	[p17l8t2563r290b2654],
24	receptor	NN	O	receptor	prep_of	18	SENT_351	[p17l336t2583r738b2680],
25	in	IN	O	in	_	0	SENT_351	[p17l785t2565r879b2653],
26	an	DT	O	a	det	28	SENT_351	[p17l928t2594r1044b2654],
27	elderly	JJ	O	elderly	amod	28	SENT_351	[p17l1095t2565r1418b2680],
28	man	NN	O	man	prep_in	2	SENT_351	[p17l1463t2593r1678b2654],
29	with	IN	O	with	_	0	SENT_351	[p17l1723t2565r1940b2656],
30	ad52	NN	O	ad52	prep_with	2	SENT_351	[p17l1990t2565r2139b2654, p17l695t2761r729b2782],
31	;	:	O	;	_	0	SENT_351	[p17l1990t2565r2139b2654, p17l695t2761r729b2782],

1	w	NN	O	w	_	0	SENT_352	[p17l781t2761r802b2776],
2	.	.	O	.	_	0	SENT_352	[p17l852t2772r856b2776],

1	.	.	O	.	_	0	SENT_353	[p17l932t2772r936b2776],

1	The	DT	O	the	det	4	SENT_354	[p17l702t2793r753b2816],
2	New	NNP	O	New	nn	4	SENT_354	[p17l762t2794r824b2816],
3	England	NNP	O	England	nn	4	SENT_354	[p17l833t2793r944b2823],
4	Journal	NNP	O	Journal	_	0	SENT_354	[p17l952t2793r1050b2816],
5	of	IN	O	of	_	0	SENT_354	[p17l1060t2793r1088b2816],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_354	[p17l1095t2793r1220b2816],

1	Downloaded	VBN	O	download	_	0	SENT_355	[p17l144t2833r314b2856],
2	from	IN	O	from	_	0	SENT_355	[p17l323t2833r387b2856],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_355	[p17l396t2833r514b2863],
4	at	IN	O	at	_	0	SENT_355	[p17l524t2837r547b2856],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_355	[p17l556t2833r739b2856],
6	on	IN	O	on	_	0	SENT_355	[p17l748t2840r780b2856],
7	Janu	NNP	DATE	Janu	prep_on	1	SENT_355	[p17l789t2833r849b2856],
8	2014	CD	DATE	2014	num	7	SENT_355	[p17l935t2833r1007b2856],
9	.	.	O	.	_	0	SENT_355	[p17l935t2833r1007b2856],

1	or	CC	O	or	dep	4	SENT_356	[p17l1037t2840r1064b2856],
2	ersonal	JJ	O	ersonal	amod	3	SENT_356	[p17l1089t2833r1184b2856],
3	use	NN	O	use	npadvmod	4	SENT_356	[p17l1194t2840r1237b2856],
4	only	RB	O	only	_	0	SENT_356	[p17l1247t2833r1311b2863],
5	.	.	O	.	_	0	SENT_356	[p17l1247t2833r1311b2863],

1	No	DT	O	no	det	3	SENT_357	[p17l1322t2833r1362b2856],
2	other	JJ	O	other	amod	3	SENT_357	[p17l1372t2833r1440b2856],
3	uses	NNS	O	use	_	0	SENT_357	[p17l1448t2840r1504b2856],
4	without	IN	O	without	_	0	SENT_357	[p17l1514t2833r1615b2856],
5	permission	NN	O	permission	prep_without	3	SENT_357	[p17l1624t2833r1776b2863],
6	.	.	O	.	_	0	SENT_357	[p17l1624t2833r1776b2863],

1	ww	NN	O	ww	_	0	SENT_358	[p17l804t2761r848b2776],
2	NEJM	NNP	O	NEJM	dep	1	SENT_358	[p17l862t2761r926b2782],
3	one	CD	NUMBER	one	num	2	SENT_358	[p17l940t2761r992b2776],
4	FEBRUARY	NNP	DATE	FEBRUARY	dep	1	SENT_358	[p17l1032t2761r1159b2776],
5	24,2005	CD	DATE	24,2005	num	4	SENT_358	[p17l1171t2761r1285b2782],

1	Copyright	NN	O	copyright	_	0	SENT_359	[p17l494t2874r629b2904],
2	©	CD	NUMBER	©	num	5	SENT_359	[p17l638t2874r661b2897],
3	2005	CD	DATE	2005	num	5	SENT_359	[p17l672t2874r735b2897],
4	Massac	NNP	LOCATION	Massac	nn	5	SENT_359	[p17l746t2875r844b2897],
5	usetts	NNS	O	usett	dep	1	SENT_359	[p17l863t2878r937b2897],
6	Medica	NNP	ORGANIZATION	Medica	nn	7	SENT_359	[p17l947t2874r1046b2897],
7	ociety	NN	O	ociety	dep	5	SENT_359	[p17l1083t2874r1170b2904],
8	.	.	O	.	_	0	SENT_359	[p17l1083t2874r1170b2904],

1	All	DT	O	all	det	2	SENT_360	[p17l1181t2874r1223b2897],
2	rights	NNS	O	rights	nsubj	3	SENT_360	[p17l1232t2874r1306b2904],
3	reserved	VBN	O	reserve	_	0	SENT_360	[p17l1316t2874r1435b2897],
4	.	.	O	.	_	0	SENT_360	[p17l1316t2874r1435b2897],

1	vanced	JJ	O	vanced	amod	13	SENT_361	[p17l6t3195r359b3303],
2	,	,	O	,	_	0	SENT_361	[p17l6t3195r359b3303],
3	geﬁtinib	JJ	O	geﬁtinib	amod	4	SENT_361	[p17l400t3195r1368b3309],
4	—	NN	O	—	npadvmod	8	SENT_361	[p17l400t3195r1368b3309],
5	responsive	JJ	O	responsive	amod	7	SENT_361	[p17l400t3195r1368b3309],
6	,	,	O	,	_	0	SENT_361	[p17l400t3195r1368b3309],
7	non	JJ	O	non	amod	4	SENT_361	[p17l1409t3195r2094b3284],
8	—	JJ	O	—	amod	13	SENT_361	[p17l1409t3195r2094b3284],
9	small	JJ	O	small	amod	13	SENT_361	[p17l1409t3195r2094b3284],
10	—	NN	O	—	nn	13	SENT_361	[p17l1409t3195r2094b3284],
11	cell	NN	O	cell	nn	13	SENT_361	[p17l1409t3195r2094b3284],
12	lung	NN	O	lung	nn	13	SENT_361	[p17l10t3340r227b3454],
13	cancer	NN	O	cancer	_	0	SENT_361	[p17l251t3349r641b3443],
14	]	CD	NUMBER	]	num	16	SENT_361	[p17l251t3349r641b3443],
15	Clin	NNP	O	Clin	nn	16	SENT_361	[p17l665t3340r858b3429],
16	Oncol	NNP	O	Oncol	dep	13	SENT_361	[p17l885t3342r1170b3429],
17	2005	CD	DATE	2005	num	16	SENT_361	[p17l1197t3348r1425b3429],
18	;	:	O	;	_	0	SENT_361	[p17l1440t3348r1912b3448],
19	23:235	CD	NUMBER	23:235	num	20	SENT_361	[p17l1440t3348r1912b3448],
20	—	NN	O	—	dep	13	SENT_361	[p17l1440t3348r1912b3448],
21	7	CD	NUMBER	7	dep	20	SENT_361	[p17l1440t3348r1912b3448],
22	.	.	O	.	_	0	SENT_361	[p17l1440t3348r1912b3448],

1	14	CD	NUMBER	14	_	0	SENT_362	[p17l15t3496r144b3574],
2	.	.	O	.	_	0	SENT_362	[p17l15t3496r144b3574],

1	Stamos	NNP	PERSON	Stamos	nn	2	SENT_363	[p17l208t3492r557b3574],
2	J	NNP	PERSON	J	_	0	SENT_363	[p17l580t3493r647b3593],
3	,	,	O	,	_	0	SENT_363	[p17l580t3493r647b3593],
4	Sliwkowski	NNP	O	Sliwkowski	nn	5	SENT_363	[p17l689t3485r1231b3574],
5	MX	NNP	O	MX	appos	2	SENT_363	[p17l1259t3493r1450b3593],
6	,	,	O	,	_	0	SENT_363	[p17l1259t3493r1450b3593],
7	Eigenbrot	NNP	O	Eigenbrot	nn	9	SENT_363	[p17l1488t3485r1966b3599],
8	C.	NNP	O	C.	nn	9	SENT_363	[p17l1993t3492r2086b3574],
9	Structure	NN	O	structure	appos	2	SENT_363	[p17l14t3638r446b3719],
10	of	IN	O	of	_	0	SENT_363	[p17l477t3630r590b3719],
11	the	DT	O	the	det	15	SENT_363	[p17l601t3630r747b3719],
12	epidermal	JJ	O	epidermal	amod	15	SENT_363	[p17l778t3630r1259b3744],
13	growth	NN	O	growth	nn	15	SENT_363	[p17l1288t3630r1630b3744],
14	factor	NN	O	factor	nn	15	SENT_363	[p17l1661t3630r1939b3719],
15	receptor	NN	O	receptor	prep_of	9	SENT_363	[p17l1966t3661r2092b3719, p18l12t41r313b136],

1	kinase	NN	O	kinase	nn	2	SENT_364	[p18l340t24r646b113],
2	domain	NN	O	domain	_	0	SENT_364	[p18l677t22r1042b111],
3	alone	RB	O	alone	dep	6	SENT_364	[p18l1073t22r1331b111],
4	and	CC	O	and	_	0	SENT_364	[p18l1360t22r1537b111],
5	in	IN	O	in	conj_and	3	SENT_364	[p18l1566t24r1658b109],
6	complex	NN	O	complex	dep	2	SENT_364	[p18l1690t24r2096b136],
7	with	IN	O	with	_	0	SENT_364	[p18l6t167r220b256],
8	a	DT	O	a	det	10	SENT_364	[p18l252t198r301b256],
9	4-anilinoquinazoline	JJ	O	4-anilinoquinazoline	amod	10	SENT_364	[p18l332t167r1333b281],
10	inhibitor	NN	O	inhibitor	prep_with	6	SENT_364	[p18l1366t169r1807b256],
11	.	.	O	.	_	0	SENT_364	[p18l1366t169r1807b256],

1	J	NNP	O	J	nn	3	SENT_365	[p18l1834t176r1877b270],
2	Biol	NNP	O	Biol	nn	3	SENT_365	[p18l1902t167r2092b256],
3	Chem	NNP	O	Chem	_	0	SENT_365	[p18l12t312r295b402],
4	2002	CD	DATE	2002	num	3	SENT_365	[p18l322t320r1285b421],
5	;	:	O	;	_	0	SENT_365	[p18l322t320r1285b421],
6	277:46265	CD	NUMBER	277:46265	number	7	SENT_365	[p18l322t320r1285b421],
7	-72	CD	NUMBER	-72	dep	3	SENT_365	[p18l322t320r1285b421],
8	.	.	O	.	_	0	SENT_365	[p18l322t320r1285b421],

1	15	CD	NUMBER	15	_	0	SENT_366	[p18l15t470r144b548],
2	.	.	O	.	_	0	SENT_366	[p18l15t470r144b548],

1	Morris	NNP	ORGANIZATION	Morris	nn	2	SENT_367	[p18l202t460r522b548],
2	GM	NNP	ORGANIZATION	GM	_	0	SENT_367	[p18l565t466r771b567],
3	,	,	O	,	_	0	SENT_367	[p18l565t466r771b567],
4	Goodsell	NNP	ORGANIZATION	Goodsell	nn	5	SENT_367	[p18l819t458r1248b548],
5	DS	NN	ORGANIZATION	d	appos	2	SENT_367	[p18l1288t466r1450b567],
6	,	,	O	,	_	0	SENT_367	[p18l1288t466r1450b567],
7	Halliday	NNP	O	Halliday	nn	8	SENT_367	[p18l1498t458r1896b571],
8	RS	NN	O	r	appos	2	SENT_367	[p18l1931t466r2086b567],
9	,	,	O	,	_	0	SENT_367	[p18l1931t466r2086b567],
10	et	FW	O	et	nn	11	SENT_367	[p18l12t623r99b693],
11	al.	FW	O	al.	appos	2	SENT_367	[p18l122t604r229b693],
12	.	.	O	.	_	0	SENT_367	[p18l122t604r229b693],

1	Automated	VBN	O	automate	amod	2	SENT_368	[p18l260t604r792b693],
2	docking	NN	O	docking	nsubj	3	SENT_368	[p18l823t604r1213b718],
3	using	VBG	O	use	_	0	SENT_368	[p18l1240t606r1506b718],
4	a	DT	O	a	det	6	SENT_368	[p18l1533t635r1582b693],
5	Lamarcl	NN	O	lamarcl	dep	6	SENT_368	[p18l1609t604r2092b693, p18l10t778r124b838],
6	<	JJR	O	<	nsubj	9	SENT_368	[p18l1609t604r2092b693, p18l10t778r124b838],
7	ian	CD	NUMBER	ian	num	9	SENT_368	[p18l1609t604r2092b693, p18l10t778r124b838],
8	genetic	JJ	O	genetic	amod	9	SENT_368	[p18l155t751r497b863],
9	algorithm	NN	O	algorithm	xcomp	3	SENT_368	[p18l528t749r1002b863],
10	and	CC	O	and	_	0	SENT_368	[p18l1033t749r1209b838],
11	empirical	JJ	O	empirical	amod	12	SENT_368	[p18l1242t749r1689b863],
12	binding	NN	O	binding	dep	15	SENT_368	[p18l1721t749r2096b863],
13	free	JJ	O	free	amod	15	SENT_368	[p18l12t894r189b983],
14	energy	NN	O	energy	nn	15	SENT_368	[p18l221t923r540b1008],
15	ﬁmction	NN	O	ﬁmction	conj_and	3	SENT_368	[p18l566t894r996b983],
16	.	.	O	.	_	0	SENT_368	[p18l566t894r996b983],

1	J	NNP	O	J	nn	3	SENT_369	[p18l1021t903r1064b997],
2	Comput	NNP	O	Comput	nn	3	SENT_369	[p18l1093t902r1487b1008],
3	Chem	NNP	O	Chem	_	0	SENT_369	[p18l1512t896r1795b983],
4	1998	CD	DATE	1998	num	3	SENT_369	[p18l1830t902r2088b1002],
5	;	:	O	;	_	0	SENT_369	[p18l1830t902r2088b1002],
6	19:1639	CD	NUMBER	19:1639	number	7	SENT_369	[p18l15t1047r582b1128],
7	-62	CD	NUMBER	-62	dep	3	SENT_369	[p18l15t1047r582b1128],
8	.	.	O	.	_	0	SENT_369	[p18l15t1047r582b1128],

1	16	CD	NUMBER	16	_	0	SENT_370	[p18l15t1195r144b1274],
2	.	.	O	.	_	0	SENT_370	[p18l15t1195r144b1274],

1	Schuettelkopf	NNP	O	Schuettelkopf	nn	2	SENT_371	[p18l208t1184r885b1297],
2	AW	NNP	O	AW	_	0	SENT_371	[p18l941t1192r1124b1293],
3	,	,	O	,	_	0	SENT_371	[p18l941t1192r1124b1293],
4	van	NNP	O	van	nn	6	SENT_371	[p18l1207t1213r1372b1274],
5	Aalten	NNP	O	Aalten	nn	6	SENT_371	[p18l1448t1184r1756b1274],
6	DMF	NNP	O	DMF	appos	2	SENT_371	[p18l1834t1192r2086b1274],
7	.	.	O	.	_	0	SENT_371	[p18l1834t1192r2086b1274],

1	PRODRG	NN	O	prodrg	_	0	SENT_372	[p18l10t1338r483b1425],
2	;	:	O	;	_	0	SENT_372	[p18l10t1338r483b1425],
3	a	DT	O	a	det	4	SENT_372	[p18l528t1361r579b1419],
4	tool	NN	O	tool	dep	1	SENT_372	[p18l619t1332r804b1419],
5	for	IN	O	for	_	0	SENT_372	[p18l844t1330r982b1419],
6	high-throughput	JJ	O	high-throughput	amod	7	SENT_372	[p18l1021t1330r1834b1444],
7	crystallography	NN	O	crystallography	prep_for	4	SENT_372	[p18l1871t1361r2092b1444, p18l12t1475r559b1589],
8	of	IN	O	of	_	0	SENT_372	[p18l629t1475r741b1564],
9	protein-ligand	JJ	O	protein-ligand	amod	10	SENT_372	[p18l792t1475r1481b1589],
10	complexes	NNS	O	complex	prep_of	7	SENT_372	[p18l1556t1477r2086b1589],
11	.	.	O	.	_	0	SENT_372	[p18l1556t1477r2086b1589],

1	Acta	NNP	PERSON	Acta	nn	5	SENT_373	[p18l8t1629r222b1709],
2	Crystallogr	NNP	PERSON	Crystallogr	nn	5	SENT_373	[p18l248t1622r777b1734],
3	D	NNP	O	D	nn	5	SENT_373	[p18l799t1628r877b1709],
4	Biol	NNP	O	Biol	nn	5	SENT_373	[p18l902t1620r1093b1709],
5	Crystallogr	NNP	O	Crystallogr	_	0	SENT_373	[p18l1120t1620r1649b1734],
6	2004	CD	DATE	2004	num	5	SENT_373	[p18l1673t1628r2088b1728],
7	;	:	O	;	_	0	SENT_373	[p18l1673t1628r2088b1728],
8	60	CD	NUMBER	60	num	10	SENT_373	[p18l1673t1628r2088b1728],
9	:	:	O	:	_	0	SENT_373	[p18l1673t1628r2088b1728],
10	1355-63	CD	NUMBER	1355-63	dep	5	SENT_373	[p18l15t1773r429b1854],
11	.	.	O	.	_	0	SENT_373	[p18l15t1773r429b1854],

1	17	CD	NUMBER	17	_	0	SENT_374	[p18l15t1922r144b2000],
2	.	.	O	.	_	0	SENT_374	[p18l15t1922r144b2000],

1	Discafani	NNP	O	Discafani	nn	2	SENT_375	[p18l204t1910r664b2000],
2	CM	NN	O	cm	_	0	SENT_375	[p18l691t1918r887b2019],
3	,	,	O	,	_	0	SENT_375	[p18l691t1918r887b2019],
4	Carroll	NNP	PERSON	Carroll	nn	5	SENT_375	[p18l922t1910r1260b2000],
5	ML	NNP	O	ML	appos	2	SENT_375	[p18l1285t1918r1471b2019],
6	,	,	O	,	_	0	SENT_375	[p18l1285t1918r1471b2019],
7	Floyd	NNP	PERSON	Floyd	nn	9	SENT_375	[p18l1504t1910r1770b2023],
8	MB	NNP	PERSON	MB	nn	9	SENT_375	[p18l1795t1918r1960b2000],
9	Jr	NNP	PERSON	Jr	appos	2	SENT_375	[p18l1979t1918r2084b2019],
10	,	,	O	,	_	0	SENT_375	[p18l1979t1918r2084b2019],
11	et	FW	O	et	nn	12	SENT_375	[p18l12t2075r99b2145],
12	al.	FW	O	al.	appos	2	SENT_375	[p18l146t2056r255b2145],
13	.	.	O	.	_	0	SENT_375	[p18l146t2056r255b2145],

1	Irreversible	JJ	O	irreversible	amod	2	SENT_376	[p18l312t2056r864b2145],
2	inhibition	NN	O	inhibition	_	0	SENT_376	[p18l916t2058r1401b2145],
3	of	IN	O	of	_	0	SENT_376	[p18l1455t2056r1570b2145],
4	epidermal	JJ	O	epidermal	prep_of	2	SENT_376	[p18l1603t2056r2092b2170],

1	BRIEF	JJ	O	brief	amod	2	SENT_377	[p18l325t2607r511b2642],
2	REPORT	NN	O	report	_	0	SENT_377	[p18l539t2607r786b2642],

1	growth	NN	O	growth	nn	5	SENT_378	[p18l49t2784r219b2840],
2	factor	NN	O	factor	nn	5	SENT_378	[p18l232t2784r371b2828],
3	receptor	NN	O	receptor	nn	5	SENT_378	[p18l383t2793r581b2840],
4	tyrosine	NN	O	tyrosine	nn	5	SENT_378	[p18l593t2785r782b2840],
5	kinase	NN	O	kinase	_	0	SENT_378	[p18l795t2784r947b2828],
6	with	IN	O	with	_	0	SENT_378	[p18l958t2784r1065b2828],
7	D	NN	O	d	prep_with	5	SENT_378	[p18l1137t2788r1186b2837],
8	,	,	O	,	_	0	SENT_378	[p18l1137t2788r1186b2837],
9	Sawyers	NNP	O	Sawyers	nn	10	SENT_378	[p18l1216t2787r1400b2839],
10	CL	NN	O	cl	appos	7	SENT_378	[p18l1426t2787r1502b2828],
11	.	.	O	.	_	0	SENT_378	[p18l1426t2787r1502b2828],

1	Overriding	JJ	O	overriding	amod	2	SENT_379	[p18l1530t2784r1783b2840],
2	imatinib	NN	O	imatinib	_	0	SENT_379	[p18l1806t2784r2002b2828],
3	resisin	FW	O	resisin	nn	5	SENT_379	[p18l2029t2785r2153b2828, p18l49t2855r94b2897],
4	vivo	FW	O	vivo	nn	5	SENT_379	[p18l135t2855r228b2898],
5	activity	NN	O	activity	dep	2	SENT_379	[p18l271t2855r438b2910],
6	by	IN	O	by	_	0	SENT_379	[p18l479t2854r533b2910],
7	N	NN	O	n	prep_by	5	SENT_379	[p18l573t2854r1064b2910],
8	-	:	O	-	_	0	SENT_379	[p18l573t2854r1064b2910],
9	[	NN	O	[	dep	5	SENT_379	[p18l573t2854r1064b2910],
10	4	CD	NUMBER	4	dep	9	SENT_379	[p18l573t2854r1064b2910],
11	-	:	O	-	_	0	SENT_379	[p18l573t2854r1064b2910],
12	[	CD	NUMBER	[	number	13	SENT_379	[p18l573t2854r1064b2910],
13	(	CD	NUMBER	(	dep	5	SENT_379	[p18l573t2854r1064b2910],
14	3-bromophe	NN	O	3-bromophe	dep	13	SENT_379	[p18l573t2854r1064b2910],
15	-	:	O	-	_	0	SENT_379	[p18l573t2854r1064b2910],
16	tance	NN	O	tance	dep	5	SENT_379	[p18l1138t2863r1261b2898],
17	with	IN	O	with	_	0	SENT_379	[p18l1273t2854r1377b2898],
18	a	DT	O	a	det	22	SENT_379	[p18l1390t2869r1415b2898],
19	novel	JJ	O	novel	amod	22	SENT_379	[p18l1428t2854r1551b2898],
20	ABL	NN	ORGANIZATION	abl	nn	22	SENT_379	[p18l1563t2858r1661b2898],
21	kinase	NN	O	kinase	nn	22	SENT_379	[p18l1674t2854r1823b2898],
22	inhibitor	NN	O	inhibitor	prep_with	16	SENT_379	[p18l1836t2854r2051b2898],
23	.	.	O	.	_	0	SENT_379	[p18l1836t2854r2051b2898],

1	Scinyl	NNP	O	Scinyl	_	0	SENT_380	[p18l2069t2855r2152b2898, p18l49t2924r1054b2980],
2	)	CD	NUMBER	)	num	1	SENT_380	[p18l2069t2855r2152b2898, p18l49t2924r1054b2980],
3	amino	NN	O	amino	prep	1	SENT_380	[p18l2069t2855r2152b2898, p18l49t2924r1054b2980],
4	]	CD	NUMBER	]	num	5	SENT_380	[p18l2069t2855r2152b2898, p18l49t2924r1054b2980],
5	-6	CD	NUMBER	-6	dep	3	SENT_380	[p18l2069t2855r2152b2898, p18l49t2924r1054b2980],
6	-	:	O	-	_	0	SENT_380	[p18l2069t2855r2152b2898, p18l49t2924r1054b2980],
7	quinazolinyl	NN	O	quinazolinyl	dep	1	SENT_380	[p18l2069t2855r2152b2898, p18l49t2924r1054b2980],
8	]	CD	NUMBER	]	num	9	SENT_380	[p18l2069t2855r2152b2898, p18l49t2924r1054b2980],
9	-2	CD	NUMBER	-2	dep	7	SENT_380	[p18l2069t2855r2152b2898, p18l49t2924r1054b2980],
10	-	:	O	-	_	0	SENT_380	[p18l2069t2855r2152b2898, p18l49t2924r1054b2980],
11	butynamide	NN	O	butynamide	nn	13	SENT_380	[p18l2069t2855r2152b2898, p18l49t2924r1054b2980],
12	(	CD	NUMBER	(	num	13	SENT_380	[p18l52t2998r379b3047],
13	CL-387	NN	O	cl-387	dep	1	SENT_380	[p18l52t2998r379b3047],
14	,785	CD	NUMBER	,785	num	15	SENT_380	[p18l52t2998r379b3047],
15	)	NN	O	)	dep	13	SENT_380	[p18l52t2998r379b3047],
16	.	.	O	.	_	0	SENT_380	[p18l52t2998r379b3047],

1	Biochem	NNP	O	Biochem	nn	2	SENT_381	[p18l410t2994r621b3038],
2	Pharmacol	NNP	O	Pharmacol	_	0	SENT_381	[p18l649t2995r904b3038],
3	1999	CD	DATE	1999	num	2	SENT_381	[p18l934t2998r1062b3047],
4	;	:	O	;	_	0	SENT_381	[p18l934t2998r1062b3047],
5	57:917	CD	NUMBER	57:917	number	6	SENT_381	[p18l50t3068r304b3108],
6	-25	CD	NUMBER	-25	dep	2	SENT_381	[p18l50t3068r304b3108],
7	.	.	O	.	_	0	SENT_381	[p18l50t3068r304b3108],

1	18	CD	NUMBER	18	_	0	SENT_382	[p18l51t3139r114b3178],
2	.	.	O	.	_	0	SENT_382	[p18l51t3139r114b3178],

1	Gorre	NNP	ORGANIZATION	Gorre	nn	2	SENT_383	[p18l144t3137r279b3178],
2	ME	NNP	O	ME	_	0	SENT_383	[p18l299t3138r391b3187],
3	,	,	O	,	_	0	SENT_383	[p18l299t3138r391b3187],
4	Mohammed	NNP	PERSON	Mohammed	nn	5	SENT_383	[p18l413t3134r699b3178],
5	M	NNP	PERSON	M	appos	2	SENT_383	[p18l719t3138r779b3187],
6	,	,	O	,	_	0	SENT_383	[p18l719t3138r779b3187],
7	Ellwood	NNP	PERSON	Ellwood	nn	8	SENT_383	[p18l802t3134r994b3178],
8	K	NNP	PERSON	K	appos	2	SENT_383	[p18l1014t3138r1062b3187],
9	,	,	O	,	_	0	SENT_383	[p18l1014t3138r1062b3187],
10	et	FW	O	et	nn	11	SENT_383	[p18l49t3213r92b3248],
11	al.	FW	O	al.	appos	2	SENT_383	[p18l111t3204r163b3248],
12	.	.	O	.	_	0	SENT_383	[p18l111t3204r163b3248],

1	Clinical	JJ	O	clinical	amod	2	SENT_384	[p18l188t3204r365b3248],
2	resistance	NN	O	resistance	nsubj	7	SENT_384	[p18l387t3205r620b3248],
3	to	TO	O	to	_	0	SENT_384	[p18l642t3213r685b3248],
4	STI-571	NN	O	sti-571	nn	6	SENT_384	[p18l709t3208r892b3248],
5	cancer	NN	O	cancer	nn	6	SENT_384	[p18l915t3219r1066b3248],
6	therapy	NN	O	therapy	prep_to	2	SENT_384	[p18l49t3274r224b3330],
7	caused	VBN	O	cause	_	0	SENT_384	[p18l241t3274r398b3318],
8	by	IN	O	by	_	0	SENT_384	[p18l418t3275r471b3330],
9	BCR-ABL	NN	O	bcr-abl	nn	11	SENT_384	[p18l487t3278r704b3321],
10	gene	NN	O	gene	nn	11	SENT_384	[p18l722t3289r831b3330],
11	mutation	NN	O	mutation	prep_by	7	SENT_384	[p18l850t3275r1064b3318],
12	or	CC	O	or	_	0	SENT_384	[p18l49t3358r99b3388],
13	ampliﬁcation	NN	O	ampliﬁcation	prep_by	7	SENT_384	[p18l110t3344r435b3400],
14	.	.	O	.	_	0	SENT_384	[p18l110t3344r435b3400],

1	Science	NNP	O	Science	_	0	SENT_385	[p18l453t3345r625b3388],
2	2001	CD	DATE	2001	num	1	SENT_385	[p18l639t3348r1050b3397],
3	;	:	O	;	_	0	SENT_385	[p18l639t3348r1050b3397],
4	293:876	CD	NUMBER	293:876	number	5	SENT_385	[p18l639t3348r1050b3397],
5	-80	CD	NUMBER	-80	dep	1	SENT_385	[p18l639t3348r1050b3397],
6	.	.	O	.	_	0	SENT_385	[p18l639t3348r1050b3397],

1	19	CD	NUMBER	19	_	0	SENT_386	[p18l51t3419r114b3458],
2	.	.	O	.	_	0	SENT_386	[p18l51t3419r114b3458],

1	Chen	NNP	PERSON	Chen	nn	2	SENT_387	[p18l144t3414r266b3458],
2	LL	NNP	O	LL	_	0	SENT_387	[p18l283t3418r352b3467],
3	,	,	O	,	_	0	SENT_387	[p18l283t3418r352b3467],
4	Trent	NNP	PERSON	Trent	nn	5	SENT_387	[p18l371t3418r499b3457],
5	JC	NNP	PERSON	JC	appos	2	SENT_387	[p18l508t3418r577b3467],
6	,	,	O	,	_	0	SENT_387	[p18l508t3418r577b3467],
7	Wu	NNP	O	Wu	nn	8	SENT_387	[p18l596t3418r675b3458],
8	EF	NNP	O	EF	appos	2	SENT_387	[p18l692t3418r759b3467],
9	,	,	O	,	_	0	SENT_387	[p18l692t3418r759b3467],
10	et	FW	O	et	nn	11	SENT_387	[p18l780t3423r823b3457],
11	al.	FW	O	al.	appos	2	SENT_387	[p18l837t3414r889b3458],
12	.	.	O	.	_	0	SENT_387	[p18l837t3414r889b3458],

1	A	DT	O	a	det	3	SENT_388	[p18l908t3418r945b3457],
2	missense	NN	O	missense	nn	3	SENT_388	[p18l961t3415r1064b3457, p18l50t3498r177b3528],
3	mutation	NN	O	mutation	nsubj	9	SENT_388	[p18l191t3485r405b3528],
4	in	IN	O	in	_	0	SENT_388	[p18l419t3485r463b3527],
5	KIT	NN	O	kit	nn	7	SENT_388	[p18l477t3488r565b3529],
6	kinase	NN	O	kinase	nn	7	SENT_388	[p18l577t3484r726b3528],
7	domain	NN	O	domain	prep_in	3	SENT_388	[p18l740t3484r919b3528],
8	1	CD	NUMBER	1	dep	7	SENT_388	[p18l935t3488r959b3527],
9	correlates	VBZ	O	correlate	_	0	SENT_388	[p18l973t3498r1064b3528, p18l49t3555r199b3598],
10	with	IN	O	with	_	0	SENT_388	[p18l213t3555r318b3598],
11	imatinib	NN	O	imatinib	nn	12	SENT_388	[p18l333t3555r529b3598],
12	resistance	NN	O	resistance	prep_with	9	SENT_388	[p18l546t3555r778b3598],
13	in	IN	O	in	_	0	SENT_388	[p18l793t3555r838b3597],
14	gastrointestinal	JJ	O	gastrointestinal	amod	16	SENT_388	[p18l854t3555r1064b3610, p18l49t3624r219b3668],
15	stromal	JJ	O	stromal	amod	16	SENT_388	[p18l242t3624r419b3668],
16	tumors	NNS	O	tumor	prep_in	12	SENT_388	[p18l441t3633r621b3668],
17	.	.	O	.	_	0	SENT_388	[p18l441t3633r621b3668],

1	Cancer	NNP	O	Cancer	nn	2	SENT_389	[p18l647t3628r810b3668],
2	Res	NNP	O	Res	_	0	SENT_389	[p18l829t3628r911b3671],
3	2004	CD	DATE	2004	num	2	SENT_389	[p18l935t3628r1063b3677],
4	;	:	O	;	_	0	SENT_389	[p18l935t3628r1063b3677],
5	64:5913	CD	NUMBER	64:5913	number	6	SENT_389	[p18l49t3698r299b3738],
6	-9	CD	NUMBER	-9	dep	2	SENT_389	[p18l49t3698r299b3738],
7	.	.	O	.	_	0	SENT_389	[p18l49t3698r299b3738],

1	20	CD	NUMBER	20	_	0	SENT_390	[p18l48t3769r114b3808],
2	.	.	O	.	_	0	SENT_390	[p18l48t3769r114b3808],

1	Azam	NNP	PERSON	Azam	nn	2	SENT_391	[p18l142t3768r277b3807],
2	M	NNP	PERSON	M	_	0	SENT_391	[p18l296t3768r356b3817],
3	,	,	O	,	_	0	SENT_391	[p18l296t3768r356b3817],
4	Latek	NNP	ORGANIZATION	Latek	nn	5	SENT_391	[p18l379t3764r506b3808],
5	RR	NNP	ORGANIZATION	RR	appos	2	SENT_391	[p18l524t3768r607b3817],
6	,	,	O	,	_	0	SENT_391	[p18l524t3768r607b3817],
7	Daley	NNP	PERSON	Daley	nn	8	SENT_391	[p18l630t3764r760b3819],
8	GQ	NNP	O	GQ	appos	5	SENT_391	[p18l778t3767r869b3818],
9	.	.	O	.	_	0	SENT_391	[p18l778t3767r869b3818],

1	Mechaence	NN	O	mechaence	_	0	SENT_392	[p18l891t3764r1064b3807, p18l1138t2939r1242b2968],

1	2004	CD	DATE	2004	_	0	SENT_393	[p18l1256t2928r1697b2977],
2	;	:	O	;	_	0	SENT_393	[p18l1256t2928r1697b2977],
3	305:399	CD	NUMBER	305:399	number	4	SENT_393	[p18l1256t2928r1697b2977],
4	-401	CD	NUMBER	-401	dep	1	SENT_393	[p18l1256t2928r1697b2977],
5	.	.	O	.	_	0	SENT_393	[p18l1256t2928r1697b2977],

1	22	CD	NUMBER	22	_	0	SENT_394	[p18l1137t3000r1203b3037],
2	.	.	O	.	_	0	SENT_394	[p18l1137t3000r1203b3037],

1	Blencke	NNP	O	Blencke	nn	2	SENT_395	[p18l1232t2994r1415b3038],
2	S	NNP	O	S	nsubj	19	SENT_395	[p18l1432t2997r1470b3047],
3	,	,	O	,	_	0	SENT_395	[p18l1432t2997r1470b3047],
4	Ullrich	NNP	PERSON	Ullrich	nn	5	SENT_395	[p18l1488t2994r1649b3038],
5	A	NNP	O	A	appos	2	SENT_395	[p18l1662t2998r1710b3047],
6	,	,	O	,	_	0	SENT_395	[p18l1662t2998r1710b3047],
7	Daub	NNP	PERSON	Daub	nn	9	SENT_395	[p18l1728t2994r1851b3038],
8	H.	NNP	O	H.	nn	9	SENT_395	[p18l1867t2998r1921b3038],
9	Mutation	NN	O	mutation	appos	2	SENT_395	[p18l1938t2995r2153b3038],
10	of	IN	O	of	_	0	SENT_395	[p18l1138t3064r1193b3108],
11	threonine	NN	O	threonine	prep_of	9	SENT_395	[p18l1207t3064r1433b3108],
12	766	CD	NUMBER	766	num	11	SENT_395	[p18l1457t3068r1542b3108],
13	in	IN	O	in	_	0	SENT_395	[p18l1565t3065r1610b3107],
14	the	DT	O	the	det	18	SENT_395	[p18l1634t3064r1705b3108],
15	epidermal	JJ	O	epidermal	amod	18	SENT_395	[p18l1729t3064r1964b3120],
16	growth	NN	O	growth	nn	18	SENT_395	[p18l1987t3064r2154b3120],
17	factor	NN	O	factor	nn	18	SENT_395	[p18l1138t3134r1274b3178],
18	receptor	NN	O	receptor	prep_in	11	SENT_395	[p18l1295t3143r1489b3190],
19	reveals	VBZ	O	reveal	_	0	SENT_395	[p18l1510t3134r1667b3178],
20	a	DT	O	a	det	21	SENT_395	[p18l1691t3149r1715b3178],
21	hotspot	NN	O	hotspot	dobj	19	SENT_395	[p18l1737t3134r1919b3190],
22	for	IN	O	for	_	0	SENT_395	[p18l1939t3134r2007b3178],
23	resistance	NN	O	resistance	nn	24	SENT_395	[p18l2028t3135r2153b3178, p18l1138t3213r1261b3248],
24	formation	NN	O	formation	prep_for	21	SENT_395	[p18l1290t3204r1524b3248],
25	against	IN	O	against	_	0	SENT_395	[p18l1552t3205r1722b3260],
26	selective	JJ	O	selective	amod	29	SENT_395	[p18l1748t3205r1940b3248],
27	tyrosine	NN	O	tyrosine	nn	29	SENT_395	[p18l1969t3205r2153b3260],
28	kinase	NN	O	kinase	nn	29	SENT_395	[p18l1138t3274r1287b3318],
29	inhibitors	NNS	O	inhibitor	prep_against	24	SENT_395	[p18l1315t3274r1558b3318],
30	.	.	O	.	_	0	SENT_395	[p18l1315t3274r1558b3318],

1	J	NNP	O	J	nn	3	SENT_396	[p18l1584t3278r1605b3325],
2	Biol	NNP	O	Biol	nn	3	SENT_396	[p18l1631t3274r1724b3318],
3	Chem	NNP	O	Chem	_	0	SENT_396	[p18l1753t3274r1891b3318],
4	2003	CD	DATE	2003	num	3	SENT_396	[p18l1920t3278r2151b3327],
5	;	:	O	;	_	0	SENT_396	[p18l1920t3278r2151b3327],
6	278	CD	NUMBER	278	num	8	SENT_396	[p18l1920t3278r2151b3327],
7	:	:	O	:	_	0	SENT_396	[p18l1920t3278r2151b3327],
8	15435-40	CD	NUMBER	15435-40	dep	3	SENT_396	[p18l1140t3348r1371b3388],
9	.	.	O	.	_	0	SENT_396	[p18l1140t3348r1371b3388],

1	23	CD	NUMBER	23	_	0	SENT_397	[p18l1137t3419r1203b3458],
2	.	.	O	.	_	0	SENT_397	[p18l1137t3419r1203b3458],

1	Albanell	NNP	PERSON	Albanell	nn	2	SENT_398	[p18l1231t3414r1425b3458],
2	J	NNP	PERSON	J	_	0	SENT_398	[p18l1448t3418r1480b3467],
3	,	,	O	,	_	0	SENT_398	[p18l1448t3418r1480b3467],
4	Rojo	NNP	PERSON	Rojo	nn	5	SENT_398	[p18l1511t3415r1617b3469],
5	F	NN	O	f	appos	2	SENT_398	[p18l1646t3418r1680b3467],
6	,	,	O	,	_	0	SENT_398	[p18l1646t3418r1680b3467],
7	Averbuch	NNP	PERSON	Averbuch	nn	8	SENT_398	[p18l1710t3414r1931b3458],
8	S	NNP	O	S	appos	2	SENT_398	[p18l1961t3418r1999b3467],
9	,	,	O	,	_	0	SENT_398	[p18l1961t3418r1999b3467],
10	et	FW	O	et	nn	11	SENT_398	[p18l2031t3423r2073b3457],
11	al.	FW	O	al.	appos	2	SENT_398	[p18l2098t3414r2150b3458],
12	.	.	O	.	_	0	SENT_398	[p18l2098t3414r2150b3458],

1	Pharmacodynamic	JJ	MISC	pharmacodynamic	amod	2	SENT_399	[p18l1137t3484r1572b3540],
2	studies	NNS	O	study	_	0	SENT_399	[p18l1589t3484r1751b3528],
3	of	IN	O	of	_	0	SENT_399	[p18l1769t3484r1824b3528],
4	the	DT	O	the	det	10	SENT_399	[p18l1831t3485r1902b3528],
5	epidermal	JJ	O	epidermal	amod	10	SENT_399	[p18l1920t3484r2154b3540],
6	growth	NN	O	growth	nn	10	SENT_399	[p18l1138t3554r1305b3610],
7	factor	NN	O	factor	nn	10	SENT_399	[p18l1323t3554r1458b3598],
8	receptor	NN	O	receptor	nn	10	SENT_399	[p18l1474t3563r1668b3610],
9	inhibitor	NN	O	inhibitor	nn	10	SENT_399	[p18l1683t3554r1890b3598],
10	ZD1839	NN	O	zd1839	prep_of	2	SENT_399	[p18l1905t3558r2091b3598],
11	in	IN	O	in	_	0	SENT_399	[p18l2109t3555r2154b3597],
12	skin	NN	O	skin	prep_in	10	SENT_399	[p18l1139t3624r1236b3668],
13	from	IN	O	from	_	0	SENT_399	[p18l1257t3624r1371b3668],
14	cancer	NN	O	cancer	nn	15	SENT_399	[p18l1394t3639r1545b3668],
15	patients	NNS	O	patient	prep_from	12	SENT_399	[p18l1564t3625r1764b3680],
16	:	:	O	:	_	0	SENT_399	[p18l1564t3625r1764b3680],
17	histopathologic	JJ	O	histopathologic	amod	20	SENT_399	[p18l1787t3624r2154b3680],
18	and	CC	O	and	_	0	SENT_399	[p18l1137t3694r1223b3738],
19	molecular	JJ	O	molecular	conj_and	17	SENT_399	[p18l1238t3694r1472b3738],
20	consequences	NNS	O	consequence	dep	2	SENT_399	[p18l1485t3708r1809b3750],
21	of	IN	O	of	_	0	SENT_399	[p18l1824t3694r1880b3738],
22	receptor	NN	O	receptor	nn	23	SENT_399	[p18l1884t3703r2078b3750],
23	inhibition	NN	O	inhibition	prep_of	20	SENT_399	[p18l2090t3695r2153b3737, p18l1138t3764r1335b3808],
24	.	.	O	.	_	0	SENT_399	[p18l2090t3695r2153b3737, p18l1138t3764r1335b3808],

1	J	NNP	O	J	nn	3	SENT_400	[p18l1346t3768r1367b3814],
2	Clin	NNP	O	Clin	nn	3	SENT_400	[p18l1379t3764r1475b3808],
3	Oncol	NNP	O	Oncol	_	0	SENT_400	[p18l1489t3765r1629b3808],
4	2002	CD	DATE	2002	num	3	SENT_400	[p18l1642t3768r2024b3817],
5	;	:	O	;	_	0	SENT_400	[p18l1642t3768r2024b3817],
6	20:110	CD	NUMBER	20:110	number	7	SENT_400	[p18l1642t3768r2024b3817],
7	-24	CD	NUMBER	-24	dep	3	SENT_400	[p18l1642t3768r2024b3817],
8	.	.	O	.	_	0	SENT_400	[p18l1642t3768r2024b3817],

1	nisms	NNS	O	nism	_	0	SENT_401	[p19l49t15r188b58],
2	Of	IN	O	of	_	0	SENT_401	[p19l215t14r270b58],
3	autoinhibition	NN	O	autoinhibition	prep_of	1	SENT_401	[p19l285t14r620b58],
4	and	CC	O	and	_	0	SENT_401	[p19l646t14r731b58],
5	STI-571lima	NN	O	sti-571lima	prep_of	1	SENT_401	[p19l758t15r1064b64],
6	-	:	O	-	_	0	SENT_401	[p19l758t15r1064b64],
7	Copyright	NN	O	copyright	nn	12	SENT_401	[p19l1139t21r1315b69],
8	©	CD	NUMBER	©	num	12	SENT_401	[p19l1330t25r1369b65],
9	2005	CD	DATE	2005	num	12	SENT_401	[p19l1387t24r1479b58],
10	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	12	SENT_401	[p19l1494t21r1760b57],
11	Medical	NNP	ORGANIZATION	Medical	nn	12	SENT_401	[p19l1775t21r1920b58],
12	Society	NNP	ORGANIZATION	Society	dep	1	SENT_401	[p19l1933t23r2067b68],
13	.	.	O	.	_	0	SENT_401	[p19l1933t23r2067b68],

1	tinib	NN	O	tinib	nn	2	SENT_402	[p19l49t85r156b128],
2	resistance	NN	O	resistance	nsubj	3	SENT_402	[p19l175t85r408b128],
3	revealed	VBN	O	reveal	_	0	SENT_402	[p19l427t84r616b128],
4	by	IN	O	by	_	0	SENT_402	[p19l635t84r689b140],
5	mutagenesis	NN	O	mutagenesis	prep_by	3	SENT_402	[p19l705t85r999b140],
6	of	IN	O	of	_	0	SENT_402	[p19l1019t84r1075b128],
7	BCR-ABL	NN	O	bcr-abl	prep_of	5	SENT_402	[p19l49t158r278b200],
8	.	.	O	.	_	0	SENT_402	[p19l49t158r278b200],

1	Cell	NN	O	cell	_	0	SENT_403	[p19l295t154r384b198],
2	2003	CD	DATE	2003	num	1	SENT_403	[p19l398t158r809b207],
3	;	:	O	;	_	0	SENT_403	[p19l398t158r809b207],
4	112:831	CD	NUMBER	112:831	number	5	SENT_403	[p19l398t158r809b207],
5	-43	CD	NUMBER	-43	dep	1	SENT_403	[p19l398t158r809b207],
6	.	.	O	.	_	0	SENT_403	[p19l398t158r809b207],

1	21	CD	NUMBER	21	_	0	SENT_404	[p19l48t230r114b267],
2	.	.	O	.	_	0	SENT_404	[p19l48t230r114b267],

1	Shah	NNP	O	Shah	nn	2	SENT_405	[p19l145t224r259b268],
2	NP	NNP	ORGANIZATION	NP	_	0	SENT_405	[p19l273t228r350b277],
3	,	,	O	,	_	0	SENT_405	[p19l273t228r350b277],
4	Tran	NNP	PERSON	Tran	nn	5	SENT_405	[p19l366t228r474b267],
5	C	NNP	PERSON	C	appos	2	SENT_405	[p19l489t227r535b277],
6	,	,	O	,	_	0	SENT_405	[p19l489t227r535b277],
7	Lee	NNP	PERSON	Lee	nn	8	SENT_405	[p19l552t228r629b267],
8	FY	NNP	O	FY	appos	2	SENT_405	[p19l643t228r709b277],
9	,	,	O	,	_	0	SENT_405	[p19l643t228r709b277],
10	Chen	NNP	PERSON	Chen	nn	11	SENT_405	[p19l726t224r848b268],
11	P	NN	PERSON	p	appos	2	SENT_405	[p19l862t228r897b277],
12	,	,	O	,	_	0	SENT_405	[p19l862t228r897b277],
13	Norris	NNP	PERSON	Norris	appos	2	SENT_405	[p19l914t225r1064b268],

1	FULL	JJ	O	full	amod	2	SENT_406	[p19l785t462r847b479],
2	TEXT	NN	O	text	_	0	SENT_406	[p19l858t462r920b479],
3	OF	IN	O	of	_	0	SENT_406	[p19l931t462r966b479],
4	ALL	NN	O	all	nn	5	SENT_406	[p19l978t462r1022b479],
5	JOURNAL	NN	O	journal	prep_of	2	SENT_406	[p19l1029t462r1155b485],
6	ARTICLES	VBZ	O	article	rcmod	2	SENT_406	[p19l1167t462r1287b479],
7	ON	IN	O	on	_	0	SENT_406	[p19l1300t462r1339b479],
8	THE	DT	O	the	det	11	SENT_406	[p19l1353t463r1405b479],
9	WORLD	NN	O	world	nn	11	SENT_406	[p19l1417t462r1513b479],
10	WIDE	NN	O	wide	nn	11	SENT_406	[p19l1525t462r1594b479],
11	WEB	NN	O	web	prep_on	2	SENT_406	[p19l1606t463r1661b479],

1	Access	NN	O	access	nsubj	12	SENT_407	[p19l416t516r500b537],
2	to	TO	O	to	_	0	SENT_407	[p19l509t519r533b537],
3	the	DT	O	the	det	5	SENT_407	[p19l542t514r580b537],
4	complete	JJ	O	complete	amod	5	SENT_407	[p19l589t514r704b543],
5	text	NN	O	text	prep_to	1	SENT_407	[p19l713t518r759b537],
6	of	IN	O	of	_	0	SENT_407	[p19l766t513r796b537],
7	thejaumal	NN	O	thejaumal	prep_of	5	SENT_407	[p19l799t514r927b543],
8	on	IN	O	on	_	0	SENT_407	[p19l935t521r967b537],
9	the	DT	O	the	det	10	SENT_407	[p19l975t514r1014b537],
10	Internet	NN	MISC	internet	prep_on	7	SENT_407	[p19l1022t516r1123b537],
11	is	VBZ	O	be	cop	12	SENT_407	[p19l1130t514r1149b537],
12	free	JJ	O	free	_	0	SENT_407	[p19l1158t513r1205b537],
13	to	TO	O	to	_	0	SENT_407	[p19l1214t518r1238b537],
14	all	DT	O	all	det	15	SENT_407	[p19l1246t514r1276b536],
15	subscribers	NNS	O	subscriber	prep_to	12	SENT_407	[p19l1285t514r1435b537],
16	.	.	O	.	_	0	SENT_407	[p19l1285t514r1435b537],

1	To	TO	O	to	aux	2	SENT_408	[p19l1445t515r1475b537],
2	use	VB	O	use	purpcl	9	SENT_408	[p19l1484t521r1525b537],
3	this	DT	O	this	det	5	SENT_408	[p19l1534t514r1579b537],
4	Web	NN	O	web	nn	5	SENT_408	[p19l1587t514r1643b537],
5	site	NN	O	site	dobj	2	SENT_408	[p19l1652t514r1702b541],
6	,	,	O	,	_	0	SENT_408	[p19l1652t514r1702b541],
7	subscribers	NNS	O	subscriber	nsubj	9	SENT_408	[p19l1712t514r1855b537],
8	should	MD	O	should	aux	9	SENT_408	[p19l1865t514r1950b537],
9	go	VB	O	go	_	0	SENT_408	[p19l1958t521r1989b543],
10	to	TO	O	to	_	0	SENT_408	[p19l1998t518r2021b537],
11	the	DT	O	the	det	12	SENT_408	[p19l417t553r564b582],
12	]	NN	O	]	poss	19	SENT_408	[p19l417t553r564b582],
13	oumal	JJ	O	oumal	amod	12	SENT_408	[p19l417t553r564b582],
14	’s	POS	O	’s	_	0	SENT_408	[p19l417t553r564b582],
15	home	NN	O	home	nn	19	SENT_408	[p19l574t553r645b576],
16	page	NN	O	page	nn	19	SENT_408	[p19l654t561r713b583],
17	(	CD	NUMBER	(	num	19	SENT_408	[p19l724t553r933b583],
18	www.nejm.org	NN	O	www.nejm.org	nn	19	SENT_408	[p19l724t553r933b583],
19	)	NN	O	)	prep_to	9	SENT_408	[p19l724t553r933b583],
20	and	CC	O	and	_	0	SENT_408	[p19l944t553r990b576],
21	register	NN	O	register	conj_and	19	SENT_408	[p19l999t553r1095b583],
22	by	IN	O	by	_	0	SENT_408	[p19l1104t553r1133b582],
23	entering	VBG	O	enter	prepc_by	9	SENT_408	[p19l1141t553r1247b583],
24	their	PRP$	O	they	poss	25	SENT_408	[p19l1255t553r1314b576],
25	names	NNS	O	name	dobj	23	SENT_408	[p19l1322t561r1403b576],
26	and	CC	O	and	_	0	SENT_408	[p19l1413t553r1459b576],
27	subscriber	NN	O	subscriber	nn	28	SENT_408	[p19l1469t553r1601b576],
28	numbers	NNS	O	number	conj_and	25	SENT_408	[p19l1609t553r1720b576],
29	as	IN	O	as	mark	31	SENT_408	[p19l1730t561r1755b576],
30	they	PRP	O	they	nsubj	31	SENT_408	[p19l1765t553r1817b582],
31	appear	VBP	O	appear	advcl	23	SENT_408	[p19l1825t561r1911b582],
32	on	IN	O	on	_	0	SENT_408	[p19l1919t561r1951b576],
33	their	PRP$	O	they	poss	35	SENT_408	[p19l1960t553r2019b576],
34	mailing	NN	O	mailing	nn	35	SENT_408	[p19l417t593r515b622],
35	labels	NNS	O	label	prep_on	31	SENT_408	[p19l522t593r602b616],
36	.	.	O	.	_	0	SENT_408	[p19l522t593r602b616],

1	After	IN	O	after	_	0	SENT_409	[p19l611t592r674b616],
2	this	DT	O	this	det	6	SENT_409	[p19l682t593r728b616],
3	one	CD	NUMBER	one	num	6	SENT_409	[p19l737t593r850b616],
4	—	NN	O	—	nn	6	SENT_409	[p19l737t593r850b616],
5	time	NN	O	time	nn	6	SENT_409	[p19l737t593r850b616],
6	registration	NN	O	registration	prep_after	10	SENT_409	[p19l859t593r1012b622],
7	,	,	O	,	_	0	SENT_409	[p19l859t593r1012b622],
8	subscribers	NNS	O	subscriber	nsubj	10	SENT_409	[p19l1023t593r1166b616],
9	can	MD	O	can	aux	10	SENT_409	[p19l1176t600r1218b616],
10	use	VB	O	use	_	0	SENT_409	[p19l1227t600r1268b616],
11	their	PRP$	O	they	poss	12	SENT_409	[p19l1277t593r1336b616],
12	passwords	NNS	O	password	dobj	10	SENT_409	[p19l1343t593r1476b622],
13	to	TO	O	to	aux	14	SENT_409	[p19l1486t598r1509b616],
14	log	VB	O	log	xcomp	10	SENT_409	[p19l1518t593r1559b622],
15	on	IN	O	on	dep	14	SENT_409	[p19l1566t600r1598b616],
16	for	IN	O	for	_	0	SENT_409	[p19l1607t592r1643b616],
17	electronic	JJ	O	electronic	amod	18	SENT_409	[p19l1651t593r1775b616],
18	access	NN	O	access	prep_for	14	SENT_409	[p19l1783t600r1861b616],
19	to	TO	O	to	_	0	SENT_409	[p19l1871t597r1894b616],
20	the	DT	O	the	det	22	SENT_409	[p19l1903t593r1942b616],
21	entire	JJ	O	entire	amod	22	SENT_409	[p19l1951t593r2022b616],
22	journal	NN	O	journal	prep_to	18	SENT_409	[p19l412t632r498b662],
23	from	IN	O	from	_	0	SENT_409	[p19l507t632r568b655],
24	any	DT	O	any	det	25	SENT_409	[p19l577t640r621b662],
25	computer	NN	O	computer	prep_from	14	SENT_409	[p19l629t637r751b662],
26	that	WDT	O	that	nsubjpass	28	SENT_409	[p19l760t632r809b655],
27	is	VBZ	O	be	auxpass	28	SENT_409	[p19l817t633r836b655],
28	connected	VBN	O	connect	rcmod	25	SENT_409	[p19l846t632r975b655],
29	to	TO	O	to	_	0	SENT_409	[p19l984t637r1008b655],
30	the	DT	O	the	det	31	SENT_409	[p19l1018t632r1056b655],
31	Internet	NN	MISC	internet	prep_to	28	SENT_409	[p19l1065t634r1172b655],
32	.	.	O	.	_	0	SENT_409	[p19l1065t634r1172b655],

1	Features	NNS	O	feature	nsubj	2	SENT_410	[p19l1183t634r1288b656],
2	include	VBP	O	include	_	0	SENT_410	[p19l1297t632r1390b655],
3	a	DT	O	a	det	4	SENT_410	[p19l1399t640r1412b655],
4	library	NN	O	library	dobj	2	SENT_410	[p19l1421t632r1503b662],
5	of	IN	O	of	_	0	SENT_410	[p19l1511t632r1541b655],
6	all	DT	O	all	det	7	SENT_410	[p19l1545t632r1574b655],
7	issues	NNS	O	issue	prep_of	4	SENT_410	[p19l1583t633r1658b656],
8	since	IN	O	since	_	0	SENT_410	[p19l1669t633r1732b655],
9	January	NNP	DATE	January	prep_since	7	SENT_410	[p19l1739t634r1836b662],
10	1993	CD	DATE	1993	num	9	SENT_410	[p19l1845t634r1904b655],
11	and	CC	O	and	_	0	SENT_410	[p19l1914t632r1960b655],
12	abstracts	NNS	O	abstract	prep_of	4	SENT_410	[p19l417t672r528b695],
13	since	IN	O	since	_	0	SENT_410	[p19l538t672r602b695],
14	January	NNP	DATE	January	prep_since	12	SENT_410	[p19l608t674r705b701],
15	1975	CD	DATE	1975	num	14	SENT_410	[p19l713t674r781b700],
16	,	,	O	,	_	0	SENT_410	[p19l713t674r781b700],
17	a	DT	O	a	det	20	SENT_410	[p19l791t680r804b695],
18	full-text	JJ	O	full-text	amod	20	SENT_410	[p19l813t672r913b695],
19	search	NN	O	search	nn	20	SENT_410	[p19l921t672r1001b695],
20	capacity	NN	O	capacity	dobj	2	SENT_410	[p19l1010t672r1115b701],
21	,	,	O	,	_	0	SENT_410	[p19l1010t672r1115b701],
22	and	CC	O	and	_	0	SENT_410	[p19l1125t672r1171b695],
23	a	DT	O	a	det	25	SENT_410	[p19l1180t680r1193b695],
24	personal	JJ	O	personal	amod	25	SENT_410	[p19l1201t672r1310b701],
25	archive	NN	O	archive	dobj	2	SENT_410	[p19l1318t672r1408b695],
26	for	IN	O	for	_	0	SENT_410	[p19l1417t672r1453b695],
27	saving	VBG	O	save	prepc_for	25	SENT_410	[p19l1462t672r1542b701],
28	articles	NNS	O	article	dobj	27	SENT_410	[p19l1550t672r1639b695],
29	and	CC	O	and	_	0	SENT_410	[p19l1648t672r1695b695],
30	search	NN	O	search	nn	31	SENT_410	[p19l1704t672r1784b695],
31	results	NNS	O	result	dobj	27	SENT_410	[p19l1793t672r1876b695],
32	of	IN	O	of	_	0	SENT_410	[p19l1885t672r1915b695],
33	interest	NN	O	interest	prep_of	28	SENT_410	[p19l1919t672r2020b695],
34	.	.	O	.	_	0	SENT_410	[p19l1919t672r2020b695],

1	All	DT	O	all	det	2	SENT_411	[p19l416t712r451b734],
2	articles	NNS	O	article	nsubjpass	5	SENT_411	[p19l459t712r546b734],
3	can	MD	O	can	aux	5	SENT_411	[p19l555t719r597b734],
4	be	VB	O	be	auxpass	5	SENT_411	[p19l605t712r633b735],
5	printed	VBN	O	print	_	0	SENT_411	[p19l641t711r731b741],
6	in	IN	O	in	_	0	SENT_411	[p19l739t712r763b734],
7	a	DT	O	a	det	8	SENT_411	[p19l771t719r784b734],
8	format	NN	O	format	prep_in	5	SENT_411	[p19l791t711r876b735],
9	that	WDT	O	that	nsubj	12	SENT_411	[p19l883t712r931b734],
10	is	VBZ	O	be	cop	12	SENT_411	[p19l938t712r957b734],
11	virtually	RB	O	virtually	advmod	12	SENT_411	[p19l965t712r1064b741],
12	identical	JJ	O	identical	rcmod	8	SENT_411	[p19l1071t712r1177b735],
13	to	TO	O	to	_	0	SENT_411	[p19l1185t716r1208b735],
14	that	DT	O	that	prep_to	12	SENT_411	[p19l1217t712r1265b734],
15	of	IN	O	of	_	0	SENT_411	[p19l1272t711r1301b735],
16	the	DT	O	the	det	18	SENT_411	[p19l1304t712r1342b734],
17	typeset	NN	O	typeset	nn	18	SENT_411	[p19l1350t716r1437b741],
18	pages	NNS	O	page	prep_of	14	SENT_411	[p19l1443t719r1521b741],
19	.	.	O	.	_	0	SENT_411	[p19l1443t719r1521b741],

1	Beginning	VBG	O	begin	prep	18	SENT_412	[p19l1530t712r1659b741],
2	six	CD	DURATION	six	num	3	SENT_412	[p19l1667t712r1701b734],
3	months	NNS	NUMBER	month	npadvmod	4	SENT_412	[p19l1708t712r1802b735],
4	after	IN	O	after	pcomp	1	SENT_412	[p19l1811t711r1867b734],
5	publication	NN	O	publication	pobj	4	SENT_412	[p19l1874t712r2021b741],
6	,	,	O	,	_	0	SENT_412	[p19l1874t712r2021b741],
7	the	DT	O	the	det	9	SENT_412	[p19l417t751r455b774],
8	ﬁ1ll	NN	O	ﬁ1ll	nn	9	SENT_412	[p19l464t751r504b774],
9	text	NN	O	text	nsubj	18	SENT_412	[p19l513t756r558b774],
10	of	IN	O	of	_	0	SENT_412	[p19l566t751r595b774],
11	all	DT	O	all	det	13	SENT_412	[p19l598t751r627b774],
12	Original	JJ	O	original	amod	13	SENT_412	[p19l636t751r737b781],
13	Articles	NNPS	O	Articles	prep_of	9	SENT_412	[p19l745t751r838b774],
14	and	CC	O	and	_	0	SENT_412	[p19l847t751r892b774],
15	Special	JJ	O	special	amod	16	SENT_412	[p19l902t751r988b780],
16	Articles	NNPS	O	Articles	conj_and	13	SENT_412	[p19l995t751r1088b774],
17	is	VBZ	O	be	cop	18	SENT_412	[p19l1097t751r1116b774],
18	available	JJ	O	available	_	0	SENT_412	[p19l1125t751r1231b774],
19	free	JJ	O	free	advmod	18	SENT_412	[p19l1240t751r1286b774],
20	to	TO	O	to	_	0	SENT_412	[p19l1295t756r1318b774],
21	nonsubscribers	NNS	O	nonsubscriber	prep_to	19	SENT_412	[p19l1327t751r1517b774],
22	who	WP	O	who	nsubj	24	SENT_412	[p19l1525t751r1578b774],
23	have	VBP	O	have	aux	24	SENT_412	[p19l1587t751r1642b774],
24	completed	VBN	O	complete	rcmod	21	SENT_412	[p19l1651t751r1780b780],
25	a	DT	O	a	det	27	SENT_412	[p19l1789t759r1802b774],
26	brief	JJ	O	brief	amod	27	SENT_412	[p19l1810t751r1872b774],
27	registration	NN	O	registration	dobj	24	SENT_412	[p19l1875t751r2024b781],
28	.	.	O	.	_	0	SENT_412	[p19l1875t751r2024b781],

1	792	CD	NUMBER	792	num	2	SENT_413	[p19l92t898r149b920],
2	N	NN	O	n	_	0	SENT_413	[p19l823t899r837b915],
3	ENG	NNP	O	ENG	nn	6	SENT_413	[p19l852t899r901b915],
4	L	NNP	O	L	nn	6	SENT_413	[p19l909t899r918b915],
5	J	NNP	O	J	nn	6	SENT_413	[p19l928t899r936b921],
6	MED	NNP	O	MED	dep	2	SENT_413	[p19l951t899r1004b915],
7	352	CD	NUMBER	352	num	6	SENT_413	[p19l1016t893r1082b921],
8	;	:	O	;	_	0	SENT_413	[p19l1016t893r1082b921],
9	8	CD	NUMBER	8	num	10	SENT_413	[p19l1016t893r1082b921],
10	WWW	NN	O	www	dep	2	SENT_413	[p19l1117t899r1211b915],
11	.	.	O	.	_	0	SENT_413	[p19l1117t899r1211b915],

1	N	NN	O	n	nn	2	SENT_414	[p19l1117t899r1211b915],
2	E	NN	O	e	_	0	SENT_414	[p19l1219t899r1237b921],
3	]	CD	NUMBER	]	dep	2	SENT_414	[p19l1219t899r1237b921],
4	M.ORG	NNP	O	M.ORG	nn	5	SENT_414	[p19l1245t899r1328b915],
5	FEBRUARY	NNP	DATE	FEBRUARY	dep	2	SENT_414	[p19l1367t899r1494b915],
6	24	CD	DATE	24	num	5	SENT_414	[p19l1507t899r1544b921],
7	,	,	O	,	_	0	SENT_414	[p19l1507t899r1544b921],
8	2oo5	CD	NUMBER	2oo5	num	5	SENT_414	[p19l1558t899r1621b921],

1	The	DT	O	the	det	4	SENT_415	[p19l879t932r930b956],
2	New	NNP	O	New	nn	4	SENT_415	[p19l939t933r1001b956],
3	England	NNP	O	England	nn	4	SENT_415	[p19l1010t932r1121b963],
4	Journal	NNP	O	Journal	_	0	SENT_415	[p19l1130t932r1227b956],
5	of	IN	O	of	_	0	SENT_415	[p19l1237t932r1266b956],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_415	[p19l1272t932r1397b956],

1	Downloaded	VBN	O	download	_	0	SENT_416	[p19l321t973r491b996],
2	from	IN	O	from	_	0	SENT_416	[p19l500t973r564b996],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_416	[p19l573t973r691b1003],
4	at	IN	O	at	_	0	SENT_416	[p19l701t977r725b996],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_416	[p19l733t973r916b996],
6	on	IN	O	on	_	0	SENT_416	[p19l925t980r957b996],
7	January	NNP	DATE	January	prep_on	1	SENT_416	[p19l966t973r1069b1003],
8	5	CD	DATE	5	num	7	SENT_416	[p19l1079t973r1101b1001],
9	,	,	DATE	,	_	0	SENT_416	[p19l1079t973r1101b1001],
10	2014	CD	DATE	2014	num	7	SENT_416	[p19l1112t973r1184b996],
11	.	.	O	.	_	0	SENT_416	[p19l1112t973r1184b996],

1	For	IN	O	for	_	0	SENT_417	[p19l1195t973r1241b996],
2	personal	JJ	O	personal	amod	3	SENT_417	[p19l1249t973r1362b1003],
3	use	NN	O	use	pobj	1	SENT_417	[p19l1371t980r1414b996],
4	only	RB	O	only	advmod	3	SENT_417	[p19l1424t973r1489b1003],
5	.	.	O	.	_	0	SENT_417	[p19l1424t973r1489b1003],

1	No	DT	O	no	det	3	SENT_418	[p19l1499t973r1539b996],
2	other	JJ	O	other	amod	3	SENT_418	[p19l1549t973r1617b996],
3	uses	NNS	O	use	_	0	SENT_418	[p19l1626t980r1681b996],
4	without	IN	O	without	_	0	SENT_418	[p19l1692t973r1793b996],
5	permission	NN	O	permission	prep_without	3	SENT_418	[p19l1801t973r1954b1003],
6	.	.	O	.	_	0	SENT_418	[p19l1801t973r1954b1003],

1	Copyright	NN	O	copyright	_	0	SENT_419	[p19l671t1014r806b1045],
2	©	CD	NUMBER	©	num	6	SENT_419	[p19l815t1014r838b1038],
3	2005	CD	DATE	2005	num	6	SENT_419	[p19l849t1014r913b1038],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_419	[p19l923t1014r1114b1038],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_419	[p19l1124t1014r1232b1038],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_419	[p19l1242t1014r1347b1045],
7	.	.	O	.	_	0	SENT_419	[p19l1242t1014r1347b1045],

1	All	DT	O	all	det	2	SENT_420	[p19l1358t1014r1400b1038],
2	rights	NNS	O	rights	nsubj	3	SENT_420	[p19l1409t1014r1484b1045],
3	reserved	VBN	O	reserve	_	0	SENT_420	[p19l1493t1014r1612b1038],
4	.	.	O	.	_	0	SENT_420	[p19l1493t1014r1612b1038],

